{"id":24818,"date":"2025-11-21T16:04:01","date_gmt":"2025-11-21T15:04:01","guid":{"rendered":"https:\/\/jegharkraeft.dk\/?p=24818"},"modified":"2025-11-30T15:32:15","modified_gmt":"2025-11-30T14:32:15","slug":"tarmkraeft-metabolisk-blokering","status":"publish","type":"post","link":"https:\/\/jegharkraeft.dk\/en\/tarmkraeft-metabolisk-blokering\/","title":{"rendered":"Tarmkr\u00e6ft. Tyktarmskr\u00e6ft. Endetarmskr\u00e6ft. Adenokarcinom. MSS. MSI-High. KRAS-mutation. BRAF-mutation. PIK3CA-mutation. Mucin\u00f8s karcinom. Signetringscellekr\u00e6ft. H\u00f8jresidig tarmkr\u00e6ft. Venstresidig tarmkr\u00e6ft. Metastatisk tarmkr\u00e6ft. Metabolisk blokering"},"content":{"rendered":"\n<div class=\"wp-block-group alignfull is-style-section-5 has-contrast-color has-base-background-color has-text-color has-background has-link-color wp-elements-7da191ee511188f273ca8ff36c5ed5d4 has-global-padding is-layout-constrained wp-block-group-is-layout-constrained is-style-section-5--2\" id=\"menu\" style=\"margin-top:0;margin-bottom:0;padding-top:var(--wp--preset--spacing--50);padding-bottom:var(--wp--preset--spacing--50)\">\n<div class=\"wp-block-columns alignwide is-layout-flex wp-container-core-columns-is-layout-ca2dd60b wp-block-columns-is-layout-flex\">\n<div class=\"wp-block-column is-layout-flow wp-block-column-is-layout-flow\">\n<h2 class=\"wp-block-heading has-custom-int-link-p-sort-1-color has-text-color has-link-color wp-elements-7dcb782fe06e372bd968f4bf90d58c0a\"><span class=\"ez-toc-section\" id=\"Behandlinger\"><\/span><a href=\"https:\/\/jegharkraeft.dk\/kraeft-behandlinger\">Behandlinger <\/a><span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<div class=\"wp-block-group has-custom-interne-links-color has-text-color has-link-color wp-elements-6fcd9f9e829dac26d3d28b8c96e6a84a has-global-padding is-layout-constrained wp-block-group-is-layout-constrained\">\n<h4 class=\"wp-block-heading has-custom-int-link-p-sort-1-color has-text-color has-link-color wp-elements-464fa8703829e995355c4a8410e746b1\"><a href=\"https:\/\/jegharkraeft.dk\/metabolisk\">Bloker kr\u00e6ftens v\u00e6kstveje<\/a><\/h4>\n\n\n\n<ul class=\"wp-block-list\">\n<li class=\"has-custom-int-link-p-sort-1-color has-text-color has-link-color wp-elements-3518050879f43288ecab16b054f2d356\"><a href=\"https:\/\/jegharkraeft.dk\/ingen-medicin-plan-b\/\">Ingen medicin &#8211; Plan B<\/a><\/li>\n\n\n\n<li class=\"has-custom-int-link-p-sort-1-color has-text-color has-link-color wp-elements-508a525ce225066d7a7f50de78307fb8\"><a href=\"https:\/\/jegharkraeft.dk\/metabolisk\">Kr\u00e6ft som metabolisk lidelse<\/a><\/li>\n\n\n\n<li class=\"has-custom-int-link-p-sort-1-color has-text-color has-link-color wp-elements-de45ce73f572fc32d0aa2754927f2b14\"><a href=\"https:\/\/jegharkraeft.dk\/metaboliske-principper-kraeftbehandling\/\">Metaboliske principper i kr\u00e6ftforskning<\/a><\/li>\n\n\n\n<li class=\"has-custom-hvid-tekst-color has-text-color has-link-color wp-elements-f294b5ef7ad7074cf94bb3decbb110ff\"><a href=\"https:\/\/jegharkraeft.dk\/metabolisk-strategi\/\">Metabolisk strategi \u2013 bloker signalveje efter kr\u00e6fttype \u2013 skema-oversigter<\/a>\n<ul class=\"wp-block-list\">\n<li><a href=\"https:\/\/jegharkraeft.dk\/metabolisk-blodkraeft\/\">Kr\u00e6ftformer &#8211; Skema\/ Oversigt<\/a>\n<ul class=\"wp-block-list\">\n<li class=\"has-custom-int-link-p-sort-1-color has-text-color has-link-color wp-elements-0f7045a29bb7f5e1edbf4bffada7c476\"><a href=\"https:\/\/jegharkraeft.dk\/metabolisk-blodkraeft\/\">Blodkr\u00e6ft, Leuk\u00e6mi <\/a><\/li>\n\n\n\n<li class=\"has-custom-int-link-p-sort-1-color has-text-color has-link-color wp-elements-20f56ccab03964097e3db39e17c24350\"><a href=\"\/metabolisk-brystkraeft\">Brystkr\u00e6ft<\/a><\/li>\n\n\n\n<li class=\"has-custom-int-link-p-sort-1-color has-text-color has-link-color wp-elements-505814121f65a57e936f1a514a1ef5dd\"><a href=\"https:\/\/jegharkraeft.dk\/metabolisk-bugspytkirtelkraeft\/\">Bugspytkirtelkr\u00e6ft<\/a><\/li>\n\n\n\n<li class=\"has-custom-int-link-p-sort-1-color has-text-color has-link-color wp-elements-04f18a35d7544a3fcf881a2775847324\"><a href=\"\/metabolisk-gynaekologiske-kraeftformer\">Gyn\u00e6kologiske kr\u00e6ftformer<\/a><\/li>\n\n\n\n<li class=\"has-custom-int-link-p-sort-1-color has-text-color has-link-color wp-elements-f5f4d33e4f0200dee305b72cb7be8554\"><a href=\"https:\/\/jegharkraeft.dk\/metabolisk-glioblastom\/\">Hjernekr\u00e6ft<\/a><\/li>\n\n\n\n<li class=\"has-custom-int-link-p-sort-1-color has-text-color has-link-color wp-elements-3606886fc07d1008755cec8ea2c945f5\"><a href=\"https:\/\/jegharkraeft.dk\/metabolisk-hovedkraeft\/\">Hoved- halskr\u00e6ft og \u00f8jenkr\u00e6ft<\/a><\/li>\n\n\n\n<li class=\"has-custom-int-link-p-sort-1-color has-text-color has-link-color wp-elements-d56a8daa4d9c28959e7f04852628fecb\"><a href=\"https:\/\/jegharkraeft.dk\/metabolisk-hudkraeft\/\">Hudkr\u00e6ft og moderm\u00e6rkekr\u00e6ft<\/a><\/li>\n\n\n\n<li class=\"has-custom-int-link-p-sort-1-color has-text-color has-link-color wp-elements-8fd5903d295b7333bac8db67ca610261\"><a href=\"\/metabolisk-knoglekraeft\">Knoglekr\u00e6ft<\/a><\/li>\n\n\n\n<li class=\"has-custom-int-link-p-sort-1-color has-text-color has-link-color wp-elements-549e364f5cc941c8b804fef2823f69ca\"><a href=\"https:\/\/jegharkraeft.dk\/leverkraeft-metabolisk\/\">Leverkr\u00e6ft<\/a><\/li>\n\n\n\n<li class=\"has-custom-int-link-p-sort-1-color has-text-color has-link-color wp-elements-a7deb747feb103b3d510e4c84d5e3b05\"><a href=\"\/metabolisk-lungekraeft\">Lungekr\u00e6ft<\/a><\/li>\n\n\n\n<li class=\"has-custom-int-link-p-sort-1-color has-text-color has-link-color wp-elements-2d0a0c90f3a3164392c181ca19dc9b3b\"><a href=\"https:\/\/jegharkraeft.dk\/metabolisk-mave-tarmkraeft\/\"><mark style=\"background-color:rgba(0, 0, 0, 0)\" class=\"has-inline-color has-custom-hvid-tekst-color\">Mave- Tarmkr\u00e6ft<\/mark><\/a>\n<ul class=\"wp-block-list\">\n<li class=\"has-custom-int-link-p-sort-1-color has-text-color has-link-color wp-elements-3c7a8d4cc1bdc25a5bbadb028b26f3f7\"><a href=\"https:\/\/jegharkraeft.dk\/analkraeft-bloker-pathways\/\">Analkr\u00e6ft<\/a><\/li>\n\n\n\n<li class=\"has-custom-int-link-p-sort-1-color has-text-color has-link-color wp-elements-922a7c802ea9a08e9fb74de49ec904f6\"><a href=\"https:\/\/jegharkraeft.dk\/endetarmskraeft-bloker-pathways\/\">Endetarmskr\u00e6ft<\/a><\/li>\n\n\n\n<li class=\"has-custom-int-link-p-sort-1-color has-text-color has-link-color wp-elements-faeba29c12dd0ebd3b80c966101f3688\"><a href=\"https:\/\/jegharkraeft.dk\/metabolisk-mave-tarmkraeft\/\">Maves\u00e6kkr\u00e6ft<\/a><\/li>\n\n\n\n<li class=\"has-custom-int-link-p-sort-1-color has-text-color has-link-color wp-elements-7da51ceb12d9bae42498004b9365233b\"><a href=\"https:\/\/jegharkraeft.dk\/spiserorskraeft-bloker-pathways\/\">Spiser\u00f8rskr\u00e6ft<\/a><\/li>\n\n\n\n<li class=\"has-custom-her-st-r-du-color has-text-color has-link-color wp-elements-3a2875f9c97a8461b898f85b889cbf9f\"><a href=\"#metabolisk-tarmkraeft\">Tarmkr\u00e6ft (scroll ned)<\/a><\/li>\n<\/ul>\n<\/li>\n\n\n\n<li class=\"has-custom-int-link-p-sort-1-color has-text-color has-link-color wp-elements-4c886f8d37570355cd9d1eed20cd9082\"><a href=\"https:\/\/jegharkraeft.dk\/metabolsk-strategi-metaplastiske-kraeftformer\/\">Metaplastisk kr\u00e6ft<\/a><\/li>\n\n\n\n<li class=\"has-custom-int-link-p-sort-1-color has-text-color has-link-color wp-elements-e3d58abc6c05aff97f6bbdeae4e89662\"><a href=\"https:\/\/jegharkraeft.dk\/braf-mutation-metabolisk-strategi\/\">Mutationer<\/a><\/li>\n\n\n\n<li class=\"has-custom-int-link-p-sort-1-color has-text-color has-link-color wp-elements-d4483db4a0cfc74a3cb2706df49035bf\"><a href=\"https:\/\/jegharkraeft.dk\/metabolisk-nyrekraeft\/\"><\/a><a href=\"https:\/\/jegharkraeft.dk\/metabolisk-nyrekraeft\/\">Nyre- og urinvejskr\u00e6ft<\/a><\/li>\n\n\n\n<li class=\"has-custom-int-link-p-sort-1-color has-text-color has-link-color wp-elements-0833927134f074fb5945026b304c09cf\"><a href=\"\/metabolisk-prostatakraeft\">Prostatakr\u00e6ft<\/a><\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<\/li>\n\n\n\n<li class=\"has-custom-int-link-p-sort-1-color has-text-color has-link-color wp-elements-9055a0418dcb7daa7ea35a4803aef9ac\"><a href=\"https:\/\/jegharkraeft.dk\/kraeftens-signalveje\/\">Kr\u00e6ftens signalveje<\/a><\/li>\n\n\n\n<li class=\"has-custom-int-link-p-sort-1-color has-text-color has-link-color wp-elements-ab5c242351c577585810084d97780655\"><a href=\"https:\/\/jegharkraeft.dk\/kraeftens-energiveje\/\">Bloker kr\u00e6ftens energiveje<\/a><\/li>\n\n\n\n<li class=\"has-custom-int-link-p-sort-1-color has-text-color has-link-color wp-elements-8e60d8413cc37600b51788d4316fb09e\"><a href=\"https:\/\/jegharkraeft.dk\/medicin-logistik\/\">Medicin logistik<\/a><\/li>\n<\/ul>\n\n\n\n<div class=\"wp-block-buttons is-content-justification-left is-layout-flex wp-container-core-buttons-is-layout-3b8eca09 wp-block-buttons-is-layout-flex\">\n<div class=\"wp-block-button\"><a class=\"wp-block-button__link has-custom-hvid-tekst-color has-custom-bl-baggrund-background-color has-text-color has-background has-link-color wp-element-button\" href=\"https:\/\/www.facebook.com\/groups\/1276867696609057\" target=\"_blank\" rel=\"noopener\">bliv medlem af  fb-gruppen<\/a><\/div>\n<\/div>\n<\/div>\n<\/div>\n\n\n\n<div class=\"wp-block-column is-vertically-aligned-center is-layout-flow wp-block-column-is-layout-flow\" style=\"flex-basis:50%\">\n<figure class=\"wp-block-image aligncenter size-full is-resized\"><img loading=\"lazy\" decoding=\"async\" width=\"1280\" height=\"675\" src=\"https:\/\/jegharkraeft.dk\/wp-content\/uploads\/2025\/11\/Tarmkraeft-Metabolisk-blokering.jpg\" alt=\"Tarmkr\u00e6ft - Metabolisk blokering symboliseret ved r\u00f8dt indkig i en tarm med fimerh\u00e5r.\" class=\"wp-image-24821\" style=\"aspect-ratio:3\/2;object-fit:cover;width:550px\" srcset=\"https:\/\/jegharkraeft.dk\/wp-content\/uploads\/2025\/11\/Tarmkraeft-Metabolisk-blokering.jpg 1280w, https:\/\/jegharkraeft.dk\/wp-content\/uploads\/2025\/11\/Tarmkraeft-Metabolisk-blokering-600x316.jpg 600w, https:\/\/jegharkraeft.dk\/wp-content\/uploads\/2025\/11\/Tarmkraeft-Metabolisk-blokering-300x158.jpg 300w, https:\/\/jegharkraeft.dk\/wp-content\/uploads\/2025\/11\/Tarmkraeft-Metabolisk-blokering-1024x540.jpg 1024w, https:\/\/jegharkraeft.dk\/wp-content\/uploads\/2025\/11\/Tarmkraeft-Metabolisk-blokering-768x405.jpg 768w\" sizes=\"auto, (max-width: 1280px) 100vw, 1280px\" \/><\/figure>\n<\/div>\n<\/div>\n<\/div>\n\n\n\n<div class=\"wp-block-group alignfull is-style-default has-global-padding is-layout-constrained wp-container-core-group-is-layout-b040ace0 wp-block-group-is-layout-constrained has-background\" style=\"margin-top:0;margin-bottom:0;padding-top:var(--wp--preset--spacing--60);padding-right:var(--wp--preset--spacing--20);padding-bottom:var(--wp--preset--spacing--60);padding-left:var(--wp--preset--spacing--20);background-image:url(&apos;https:\/\/jegharkraeft.dk\/wp-content\/uploads\/2025\/11\/Tarmkraeft-Metabolisk-blokering.jpg&apos;);background-size:cover;\">\n<div class=\"gb-element-906497af\">\n<h1 class=\"wp-block-heading\" id=\"metabolisk-tarmkraeft\"><span class=\"ez-toc-section\" id=\"Tarmkraeft_%E2%80%93_skemaoversigt_Metabolisk_strategi_mod_kraeft_%E2%80%93_Pathways_blokering\"><\/span>Tarmkr\u00e6ft &#8211; skemaoversigt<br>Metabolisk strategi mod kr\u00e6ft &#8211; Pathways blokering<span class=\"ez-toc-section-end\"><\/span><\/h1>\n\n\n\n<p class=\"has-custom-bl-links-color has-text-color has-link-color wp-elements-0282a336e93bc98a9ce931a7f37e739e wp-block-paragraph\"><strong>OBS.: For at se alt indhold i skemaet, skal der swipes\/scrolles til h\u00f8jre. (Der er desuden mange r\u00e6kker).<\/strong><\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Indhold:<\/strong><\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-30ce046fc0c9e5260a2df561b4e6c244\"><a href=\"#resume\"><strong>Kort resum\u00e9<\/strong><\/a><strong> (scroll ned)<\/strong><\/li>\n\n\n\n<li><a href=\"#1\">Tarmkr\u00e6ft &#8211; Skemaoversigt<\/a> (rul til)<\/li>\n\n\n\n<li><a href=\"#skema-01\">L\u00e6gemidler &#8211; Oversigt 1<\/a> (rul til)<\/li>\n\n\n\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-cb41309824d28f5ac24f6b6961578059\"><a href=\"#skema-02\">Kosttilskud &#8211; Oversigt 2<\/a> (rul til)<\/li>\n\n\n\n<li><a href=\"#links\">Links<\/a> (rul til)<\/li>\n<\/ul>\n\n\n\n<h4 class=\"wp-block-heading\" id=\"resume\">Kort resum\u00e9 om Metabolisk tilgang<\/h4>\n\n\n\n<p class=\"wp-block-paragraph\">Dette er en side, der giver overblik over hvilke strategier der kan v\u00e6re hensigtsm\u00e6ssige, hvis man vil udfordre kr\u00e6ftens metabolisme. <\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>V\u00e6rkt\u00f8jerne<\/strong><\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Her findes detaljerede oversigter over en r\u00e6kke kosttilskud og repurposed drugs (l\u00e6gemidler til andre form\u00e5l), som i forskningen unders\u00f8ges for netop disse effekter.<\/li>\n<\/ul>\n\n\n\n<figure class=\"wp-block-image size-thumbnail is-resized\"><img loading=\"lazy\" decoding=\"async\" width=\"150\" height=\"150\" src=\"https:\/\/jegharkraeft.dk\/wp-content\/uploads\/2025\/06\/Metabolisk-2a-150x150.jpg\" alt=\"Metaboliske strategier symboliseret ved nogle kr\u00e6fteller p\u00e5 kongebl\u00e5 baggrund. Man kan se hvordan deres forsyning blokeres ved gule og lysebl\u00e5 blokeringer der er sat ind som skiver. R\u00f8de linjer der illustrerer blodforsyning er ogs\u00e5 afbrudt.\" class=\"wp-image-13458\" style=\"width:auto;height:150px\" srcset=\"https:\/\/jegharkraeft.dk\/wp-content\/uploads\/2025\/06\/Metabolisk-2a-150x150.jpg 150w, https:\/\/jegharkraeft.dk\/wp-content\/uploads\/2025\/06\/Metabolisk-2a-300x300.jpg 300w, https:\/\/jegharkraeft.dk\/wp-content\/uploads\/2025\/06\/Metabolisk-2a-100x100.jpg 100w, https:\/\/jegharkraeft.dk\/wp-content\/uploads\/2025\/06\/Metabolisk-2a-600x600.jpg 600w, https:\/\/jegharkraeft.dk\/wp-content\/uploads\/2025\/06\/Metabolisk-2a-768x768.jpg 768w, https:\/\/jegharkraeft.dk\/wp-content\/uploads\/2025\/06\/Metabolisk-2a.jpg 1024w\" sizes=\"auto, (max-width: 150px) 100vw, 150px\" \/><\/figure>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Strategien &#8211; bloker kr\u00e6ftens signalveje (pathways<\/strong>)<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Kombination er afg\u00f8rende:<\/strong> Kr\u00e6ftceller har stor tilpasningsevne og kan ofte finde en &#8220;omvej&#8221;, hvis kun \u00e9n enkelt signalvej (pathway) blokeres. <br>Derfor er en central del af den metaboliske tilgang en &#8220;multi-target&#8221; strategi, hvor man kombinerer flere stoffer for at ramme kr\u00e6ftens s\u00e5rbarheder fra flere vinkler samtidigt.<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>S\u00e5dan er det bygget op<\/strong><\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Informationen er delt op i oversigt over de enkelte l\u00e6gemidler \/ kosttilskud og deres virkning, samt en r\u00e6kke oversigter for specifikke kr\u00e6fttyper, der viser, hvilke stoffer der kan v\u00e6re relevante ved disse.<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Form\u00e5let<\/strong><\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>At give vidensgrundlag til samtale med en kvalificeret behandler om supplerende behandlingsmuligheder \/ forebyggende tiltag.<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Vigtigt<\/strong><\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>For en dybere og n\u00f8dvendig forst\u00e5else af principperne bag metaboliske strategier mod kr\u00e6ft, anbefales det i h\u00f8j grad, at du l\u00e6se om dette her: <a href=\"https:\/\/jegharkraeft.dk\/metabolisk-strategi\/#metabolisk-tilgang\">Metabolisk strategi<\/a>.<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Det er ikke en guide til selvbehandling<\/strong><\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Faktorer som korrekt dosering, interaktioner med igangv\u00e6rende behandling, og uventede bivirkninger er reelle risici, der kr\u00e6ver overv\u00e5gning af en sundhedsfaglig person med indsigt i omr\u00e5det. Gerne en, der har erfaring med <a href=\"https:\/\/jegharkraeft.dk\/integrativ-onkologi\/\">integrativ onkologi<\/a>.<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">Se ogs\u00e5 <a href=\"https:\/\/jegharkraeft.dk\/kosttilskud-og-kemoterapi\/\">Kosttilskud og Kemoterapi &#8211; hvordan virker det<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Forts\u00e6ttes&#8230;<\/strong><a href=\"https:\/\/jegharkraeft.dk\/dr-vogl\"><\/a><\/p>\n\n\n\n<p class=\"has-custom-menu-links-color has-text-color has-link-color wp-elements-78958270cc4840b7bdca48105c79180e wp-block-paragraph\"><strong><a href=\"#menu\" data-type=\"internal\" data-id=\"#diagnose\">(Til menu)<\/a><\/strong><\/p>\n\n\n\n<p class=\"has-text-align-center wp-block-paragraph\"><mark style=\"background-color:rgba(0, 0, 0, 0)\" class=\"has-inline-color has-custom-menu-links-color\">\u2764<\/mark><\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Hvad du l\u00e6ser p\u00e5 <\/strong><em><strong>Jeg har Kr\u00e6ft<\/strong><\/em><strong> er ikke en anbefaling. S\u00f8g kompetent vejledning.<\/strong><\/p>\n<\/div>\n<\/div>\n\n\n\n<div class=\"wp-block-group alignfull is-style-default has-global-padding is-layout-constrained wp-container-core-group-is-layout-b040ace0 wp-block-group-is-layout-constrained has-background\" style=\"margin-top:0;margin-bottom:0;padding-top:var(--wp--preset--spacing--60);padding-right:var(--wp--preset--spacing--20);padding-bottom:var(--wp--preset--spacing--60);padding-left:var(--wp--preset--spacing--20);background-image:url(&apos;https:\/\/jegharkraeft.dk\/wp-content\/uploads\/2025\/11\/Tarmkraeft-Metabolisk-blokering.jpg&apos;);background-position:44% 36%;background-size:cover;\">\n<div class=\"gb-element-6d0ec837\">\n<h2 class=\"wp-block-heading\" id=\"1\"><span class=\"ez-toc-section\" id=\"Tarmkraeft_%E2%80%93_Oversigt\"><\/span>Tarmkr\u00e6ft &#8211; Oversigt<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Indhold:<\/strong><\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><a href=\"#resume\">Kort resum\u00e9<\/a> (scroll ned)<\/li>\n\n\n\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-e095cf1c49c2b83af2fc84fe1584e99f\"><strong><a href=\"#1\">Tarmkr\u00e6ft &#8211; Skemaoversigt<\/a> (scroll ned)<\/strong><\/li>\n\n\n\n<li><a href=\"#skema-01\">L\u00e6gemidler &#8211; Oversigt 1<\/a> (rul til)<\/li>\n\n\n\n<li><a href=\"#skema-02\">Kosttilskud &#8211; Oversigt 2<\/a> (rul til)<\/li>\n\n\n\n<li><a href=\"#links\">Links<\/a> (rul til)<\/li>\n<\/ul>\n\n\n\n<h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Metaboliske_strategier_ved_Tarmkraeft\"><\/span>Metaboliske strategier ved Tarmkr\u00e6ft<span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<figure class=\"wp-block-image size-thumbnail is-resized\"><img loading=\"lazy\" decoding=\"async\" width=\"150\" height=\"150\" src=\"https:\/\/jegharkraeft.dk\/wp-content\/uploads\/2025\/11\/Tarmkraeft-Metabolisk-blokering-150x150.jpg\" alt=\"Tarmkr\u00e6ft - Metabolisk blokering symboliseret ved r\u00f8dt indkig i en tarm med fimerh\u00e5r.\" class=\"wp-image-24821\" style=\"width:auto;height:150px\" srcset=\"https:\/\/jegharkraeft.dk\/wp-content\/uploads\/2025\/11\/Tarmkraeft-Metabolisk-blokering-150x150.jpg 150w, https:\/\/jegharkraeft.dk\/wp-content\/uploads\/2025\/11\/Tarmkraeft-Metabolisk-blokering-300x300.jpg 300w, https:\/\/jegharkraeft.dk\/wp-content\/uploads\/2025\/11\/Tarmkraeft-Metabolisk-blokering-100x100.jpg 100w\" sizes=\"auto, (max-width: 150px) 100vw, 150px\" \/><\/figure>\n\n\n\n<p class=\"wp-block-paragraph\">Find din kr\u00e6ftform under skemaet.<\/p>\n\n\n\n<h4 class=\"wp-block-heading\">\u26a0\ufe0f Skemaet er ikke en klinisk anbefaling<\/h4>\n\n\n\n<p class=\"wp-block-paragraph\">Denne oversigt er udarbejdet ud fra en samling af viden om virkemekanismer for udvalgte repurposed drugs og kosttilskud i forhold til kr\u00e6ftcellens s\u00e5rbarheder. Skemaet er&nbsp;<strong>ikke<\/strong>&nbsp;en liste over pr\u00e6parater, der skal tages samtidigt.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">V\u00e6r opm\u00e6rksom p\u00e5, at kr\u00e6ftceller har den uheldige evne, at de hurtigt finder nye forsyningsveje (energi- og signalveje\/ metaboliske omveje), hvis man kun blokerer en enkelt af disse. Derfor b\u00f8r man altid v\u00e6lge mindst 5 til 7 midler fra kategorierne (1) og (2) (Hovedstrategi og h\u00f8j relevans) \u2013 i samr\u00e5d med sin behandler.<\/p>\n\n\n\n<h4 class=\"wp-block-heading\">S\u00e5dan l\u00e6ses tabellerne<\/h4>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Styrken af virkning:<\/strong><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Hver note i tabellen forsynet med et prioriterings-tal i parentes. Dette tal er en vejledende rangering af, hvor relevant eller central den specifikke mekanisme er i netop denne sammenh\u00e6ng, baseret p\u00e5 den tilg\u00e6ngelige forskning.<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>(1) Hovedstrategi:<\/strong>&nbsp;De mest centrale og veldokumenterede stoffer for denne specifikke s\u00e5rbarhed.<\/li>\n\n\n\n<li><strong>(2) H\u00f8j relevans:<\/strong>&nbsp;Stoffer med st\u00e6rke data fra laboratoriefors\u00f8g, der rammer meget pr\u00e6cist.<\/li>\n\n\n\n<li><strong>(3) Underst\u00f8ttende relevans:<\/strong>&nbsp;Stoffer, der rammer en vigtig \u201cplan B\u201d eller st\u00f8ttemekanisme.<\/li>\n\n\n\n<li><strong>(4) Generel st\u00f8tte:<\/strong>&nbsp;Stoffer, der er gavnlige for kroppens generelle balance (f.eks. immunst\u00f8tte eller anti-inflammation).<\/li>\n\n\n\n<li><strong>(5) Teoretisk \/ manglende data:<\/strong>&nbsp;Stoffer, hvor koblingen er mere spekulativ, eller hvor der mangler specifik forskning.<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Uafh\u00e6ngige angrebsveje:<\/strong><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">For at sikre, at angrebet er flerstrenget, b\u00f8r man i sit valg v\u00e6lge mindst \u00e9t pr\u00e6parat fra hver af de f\u00f8lgende fem uafh\u00e6ngige strategiske grupper\/ koder:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>(A) Hovedmotor:<\/strong>&nbsp;Blokerer v\u00e6kstspeederen (PI3K\/Akt\/mTOR).<\/li>\n\n\n\n<li><strong>(B) Affaldssystem:<\/strong>&nbsp;Stopper genbrugsstationen (Autofagi).<\/li>\n\n\n\n<li><strong>(C) Fedtstof-Fabrikken:<\/strong>&nbsp;Blokerer byggesten til cellemembraner (Mevalonat-vejen).<\/li>\n\n\n\n<li><strong>(D) Bet\u00e6ndelses-Signalet:<\/strong>&nbsp;Slukker for kronisk bet\u00e6ndelse (NF-\u03baB\/STAT3).<\/li>\n\n\n\n<li><strong>(E) Celled\u00f8d via Stress:<\/strong>&nbsp;Dr\u00e6ber via oxidativt stress\/jernstress (Ferroptose).<\/li>\n<\/ul>\n\n\n\n<h4 class=\"wp-block-heading\">Vejledning til valg af kolonne<\/h4>\n\n\n\n<p class=\"wp-block-paragraph\">N\u00e5r man v\u00e6lger strategi for at blokere kr\u00e6ften, b\u00f8r man finde den kolonne i skemaet, der er mest relevant for ens situation. Her er kr\u00e6ftcellens biologiske type (f.eks. en specifik mutation eller en subtype som triple negativ brystkr\u00e6ft) den mest afg\u00f8rende faktor for valg af protokol\/ kolonne.<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Specifik type er n\u00e6vnt:<\/strong>&nbsp;Er din specifikke mutation eller subtype medtaget, b\u00f8r du fokusere p\u00e5 den p\u00e5g\u00e6ldende kolonne.<\/li>\n\n\n\n<li><strong>Type er ikke n\u00e6vnt:<\/strong>&nbsp;Er din type sj\u00e6lden, ukendt, eller ikke specifikt listet, b\u00f8r du fokusere p\u00e5 den sidste kolonne, der er ben\u00e6vnt \u2018Generel strategi \/ uspecificeret type\u2019. V\u00e6lg 5-7 midler, der d\u00e6kker de 5 angrebs-grupper (A-E), ud fra denne kolonne. Denne generelle strategi angriber\/ m\u00e5lretter de s\u00e5rbarheder, der er f\u00e6lles for n\u00e6sten al aggressiv kr\u00e6ft.<\/li>\n<\/ul>\n\n\n\n<h4 class=\"wp-block-heading\">Advarsel<\/h4>\n\n\n\n<p class=\"wp-block-paragraph\">Denne tabel er udelukkende til information og inspiration for en dialog med en kvalificeret l\u00e6ge. Den er <strong>ikke<\/strong> en behandlingsvejledning.<\/p>\n\n\n<h2 id=\"tablepress-67-name\" class=\"tablepress-table-name tablepress-table-name-id-67\"><span class=\"ez-toc-section\" id=\"Tarmkraeft_%E2%80%93_Bloker_Pathways\"><\/span>Tarmkr\u00e6ft &#8211; Bloker Pathways<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n<table id=\"tablepress-67\" class=\"tablepress tablepress-id-67\" aria-labelledby=\"tablepress-67-name\">\n<thead>\n<tr class=\"row-1\">\n\t<th class=\"column-1\">Stof<\/th><th class=\"column-2\">1. Standard (MSS)<\/th><th class=\"column-3\">2. MSI-High<\/th><th class=\"column-4\">Stof<\/th><th class=\"column-5\">3. KRAS-muteret<\/th><th class=\"column-6\">4. BRAF-muteret<\/th><th class=\"column-7\">Stof<\/th><th class=\"column-8\">5. PIK3CA-muteret<\/th><th class=\"column-9\">6. Mucin\u00f8s<\/th><th class=\"column-10\">Stof<\/th><th class=\"column-11\">7. H\u00f8jresidig<\/th><th class=\"column-12\">8. Venstresidig<\/th><th class=\"column-13\">Stof<\/th><th class=\"column-14\">9. Metastatisk<\/th><th class=\"column-15\">10. Generel strategi<\/th><th class=\"column-16\">Stof<\/th>\n<\/tr>\n<\/thead>\n<tbody class=\"row-striping row-hover\">\n<tr class=\"row-2\">\n\t<td class=\"column-1\">Benzimidazoler<\/td><td class=\"column-2\">(2) (A (C)) H\u00f8j Relevans. H\u00e6mmer Wnt (kopi-knap) \/ Sekund\u00e6r H\u00e6mmer sukkeroptag.<\/td><td class=\"column-3\">(3) (A (E)) H\u00e6mmer v\u00e6kst \/ Sekund\u00e6r Fremmer celled\u00f8d.<\/td><td class=\"column-4\">Benzimidazoler<\/td><td class=\"column-5\">(2) (A (C)) H\u00f8j Relevans. Rammer resistente celler \/ Sekund\u00e6r H\u00e6mmer sukker.<\/td><td class=\"column-6\">(3) (A (E)) H\u00e6mmer mikrotubuli (cellens skelet) \/ Sekund\u00e6r Fremmer celled\u00f8d.<\/td><td class=\"column-7\">Benzimidazoler<\/td><td class=\"column-8\">(3) (A (C)) H\u00e6mmer v\u00e6kst \/ Sekund\u00e6r H\u00e6mmer energi.<\/td><td class=\"column-9\">(3) (A) H\u00e6mmer v\u00e6kst \/ Sekund\u00e6r \u00d8del\u00e6gger struktur.<\/td><td class=\"column-10\">Benzimidazoler<\/td><td class=\"column-11\">(3) (A) H\u00e6mmer v\u00e6kst \/ Sekund\u00e6r H\u00e6mmer struktur.<\/td><td class=\"column-12\">(2) (A) H\u00f8j Relevans. H\u00e6mmer Wnt-signalet (kopi-knap) \/ Sekund\u00e6r H\u00e6mmer struktur.<\/td><td class=\"column-13\">Benzimidazoler<\/td><td class=\"column-14\">(2) (A (C)) H\u00f8j Relevans. Rammer resistente celler \/ Sekund\u00e6r H\u00e6mmer energi.<\/td><td class=\"column-15\">(2) (A (C)) H\u00f8j Relevans. H\u00e6mmer Wnt og struktur \/ Sekund\u00e6r H\u00e6mmer sukker.<\/td><td class=\"column-16\">Benzimidazoler<\/td>\n<\/tr>\n<tr class=\"row-3\">\n\t<td class=\"column-1\">Desloratadin<\/td><td class=\"column-2\">(4) (D) D\u00e6mper inflammation (bet\u00e6ndelse) \/ Sekund\u00e6r St\u00f8tter immunsystem.<\/td><td class=\"column-3\">(4) (D) D\u00e6mper inflammation \/ Sekund\u00e6r St\u00f8tter immunsystem.<\/td><td class=\"column-4\">Desloratadin<\/td><td class=\"column-5\">(4) (D) D\u00e6mper inflammation \/ Sekund\u00e6r St\u00f8tter immunsystem.<\/td><td class=\"column-6\">(4) (D) D\u00e6mper inflammation \/ Sekund\u00e6r St\u00f8tter immunsystem.<\/td><td class=\"column-7\">Desloratadin<\/td><td class=\"column-8\">(4) (D) D\u00e6mper inflammation \/ Sekund\u00e6r St\u00f8tter immunsystem.<\/td><td class=\"column-9\">(4) (D) D\u00e6mper inflammation \/ Sekund\u00e6r St\u00f8tter immunsystem.<\/td><td class=\"column-10\">Desloratadin<\/td><td class=\"column-11\">(4) (D) D\u00e6mper inflammation \/ Sekund\u00e6r St\u00f8tter immunsystem.<\/td><td class=\"column-12\">(4) (D) D\u00e6mper inflammation \/ Sekund\u00e6r St\u00f8tter immunsystem.<\/td><td class=\"column-13\">Desloratadin<\/td><td class=\"column-14\">(4) (D (B)) D\u00e6mper systemisk inflammation \/ Sekund\u00e6r Rammer lysosomer (rensningsanl\u00e6g).<\/td><td class=\"column-15\">(4) (D) D\u00e6mper kronisk bet\u00e6ndelse \/ Sekund\u00e6r St\u00f8tter immunsystem.<\/td><td class=\"column-16\">Desloratadin<\/td>\n<\/tr>\n<tr class=\"row-4\">\n\t<td class=\"column-1\">Disulfiram<\/td><td class=\"column-2\">(2) (E (A)) H\u00f8j Relevans. Rammer kr\u00e6ftstamceller \/ Sekund\u00e6r H\u00e6mmer v\u00e6kst.<\/td><td class=\"column-3\">(3) (E) Skaber stress i cellen \/ Sekund\u00e6r H\u00e6mmer forsvar.<\/td><td class=\"column-4\">Disulfiram<\/td><td class=\"column-5\">(2) (E (A)) H\u00f8j Relevans. Rammer resistente stamceller \/ Sekund\u00e6r H\u00e6mmer NF-kB (bet\u00e6ndelse).<\/td><td class=\"column-6\">(3) (E) Skaber stress i cellen \/ Sekund\u00e6r H\u00e6mmer forsvar.<\/td><td class=\"column-7\">Disulfiram<\/td><td class=\"column-8\">(3) (E) Rammer stamceller \/ Sekund\u00e6r H\u00e6mmer v\u00e6kst.<\/td><td class=\"column-9\">(3) (E) Rammer stamceller \/ Sekund\u00e6r H\u00e6mmer v\u00e6kst.<\/td><td class=\"column-10\">Disulfiram<\/td><td class=\"column-11\">(3) (E) Rammer stamceller \/ Sekund\u00e6r H\u00e6mmer v\u00e6kst.<\/td><td class=\"column-12\">(2) (E (A)) H\u00f8j Relevans. Rammer stamceller (Wnt-drevne) \/ Sekund\u00e6r H\u00e6mmer v\u00e6kst.<\/td><td class=\"column-13\">Disulfiram<\/td><td class=\"column-14\">(2) (E (A)) H\u00f8j Relevans. Rammer metastase-stamceller \/ Sekund\u00e6r H\u00e6mmer v\u00e6kst.<\/td><td class=\"column-15\">(2) (E (A)) H\u00f8j Relevans. Rammer stamceller \/ Sekund\u00e6r H\u00e6mmer v\u00e6kst.<\/td><td class=\"column-16\">Disulfiram<\/td>\n<\/tr>\n<tr class=\"row-5\">\n\t<td class=\"column-1\">Dipyridamol<\/td><td class=\"column-2\">(3) (D (A)) H\u00e6mmer Wnt-signalering (kopi-knap) \/ Sekund\u00e6r St\u00f8tter immunforsvar.<\/td><td class=\"column-3\">(3) (D) St\u00f8tter immunforsvaret (fjerner bremse) \/ Sekund\u00e6r H\u00e6mmer v\u00e6kst.<\/td><td class=\"column-4\">Dipyridamol<\/td><td class=\"column-5\">(3) (D (A)) H\u00e6mmer v\u00e6kst \/ Sekund\u00e6r H\u00e6mmer blodplader.<\/td><td class=\"column-6\">(3) (D) H\u00e6mmer v\u00e6kst \/ Sekund\u00e6r H\u00e6mmer blodplader.<\/td><td class=\"column-7\">Dipyridamol<\/td><td class=\"column-8\">(3) (D) H\u00e6mmer v\u00e6kst \/ Sekund\u00e6r H\u00e6mmer blodplader.<\/td><td class=\"column-9\">(3) (D) H\u00e6mmer v\u00e6kst \/ Sekund\u00e6r H\u00e6mmer blodplader.<\/td><td class=\"column-10\">Dipyridamol<\/td><td class=\"column-11\">(3) (D) H\u00e6mmer v\u00e6kst \/ Sekund\u00e6r H\u00e6mmer blodplader.<\/td><td class=\"column-12\">(3) (D (A)) H\u00e6mmer Wnt-v\u00e6kst \/ Sekund\u00e6r H\u00e6mmer blodplader.<\/td><td class=\"column-13\">Dipyridamol<\/td><td class=\"column-14\">(2) (D (A)) H\u00f8j Relevans. H\u00e6mmer spredning via blodplader \/ Sekund\u00e6r H\u00e6mmer v\u00e6kst.<\/td><td class=\"column-15\">(3) (D (A)) H\u00e6mmer Wnt-v\u00e6kst \/ Sekund\u00e6r St\u00f8tter immunforsvar.<\/td><td class=\"column-16\">Dipyridamol<\/td>\n<\/tr>\n<tr class=\"row-6\">\n\t<td class=\"column-1\">Doxycyclin<\/td><td class=\"column-2\">(3) (E (C)) H\u00e6mmer mitokondrier (energi) \/ Sekund\u00e6r H\u00e6mmer v\u00e6kst.<\/td><td class=\"column-3\">(3) (E (C)) H\u00e6mmer mitokondrier \/ Sekund\u00e6r H\u00e6mmer v\u00e6kst.<\/td><td class=\"column-4\">Doxycyclin<\/td><td class=\"column-5\">(2) (E (C)) H\u00f8j Relevans. Rammer resistente cellers energi \/ Sekund\u00e6r H\u00e6mmer v\u00e6kst.<\/td><td class=\"column-6\">(2) (E (C)) H\u00f8j Relevans. Rammer resistente cellers energi \/ Sekund\u00e6r H\u00e6mmer v\u00e6kst.<\/td><td class=\"column-7\">Doxycyclin<\/td><td class=\"column-8\">(3) (E (C)) H\u00e6mmer mitokondrier \/ Sekund\u00e6r H\u00e6mmer v\u00e6kst.<\/td><td class=\"column-9\">(3) (E (C)) H\u00e6mmer mitokondrier \/ Sekund\u00e6r H\u00e6mmer v\u00e6kst.<\/td><td class=\"column-10\">Doxycyclin<\/td><td class=\"column-11\">(3) (E (C)) H\u00e6mmer mitokondrier \/ Sekund\u00e6r H\u00e6mmer v\u00e6kst.<\/td><td class=\"column-12\">(3) (E (C)) H\u00e6mmer mitokondrier \/ Sekund\u00e6r H\u00e6mmer v\u00e6kst.<\/td><td class=\"column-13\">Doxycyclin<\/td><td class=\"column-14\">(2) (E (C)) H\u00f8j Relevans. H\u00e6mmer spredning (MMP) \/ Sekund\u00e6r Rammer energi.<\/td><td class=\"column-15\">(3) (E (C)) Rammer energifabrikker \/ Sekund\u00e6r H\u00e6mmer spredning.<\/td><td class=\"column-16\">Doxycyclin<\/td>\n<\/tr>\n<tr class=\"row-7\">\n\t<td class=\"column-1\">Hjertemagnyl (Aspirin)<\/td><td class=\"column-2\">(1) (D (A)) Hovedstrategi. H\u00e6mmer Wnt (hoved-driver) \/ Sekund\u00e6r D\u00e6mper inflammation.<\/td><td class=\"column-3\">(1) (D (E)) Hovedstrategi. St\u00e6rk effekt ved denne type \/ Sekund\u00e6r D\u00e6mper inflammation.<\/td><td class=\"column-4\">Hjertemagnyl (Aspirin)<\/td><td class=\"column-5\">(2) (D (A)) H\u00f8j Relevans. D\u00e6mper inflammation \/ Sekund\u00e6r H\u00e6mmer v\u00e6kst.<\/td><td class=\"column-6\">(2) (D (A)) H\u00f8j Relevans. D\u00e6mper inflammation \/ Sekund\u00e6r H\u00e6mmer v\u00e6kst.<\/td><td class=\"column-7\">Hjertemagnyl (Aspirin)<\/td><td class=\"column-8\">(1) (A (D)) Hovedstrategi. S\u00e6rligt effektiv ved PIK3CA (slukker signalet) \/ Sekund\u00e6r D\u00e6mper inflammation.<\/td><td class=\"column-9\">(3) (D) D\u00e6mper inflammation \/ Sekund\u00e6r H\u00e6mmer v\u00e6kst.<\/td><td class=\"column-10\">Hjertemagnyl (Aspirin)<\/td><td class=\"column-11\">(2) (D (A)) H\u00f8j Relevans. D\u00e6mper inflammation \/ Sekund\u00e6r H\u00e6mmer v\u00e6kst.<\/td><td class=\"column-12\">(1) (D (A)) Hovedstrategi. H\u00e6mmer Wnt-v\u00e6kst \/ Sekund\u00e6r D\u00e6mper inflammation.<\/td><td class=\"column-13\">Hjertemagnyl (Aspirin)<\/td><td class=\"column-14\">(1) (D (C)) Hovedstrategi. H\u00e6mmer spredning (blodplader) \/ Sekund\u00e6r D\u00e6mper inflammation.<\/td><td class=\"column-15\">(1) (D (A)) Hovedstrategi. Grundpille i tarmkr\u00e6ft-strategi \/ Sekund\u00e6r V\u00e6ksth\u00e6mning.<\/td><td class=\"column-16\">Hjertemagnyl (Aspirin)<\/td>\n<\/tr>\n<tr class=\"row-8\">\n\t<td class=\"column-1\">Hydroxychloroquin<\/td><td class=\"column-2\">(2) (B (E)) H\u00f8j Relevans. Blokerer autofagi (genbrug) \/ Sekund\u00e6r Skaber stress.<\/td><td class=\"column-3\">(3) (B (E)) H\u00e6mmer autofagi \/ Sekund\u00e6r Skaber stress.<\/td><td class=\"column-4\">Hydroxychloroquin<\/td><td class=\"column-5\">(1) (B (E)) Hovedstrategi. KRAS-celler er afh\u00e6ngige af autofagi \/ Sekund\u00e6r Skaber stress.<\/td><td class=\"column-6\">(1) (B (E)) Hovedstrategi. BRAF-celler bruger autofagi til resistens \/ Sekund\u00e6r Skaber stress.<\/td><td class=\"column-7\">Hydroxychloroquin<\/td><td class=\"column-8\">(2) (B (E)) H\u00f8j Relevans. H\u00e6mmer overlevelse \/ Sekund\u00e6r Skaber stress.<\/td><td class=\"column-9\">(1) (B (E)) Hovedstrategi. H\u00e6mmer slim-produktion (autofagi-linket) \/ Sekund\u00e6r Skaber stress.<\/td><td class=\"column-10\">Hydroxychloroquin<\/td><td class=\"column-11\">(2) (B (E)) H\u00f8j Relevans. H\u00e6mmer autofagi \/ Sekund\u00e6r Skaber stress.<\/td><td class=\"column-12\">(2) (B (E)) H\u00f8j Relevans. H\u00e6mmer autofagi \/ Sekund\u00e6r Skaber stress.<\/td><td class=\"column-13\">Hydroxychloroquin<\/td><td class=\"column-14\">(1) (B (E)) Hovedstrategi. Fjerner overlevelsesmekanisme \/ Sekund\u00e6r \u00d8ger stress.<\/td><td class=\"column-15\">(2) (B (E)) H\u00f8j Relevans. Blokerer reparation \/ Sekund\u00e6r \u00d8ger stress.<\/td><td class=\"column-16\">Hydroxychloroquin<\/td>\n<\/tr>\n<tr class=\"row-9\">\n\t<td class=\"column-1\">Ivermectin<\/td><td class=\"column-2\">(1) (A (E)) Hovedstrategi. H\u00e6mmer Wnt-signalvejen (kopi-knap) \/ Sekund\u00e6r Inducerer apoptose.<\/td><td class=\"column-3\">(3) (A (E)) H\u00e6mmer v\u00e6kst \/ Sekund\u00e6r Fremmer celled\u00f8d.<\/td><td class=\"column-4\">Ivermectin<\/td><td class=\"column-5\">(3) (A (E)) H\u00e6mmer v\u00e6kst \/ Sekund\u00e6r Fremmer celled\u00f8d.<\/td><td class=\"column-6\">(3) (A (E)) H\u00e6mmer v\u00e6kst \/ Sekund\u00e6r Fremmer celled\u00f8d.<\/td><td class=\"column-7\">Ivermectin<\/td><td class=\"column-8\">(3) (A (E)) H\u00e6mmer v\u00e6kst \/ Sekund\u00e6r Fremmer celled\u00f8d.<\/td><td class=\"column-9\">(2) (A (E)) H\u00f8j Relevans. H\u00e6mmer Wnt (vigtig i mucin\u00f8s) \/ Sekund\u00e6r Fremmer d\u00f8d.<\/td><td class=\"column-10\">Ivermectin<\/td><td class=\"column-11\">(3) (A (E)) H\u00e6mmer v\u00e6kst \/ Sekund\u00e6r Fremmer celled\u00f8d.<\/td><td class=\"column-12\">(1) (A (E)) Hovedstrategi. H\u00e6mmer Wnt (dominerende i venstre) \/ Sekund\u00e6r Fremmer d\u00f8d.<\/td><td class=\"column-13\">Ivermectin<\/td><td class=\"column-14\">(3) (A (E)) Inducerer apoptose \/ Sekund\u00e6r H\u00e6mmer v\u00e6kst.<\/td><td class=\"column-15\">(1) (A (E)) Hovedstrategi. H\u00e6mmer Wnt-signalet \/ Sekund\u00e6r Fremmer celled\u00f8d.<\/td><td class=\"column-16\">Ivermectin<\/td>\n<\/tr>\n<tr class=\"row-10\">\n\t<td class=\"column-1\">Lav-dosis Naltrexon (LDN)<\/td><td class=\"column-2\">(4) (D (A)) Modulerer immunforsvaret \/ Sekund\u00e6r D\u00e6mper v\u00e6kstfaktorer.<\/td><td class=\"column-3\">(2) (D (A)) H\u00f8j Relevans. St\u00f8tter kroppens eget angreb \/ Sekund\u00e6r D\u00e6mper v\u00e6kst.<\/td><td class=\"column-4\">Lav-dosis Naltrexon (LDN)<\/td><td class=\"column-5\">(4) (D) Modulerer immunforsvaret \/ Sekund\u00e6r Skaber balance.<\/td><td class=\"column-6\">(4) (D) Modulerer immunforsvaret \/ Sekund\u00e6r Skaber balance.<\/td><td class=\"column-7\">Lav-dosis Naltrexon (LDN)<\/td><td class=\"column-8\">(4) (D) Modulerer immunforsvaret \/ Sekund\u00e6r Skaber balance.<\/td><td class=\"column-9\">(4) (D) Modulerer immunforsvaret \/ Sekund\u00e6r Skaber balance.<\/td><td class=\"column-10\">Lav-dosis Naltrexon (LDN)<\/td><td class=\"column-11\">(2) (D (A)) H\u00f8j Relevans. Styrker immun-aktivitet (h\u00f8jresidig) \/ Sekund\u00e6r D\u00e6mper v\u00e6kst.<\/td><td class=\"column-12\">(4) (D) Modulerer immunforsvaret \/ Sekund\u00e6r Skaber balance.<\/td><td class=\"column-13\">Lav-dosis Naltrexon (LDN)<\/td><td class=\"column-14\">(4) (D) Styrker immunforsvaret \/ Sekund\u00e6r D\u00e6mper v\u00e6kst.<\/td><td class=\"column-15\">(4) (D) St\u00f8tter kroppens eget forsvar mod kr\u00e6ft \/ Sekund\u00e6r Immun-regulering.<\/td><td class=\"column-16\">Lav-dosis Naltrexon (LDN)<\/td>\n<\/tr>\n<tr class=\"row-11\">\n\t<td class=\"column-1\">Metformin<\/td><td class=\"column-2\">(2) (A (C)) H\u00f8j Relevans. Aktiverer AMPK (n\u00f8dbremse) \/ Sekund\u00e6r H\u00e6mmer Wnt.<\/td><td class=\"column-3\">(3) (A (C)) Regulerer metabolisme \/ Sekund\u00e6r S\u00e6nker insulin.<\/td><td class=\"column-4\">Metformin<\/td><td class=\"column-5\">(1) (A (C)) Hovedstrategi. H\u00e6mmer mTOR (KRAS-drevet) \/ Sekund\u00e6r S\u00e6nker sukker-tilf\u00f8rsel.<\/td><td class=\"column-6\">(2) (A (C)) H\u00f8j Relevans. H\u00e6mmer mTOR \/ Sekund\u00e6r S\u00e6nker sukker.<\/td><td class=\"column-7\">Metformin<\/td><td class=\"column-8\">(1) (A (C)) Hovedstrategi. H\u00e6mmer PI3K\/mTOR \/ Sekund\u00e6r Aktiverer AMPK.<\/td><td class=\"column-9\">(2) (A (C)) H\u00f8j Relevans. H\u00e6mmer v\u00e6kst \/ Sekund\u00e6r S\u00e6nker sukker.<\/td><td class=\"column-10\">Metformin<\/td><td class=\"column-11\">(2) (A (C)) H\u00f8j Relevans. S\u00e6nker insulin \/ Sekund\u00e6r Skaber metabolisk stress.<\/td><td class=\"column-12\">(2) (A (C)) H\u00f8j Relevans. H\u00e6mmer Wnt via AMPK \/ Sekund\u00e6r S\u00e6nker sukker.<\/td><td class=\"column-13\">Metformin<\/td><td class=\"column-14\">(2) (A (E)) H\u00f8j Relevans. S\u00e6nker systemiske v\u00e6kstfaktorer \/ Sekund\u00e6r Skaber stress.<\/td><td class=\"column-15\">(1) (A (C)) Hovedstrategi. S\u00e6nker blodsukker \/ Sekund\u00e6r Aktiverer n\u00f8dbremse (AMPK).<\/td><td class=\"column-16\">Metformin<\/td>\n<\/tr>\n<tr class=\"row-12\">\n\t<td class=\"column-1\">Propranolol<\/td><td class=\"column-2\">(3) (D (C)) D\u00e6mper stress \/ Sekund\u00e6r H\u00e6mmer angiogenese (blodkar).<\/td><td class=\"column-3\">(3) (D (C)) D\u00e6mper stress \/ Sekund\u00e6r H\u00e6mmer angiogenese.<\/td><td class=\"column-4\">Propranolol<\/td><td class=\"column-5\">(3) (D (C)) D\u00e6mper stress \/ Sekund\u00e6r H\u00e6mmer angiogenese.<\/td><td class=\"column-6\">(3) (D (C)) D\u00e6mper stress \/ Sekund\u00e6r H\u00e6mmer angiogenese.<\/td><td class=\"column-7\">Propranolol<\/td><td class=\"column-8\">(3) (D (C)) D\u00e6mper stress \/ Sekund\u00e6r H\u00e6mmer angiogenese.<\/td><td class=\"column-9\">(3) (D (C)) D\u00e6mper stress \/ Sekund\u00e6r H\u00e6mmer angiogenese.<\/td><td class=\"column-10\">Propranolol<\/td><td class=\"column-11\">(3) (D (C)) D\u00e6mper stress \/ Sekund\u00e6r H\u00e6mmer angiogenese.<\/td><td class=\"column-12\">(3) (D (C)) D\u00e6mper stress \/ Sekund\u00e6r H\u00e6mmer angiogenese.<\/td><td class=\"column-13\">Propranolol<\/td><td class=\"column-14\">(2) (C (D)) H\u00f8j Relevans. H\u00e6mmer metastase-processer \/ Sekund\u00e6r D\u00e6mper stress.<\/td><td class=\"column-15\">(3) (C (D)) Blokerer stress-signaler \/ Sekund\u00e6r H\u00e6mmer blodkar-dannelse.<\/td><td class=\"column-16\">Propranolol<\/td>\n<\/tr>\n<tr class=\"row-13\">\n\t<td class=\"column-1\">Statiner<\/td><td class=\"column-2\">(2) (C (A)) H\u00f8j Relevans. H\u00e6mmer Mevalonat (fedtstof) \/ Sekund\u00e6r H\u00e6mmer Wnt.<\/td><td class=\"column-3\">(3) (C (A)) H\u00e6mmer proliferation \/ Sekund\u00e6r H\u00e6mmer fedtstofskifte.<\/td><td class=\"column-4\">Statiner<\/td><td class=\"column-5\">(1) (C (A)) Hovedstrategi. Blokerer KRAS-forankring \/ Sekund\u00e6r H\u00e6mmer proliferation.<\/td><td class=\"column-6\">(2) (C (A)) H\u00f8j Relevans. H\u00e6mmer v\u00e6kstsignaler \/ Sekund\u00e6r H\u00e6mmer Mevalonat.<\/td><td class=\"column-7\">Statiner<\/td><td class=\"column-8\">(2) (C (A)) H\u00f8j Relevans. H\u00e6mmer PI3K-signalering \/ Sekund\u00e6r H\u00e6mmer fedtstofskifte.<\/td><td class=\"column-9\">(3) (C (A)) H\u00e6mmer proliferation \/ Sekund\u00e6r H\u00e6mmer fedtstofskifte.<\/td><td class=\"column-10\">Statiner<\/td><td class=\"column-11\">(3) (C (A)) H\u00e6mmer proliferation \/ Sekund\u00e6r H\u00e6mmer fedtstofskifte.<\/td><td class=\"column-12\">(2) (C (A)) H\u00f8j Relevans. H\u00e6mmer Wnt \/ Sekund\u00e6r H\u00e6mmer Mevalonat.<\/td><td class=\"column-13\">Statiner<\/td><td class=\"column-14\">(2) (C (A)) H\u00f8j Relevans. H\u00e6mmer overlevelse i leveren \/ Sekund\u00e6r H\u00e6mmer v\u00e6kst.<\/td><td class=\"column-15\">(2) (C (A)) H\u00f8j Relevans. Lukker for byggesten \/ Sekund\u00e6r H\u00e6mmer v\u00e6kst.<\/td><td class=\"column-16\">Statiner<\/td>\n<\/tr>\n<tr class=\"row-14\">\n\t<td class=\"column-1\">&#8212; Kosttilskud &#8212;<\/td><td class=\"column-2\"><\/td><td class=\"column-3\"><\/td><td class=\"column-4\">&#8212; Kosttilskud &#8212;<\/td><td class=\"column-5\"><\/td><td class=\"column-6\"><\/td><td class=\"column-7\">&#8212; Kosttilskud &#8212;<\/td><td class=\"column-8\"><\/td><td class=\"column-9\"><\/td><td class=\"column-10\">&#8212; Kosttilskud &#8212;<\/td><td class=\"column-11\"><\/td><td class=\"column-12\"><\/td><td class=\"column-13\">&#8212; Kosttilskud &#8212;<\/td><td class=\"column-14\"><\/td><td class=\"column-15\"><\/td><td class=\"column-16\">&#8212; Kosttilskud &#8212;<\/td>\n<\/tr>\n<tr class=\"row-15\">\n\t<td class=\"column-1\">AHCC<\/td><td class=\"column-2\">(4) (D) Styrker immunforsvaret.<\/td><td class=\"column-3\">(3) (D) Underst\u00f8ttende. Styrker kroppens eget angreb \/ Sekund\u00e6r Fremmer celled\u00f8d.<\/td><td class=\"column-4\">AHCC<\/td><td class=\"column-5\">(4) (D) Styrker immunforsvaret \/ Sekund\u00e6r St\u00f8tter kroppens kamp.<\/td><td class=\"column-6\">(4) (D) Styrker immunforsvaret \/ Sekund\u00e6r St\u00f8tter kroppens kamp.<\/td><td class=\"column-7\">AHCC<\/td><td class=\"column-8\">(4) (D) Styrker immunforsvaret \/ Sekund\u00e6r St\u00f8tter kroppens kamp.<\/td><td class=\"column-9\">(4) (D) Styrker immunforsvaret \/ Sekund\u00e6r St\u00f8tter kroppens kamp.<\/td><td class=\"column-10\">AHCC<\/td><td class=\"column-11\">(3) (D) Styrker immunforsvaret (h\u00f8jresidig er immun-aktiv) \/ Sekund\u00e6r Generel st\u00f8tte.<\/td><td class=\"column-12\">(4) (D) Styrker immunforsvaret \/ Sekund\u00e6r Generel st\u00f8tte.<\/td><td class=\"column-13\">AHCC<\/td><td class=\"column-14\">(4) (D) Styrker immunforsvaret \/ Sekund\u00e6r Generel st\u00f8tte.<\/td><td class=\"column-15\">(4) (D) Generel styrkelse af immunforsvaret.<\/td><td class=\"column-16\">AHCC<\/td>\n<\/tr>\n<tr class=\"row-16\">\n\t<td class=\"column-1\">Alfa-liponsyre (ALA)<\/td><td class=\"column-2\">(3) (A (E)) H\u00e6mmer glykolyse (sukker) \/ Sekund\u00e6r Aktiverer AMPK.<\/td><td class=\"column-3\">(4) (C (E)) St\u00f8tter stofskiftet \/ Sekund\u00e6r Antioxidant beskyttelse.<\/td><td class=\"column-4\">Alfa-liponsyre (ALA)<\/td><td class=\"column-5\">(3) (A (E)) H\u00e6mmer glykolyse (KRAS er sukker-afh\u00e6ngig) \/ Sekund\u00e6r Aktiverer AMPK.<\/td><td class=\"column-6\">(3) (A (E)) H\u00e6mmer glykolyse \/ Sekund\u00e6r Aktiverer AMPK.<\/td><td class=\"column-7\">Alfa-liponsyre (ALA)<\/td><td class=\"column-8\">(3) (A (E)) H\u00e6mmer glykolyse \/ Sekund\u00e6r Aktiverer AMPK.<\/td><td class=\"column-9\">(4) (C (E)) St\u00f8tter stofskiftet \/ Sekund\u00e6r Antioxidant.<\/td><td class=\"column-10\">Alfa-liponsyre (ALA)<\/td><td class=\"column-11\">(3) (A (E)) H\u00e6mmer glykolyse \/ Sekund\u00e6r Aktiverer AMPK.<\/td><td class=\"column-12\">(3) (A (E)) H\u00e6mmer glykolyse \/ Sekund\u00e6r Aktiverer AMPK.<\/td><td class=\"column-13\">Alfa-liponsyre (ALA)<\/td><td class=\"column-14\">(4) (C (E)) Kan hj\u00e6lpe mod neuropati \/ Sekund\u00e6r Metabolisk st\u00f8tte.<\/td><td class=\"column-15\">(3) (A (C)) Hj\u00e6lper med at regulere blodsukker \/ Sekund\u00e6r St\u00f8tter stofskifte.<\/td><td class=\"column-16\">Alfa-liponsyre (ALA)<\/td>\n<\/tr>\n<tr class=\"row-17\">\n\t<td class=\"column-1\">Apigenin<\/td><td class=\"column-2\">(2) (A (D)) H\u00f8j Relevans. H\u00e6mmer Wnt-signalvejen \/ Sekund\u00e6r D\u00e6mper inflammation.<\/td><td class=\"column-3\">(3) (A (D)) H\u00e6mmer v\u00e6kst \/ Sekund\u00e6r D\u00e6mper inflammation.<\/td><td class=\"column-4\">Apigenin<\/td><td class=\"column-5\">(3) (A (D)) H\u00e6mmer v\u00e6kst \/ Sekund\u00e6r D\u00e6mper inflammation.<\/td><td class=\"column-6\">(3) (A (D)) H\u00e6mmer v\u00e6kst \/ Sekund\u00e6r D\u00e6mper inflammation.<\/td><td class=\"column-7\">Apigenin<\/td><td class=\"column-8\">(3) (A (D)) H\u00e6mmer PI3K\/Akt \/ Sekund\u00e6r D\u00e6mper inflammation.<\/td><td class=\"column-9\">(3) (A (D)) H\u00e6mmer v\u00e6kst \/ Sekund\u00e6r D\u00e6mper inflammation.<\/td><td class=\"column-10\">Apigenin<\/td><td class=\"column-11\">(3) (A (D)) H\u00e6mmer v\u00e6kst \/ Sekund\u00e6r D\u00e6mper inflammation.<\/td><td class=\"column-12\">(2) (A (D)) H\u00f8j Relevans. H\u00e6mmer Wnt \/ Sekund\u00e6r D\u00e6mper inflammation.<\/td><td class=\"column-13\">Apigenin<\/td><td class=\"column-14\">(3) (A (D)) H\u00e6mmer metastase \/ Sekund\u00e6r D\u00e6mper inflammation.<\/td><td class=\"column-15\">(3) (D (A)) D\u00e6mper inflammation \/ Sekund\u00e6r H\u00e6mmer v\u00e6kstsignaler.<\/td><td class=\"column-16\">Apigenin<\/td>\n<\/tr>\n<tr class=\"row-18\">\n\t<td class=\"column-1\">Artemisinin<\/td><td class=\"column-2\">(3) (E (C)) Inducerer ferroptose (jern-d\u00f8d) \/ Sekund\u00e6r H\u00e6mmer blodkar.<\/td><td class=\"column-3\">(3) (E (C)) Inducerer ferroptose \/ Sekund\u00e6r H\u00e6mmer blodkar.<\/td><td class=\"column-4\">Artemisinin<\/td><td class=\"column-5\">(3) (E (C)) Inducerer ferroptose \/ Sekund\u00e6r H\u00e6mmer blodkar.<\/td><td class=\"column-6\">(3) (E (C)) Inducerer ferroptose \/ Sekund\u00e6r H\u00e6mmer blodkar.<\/td><td class=\"column-7\">Artemisinin<\/td><td class=\"column-8\">(3) (E (C)) Inducerer ferroptose \/ Sekund\u00e6r H\u00e6mmer blodkar.<\/td><td class=\"column-9\">(3) (E (C)) Inducerer ferroptose \/ Sekund\u00e6r H\u00e6mmer blodkar.<\/td><td class=\"column-10\">Artemisinin<\/td><td class=\"column-11\">(3) (E (C)) Inducerer ferroptose \/ Sekund\u00e6r H\u00e6mmer blodkar.<\/td><td class=\"column-12\">(3) (E (C)) Inducerer ferroptose \/ Sekund\u00e6r H\u00e6mmer blodkar.<\/td><td class=\"column-13\">Artemisinin<\/td><td class=\"column-14\">(2) (E (C)) H\u00f8j Relevans. Inducerer ferroptose i metastaser \/ Sekund\u00e6r H\u00e6mmer blodkar.<\/td><td class=\"column-15\">(2) (E (C)) H\u00f8j Relevans. Udnytter jern til at dr\u00e6be kr\u00e6ft \/ Sekund\u00e6r H\u00e6mmer blodkar.<\/td><td class=\"column-16\">Artemisinin<\/td>\n<\/tr>\n<tr class=\"row-19\">\n\t<td class=\"column-1\">Astragalus<\/td><td class=\"column-2\">(3) (D (A)) D\u00e6mper bivirkninger \/ Sekund\u00e6r Kan d\u00e6mpe v\u00e6kstfaktorer.<\/td><td class=\"column-3\">(3) (D) St\u00f8tter immunforsvaret \/ Sekund\u00e6r D\u00e6mper bivirkninger.<\/td><td class=\"column-4\">Astragalus<\/td><td class=\"column-5\">(4) (D) Generel immunst\u00f8tte \/ Sekund\u00e6r Kan d\u00e6mpe v\u00e6kst.<\/td><td class=\"column-6\">(4) (D) Generel immunst\u00f8tte \/ Sekund\u00e6r Kan d\u00e6mpe v\u00e6kst.<\/td><td class=\"column-7\">Astragalus<\/td><td class=\"column-8\">(4) (D) Generel immunst\u00f8tte \/ Sekund\u00e6r Kan d\u00e6mpe v\u00e6kst.<\/td><td class=\"column-9\">(4) (D) Generel immunst\u00f8tte \/ Sekund\u00e6r Kan d\u00e6mpe v\u00e6kst.<\/td><td class=\"column-10\">Astragalus<\/td><td class=\"column-11\">(3) (D) St\u00f8tter immunforsvaret \/ Sekund\u00e6r D\u00e6mper bivirkninger.<\/td><td class=\"column-12\">(4) (D) Generel immunst\u00f8tte \/ Sekund\u00e6r Kan d\u00e6mpe v\u00e6kst.<\/td><td class=\"column-13\">Astragalus<\/td><td class=\"column-14\">(3) (D (A)) Styrker almentilstanden \/ Sekund\u00e6r Modvirker v\u00e6kst.<\/td><td class=\"column-15\">(4) (D) Generel styrkelse af krop og immunforsvar.<\/td><td class=\"column-16\">Astragalus<\/td>\n<\/tr>\n<tr class=\"row-20\">\n\t<td class=\"column-1\">Berberin<\/td><td class=\"column-2\">(1) (A (D)) Hovedstrategi. H\u00e6mmer Wnt og inflammation \/ Sekund\u00e6r Aktiverer AMPK.<\/td><td class=\"column-3\">(3) (A (D)) H\u00e6mmer v\u00e6kst \/ Sekund\u00e6r D\u00e6mper inflammation.<\/td><td class=\"column-4\">Berberin<\/td><td class=\"column-5\">(2) (A (C)) H\u00f8j Relevans. H\u00e6mmer glykolyse og stroma \/ Sekund\u00e6r H\u00e6mmer v\u00e6kst.<\/td><td class=\"column-6\">(2) (A (C)) H\u00f8j Relevans. H\u00e6mmer mTOR \/ Sekund\u00e6r H\u00e6mmer sukker.<\/td><td class=\"column-7\">Berberin<\/td><td class=\"column-8\">(2) (A (C)) H\u00f8j Relevans. H\u00e6mmer mTOR \/ Sekund\u00e6r H\u00e6mmer sukker.<\/td><td class=\"column-9\">(1) (A (D)) Hovedstrategi. H\u00e6mmer mucin-produktion \/ Sekund\u00e6r H\u00e6mmer Wnt.<\/td><td class=\"column-10\">Berberin<\/td><td class=\"column-11\">(2) (A (D)) H\u00f8j Relevans. H\u00e6mmer Wnt \/ Sekund\u00e6r D\u00e6mper inflammation.<\/td><td class=\"column-12\">(1) (A (D)) Hovedstrategi. H\u00e6mmer Wnt (venstresidig driver) \/ Sekund\u00e6r Aktiverer AMPK.<\/td><td class=\"column-13\">Berberin<\/td><td class=\"column-14\">(2) (A (C)) H\u00f8j Relevans. H\u00e6mmer metastase \/ Sekund\u00e6r H\u00e6mmer sukkerforbr\u00e6nding.<\/td><td class=\"column-15\">(1) (A (D)) Hovedstrategi. Aktiverer n\u00f8dbremsen (AMPK) \/ Sekund\u00e6r D\u00e6mper bet\u00e6ndelse.<\/td><td class=\"column-16\">Berberin<\/td>\n<\/tr>\n<tr class=\"row-21\">\n\t<td class=\"column-1\">Boswellia<\/td><td class=\"column-2\">(2) (D (A)) H\u00f8j Relevans. H\u00e6mmer 5-LOX (bet\u00e6ndelse) \/ Sekund\u00e6r D\u00e6mper Wnt.<\/td><td class=\"column-3\">(3) (D (A)) D\u00e6mper inflammation \/ Sekund\u00e6r H\u00e6mmer v\u00e6kst.<\/td><td class=\"column-4\">Boswellia<\/td><td class=\"column-5\">(3) (D (A)) D\u00e6mper inflammation \/ Sekund\u00e6r H\u00e6mmer v\u00e6kst.<\/td><td class=\"column-6\">(3) (D (A)) D\u00e6mper inflammation \/ Sekund\u00e6r H\u00e6mmer v\u00e6kst.<\/td><td class=\"column-7\">Boswellia<\/td><td class=\"column-8\">(3) (D (A)) D\u00e6mper inflammation \/ Sekund\u00e6r H\u00e6mmer v\u00e6kst.<\/td><td class=\"column-9\">(3) (D (A)) D\u00e6mper inflammation \/ Sekund\u00e6r H\u00e6mmer v\u00e6kst.<\/td><td class=\"column-10\">Boswellia<\/td><td class=\"column-11\">(3) (D (A)) D\u00e6mper inflammation \/ Sekund\u00e6r H\u00e6mmer v\u00e6kst.<\/td><td class=\"column-12\">(2) (D (A)) H\u00f8j Relevans. H\u00e6mmer 5-LOX \/ Sekund\u00e6r D\u00e6mper Wnt.<\/td><td class=\"column-13\">Boswellia<\/td><td class=\"column-14\">(3) (D (A)) D\u00e6mper det bet\u00e6ndte milj\u00f8 \/ Sekund\u00e6r H\u00e6mmer v\u00e6kst.<\/td><td class=\"column-15\">(3) (D) St\u00e6rk d\u00e6mpning af inflammation \/ Sekund\u00e6r H\u00e6mmer v\u00e6kst.<\/td><td class=\"column-16\">Boswellia<\/td>\n<\/tr>\n<tr class=\"row-22\">\n\t<td class=\"column-1\">Cat&#8217;s Claw<\/td><td class=\"column-2\">(4) (D) Anti-inflammatorisk.<\/td><td class=\"column-3\">(4) (D) Anti-inflammatorisk \/ Sekund\u00e6r Kan inducere apoptose.<\/td><td class=\"column-4\">Cat&#8217;s Claw<\/td><td class=\"column-5\">(4) (D) Anti-inflammatorisk \/ Sekund\u00e6r Kan inducere apoptose.<\/td><td class=\"column-6\">(4) (D) Anti-inflammatorisk \/ Sekund\u00e6r Kan inducere apoptose.<\/td><td class=\"column-7\">Cat&#8217;s Claw<\/td><td class=\"column-8\">(4) (D) Anti-inflammatorisk \/ Sekund\u00e6r Kan inducere apoptose.<\/td><td class=\"column-9\">(4) (D) Anti-inflammatorisk \/ Sekund\u00e6r Kan inducere apoptose.<\/td><td class=\"column-10\">Cat&#8217;s Claw<\/td><td class=\"column-11\">(4) (D) Anti-inflammatorisk \/ Sekund\u00e6r Kan inducere apoptose.<\/td><td class=\"column-12\">(4) (D) Anti-inflammatorisk \/ Sekund\u00e6r Kan inducere apoptose.<\/td><td class=\"column-13\">Cat&#8217;s Claw<\/td><td class=\"column-14\">(4) (D) Anti-inflammatorisk \/ Sekund\u00e6r Kan inducere apoptose.<\/td><td class=\"column-15\">(4) (D) Generel d\u00e6mpning af inflammation \/ Sekund\u00e6r D\u00e6mper stress.<\/td><td class=\"column-16\">Cat&#8217;s Claw<\/td>\n<\/tr>\n<tr class=\"row-23\">\n\t<td class=\"column-1\">Coenzym Q10<\/td><td class=\"column-2\">(4) (A (E)) St\u00f8tter mitokondrier \/ Sekund\u00e6r Beskytter mod oxidativ skade.<\/td><td class=\"column-3\">(4) (A) St\u00f8tter mitokondrier \/ Sekund\u00e6r Beskytter mod oxidativ skade.<\/td><td class=\"column-4\">Coenzym Q10<\/td><td class=\"column-5\">(4) (A) St\u00f8tter mitokondrier \/ Sekund\u00e6r Beskytter mod oxidativ skade.<\/td><td class=\"column-6\">(4) (A) St\u00f8tter mitokondrier \/ Sekund\u00e6r Beskytter mod oxidativ skade.<\/td><td class=\"column-7\">Coenzym Q10<\/td><td class=\"column-8\">(4) (A) St\u00f8tter mitokondrier \/ Sekund\u00e6r Beskytter mod oxidativ skade.<\/td><td class=\"column-9\">(4) (A) St\u00f8tter mitokondrier \/ Sekund\u00e6r Beskytter mod oxidativ skade.<\/td><td class=\"column-10\">Coenzym Q10<\/td><td class=\"column-11\">(4) (A) St\u00f8tter mitokondrier \/ Sekund\u00e6r Beskytter mod oxidativ skade.<\/td><td class=\"column-12\">(4) (A) St\u00f8tter mitokondrier \/ Sekund\u00e6r Beskytter mod oxidativ skade.<\/td><td class=\"column-13\">Coenzym Q10<\/td><td class=\"column-14\">(4) (A (E)) St\u00f8tter energiproduktion \/ Sekund\u00e6r Cellebeskyttelse.<\/td><td class=\"column-15\">(4) (A) Generel cellul\u00e6r energist\u00f8tte \/ Sekund\u00e6r Antioxidant.<\/td><td class=\"column-16\">Coenzym Q10<\/td>\n<\/tr>\n<tr class=\"row-24\">\n\t<td class=\"column-1\">Curcumin<\/td><td class=\"column-2\">(1) (D (A)) Hovedstrategi. H\u00e6mmer NF-kB, Wnt og v\u00e6kst \/ Sekund\u00e6r D\u00e6mper inflammation.<\/td><td class=\"column-3\">(1) (D (A)) Hovedstrategi. H\u00e6mmer NF-kB og st\u00f8tter immunforsvar \/ Sekund\u00e6r H\u00e6mmer v\u00e6kst.<\/td><td class=\"column-4\">Curcumin<\/td><td class=\"column-5\">(2) (A (D)) H\u00f8j Relevans. H\u00e6mmer v\u00e6kstveje \/ Sekund\u00e6r D\u00e6mper inflammation.<\/td><td class=\"column-6\">(2) (A (D)) H\u00f8j Relevans. H\u00e6mmer MAPK-vejen \/ Sekund\u00e6r D\u00e6mper inflammation.<\/td><td class=\"column-7\">Curcumin<\/td><td class=\"column-8\">(2) (A (D)) H\u00f8j Relevans. H\u00e6mmer PI3K\/Akt \/ Sekund\u00e6r D\u00e6mper inflammation.<\/td><td class=\"column-9\">(2) (A (D)) H\u00f8j Relevans. H\u00e6mmer mucin-produktion \/ Sekund\u00e6r D\u00e6mper inflammation.<\/td><td class=\"column-10\">Curcumin<\/td><td class=\"column-11\">(2) (D (A)) H\u00f8j Relevans. D\u00e6mper inflammation \/ Sekund\u00e6r H\u00e6mmer v\u00e6kst.<\/td><td class=\"column-12\">(1) (D (A)) Hovedstrategi. H\u00e6mmer Wnt og NF-kB \/ Sekund\u00e6r H\u00e6mmer v\u00e6kst.<\/td><td class=\"column-13\">Curcumin<\/td><td class=\"column-14\">(1) (D (A)) Hovedstrategi. H\u00e6mmer metastase \/ Sekund\u00e6r H\u00e6mmer angiogenese.<\/td><td class=\"column-15\">(1) (D (A)) Hovedstrategi. Rammer bet\u00e6ndelse \/ Sekund\u00e6r Rammer v\u00e6kst og blodforsyning.<\/td><td class=\"column-16\">Curcumin<\/td>\n<\/tr>\n<tr class=\"row-25\">\n\t<td class=\"column-1\">DIM \/ I3C<\/td><td class=\"column-2\">(2) (A (D)) H\u00f8j Relevans. H\u00e6mmer Wnt-signalvejen \/ Sekund\u00e6r D\u00e6mper inflammation.<\/td><td class=\"column-3\">(3) (A (D)) H\u00e6mmer v\u00e6kst \/ Sekund\u00e6r D\u00e6mper inflammation.<\/td><td class=\"column-4\">DIM \/ I3C<\/td><td class=\"column-5\">(3) (A (D)) H\u00e6mmer v\u00e6kst \/ Sekund\u00e6r D\u00e6mper inflammation.<\/td><td class=\"column-6\">(3) (A (D)) H\u00e6mmer v\u00e6kst \/ Sekund\u00e6r D\u00e6mper inflammation.<\/td><td class=\"column-7\">DIM \/ I3C<\/td><td class=\"column-8\">(3) (A (D)) H\u00e6mmer v\u00e6kst \/ Sekund\u00e6r D\u00e6mper inflammation.<\/td><td class=\"column-9\">(3) (A (D)) H\u00e6mmer v\u00e6kst \/ Sekund\u00e6r D\u00e6mper inflammation.<\/td><td class=\"column-10\">DIM \/ I3C<\/td><td class=\"column-11\">(3) (A (D)) H\u00e6mmer v\u00e6kst \/ Sekund\u00e6r D\u00e6mper inflammation.<\/td><td class=\"column-12\">(2) (A (D)) H\u00f8j Relevans. H\u00e6mmer Wnt \/ Sekund\u00e6r D\u00e6mper inflammation.<\/td><td class=\"column-13\">DIM \/ I3C<\/td><td class=\"column-14\">(3) (A (D)) H\u00e6mmer spredning \/ Sekund\u00e6r D\u00e6mper inflammation.<\/td><td class=\"column-15\">(3) (A (D)) Kan h\u00e6mme v\u00e6kstsignaler \/ Sekund\u00e6r D\u00e6mper bet\u00e6ndelse.<\/td><td class=\"column-16\">DIM \/ I3C<\/td>\n<\/tr>\n<tr class=\"row-26\">\n\t<td class=\"column-1\">EGCG (Gr\u00f8n te)<\/td><td class=\"column-2\">(2) (A (D)) H\u00f8j Relevans. H\u00e6mmer Wnt og glykolyse \/ Sekund\u00e6r H\u00e6mmer inflammation.<\/td><td class=\"column-3\">(3) (A (D)) H\u00e6mmer v\u00e6kst \/ Sekund\u00e6r H\u00e6mmer inflammation.<\/td><td class=\"column-4\">EGCG (Gr\u00f8n te)<\/td><td class=\"column-5\">(2) (A (C)) H\u00f8j Relevans. H\u00e6mmer MAPK og glykolyse \/ Sekund\u00e6r H\u00e6mmer v\u00e6kst.<\/td><td class=\"column-6\">(2) (A (C)) H\u00f8j Relevans. H\u00e6mmer MAPK og glykolyse \/ Sekund\u00e6r H\u00e6mmer v\u00e6kst.<\/td><td class=\"column-7\">EGCG (Gr\u00f8n te)<\/td><td class=\"column-8\">(2) (A (C)) H\u00f8j Relevans. H\u00e6mmer PI3K\/Akt \/ Sekund\u00e6r H\u00e6mmer sukker.<\/td><td class=\"column-9\">(3) (A (C)) H\u00e6mmer v\u00e6kst \/ Sekund\u00e6r H\u00e6mmer sukker.<\/td><td class=\"column-10\">EGCG (Gr\u00f8n te)<\/td><td class=\"column-11\">(2) (A (D)) H\u00f8j Relevans. H\u00e6mmer v\u00e6kst \/ Sekund\u00e6r D\u00e6mper inflammation.<\/td><td class=\"column-12\">(2) (A (D)) H\u00f8j Relevans. H\u00e6mmer Wnt \/ Sekund\u00e6r D\u00e6mper inflammation.<\/td><td class=\"column-13\">EGCG (Gr\u00f8n te)<\/td><td class=\"column-14\">(2) (A (C)) H\u00f8j Relevans. H\u00e6mmer metastase \/ Sekund\u00e6r H\u00e6mmer angiogenese.<\/td><td class=\"column-15\">(2) (A (D)) H\u00f8j Relevans. Rammer sukkerforbr\u00e6nding \/ Sekund\u00e6r H\u00e6mmer blodforsyning.<\/td><td class=\"column-16\">EGCG (Gr\u00f8n te)<\/td>\n<\/tr>\n<tr class=\"row-27\">\n\t<td class=\"column-1\">H\u00f8j-dosis Vitamin C (IV)<\/td><td class=\"column-2\">(3) (E (C)) Pro-oxidant effekt \/ Sekund\u00e6r H\u00e6mmer glykolyse.<\/td><td class=\"column-3\">(3) (E (C)) Pro-oxidant effekt \/ Sekund\u00e6r H\u00e6mmer glykolyse.<\/td><td class=\"column-4\">H\u00f8j-dosis Vitamin C (IV)<\/td><td class=\"column-5\">(1) (E (C)) Hovedstrategi. Skaber oxidativt stress i KRAS-celler \/ Sekund\u00e6r H\u00e6mmer glykolyse.<\/td><td class=\"column-6\">(1) (E (C)) Hovedstrategi. Skaber oxidativt stress i BRAF-celler \/ Sekund\u00e6r H\u00e6mmer glykolyse.<\/td><td class=\"column-7\">H\u00f8j-dosis Vitamin C (IV)<\/td><td class=\"column-8\">(2) (E (C)) H\u00f8j Relevans. Pro-oxidant effekt \/ Sekund\u00e6r H\u00e6mmer glykolyse.<\/td><td class=\"column-9\">(3) (E) Pro-oxidant effekt \/ Sekund\u00e6r Kan tr\u00e6nge gennem slim.<\/td><td class=\"column-10\">H\u00f8j-dosis Vitamin C (IV)<\/td><td class=\"column-11\">(2) (E) H\u00f8j Relevans. Pro-oxidant effekt \/ Sekund\u00e6r Skaber stress.<\/td><td class=\"column-12\">(2) (E) H\u00f8j Relevans. Pro-oxidant effekt \/ Sekund\u00e6r Skaber stress.<\/td><td class=\"column-13\">H\u00f8j-dosis Vitamin C (IV)<\/td><td class=\"column-14\">(2) (E (D)) H\u00f8j Relevans. Forbedrer livskvalitet \/ Sekund\u00e6r Pro-oxidant.<\/td><td class=\"column-15\">(1) (E (C)) Hovedstrategi. Skaber m\u00e5lrettet stress \/ Sekund\u00e6r Rammer energi.<\/td><td class=\"column-16\">H\u00f8j-dosis Vitamin C (IV)<\/td>\n<\/tr>\n<tr class=\"row-28\">\n\t<td class=\"column-1\">Ingef\u00e6r<\/td><td class=\"column-2\">(3) (D (E)) D\u00e6mper inflammation (NF-kB) \/ Sekund\u00e6r Kan inducere apoptose.<\/td><td class=\"column-3\">(3) (D) D\u00e6mper inflammation \/ Sekund\u00e6r Kan inducere apoptose.<\/td><td class=\"column-4\">Ingef\u00e6r<\/td><td class=\"column-5\">(4) (D) Anti-inflammatorisk \/ Sekund\u00e6r Kan inducere apoptose.<\/td><td class=\"column-6\">(4) (D) Anti-inflammatorisk \/ Sekund\u00e6r Kan inducere apoptose.<\/td><td class=\"column-7\">Ingef\u00e6r<\/td><td class=\"column-8\">(4) (D) Anti-inflammatorisk \/ Sekund\u00e6r Kan inducere apoptose.<\/td><td class=\"column-9\">(3) (D (E)) D\u00e6mper inflammation \/ Sekund\u00e6r Modvirker kvalme.<\/td><td class=\"column-10\">Ingef\u00e6r<\/td><td class=\"column-11\">(3) (D) D\u00e6mper inflammation \/ Sekund\u00e6r D\u00e6mper mikromilj\u00f8.<\/td><td class=\"column-12\">(3) (D) D\u00e6mper inflammation \/ Sekund\u00e6r D\u00e6mper v\u00e6kst.<\/td><td class=\"column-13\">Ingef\u00e6r<\/td><td class=\"column-14\">(3) (D (E)) Modvirker kvalme \/ Sekund\u00e6r D\u00e6mper inflammation.<\/td><td class=\"column-15\">(3) (D) D\u00e6mper inflammation \/ Sekund\u00e6r D\u00e6mper v\u00e6kst.<\/td><td class=\"column-16\">Ingef\u00e6r<\/td>\n<\/tr>\n<tr class=\"row-29\">\n\t<td class=\"column-1\">IP6 &amp; Inositol<\/td><td class=\"column-2\">(3) (A (C)) H\u00e6mmer v\u00e6kst \/ Sekund\u00e6r H\u00e6mmer angiogenese.<\/td><td class=\"column-3\">(5) (A) H\u00e6mmer celledeling \/ Sekund\u00e6r H\u00e6mmer angiogenese.<\/td><td class=\"column-4\">IP6 &amp; Inositol<\/td><td class=\"column-5\">(3) (A (C)) H\u00e6mmer v\u00e6kst \/ Sekund\u00e6r H\u00e6mmer glykolyse.<\/td><td class=\"column-6\">(3) (A (C)) H\u00e6mmer v\u00e6kst \/ Sekund\u00e6r H\u00e6mmer glykolyse.<\/td><td class=\"column-7\">IP6 &amp; Inositol<\/td><td class=\"column-8\">(3) (A (C)) H\u00e6mmer PI3K\/Akt \/ Sekund\u00e6r H\u00e6mmer glykolyse.<\/td><td class=\"column-9\">(4) (A) H\u00e6mmer proliferation \/ Sekund\u00e6r H\u00e6mmer angiogenese.<\/td><td class=\"column-10\">IP6 &amp; Inositol<\/td><td class=\"column-11\">(3) (A) H\u00e6mmer v\u00e6kst \/ Sekund\u00e6r H\u00e6mmer angiogenese.<\/td><td class=\"column-12\">(3) (A) H\u00e6mmer v\u00e6kst \/ Sekund\u00e6r H\u00e6mmer angiogenese.<\/td><td class=\"column-13\">IP6 &amp; Inositol<\/td><td class=\"column-14\">(3) (A (C)) H\u00e6mmer metastase (spredning) \/ Sekund\u00e6r H\u00e6mmer angiogenese.<\/td><td class=\"column-15\">(3) (A (C)) Kan h\u00e6mme v\u00e6kst \/ Sekund\u00e6r P\u00e5virker sukkermetabolisme.<\/td><td class=\"column-16\">IP6 &amp; Inositol<\/td>\n<\/tr>\n<tr class=\"row-30\">\n\t<td class=\"column-1\">L\u00f8vetandrod<\/td><td class=\"column-2\">(3) (E) Inducerer apoptose \/ Sekund\u00e6r Stresser cellen.<\/td><td class=\"column-3\">(5) (E) Inducerer apoptose \/ Sekund\u00e6r Inducerer autofagi.<\/td><td class=\"column-4\">L\u00f8vetandrod<\/td><td class=\"column-5\">(3) (E) Inducerer apoptose \/ Sekund\u00e6r Stresser cellen.<\/td><td class=\"column-6\">(3) (E) Inducerer apoptose \/ Sekund\u00e6r Stresser cellen.<\/td><td class=\"column-7\">L\u00f8vetandrod<\/td><td class=\"column-8\">(3) (E) Inducerer apoptose \/ Sekund\u00e6r Stresser cellen.<\/td><td class=\"column-9\">(4) (E) Inducerer apoptose \/ Sekund\u00e6r Inducerer autofagi.<\/td><td class=\"column-10\">L\u00f8vetandrod<\/td><td class=\"column-11\">(3) (E) Inducerer apoptose \/ Sekund\u00e6r Stresser cellen.<\/td><td class=\"column-12\">(3) (E) Inducerer apoptose \/ Sekund\u00e6r Stresser cellen.<\/td><td class=\"column-13\">L\u00f8vetandrod<\/td><td class=\"column-14\">(3) (E (B)) Inducerer apoptose \/ Sekund\u00e6r Inducerer autofagi.<\/td><td class=\"column-15\">(3) (E (B)) Kan fremme celled\u00f8d \/ Sekund\u00e6r Stresser cellen.<\/td><td class=\"column-16\">L\u00f8vetandrod<\/td>\n<\/tr>\n<tr class=\"row-31\">\n\t<td class=\"column-1\">Maitake<\/td><td class=\"column-2\">(3) (D (E)) Immun-modulerende \/ Sekund\u00e6r Kan inducere apoptose.<\/td><td class=\"column-3\">(3) (D) Immun-modulerende \/ Sekund\u00e6r St\u00f8tter immunsystem.<\/td><td class=\"column-4\">Maitake<\/td><td class=\"column-5\">(4) (D) Immun-modulerende \/ Sekund\u00e6r Kan inducere apoptose.<\/td><td class=\"column-6\">(4) (D) Immun-modulerende \/ Sekund\u00e6r Kan inducere apoptose.<\/td><td class=\"column-7\">Maitake<\/td><td class=\"column-8\">(4) (D) Immun-modulerende \/ Sekund\u00e6r Kan inducere apoptose.<\/td><td class=\"column-9\">(3) (D) Underst\u00f8ttende. Vigtig immunst\u00f8tte (virus-link) \/ Sekund\u00e6r Styrker NK-celler.<\/td><td class=\"column-10\">Maitake<\/td><td class=\"column-11\">(4) (D) Immun-modulerende \/ Sekund\u00e6r Styrker NK-celler.<\/td><td class=\"column-12\">(4) (D) Generel immunst\u00f8tte \/ Sekund\u00e6r Styrker kroppens forsvar.<\/td><td class=\"column-13\">Maitake<\/td><td class=\"column-14\">(4) (D) Immun-modulerende \/ Sekund\u00e6r Kan inducere apoptose.<\/td><td class=\"column-15\">(4) (D) Generel immunst\u00f8tte \/ Sekund\u00e6r Kan fremme celled\u00f8d.<\/td><td class=\"column-16\">Maitake<\/td>\n<\/tr>\n<tr class=\"row-32\">\n\t<td class=\"column-1\">Marietidsel (Silymarin)<\/td><td class=\"column-2\">(3) (D (A)) H\u00e6mmer STAT3 \/ Sekund\u00e6r St\u00f8tter leveren.<\/td><td class=\"column-3\">(4) (D) Leverbeskyttende \/ Sekund\u00e6r H\u00e6mmer STAT3.<\/td><td class=\"column-4\">Marietidsel (Silymarin)<\/td><td class=\"column-5\">(4) (D) Leverbeskyttende \/ Sekund\u00e6r H\u00e6mmer STAT3.<\/td><td class=\"column-6\">(4) (D) Leverbeskyttende \/ Sekund\u00e6r H\u00e6mmer STAT3.<\/td><td class=\"column-7\">Marietidsel (Silymarin)<\/td><td class=\"column-8\">(4) (D) Leverbeskyttende \/ Sekund\u00e6r H\u00e6mmer STAT3.<\/td><td class=\"column-9\">(4) (D) Leverbeskyttende \/ Sekund\u00e6r H\u00e6mmer STAT3.<\/td><td class=\"column-10\">Marietidsel (Silymarin)<\/td><td class=\"column-11\">(3) (D (A)) Beskytter leveren \/ Sekund\u00e6r D\u00e6mper v\u00e6kstsignaler.<\/td><td class=\"column-12\">(3) (D (A)) Leverbeskyttelse \/ Sekund\u00e6r D\u00e6mpning af inflammation.<\/td><td class=\"column-13\">Marietidsel (Silymarin)<\/td><td class=\"column-14\">(3) (D (A)) Beskytter leveren \/ Sekund\u00e6r D\u00e6mper v\u00e6kstsignaler.<\/td><td class=\"column-15\">(3) (D (A)) Leverbeskyttelse \/ Sekund\u00e6r D\u00e6mpning af inflammation.<\/td><td class=\"column-16\">Marietidsel (Silymarin)<\/td>\n<\/tr>\n<tr class=\"row-33\">\n\t<td class=\"column-1\">Melatonin<\/td><td class=\"column-2\">(2) (A (D)) H\u00f8j Relevans. H\u00e6mmer v\u00e6kst \/ Sekund\u00e6r St\u00f8tter immunforsvar.<\/td><td class=\"column-3\">(2) (A (D)) H\u00f8j Relevans. H\u00e6mmer invasion \/ Sekund\u00e6r St\u00f8tter immunforsvar.<\/td><td class=\"column-4\">Melatonin<\/td><td class=\"column-5\">(3) (A) H\u00e6mmer proliferation \/ Sekund\u00e6r St\u00f8tter immunforsvar.<\/td><td class=\"column-6\">(3) (A) H\u00e6mmer proliferation \/ Sekund\u00e6r St\u00f8tter immunforsvar.<\/td><td class=\"column-7\">Melatonin<\/td><td class=\"column-8\">(3) (A) H\u00e6mmer proliferation \/ Sekund\u00e6r St\u00f8tter immunforsvar.<\/td><td class=\"column-9\">(3) (A) H\u00e6mmer v\u00e6kst \/ Sekund\u00e6r Forbedrer s\u00f8vn.<\/td><td class=\"column-10\">Melatonin<\/td><td class=\"column-11\">(2) (D (A)) H\u00f8j Relevans. Forbedrer s\u00f8vn \/ Sekund\u00e6r H\u00e6mmer v\u00e6kst.<\/td><td class=\"column-12\">(2) (A (D)) H\u00f8j Relevans. Generel v\u00e6ksth\u00e6mmende effekt \/ Sekund\u00e6r Immunst\u00f8tte.<\/td><td class=\"column-13\">Melatonin<\/td><td class=\"column-14\">(2) (D (A)) H\u00f8j Relevans. Forbedrer s\u00f8vn og livskvalitet \/ Sekund\u00e6r H\u00e6mmer v\u00e6kst.<\/td><td class=\"column-15\">(2) (A (D)) H\u00f8j Relevans. V\u00e6ksth\u00e6mning og immunst\u00f8tte.<\/td><td class=\"column-16\">Melatonin<\/td>\n<\/tr>\n<tr class=\"row-34\">\n\t<td class=\"column-1\">Modificeret Citrus Pectin (MCP)<\/td><td class=\"column-2\">(2) (A (D)) H\u00f8j Relevans. H\u00e6mmer Galectin-3 (spredning) \/ Sekund\u00e6r D\u00e6mper inflammation.<\/td><td class=\"column-3\">(2) (A (D)) H\u00f8j Relevans. H\u00e6mmer Galectin-3 (invasion) \/ Sekund\u00e6r D\u00e6mper inflammation.<\/td><td class=\"column-4\">Modificeret Citrus Pectin (MCP)<\/td><td class=\"column-5\">(4) (A) H\u00e6mmer metastase-protein \/ Sekund\u00e6r D\u00e6mper inflammation.<\/td><td class=\"column-6\">(4) (A) H\u00e6mmer metastase-protein \/ Sekund\u00e6r D\u00e6mper inflammation.<\/td><td class=\"column-7\">Modificeret Citrus Pectin (MCP)<\/td><td class=\"column-8\">(3) (A) H\u00e6mmer Galectin-3 \/ Sekund\u00e6r D\u00e6mper inflammation.<\/td><td class=\"column-9\">(3) (A) H\u00e6mmer Galectin-3 \/ Sekund\u00e6r D\u00e6mper inflammation.<\/td><td class=\"column-10\">Modificeret Citrus Pectin (MCP)<\/td><td class=\"column-11\">(2) (A (D)) H\u00f8j Relevans. H\u00e6mmer metastase \/ Sekund\u00e6r H\u00e6mmer fibrose.<\/td><td class=\"column-12\">(2) (A (D)) H\u00f8j Relevans. Blokerer kr\u00e6ftens evne til at sprede sig \/ Sekund\u00e6r D\u00e6mper inflammation.<\/td><td class=\"column-13\">Modificeret Citrus Pectin (MCP)<\/td><td class=\"column-14\">(2) (A (D)) H\u00f8j Relevans. H\u00e6mmer metastase \/ Sekund\u00e6r D\u00e6mper inflammation.<\/td><td class=\"column-15\">(2) (A (D)) H\u00f8j Relevans. Blokerer spredning \/ Sekund\u00e6r D\u00e6mper inflammation.<\/td><td class=\"column-16\">Modificeret Citrus Pectin (MCP)<\/td>\n<\/tr>\n<tr class=\"row-35\">\n\t<td class=\"column-1\">N-acetyl-cystein (NAC)<\/td><td class=\"column-2\">(4) (E) \u00d8ger glutathion \/ Sekund\u00e6r Kan beskytte raske celler.<\/td><td class=\"column-3\">(4) (E) \u00d8ger glutathion \/ Sekund\u00e6r Kan beskytte raske celler.<\/td><td class=\"column-4\">N-acetyl-cystein (NAC)<\/td><td class=\"column-5\">(4) (E) \u00d8ger glutathion \/ Sekund\u00e6r Kan beskytte raske celler.<\/td><td class=\"column-6\">(4) (E) \u00d8ger glutathion \/ Sekund\u00e6r Kan beskytte raske celler.<\/td><td class=\"column-7\">N-acetyl-cystein (NAC)<\/td><td class=\"column-8\">(4) (E) \u00d8ger glutathion \/ Sekund\u00e6r Kan beskytte raske celler.<\/td><td class=\"column-9\">(4) (E) \u00d8ger glutathion \/ Sekund\u00e6r Kan opl\u00f8se slim (mucin).<\/td><td class=\"column-10\">N-acetyl-cystein (NAC)<\/td><td class=\"column-11\">(4) (E) \u00d8ger glutathion \/ Sekund\u00e6r Kan beskytte raske celler.<\/td><td class=\"column-12\">(4) (E) \u00d8ger glutathion \/ Sekund\u00e6r Kan beskytte raske celler.<\/td><td class=\"column-13\">N-acetyl-cystein (NAC)<\/td><td class=\"column-14\">(4) (E) \u00d8ger glutathion \/ Sekund\u00e6r Kan beskytte raske celler.<\/td><td class=\"column-15\">(4) (E) Generel antioxidant-st\u00f8tte \/ Sekund\u00e6r Cellebeskyttelse.<\/td><td class=\"column-16\">N-acetyl-cystein (NAC)<\/td>\n<\/tr>\n<tr class=\"row-36\">\n\t<td class=\"column-1\">Omega-3 (Fiskeolie)<\/td><td class=\"column-2\">(1) (D (C)) Hovedstrategi. Modvirker kakeksi (v\u00e6gttab) \/ Sekund\u00e6r D\u00e6mper inflammation og angiogenese.<\/td><td class=\"column-3\">(3) (D (C)) St\u00e6rk anti-inflammatorisk \/ Sekund\u00e6r H\u00e6mmer angiogenese.<\/td><td class=\"column-4\">Omega-3 (Fiskeolie)<\/td><td class=\"column-5\">(3) (D (C)) Anti-inflammatorisk \/ Sekund\u00e6r H\u00e6mmer angiogenese.<\/td><td class=\"column-6\">(3) (D (C)) Anti-inflammatorisk \/ Sekund\u00e6r H\u00e6mmer angiogenese.<\/td><td class=\"column-7\">Omega-3 (Fiskeolie)<\/td><td class=\"column-8\">(2) (D (C)) H\u00f8j Relevans. D\u00e6mper inflammation ved GEJ \/ Sekund\u00e6r H\u00e6mmer angiogenese.<\/td><td class=\"column-9\">(3) (D (C)) Anti-inflammatorisk \/ Sekund\u00e6r H\u00e6mmer angiogenese.<\/td><td class=\"column-10\">Omega-3 (Fiskeolie)<\/td><td class=\"column-11\">(1) (D (C)) Hovedstrategi. Vital for at bremse v\u00e6gttab \/ Sekund\u00e6r D\u00e6mper inflammation.<\/td><td class=\"column-12\">(1) (D (C)) Hovedstrategi. D\u00e6mper inflammation \/ Sekund\u00e6r Modvirker v\u00e6gttab.<\/td><td class=\"column-13\">Omega-3 (Fiskeolie)<\/td><td class=\"column-14\">(1) (D (C)) Hovedstrategi. Modvirker kakeksi \/ Sekund\u00e6r D\u00e6mper inflammation.<\/td><td class=\"column-15\">(1) (D (C)) Hovedstrategi. D\u00e6mper inflammation \/ Sekund\u00e6r Modvirker v\u00e6gttab.<\/td><td class=\"column-16\">Omega-3 (Fiskeolie)<\/td>\n<\/tr>\n<tr class=\"row-37\">\n\t<td class=\"column-1\">Pau D&#8217;Arco<\/td><td class=\"column-2\">(3) (E (C)) Inducerer apoptose via NQO1 \/ Sekund\u00e6r H\u00e6mmer angiogenese.<\/td><td class=\"column-3\">(5) (E) Cytotoksisk \/ Sekund\u00e6r H\u00e6mmer angiogenese.<\/td><td class=\"column-4\">Pau D&#8217;Arco<\/td><td class=\"column-5\">(5) (E) Cytotoksisk \/ Sekund\u00e6r H\u00e6mmer angiogenese.<\/td><td class=\"column-6\">(5) (E) Cytotoksisk \/ Sekund\u00e6r H\u00e6mmer angiogenese.<\/td><td class=\"column-7\">Pau D&#8217;Arco<\/td><td class=\"column-8\">(5) (E) Cytotoksisk \/ Sekund\u00e6r H\u00e6mmer angiogenese.<\/td><td class=\"column-9\">(5) (E) Cytotoksisk \/ Sekund\u00e6r H\u00e6mmer angiogenese.<\/td><td class=\"column-10\">Pau D&#8217;Arco<\/td><td class=\"column-11\">(4) (E (C)) Celledr\u00e6bende effekt \/ Sekund\u00e6r H\u00e6mmer kar.<\/td><td class=\"column-12\">(3) (E (C)) Kan fremme celled\u00f8d \/ Sekund\u00e6r H\u00e6mmer blodkar.<\/td><td class=\"column-13\">Pau D&#8217;Arco<\/td><td class=\"column-14\">(3) (E (C)) Inducerer apoptose \/ Sekund\u00e6r H\u00e6mmer angiogenese.<\/td><td class=\"column-15\">(3) (E (C)) Kan fremme celled\u00f8d \/ Sekund\u00e6r H\u00e6mmer blodkar.<\/td><td class=\"column-16\">Pau D&#8217;Arco<\/td>\n<\/tr>\n<tr class=\"row-38\">\n\t<td class=\"column-1\">Probiotika<\/td><td class=\"column-2\">(2) (D (E)) H\u00f8j Relevans. Tarmfloraen p\u00e5virker PDAC-udvikling \/ Sekund\u00e6r Modulerer inflammation.<\/td><td class=\"column-3\">(1) (D (E)) Hovedstrategi. Afg\u00f8rende for effekt af immunterapi \/ Sekund\u00e6r D\u00e6mper inflammation.<\/td><td class=\"column-4\">Probiotika<\/td><td class=\"column-5\">(3) (D) Generel immunst\u00f8tte \/ Sekund\u00e6r Modulerer inflammation.<\/td><td class=\"column-6\">(3) (D) Tarm-sundhed \/ Sekund\u00e6r Modulerer inflammation.<\/td><td class=\"column-7\">Probiotika<\/td><td class=\"column-8\">(3) (D) Tarm-sundhed \/ Sekund\u00e6r Modulerer inflammation.<\/td><td class=\"column-9\">(3) (D) Tarm-sundhed \/ Sekund\u00e6r Modulerer inflammation.<\/td><td class=\"column-10\">Probiotika<\/td><td class=\"column-11\">(2) (D (E)) H\u00f8j Relevans. St\u00f8tter immunforsvar (h\u00f8jresidig) \/ Sekund\u00e6r D\u00e6mper inflammation.<\/td><td class=\"column-12\">(3) (D) St\u00f8tter immunforsvar \/ Sekund\u00e6r D\u00e6mper inflammation.<\/td><td class=\"column-13\">Probiotika<\/td><td class=\"column-14\">(2) (D (E)) H\u00f8j Relevans. D\u00e6mper systemisk inflammation \/ Sekund\u00e6r St\u00f8tter immunforsvar.<\/td><td class=\"column-15\">(2) (D (E)) H\u00f8j Relevans. Optimerer immunforsvar \/ Sekund\u00e6r D\u00e6mper inflammation.<\/td><td class=\"column-16\">Probiotika<\/td>\n<\/tr>\n<tr class=\"row-39\">\n\t<td class=\"column-1\">Quercetin<\/td><td class=\"column-2\">(2) (A (C)) H\u00f8j Relevans. H\u00e6mmer glykolyse (sukker) \/ Sekund\u00e6r H\u00e6mmer stroma.<\/td><td class=\"column-3\">(3) (E (A)) Inducerer apoptose \/ Sekund\u00e6r H\u00e6mmer v\u00e6kst.<\/td><td class=\"column-4\">Quercetin<\/td><td class=\"column-5\">(3) (E) Inducerer apoptose \/ Sekund\u00e6r H\u00e6mmer v\u00e6kst.<\/td><td class=\"column-6\">(3) (A) H\u00e6mmer v\u00e6kst \/ Sekund\u00e6r H\u00e6mmer angiogenese.<\/td><td class=\"column-7\">Quercetin<\/td><td class=\"column-8\">(2) (A) H\u00f8j Relevans. H\u00e6mmer Wnt-signalvejen \/ Sekund\u00e6r H\u00e6mmer angiogenese.<\/td><td class=\"column-9\">(3) (D (C)) Anti-inflammatorisk \/ Sekund\u00e6r H\u00e6mmer angiogenese.<\/td><td class=\"column-10\">Quercetin<\/td><td class=\"column-11\">(2) (A (C)) H\u00f8j Relevans. H\u00e6mmer v\u00e6kst og sukkeroptag \/ Sekund\u00e6r H\u00e6mmer blodkar.<\/td><td class=\"column-12\">(2) (A) H\u00f8j Relevans. H\u00e6mmer Wnt \/ Sekund\u00e6r H\u00e6mmer v\u00e6kst.<\/td><td class=\"column-13\">Quercetin<\/td><td class=\"column-14\">(3) (D (C)) Anti-inflammatorisk \/ Sekund\u00e6r H\u00e6mmer angiogenese.<\/td><td class=\"column-15\">(2) (A (C)) H\u00f8j Relevans. H\u00e6mmer v\u00e6kst \/ Sekund\u00e6r H\u00e6mmer blodkar.<\/td><td class=\"column-16\">Quercetin<\/td>\n<\/tr>\n<tr class=\"row-40\">\n\t<td class=\"column-1\">Resveratrol<\/td><td class=\"column-2\">(2) (A (C)) H\u00f8j Relevans. H\u00e6mmer glykolyse (sukker) \/ Sekund\u00e6r H\u00e6mmer KRAS-veje.<\/td><td class=\"column-3\">(3) (E (A)) Inducerer apoptose \/ Sekund\u00e6r H\u00e6mmer v\u00e6kst.<\/td><td class=\"column-4\">Resveratrol<\/td><td class=\"column-5\">(3) (E) Inducerer apoptose \/ Sekund\u00e6r H\u00e6mmer v\u00e6kst.<\/td><td class=\"column-6\">(3) (A) H\u00e6mmer v\u00e6kst \/ Sekund\u00e6r H\u00e6mmer angiogenese.<\/td><td class=\"column-7\">Resveratrol<\/td><td class=\"column-8\">(2) (A) H\u00f8j Relevans. H\u00e6mmer Wnt-signalvejen \/ Sekund\u00e6r H\u00e6mmer angiogenese.<\/td><td class=\"column-9\">(3) (A (C)) H\u00e6mmer metastase \/ Sekund\u00e6r H\u00e6mmer blodkar.<\/td><td class=\"column-10\">Resveratrol<\/td><td class=\"column-11\">(2) (A (C)) H\u00f8j Relevans. H\u00e6mmer v\u00e6kst \/ Sekund\u00e6r D\u00e6mper inflammation.<\/td><td class=\"column-12\">(2) (A) H\u00f8j Relevans. H\u00e6mmer Wnt \/ Sekund\u00e6r H\u00e6mmer v\u00e6kst.<\/td><td class=\"column-13\">Resveratrol<\/td><td class=\"column-14\">(3) (A (C)) H\u00e6mmer metastase \/ Sekund\u00e6r H\u00e6mmer blodkar.<\/td><td class=\"column-15\">(2) (A (C)) H\u00f8j Relevans. H\u00e6mmer v\u00e6kst \/ Sekund\u00e6r D\u00e6mper inflammation.<\/td><td class=\"column-16\">Resveratrol<\/td>\n<\/tr>\n<tr class=\"row-41\">\n\t<td class=\"column-1\">Selen<\/td><td class=\"column-2\">(3) (E (D)) Vigtig antioxidant \/ Sekund\u00e6r D\u00e6mper inflammation.<\/td><td class=\"column-3\">(4) (E) Vigtig antioxidant \/ Sekund\u00e6r D\u00e6mper inflammation.<\/td><td class=\"column-4\">Selen<\/td><td class=\"column-5\">(4) (E) Vigtig antioxidant \/ Sekund\u00e6r D\u00e6mper inflammation.<\/td><td class=\"column-6\">(4) (E) Vigtig antioxidant \/ Sekund\u00e6r D\u00e6mper inflammation.<\/td><td class=\"column-7\">Selen<\/td><td class=\"column-8\">(4) (E) Vigtig antioxidant \/ Sekund\u00e6r D\u00e6mper inflammation.<\/td><td class=\"column-9\">(4) (E) Vigtig antioxidant \/ Sekund\u00e6r D\u00e6mper inflammation.<\/td><td class=\"column-10\">Selen<\/td><td class=\"column-11\">(4) (E) Vigtig antioxidant \/ Sekund\u00e6r D\u00e6mper inflammation.<\/td><td class=\"column-12\">(4) (E) Vigtig antioxidant \/ Sekund\u00e6r D\u00e6mper inflammation.<\/td><td class=\"column-13\">Selen<\/td><td class=\"column-14\">(4) (E) Vigtig for immunfunktion \/ Sekund\u00e6r D\u00e6mper inflammation.<\/td><td class=\"column-15\">(4) (E (D)) Generel antioxidant-st\u00f8tte \/ Sekund\u00e6r St\u00f8tter immunforsvar.<\/td><td class=\"column-16\">Selen<\/td>\n<\/tr>\n<tr class=\"row-42\">\n\t<td class=\"column-1\">Sort Valn\u00f8d (Juglone)<\/td><td class=\"column-2\">(3) (E (A)) Celledr\u00e6bende effekt (stress) \/ Sekund\u00e6r H\u00e6mmer v\u00e6kst.<\/td><td class=\"column-3\">(5) (E) Cytotoksisk \/ Sekund\u00e6r H\u00e6mmer v\u00e6kst.<\/td><td class=\"column-4\">Sort Valn\u00f8d (Juglone)<\/td><td class=\"column-5\">(5) (E) Cytotoksisk \/ Sekund\u00e6r H\u00e6mmer v\u00e6kst.<\/td><td class=\"column-6\">(5) (E) Cytotoksisk \/ Sekund\u00e6r H\u00e6mmer v\u00e6kst.<\/td><td class=\"column-7\">Sort Valn\u00f8d (Juglone)<\/td><td class=\"column-8\">(5) (E) Cytotoksisk \/ Sekund\u00e6r H\u00e6mmer v\u00e6kst.<\/td><td class=\"column-9\">(5) (E) Cytotoksisk \/ Sekund\u00e6r H\u00e6mmer v\u00e6kst.<\/td><td class=\"column-10\">Sort Valn\u00f8d (Juglone)<\/td><td class=\"column-11\">(4) (E) Celledr\u00e6bende effekt \/ Sekund\u00e6r H\u00e6mmer v\u00e6kst.<\/td><td class=\"column-12\">(4) (E) Celledr\u00e6bende effekt \/ Sekund\u00e6r H\u00e6mmer v\u00e6kst.<\/td><td class=\"column-13\">Sort Valn\u00f8d (Juglone)<\/td><td class=\"column-14\">(4) (E) Celledr\u00e6bende effekt \/ Sekund\u00e6r H\u00e6mmer v\u00e6kst.<\/td><td class=\"column-15\">(3) (E (A)) Kan fremme celled\u00f8d \/ Sekund\u00e6r H\u00e6mmer v\u00e6kst.<\/td><td class=\"column-16\">Sort Valn\u00f8d (Juglone)<\/td>\n<\/tr>\n<tr class=\"row-43\">\n\t<td class=\"column-1\">Sulforaphane<\/td><td class=\"column-2\">(2) (A (D)) H\u00f8j Relevans. Rammer kr\u00e6ftstamceller \/ Sekund\u00e6r H\u00e6mmer NF-kB (bet\u00e6ndelse).<\/td><td class=\"column-3\">(3) (A (E)) H\u00e6mmer v\u00e6kst \/ Sekund\u00e6r Inducerer apoptose.<\/td><td class=\"column-4\">Sulforaphane<\/td><td class=\"column-5\">(3) (A) H\u00e6mmer v\u00e6kst \/ Sekund\u00e6r Inducerer apoptose.<\/td><td class=\"column-6\">(3) (A) H\u00e6mmer v\u00e6kst \/ Sekund\u00e6r Inducerer apoptose.<\/td><td class=\"column-7\">Sulforaphane<\/td><td class=\"column-8\">(3) (A) H\u00e6mmer v\u00e6kst \/ Sekund\u00e6r Inducerer apoptose.<\/td><td class=\"column-9\">(3) (A) H\u00e6mmer v\u00e6kst \/ Sekund\u00e6r Inducerer apoptose.<\/td><td class=\"column-10\">Sulforaphane<\/td><td class=\"column-11\">(2) (A (E)) H\u00f8j Relevans. Rammer resistente celler \/ Sekund\u00e6r Rammer stamceller.<\/td><td class=\"column-12\">(2) (A (D)) H\u00f8j Relevans. Rammer stamceller \/ Sekund\u00e6r D\u00e6mper bet\u00e6ndelse.<\/td><td class=\"column-13\">Sulforaphane<\/td><td class=\"column-14\">(2) (A (E)) H\u00f8j Relevans. Rammer resistente celler \/ Sekund\u00e6r Rammer stamceller.<\/td><td class=\"column-15\">(2) (A (D)) H\u00f8j Relevans. Rammer stamceller \/ Sekund\u00e6r D\u00e6mper bet\u00e6ndelse.<\/td><td class=\"column-16\">Sulforaphane<\/td>\n<\/tr>\n<tr class=\"row-44\">\n\t<td class=\"column-1\">Turkey Tail<\/td><td class=\"column-2\">(2) (D (A)) H\u00f8j Relevans. Styrker immunrespons (PSP\/PSK) \/ Sekund\u00e6r Kan h\u00e6mme v\u00e6kst.<\/td><td class=\"column-3\">(1) (D) Hovedstrategi. Styrker immunrespons (vigtig ved MSI) \/ Sekund\u00e6r D\u00e6mper inflammation.<\/td><td class=\"column-4\">Turkey Tail<\/td><td class=\"column-5\">(3) (D) Generel immunst\u00f8tte \/ Sekund\u00e6r Kan h\u00e6mme v\u00e6kst.<\/td><td class=\"column-6\">(3) (D) Generel immunst\u00f8tte \/ Sekund\u00e6r Kan h\u00e6mme v\u00e6kst.<\/td><td class=\"column-7\">Turkey Tail<\/td><td class=\"column-8\">(3) (D) Generel immunst\u00f8tte \/ Sekund\u00e6r Kan h\u00e6mme v\u00e6kst.<\/td><td class=\"column-9\">(3) (D) Generel immunst\u00f8tte \/ Sekund\u00e6r Kan h\u00e6mme v\u00e6kst.<\/td><td class=\"column-10\">Turkey Tail<\/td><td class=\"column-11\">(2) (D) H\u00f8j Relevans. Styrker immunforsvaret (h\u00f8jresidig) \/ Sekund\u00e6r D\u00e6mper inflammation.<\/td><td class=\"column-12\">(3) (D) St\u00f8tter immunforsvaret \/ Sekund\u00e6r Kan h\u00e6mme v\u00e6kst.<\/td><td class=\"column-13\">Turkey Tail<\/td><td class=\"column-14\">(2) (D) H\u00f8j Relevans. Immunst\u00f8tte ved sv\u00e6kkelse \/ Sekund\u00e6r Kan h\u00e6mme v\u00e6kst.<\/td><td class=\"column-15\">(2) (D (A)) H\u00f8j Relevans. St\u00e6rk immun-st\u00f8tte \/ Sekund\u00e6r Kan h\u00e6mme v\u00e6kst.<\/td><td class=\"column-16\">Turkey Tail<\/td>\n<\/tr>\n<tr class=\"row-45\">\n\t<td class=\"column-1\">Vitamin C (Oral)<\/td><td class=\"column-2\">(4) (E (D)) Generel antioxidant \/ Sekund\u00e6r Immunst\u00f8tte.<\/td><td class=\"column-3\">(4) (E) Generel antioxidant \/ Sekund\u00e6r Immunst\u00f8tte.<\/td><td class=\"column-4\">Vitamin C (Oral)<\/td><td class=\"column-5\">(4) (E) Generel antioxidant \/ Sekund\u00e6r Immunst\u00f8tte.<\/td><td class=\"column-6\">(4) (E) Generel antioxidant \/ Sekund\u00e6r Immunst\u00f8tte.<\/td><td class=\"column-7\">Vitamin C (Oral)<\/td><td class=\"column-8\">(4) (E) Generel antioxidant \/ Sekund\u00e6r Immunst\u00f8tte.<\/td><td class=\"column-9\">(4) (E) Generel antioxidant \/ Sekund\u00e6r Immunst\u00f8tte.<\/td><td class=\"column-10\">Vitamin C (Oral)<\/td><td class=\"column-11\">(4) (E) Generel antioxidant \/ Sekund\u00e6r Immunst\u00f8tte.<\/td><td class=\"column-12\">(4) (E) Generel antioxidant \/ Sekund\u00e6r Immunst\u00f8tte.<\/td><td class=\"column-13\">Vitamin C (Oral)<\/td><td class=\"column-14\">(4) (E) Generel antioxidant \/ Sekund\u00e6r Immunst\u00f8tte.<\/td><td class=\"column-15\">(4) (E (D)) Generel antioxidant-st\u00f8tte \/ Sekund\u00e6r St\u00f8tter immunforsvar.<\/td><td class=\"column-16\">Vitamin C (Oral)<\/td>\n<\/tr>\n<tr class=\"row-46\">\n\t<td class=\"column-1\">Vitamin D<\/td><td class=\"column-2\">(2) (D (A)) H\u00f8j Relevans. Lave niveauer er risikofaktor \/ Sekund\u00e6r H\u00e6mmer stroma.<\/td><td class=\"column-3\">(2) (A (D)) H\u00e6mmer PNET-v\u00e6kst \/ Sekund\u00e6r D\u00e6mper inflammation.<\/td><td class=\"column-4\">Vitamin D<\/td><td class=\"column-5\">(3) (D) Vigtig for immunfunktion \/ Sekund\u00e6r H\u00e6mmer v\u00e6kst.<\/td><td class=\"column-6\">(3) (D) Vigtig for immunfunktion \/ Sekund\u00e6r H\u00e6mmer v\u00e6kst.<\/td><td class=\"column-7\">Vitamin D<\/td><td class=\"column-8\">(3) (D) Vigtig for immunfunktion \/ Sekund\u00e6r H\u00e6mmer v\u00e6kst.<\/td><td class=\"column-9\">(3) (D) Vigtig for immunfunktion \/ Sekund\u00e6r H\u00e6mmer v\u00e6kst.<\/td><td class=\"column-10\">Vitamin D<\/td><td class=\"column-11\">(2) (D (A)) H\u00f8j Relevans. Styrker immunforsvaret \/ Sekund\u00e6r H\u00e6mmer v\u00e6kst.<\/td><td class=\"column-12\">(2) (D (A)) H\u00f8j Relevans. Styrker immunforsvaret \/ Sekund\u00e6r H\u00e6mmer v\u00e6kst.<\/td><td class=\"column-13\">Vitamin D<\/td><td class=\"column-14\">(2) (D (A)) H\u00f8j Relevans. Styrker knogler \/ Sekund\u00e6r H\u00e6mmer v\u00e6kst.<\/td><td class=\"column-15\">(2) (D (A)) H\u00f8j Relevans. Vigtig for immunforsvaret \/ Sekund\u00e6r V\u00e6kstkontrol.<\/td><td class=\"column-16\">Vitamin D<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<!-- #tablepress-67 from cache -->\n\n\n<h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Om_kraeft_i_tarmsystemet_%E2%80%93_typer\"><\/span><strong>Om kr\u00e6ft i tarmsystemet<\/strong> &#8211; typer<span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p class=\"wp-block-paragraph\">Ved metabolisk blokering af tarmkr\u00e6ft er afg\u00f8rende at kende sin tumors &#8220;personlighed&#8221; (biologi) og pr\u00e6cise placering, da det afg\u00f8r, hvilke signalveje der driver v\u00e6ksten.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">1. <strong>Standard adenokarcinom (MSS)<\/strong> <\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Den mest almindelige form. Den er mikrosatellit-stabil (MSS) (kr\u00e6ftcellerne ligner normale celler og snyder immunforsvaret) og drives ofte af den signalvej, der hedder Wnt-vejen (giver konstant ordre om at dele sig).<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">2. <strong>MSI-high (mikrosatellit instabil)<\/strong> <\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>En s\u00e6rlig type (ca. 15%), hvor kr\u00e6ftcellernes DNA er fyldt med fejl. Fordi cellerne derfor ser meget anderledes og &#8220;forkerte&#8221; ud, er de meget synlige for kroppens eget forsvar. Strategien her er derfor at maksimere immunforsvaret, da denne kr\u00e6ftform er den mest s\u00e5rbare over for et st\u00e6rkt immun-angreb.<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">3. <strong>KRAS-muteret<\/strong> <\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>En meget hyppig mutation (ca. 40%), der fungerer som en fastl\u00e5st speeder. Den g\u00f8r kr\u00e6ften aggressiv og resistent over for visse l\u00e6gemidler (EGFR-h\u00e6mmere). Denne type er meget afh\u00e6ngig af sukker og aminosyren glutamin.<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">4. <strong>BRAF-muteret<\/strong> <\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>En sj\u00e6ldnere (ca. 10%), men ofte meget aggressiv type. Den kr\u00e6ver en intens blokering af v\u00e6kst-signalvejen (MAPK) og er ofte s\u00e5rbar over for oxidativt stress (f.eks. fra C-vitamin).<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">5. <strong>PIK3CA-muteret<\/strong> <\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>En mutation (ca. 15-20%), der g\u00f8r cellen afh\u00e6ngig af PI3K\/Akt\/mTOR-vejen. Det er s\u00e6rligt interessant, fordi studier viser, at Aspirin (Hjertemagnyl) virker ekstra godt p\u00e5 netop denne type.<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">6. <strong>Mucin\u00f8s \/ signetringscelle<\/strong> <\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>En type, der producerer store m\u00e6ngder slim (mucin). Denne slim fungerer som et skjold, der g\u00f8r det sv\u00e6rt for medicin og immunceller at tr\u00e6nge ind til kr\u00e6ftcellerne.<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">7. <strong>H\u00f8jresidig tarmkr\u00e6ft<\/strong> <\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Kr\u00e6ft i den f\u00f8rste del af tarmen (C\u00e6cum\/Ascendens). Den er biologisk anderledes end venstresidig; den er oftere BRAF-muteret eller MSI-High og har et aktivt immun-milj\u00f8.<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">8. <strong>Venstresidig tarmkr\u00e6ft<\/strong> <\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Kr\u00e6ft i den sidste del af tarmen (Descendens\/ Sigmoideum\/ Rectum). Den er ofte drevet af v\u00e6kstfaktorer (EGFR) og Wnt-signalvejen (giver konstant ordre om at dele sig).<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">9. <strong>Metastatisk sygdom<\/strong> <\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>N\u00e5r kr\u00e6ften har spredt sig, oftest til leveren, lungerne eller bughinden. Fokus er p\u00e5 at forhindre kr\u00e6ftcellerne i at sl\u00e5 rod i de nye organer.<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">10. <strong>Generel strategi<\/strong> <\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Denne kolonne d\u00e6kker de grundl\u00e6ggende s\u00e5rbarheder ved tarmkr\u00e6ft (is\u00e6r inflammation og Wnt-vejen (giver konstant ordre om at dele sig)) og kan bruges, hvis du ikke kender din pr\u00e6cise undertype.<\/li>\n<\/ul>\n\n\n\n<h4 class=\"wp-block-heading\">Hvem kan hj\u00e6lpe<\/h4>\n\n\n\n<p class=\"wp-block-paragraph\">Her kan du f\u00e5 hj\u00e6lp til reporposed drugs (den receptpligtige del &#8211; egenbetaling) <a href=\"https:\/\/jegharkraeft.dk\/holistiske-laeger-dia\">Holistiske l\u00e6ger DK.<\/a><\/p>\n\n\n\n<h4 class=\"wp-block-heading\">Bem\u00e6rk<\/h4>\n\n\n\n<p class=\"wp-block-paragraph\">Du kan benytte ovenst\u00e5ende skema til at f\u00e5 indtryk af, hvilke repurposed drugs og kosttilskud, der principielt kan have en metabolisk gunstig virkning ved din kr\u00e6fttype.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">If\u00f8lge Warburg-effekten, kan en s\u00e5dan tilgang medvirke til at sulte kr\u00e6ften.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Hvis det f\u00f8les rigtigt for dig med denne tilgang, s\u00e5 dr\u00f8ft det med din behandler.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Se ogs\u00e5 <a href=\"https:\/\/jegharkraeft.dk\/metabolisk\/\">Kr\u00e6ft som Metabolisk lidelse<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Se ogs\u00e5 <a href=\"https:\/\/jegharkraeft.dk\/om-mitokondrier-forskning\/\">Om Mitokondrierne &#8211; hvad er det<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Se ogs\u00e5 <a href=\"https:\/\/jegharkraeft.dk\/det-skal-foeles-rigtigt\/\">Det skal f\u00f8les rigtigt<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Se ogs\u00e5 <a href=\"https:\/\/jegharkraeft.dk\/evidens\">Evidens vs Erfaring<\/a><a href=\"https:\/\/jegharkraeft.dk\/evidens\"><\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Se ogs\u00e5<a href=\"https:\/\/jegharkraeft.dk\/holistiske-laeger\"> Holistiske L\u00e6ger DK<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Se ogs\u00e5 <a href=\"https:\/\/jegharkraeft.dk\/tarmkraeft\/\">Tarmkr\u00e6ft<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Se ogs\u00e5 <a href=\"https:\/\/jegharkraeft.dk\/mavekraeft\/\">Mavekr\u00e6ft<\/a><\/p>\n\n\n\n<p class=\"has-custom-menu-links-color has-text-color has-link-color wp-elements-78958270cc4840b7bdca48105c79180e wp-block-paragraph\"><strong><a href=\"#menu\" data-type=\"internal\" data-id=\"#diagnose\">(Til menu)<\/a><\/strong><\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Siden oprettet:<\/strong><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">d. 12.11.25<\/p>\n\n\n\n<p class=\"has-text-align-center wp-block-paragraph\"><mark style=\"background-color:rgba(0, 0, 0, 0)\" class=\"has-inline-color has-custom-menu-links-color\">\u2764<\/mark><\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Hvad du l\u00e6ser p\u00e5 <\/strong><em><strong>Jeg har Kr\u00e6ft<\/strong><\/em><strong> er ikke en anbefaling. S\u00f8g kompetent vejledning.<\/strong><\/p>\n<\/div>\n<\/div>\n\n\n\n<div class=\"wp-block-group alignfull is-style-default has-global-padding is-layout-constrained wp-container-core-group-is-layout-b040ace0 wp-block-group-is-layout-constrained has-background\" style=\"margin-top:0;margin-bottom:0;padding-top:var(--wp--preset--spacing--60);padding-right:var(--wp--preset--spacing--20);padding-bottom:var(--wp--preset--spacing--60);padding-left:var(--wp--preset--spacing--20);background-image:url(&apos;https:\/\/jegharkraeft.dk\/wp-content\/uploads\/2025\/06\/Pathways4.jpg&apos;);background-size:cover;\">\n<div class=\"gb-element-ec73c46a\">\n<h2 class=\"wp-block-heading\" id=\"metabolisk-strategi\"><span class=\"ez-toc-section\" id=\"Metabolisk_strategi_Oversigt_1_%E2%80%93_Laegemidler\"><\/span>Metabolisk strategi<br>Oversigt 1 &#8211; L\u00e6gemidler<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Indhold:<\/strong><\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-a7b56640bc6f29c1ff4cc26f8551b8b9\"><a href=\"#resume\">Kort resum\u00e9<\/a> (rul til)<\/li>\n\n\n\n<li><a href=\"#1\">Kr\u00e6fttype &#8211; Skemaoversigt<\/a> (rul til)<\/li>\n\n\n\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-a8ce343188c02e7b5df27195b306424a\"><strong><a href=\"#skema-01\">L\u00e6gemidler &#8211; Oversigt 1<\/a> (scroll ned)<\/strong><\/li>\n\n\n\n<li><a href=\"#skema-02\">Kosttilskud &#8211; Oversigt 2<\/a> (rul til)<\/li>\n\n\n\n<li><a href=\"#links\">Links<\/a> (rul til)<\/li>\n<\/ul>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"skema-01\"><span class=\"ez-toc-section\" id=\"Oversigt_over_metabolisk_strategi_%E2%80%93_Laegemidler\"><\/span>Oversigt over metabolisk strategi &#8211; L\u00e6gemidler<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<figure class=\"wp-block-image size-thumbnail is-resized\"><img loading=\"lazy\" decoding=\"async\" width=\"150\" height=\"150\" src=\"https:\/\/jegharkraeft.dk\/wp-content\/uploads\/2025\/06\/Metaboliske-strategier-laegemidler-150x150.jpg\" alt=\"Metaboliske strategier - L\u00e6gemidler, symboliseret ved 6-7 forskellige piller - gule og hvide mod lys bl\u00e5 baggrund.\" class=\"wp-image-13111\" style=\"object-fit:cover;width:150px;height:150px\" srcset=\"https:\/\/jegharkraeft.dk\/wp-content\/uploads\/2025\/06\/Metaboliske-strategier-laegemidler-150x150.jpg 150w, https:\/\/jegharkraeft.dk\/wp-content\/uploads\/2025\/06\/Metaboliske-strategier-laegemidler-300x300.jpg 300w, https:\/\/jegharkraeft.dk\/wp-content\/uploads\/2025\/06\/Metaboliske-strategier-laegemidler-100x100.jpg 100w\" sizes=\"auto, (max-width: 150px) 100vw, 150px\" \/><\/figure>\n\n\n\n<h4 class=\"wp-block-heading has-custom-sort-tekst-color has-text-color has-link-color wp-elements-b4ac5a8661767c47241f99084089baf8\" id=\"skema-01\"><\/h4>\n\n\n<h2 id=\"tablepress-1-name\" class=\"tablepress-table-name tablepress-table-name-id-1\"><span class=\"ez-toc-section\" id=\"Oversigt_1_Repurposed_Drugs\"><\/span>Oversigt 1: Repurposed Drugs<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n<table id=\"tablepress-1\" class=\"tablepress tablepress-id-1\" aria-labelledby=\"tablepress-1-name\">\n<thead>\n<tr class=\"row-1\">\n\t<th class=\"column-1\">Stof<\/th><th class=\"column-2\">Type<\/th><th class=\"column-3\">Prim\u00e6r(e) mekanisme(r)<\/th><th class=\"column-4\">Potentielle synergier<\/th><th class=\"column-5\">Evidensniveau (vejledende)<\/th><th class=\"column-6\">Vigtige bem\u00e6rkninger<\/th>\n<\/tr>\n<\/thead>\n<tbody class=\"row-striping row-hover\">\n<tr class=\"row-2\">\n\t<td class=\"column-1\"><a href=\"#benzimidazoler\">Benzimidazoler (rul til)<\/a><\/td><td class=\"column-2\">Antiparasitika<\/td><td class=\"column-3\">H\u00e6mmer mikrotubuli (celledeling). Forstyrrer glukoseoptag.<\/td><td class=\"column-4\">Visse kemoterapier (f.eks. taxaner), DCA.<\/td><td class=\"column-5\">Prim\u00e6rt pr\u00e6klinisk. Mange case-rapporter.<\/td><td class=\"column-6\">Kan kr\u00e6ve h\u00f8je doser. Potentiel levertoksicitet.<\/td>\n<\/tr>\n<tr class=\"row-3\">\n\t<td class=\"column-1\"><a href=\"#celecoxib\">Celecoxib (rul til)<\/a><\/td><td class=\"column-2\">NSAID (Selektiv COX-2 h\u00e6mmer)<\/td><td class=\"column-3\">H\u00e6mmer COX-2 og PGE2. Blokerer AKT\/ERK signalveje.<\/td><td class=\"column-4\">Kemoterapi (f.eks. cisplatin), immunterapi.<\/td><td class=\"column-5\">Pr\u00e6klinisk, observationelle studier.<\/td><td class=\"column-6\">Obs p\u00e5 hjerte-kar risiko. Sk\u00e5nsom for maven.<\/td>\n<\/tr>\n<tr class=\"row-4\">\n\t<td class=\"column-1\"><a href=\"#desloratadin\">Desloratadin (rul til)<\/a><\/td><td class=\"column-2\">Antihistamin<\/td><td class=\"column-3\">H1-receptor-antagonist. Anti-inflammatorisk. Inducerer lysosomal celled\u00f8d.<\/td><td class=\"column-4\">Visse kemoterapier (f.eks. cisplatin), immunterapi.<\/td><td class=\"column-5\">Pr\u00e6klinisk, observationelle studier.<\/td><td class=\"column-6\">H\u00f8j sikkerhedsprofil. Ikke-sl\u00f8vende. En del af CAD-gruppen.<\/td>\n<\/tr>\n<tr class=\"row-5\">\n\t<td class=\"column-1\"><a href=\"#disulfiram\">Disulfiram (Antabus)(rul til)<\/a><\/td><td class=\"column-2\">Antabus<\/td><td class=\"column-3\">H\u00e6mmer ALDH-enzymet, vigtigt for kr\u00e6ftstamceller. Kr\u00e6ver kobber.<\/td><td class=\"column-4\">Kobber, visse kemoterapier.<\/td><td class=\"column-5\">Pr\u00e6klinisk. F\u00e5 tidlige kliniske studier.<\/td><td class=\"column-6\">M\u00e5 aldrig kombineres med alkohol.<\/td>\n<\/tr>\n<tr class=\"row-6\">\n\t<td class=\"column-1\"><a href=\"#dipyridamol\">Dipyridamol (rul til)<\/a><\/td><td class=\"column-2\">Blodfortyndende<\/td><td class=\"column-3\">H\u00e6mmer adenosin-optag, som ellers beskytter kr\u00e6ftceller mod immunsystemet.<\/td><td class=\"column-4\">Visse kemoterapier (f.eks. Methotrexat).<\/td><td class=\"column-5\">F\u00e5 \u00e6ldre studier.<\/td><td class=\"column-6\">Skal overv\u00e5ges, hvis man tager anden blodfortyndende medicin.<\/td>\n<\/tr>\n<tr class=\"row-7\">\n\t<td class=\"column-1\"><a href=\"#doxycyclin\">Doxycyclin (rul til)<\/a><\/td><td class=\"column-2\">Antibiotika<\/td><td class=\"column-3\">H\u00e6mmer mitokondriel proteinsyntese (rammer kr\u00e6ftstamceller).<\/td><td class=\"column-4\">H\u00f8jdosis Vit. C, Metformin.<\/td><td class=\"column-5\">Prim\u00e6rt pr\u00e6klinisk. Konceptuelt st\u00e6rkt.<\/td><td class=\"column-6\">Kan give lysf\u00f8lsomhed og p\u00e5virke tarmflora.<\/td>\n<\/tr>\n<tr class=\"row-8\">\n\t<td class=\"column-1\"><a href=\"#aspirin\">Hjertemagnyl (Aspirin) (rul til)<\/a><\/td><td class=\"column-2\">NSAID<\/td><td class=\"column-3\">Anti-inflammatorisk (COX-h\u00e6mning). P\u00e5virker blodplader.<\/td><td class=\"column-4\">Immunterapi, visse m\u00e5lrettede behandlinger.<\/td><td class=\"column-5\">St\u00e6rk evidens (is\u00e6r for tarmkr\u00e6ft).<\/td><td class=\"column-6\">Risiko for maves\u00e5r og bl\u00f8dning.<\/td>\n<\/tr>\n<tr class=\"row-9\">\n\t<td class=\"column-1\"><a href=\"#hydroxychloroquin\">Hydroxychloroquin (rul til)<\/a><\/td><td class=\"column-2\">Malaria-middel<\/td><td class=\"column-3\">H\u00e6mmer autofagi \u2013 mulighed for at benytte en overlevelsesmekanisme ved at genbruge celledele.<\/td><td class=\"column-4\">Mange kemo- &amp; m\u00e5lrettede terapier (ved at blokere resistens).<\/td><td class=\"column-5\">Mange kliniske studier, ofte med blandede resultater.<\/td><td class=\"column-6\">Kan have \u00f8jen- og hjertebivirkninger ved langtidsbrug.<\/td>\n<\/tr>\n<tr class=\"row-10\">\n\t<td class=\"column-1\"><a href=\"#ivermectin\">Ivermectin (rul til)<\/a><\/td><td class=\"column-2\">Antiparasitika<\/td><td class=\"column-3\">Flere foresl\u00e5ede mekanismer, bl.a. h\u00e6mning af WNT-signalering.<\/td><td class=\"column-4\">Visse kemoterapier (f.eks. taxaner).<\/td><td class=\"column-5\">Prim\u00e6rt pr\u00e6klinisk.<\/td><td class=\"column-6\">Kontroversielt. Kr\u00e6ver forsigtighed med dosering.<\/td>\n<\/tr>\n<tr class=\"row-11\">\n\t<td class=\"column-1\"><a href=\"#ldn\">Lav-dosis Naltrexon (LDN) (rul til)<\/a><\/td><td class=\"column-2\">Opiat-antagonist<\/td><td class=\"column-3\">Op-regulerer kroppens egne endorfiner og enkefaliner (immun-modulerende).<\/td><td class=\"column-4\">Immunterapi, visse kemoterapier (lav-dosis).<\/td><td class=\"column-5\">Prim\u00e6rt case-rapporter og mindre studier.<\/td><td class=\"column-6\">Meget f\u00e5 bivirkninger. M\u00e5 ikke tages med opioider.<\/td>\n<\/tr>\n<tr class=\"row-12\">\n\t<td class=\"column-1\"><a href=\"#metformin\">Metformin (rul til)<\/a><\/td><td class=\"column-2\">Diabetesmedicin<\/td><td class=\"column-3\">H\u00e6mmer komplekse I i mitokondrier, aktiverer AMPK, s\u00e6nker blodsukker\/insulin.<\/td><td class=\"column-4\">Glykolyse-h\u00e6mmere, mTOR-h\u00e6mmere, Statiner, kost (keto).<\/td><td class=\"column-5\">Meget st\u00e6rk evidens (pr\u00e6klinisk og epidemiologisk).<\/td><td class=\"column-6\">Meget sikker. Let maveubehag i starten.<\/td>\n<\/tr>\n<tr class=\"row-13\">\n\t<td class=\"column-1\"><a href=\"#propranolol\">Propranolol (rul til)<\/a><\/td><td class=\"column-2\">Betablokker<\/td><td class=\"column-3\">Blokerer beta-adrenerge receptorer (stress-signaler), h\u00e6mmer angiogenese.<\/td><td class=\"column-4\">Visse kemoterapier (f.eks. taxaner), anti-angiogene midler.<\/td><td class=\"column-5\">En del case-rapporter og mindre kliniske studier.<\/td><td class=\"column-6\">Kan give lavt blodtryk og puls.<\/td>\n<\/tr>\n<tr class=\"row-14\">\n\t<td class=\"column-1\"><a href=\"#statiner\">Statiner (rul til)<\/a><\/td><td class=\"column-2\">Kolesterols\u00e6nkende<\/td><td class=\"column-3\">H\u00e6mmer Mevalonat-vejen, vigtig for mange v\u00e6kstprocesser.<\/td><td class=\"column-4\">Metformin, PI3K\/Akt-h\u00e6mmere.<\/td><td class=\"column-5\">St\u00e6rk pr\u00e6klinisk og epidemiologisk evidens.<\/td><td class=\"column-6\">Kan give muskelsmerter.<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<!-- #tablepress-1 from cache -->\n\n\n<p class=\"wp-block-paragraph\"><strong>Oversigt 1:<\/strong> Her finder du en tabel for <a href=\"https:\/\/jegharkraeft.dk\/repurposed-drugs\/\">Repurposed Drugs<\/a> (genanvendte l\u00e6gemidler). Denne kan benyttes til at sl\u00e5 et specifikt stof op og hurtigt f\u00e5 et overordnet indtryk af dets virkningsmekanisme, evidens-niveau og evt. bem\u00e6rkninger.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Forts\u00e6ttes&#8230;<\/strong><a href=\"https:\/\/jegharkraeft.dk\/dr-vogl\"><\/a><\/p>\n\n\n\n<p class=\"has-custom-menu-links-color has-text-color has-link-color wp-elements-78958270cc4840b7bdca48105c79180e wp-block-paragraph\"><strong><a href=\"#menu\" data-type=\"internal\" data-id=\"#diagnose\">(Til menu)<\/a><\/strong><\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Siden oprettet:<\/strong><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">d. 10.06.25<\/p>\n\n\n\n<p class=\"has-text-align-center wp-block-paragraph\"><mark style=\"background-color:rgba(0, 0, 0, 0)\" class=\"has-inline-color has-custom-menu-links-color\">\u2764<\/mark><\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Hvad du l\u00e6ser p\u00e5 <\/strong><em><strong>Jeg har Kr\u00e6ft<\/strong><\/em><strong> er ikke en anbefaling. S\u00f8g kompetent vejledning.<\/strong><\/p>\n<\/div>\n<\/div>\n\n\n\n<div class=\"wp-block-group alignfull is-style-default has-global-padding is-layout-constrained wp-container-core-group-is-layout-b040ace0 wp-block-group-is-layout-constrained has-background\" style=\"margin-top:0;margin-bottom:0;padding-top:var(--wp--preset--spacing--60);padding-right:var(--wp--preset--spacing--20);padding-bottom:var(--wp--preset--spacing--60);padding-left:var(--wp--preset--spacing--20);background-image:url(&apos;https:\/\/jegharkraeft.dk\/wp-content\/uploads\/2025\/06\/Pathways4.jpg&apos;);background-size:cover;\">\n<div class=\"gb-element-1260d29f\">\n<h2 class=\"wp-block-heading\" id=\"metabolisk-strategi\"><span class=\"ez-toc-section\" id=\"Metabolisk_strategi_Kosttilskud_Oversigt_2\"><\/span>Metabolisk strategi<br>Kosttilskud Oversigt 2<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Indhold:<\/strong><\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-a7b56640bc6f29c1ff4cc26f8551b8b9\"><a href=\"#resume\">Kort resum\u00e9<\/a> (rul til)<\/li>\n\n\n\n<li><a href=\"#1\">Kr\u00e6fttype &#8211; Skemaoversigt<\/a> (rul til)<\/li>\n\n\n\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-db8ec2543cfa45b285b13ea99526f1ae\"><a href=\"#skema-01\">L\u00e6gemidler &#8211; Oversigt 1<\/a> (rul til)<\/li>\n\n\n\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-8ff09b67fb042210638c38bbd6215b3f\"><strong><a href=\"#skema-02\">Kosttilskud &#8211; Oversigt 2<\/a> (scroll ned)<\/strong><\/li>\n\n\n\n<li><a href=\"#links\">Links<\/a> (rul til)<\/li>\n<\/ul>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"skema-02\"><span class=\"ez-toc-section\" id=\"Oversigt_over_metabolisk_strategi_%E2%80%93_Kosttilskud\"><\/span>Oversigt over metabolisk strategi &#8211; Kosttilskud<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<figure class=\"wp-block-image size-thumbnail is-resized\"><img loading=\"lazy\" decoding=\"async\" width=\"150\" height=\"150\" src=\"https:\/\/jegharkraeft.dk\/wp-content\/uploads\/2025\/06\/Metaboliske-strategier34-150x150.jpg\" alt=\"Metabolisk strategi, Kosttilskud, symboliseret ved n\u00e6rbillede af ingef\u00e6rrod der ligger p\u00e5 bord. over en oversk\u00e5ret ingef\u00e6r. Foran en porcel\u00e6nsske med gurkemejefarvet pulver.\" class=\"wp-image-13104\" style=\"object-fit:cover;width:150px;height:150px\" srcset=\"https:\/\/jegharkraeft.dk\/wp-content\/uploads\/2025\/06\/Metaboliske-strategier34-150x150.jpg 150w, https:\/\/jegharkraeft.dk\/wp-content\/uploads\/2025\/06\/Metaboliske-strategier34-300x300.jpg 300w, https:\/\/jegharkraeft.dk\/wp-content\/uploads\/2025\/06\/Metaboliske-strategier34-100x100.jpg 100w\" sizes=\"auto, (max-width: 150px) 100vw, 150px\" \/><\/figure>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n<h2 id=\"tablepress-3-name\" class=\"tablepress-table-name tablepress-table-name-id-3\"><span class=\"ez-toc-section\" id=\"Oversigt_2_Kosttilskud\"><\/span>Oversigt 2: Kosttilskud<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n<table id=\"tablepress-3\" class=\"tablepress tablepress-id-3\" aria-labelledby=\"tablepress-3-name\">\n<thead>\n<tr class=\"row-1\">\n\t<th class=\"column-1\">Stof<\/th><th class=\"column-2\">Type<\/th><th class=\"column-3\">Prim\u00e6r(e) Mekanisme(r)<\/th><th class=\"column-4\">Potentielle Synergier<\/th><th class=\"column-5\">Evidensniveau (vejledende)<\/th><th class=\"column-6\">Vigtige Bem\u00e6rkninger<\/th>\n<\/tr>\n<\/thead>\n<tbody class=\"row-striping row-hover\">\n<tr class=\"row-2\">\n\t<td class=\"column-1\"><a href=\"#ahcc\">AHCC (rul til)<\/a><\/td><td class=\"column-2\">Svampeekstrakt<\/td><td class=\"column-3\">Immun-modulerende (\u00f8ger NK-celle aktivitet).<\/td><td class=\"column-4\">Kemoterapi (st\u00f8tte til immunforsvar), andre immun-modulatorer.<\/td><td class=\"column-5\">En del humane studier.<\/td><td class=\"column-6\">Meget sikker.<\/td>\n<\/tr>\n<tr class=\"row-3\">\n\t<td class=\"column-1\"><a href=\"#alfa-liponsyre\">Alfa-liponsyre (ALA) (rul til)<\/a><\/td><td class=\"column-2\">Antioxidant<\/td><td class=\"column-3\">Kraftig antioxidant. Forbedrer insulinf\u00f8lsomhed. P\u00e5virker glykolyse.<\/td><td class=\"column-4\">Metformin, andre antioxidanter.<\/td><td class=\"column-5\">Kliniske studier for neuropati. Stigende pr\u00e6klinisk kr\u00e6ftforskning.<\/td><td class=\"column-6\">Kan p\u00e5virke blodsukkeret.<\/td>\n<\/tr>\n<tr class=\"row-4\">\n\t<td class=\"column-1\"><a href=\"#apigenin\">Apigenin (rul til)<\/a><\/td><td class=\"column-2\">Flavonoid<\/td><td class=\"column-3\">Anti-inflammatorisk, h\u00e6mmer PI3K\/Akt-signalvejen, inducerer apoptose.<\/td><td class=\"column-4\">Visse kemoterapier (f.eks. Paclitaxel).<\/td><td class=\"column-5\">St\u00e6rk pr\u00e6klinisk evidens.<\/td><td class=\"column-6\">Findes i bl.a. persille og kamille.<\/td>\n<\/tr>\n<tr class=\"row-5\">\n\t<td class=\"column-1\"><a href=\"#artemisinin\">Artemisinin (rul til)<\/a><\/td><td class=\"column-2\">Urteekstrakt<\/td><td class=\"column-3\">Reagerer med jern i kr\u00e6ftceller og skaber oxidativt stress (ferroptose).<\/td><td class=\"column-4\">Jern, IV C-vitamin.<\/td><td class=\"column-5\">St\u00e6rk pr\u00e6klinisk evidens. Mindre humane studier.<\/td><td class=\"column-6\">Skal tages v\u00e6k fra antioxidanter. Pauser i indtag er n\u00f8dvendigt.<\/td>\n<\/tr>\n<tr class=\"row-6\">\n\t<td class=\"column-1\"><a href=\"#astragalus\">Astragalus (rul til)<\/a><\/td><td class=\"column-2\">Urteekstrakt<\/td><td class=\"column-3\">Immun-modulerende. Bruges i TCM sammen med kemo.<\/td><td class=\"column-4\">Platin-baseret kemoterapi (forbedrer effekt, mindsker bivirkninger).<\/td><td class=\"column-5\">En del humane studier (is\u00e6r fra Kina).<\/td><td class=\"column-6\">Meget sikker.<\/td>\n<\/tr>\n<tr class=\"row-7\">\n\t<td class=\"column-1\"><a href=\"#berberin\">Berberin (rul til)<\/a><\/td><td class=\"column-2\">Urteekstrakt<\/td><td class=\"column-3\">Aktiverer AMPK (som Metformin), anti-inflammatorisk.<\/td><td class=\"column-4\">Metformin.<\/td><td class=\"column-5\">St\u00e6rk pr\u00e6klinisk evidens.<\/td><td class=\"column-6\">Kan p\u00e5virke tarmflora og give mave-ubehag.<\/td>\n<\/tr>\n<tr class=\"row-8\">\n\t<td class=\"column-1\"><a href=\"#boswellia\">Boswellia (rul til)<\/a><\/td><td class=\"column-2\">Urteekstrakt<\/td><td class=\"column-3\">Anti-inflammatorisk (h\u00e6mmer 5-LOX).<\/td><td class=\"column-4\">Curcumin (synergistisk anti-inflammatorisk effekt).<\/td><td class=\"column-5\">En del humane studier (is\u00e6r for hjerne\u00f8dem).<\/td><td class=\"column-6\">Meget sikker.<\/td>\n<\/tr>\n<tr class=\"row-9\">\n\t<td class=\"column-1\"><a href=\"#cats-calw\">Cat&#8217;s Claw (rul til)<\/a><\/td><td class=\"column-2\">Urteekstrakt<\/td><td class=\"column-3\">St\u00e6rkt anti-inflammatorisk (h\u00e6mmer NF-kB), immun-modulerende.<\/td><td class=\"column-4\">Andre anti-inflammatoriske stoffer.<\/td><td class=\"column-5\">Prim\u00e6rt pr\u00e6klinisk.<\/td><td class=\"column-6\">Kan p\u00e5virke blodtryk og blodfortynding.<\/td>\n<\/tr>\n<tr class=\"row-10\">\n\t<td class=\"column-1\"><a href=\"#q10\">Coenzym Q10 (rul til)<\/a><\/td><td class=\"column-2\">Vitamin-lignende<\/td><td class=\"column-3\">Kritisk for mitokondriel energiproduktion. St\u00e6rk antioxidant.<\/td><td class=\"column-4\">Statiner (modvirker bivirkning).<\/td><td class=\"column-5\">God evidens for hjerte-kar-sundhed og statin-bivirkninger.<\/td><td class=\"column-6\">V\u00e6lg ubiquinol-formen for bedre optag.<\/td>\n<\/tr>\n<tr class=\"row-11\">\n\t<td class=\"column-1\"><a href=\"#curcumin\">Curcumin (rul til)<\/a><\/td><td class=\"column-2\">Urteekstrakt<\/td><td class=\"column-3\">St\u00e6rkt anti-inflammatorisk (h\u00e6mmer NF-kB), p\u00e5virker mange signalveje.<\/td><td class=\"column-4\">Piperin (for optagelse), Boswellia.<\/td><td class=\"column-5\">Meget st\u00e6rk pr\u00e6klinisk evidens. Mange humane studier.<\/td><td class=\"column-6\">D\u00e5rlig optagelighed alene.<\/td>\n<\/tr>\n<tr class=\"row-12\">\n\t<td class=\"column-1\"><a href=\"#dim\">DIM \/ I3C (rul til)<\/a><\/td><td class=\"column-2\">Plantestof<\/td><td class=\"column-3\">Modulerer \u00f8strogen-metabolisme til gavnlige metabolitter.<\/td><td class=\"column-4\">Hormonbehandling (f.eks. Tamoxifen), Sulforaphane.<\/td><td class=\"column-5\">St\u00e6rk pr\u00e6klinisk evidens for hormonf\u00f8lsomme kr\u00e6ftformer.<\/td><td class=\"column-6\">Findes i korsblomstrede gr\u00f8ntsager.<\/td>\n<\/tr>\n<tr class=\"row-13\">\n\t<td class=\"column-1\"><a href=\"#egcg\">EGCG (Gr\u00f8n te) (rul til)<\/a><\/td><td class=\"column-2\">Polyfenol<\/td><td class=\"column-3\">Antioxidant i lave doser, pro-oxidant i h\u00f8je. H\u00e6mmer mange signalveje.<\/td><td class=\"column-4\">Curcumin, Quercetin.<\/td><td class=\"column-5\">St\u00e6rk pr\u00e6klinisk evidens.<\/td><td class=\"column-6\">H\u00f8je doser som ekstrakt kan p\u00e5virke leveren.<\/td>\n<\/tr>\n<tr class=\"row-14\">\n\t<td class=\"column-1\"><a href=\"#c\">H\u00f8j-dosis Vit. C (IV) (rul til)<\/a><\/td><td class=\"column-2\">Vitamin<\/td><td class=\"column-3\">Pro-oxidant i h\u00f8je doser (skaber hydrogenperoxid).<\/td><td class=\"column-4\">Doxycyclin, visse kemoterapier.<\/td><td class=\"column-5\">St\u00e6rk pr\u00e6klinisk evidens. Mange case-rapporter og mindre kliniske studier. Mangler store fase III-studier.<\/td><td class=\"column-6\">Skal gives intraven\u00f8st for pro-oxidant effekt. ADVARSEL: M\u00e5 ikke gives til patienter med G6PD-mangel. Forsigtighed ved nyreproblemer. Skal gives intraven\u00f8st.<\/td>\n<\/tr>\n<tr class=\"row-15\">\n\t<td class=\"column-1\"><a href=\"#ingefaer\">Ingef\u00e6r (rul til)<\/a><\/td><td class=\"column-2\">Rodfrugt<\/td><td class=\"column-3\">Anti-inflammatorisk, kvalmestillende.<\/td><td class=\"column-4\">Kemoterapi (mod kvalme), Curcumin.<\/td><td class=\"column-5\">God evidens for kvalme.<\/td><td class=\"column-6\">Meget sikker.<\/td>\n<\/tr>\n<tr class=\"row-16\">\n\t<td class=\"column-1\"><a href=\"#inositol\">IP&amp; &amp; Inositol (rul til)<\/a><\/td><td class=\"column-2\">Sukkeralkohol<\/td><td class=\"column-3\">Immun-modulerende (\u00f8ger NK-celle aktivitet), chelaterer jern.<\/td><td class=\"column-4\">Gr\u00f8n te (EGCG).<\/td><td class=\"column-5\">En del pr\u00e6kliniske studier.<\/td><td class=\"column-6\">Meget sikker.<\/td>\n<\/tr>\n<tr class=\"row-17\">\n\t<td class=\"column-1\"><a href=\"#loevetand\">L\u00f8vetandrod (rul til)<\/a><\/td><td class=\"column-2\">Urteekstrakt<\/td><td class=\"column-3\">Inducerer apoptose i visse kr\u00e6ftceller.<\/td><td class=\"column-4\">Ingen specifik data.<\/td><td class=\"column-5\">Begr\u00e6nset, prim\u00e6rt pr\u00e6klinisk.<\/td><td class=\"column-6\">Meget sikker.<\/td>\n<\/tr>\n<tr class=\"row-18\">\n\t<td class=\"column-1\"><a href=\"#maitake\">Maitake (rul til)<\/a><\/td><td class=\"column-2\">Svampeekstrakt<\/td><td class=\"column-3\">Immun-modulerende (D-Fraction).<\/td><td class=\"column-4\">Kemoterapi (immunst\u00f8tte), Vitamin C.<\/td><td class=\"column-5\">En del humane studier.<\/td><td class=\"column-6\">Meget sikker.<\/td>\n<\/tr>\n<tr class=\"row-19\">\n\t<td class=\"column-1\"><a href=\"#marietidsel\">Marietidsel (rul til)<\/a><\/td><td class=\"column-2\">Urteekstrakt<\/td><td class=\"column-3\">Leverbeskyttende (silymarin), anti-inflammatorisk.<\/td><td class=\"column-4\">Visse kemoterapier for at beskytte leveren.<\/td><td class=\"column-5\">God evidens for leverbeskyttelse.<\/td><td class=\"column-6\">Meget sikker.<\/td>\n<\/tr>\n<tr class=\"row-20\">\n\t<td class=\"column-1\"><a href=\"#melatonin\">Melatonin (rul til)<\/a><\/td><td class=\"column-2\">Hormon<\/td><td class=\"column-3\">Onkostatisk (h\u00e6mmer v\u00e6kst), immun-modulerende, antioxidant, forbedrer s\u00f8vn.<\/td><td class=\"column-4\">N\u00e6sten alle behandlinger (is\u00e6r str\u00e5lebehandling og kemo).<\/td><td class=\"column-5\">St\u00e6rk evidens fra mange studier.<\/td><td class=\"column-6\">Meget sikker.<\/td>\n<\/tr>\n<tr class=\"row-21\">\n\t<td class=\"column-1\"><a href=\"#modificeret\">Modificeret Citrus Pectin (rul til)<\/a><\/td><td class=\"column-2\">Fiber<\/td><td class=\"column-3\">H\u00e6mmer Galectin-3 og dermed metastase og inflammation.<\/td><td class=\"column-4\">Probiotika, anti-inflammatoriske stoffer.<\/td><td class=\"column-5\">En del humane studier.<\/td><td class=\"column-6\">Meget sikker.<\/td>\n<\/tr>\n<tr class=\"row-22\">\n\t<td class=\"column-1\"><a href=\"#nac\">N-acetyl-cystein (NAC) (rul til)<\/a><\/td><td class=\"column-2\">Aminosyre<\/td><td class=\"column-3\">\u00d8ger kroppens egen antioxidant (glutathion).<\/td><td class=\"column-4\">Visse kemoterapier (beskytter raske celler).<\/td><td class=\"column-5\">Kompleks rolle. Kan beskytte raske celler.<\/td><td class=\"column-6\">Kan ved h\u00f8je doser p\u00e5virke zink- og kobber-niveauer.<\/td>\n<\/tr>\n<tr class=\"row-23\">\n\t<td class=\"column-1\"><a href=\"#omega-3\">Omega-3 (Fiskeolie) (rul til)<\/a><\/td><td class=\"column-2\">Fedtsyrer<\/td><td class=\"column-3\">St\u00e6rkt anti-inflammatorisk (konkurrerer med omega-6). Kan modvirke kakeksi.<\/td><td class=\"column-4\">Andre anti-inflammatoriske stoffer.<\/td><td class=\"column-5\">St\u00e6rk evidens for inflammation og kakeksi.<\/td><td class=\"column-6\">Kvalitet (renhed, TOTOX-v\u00e6rdi) er afg\u00f8rende.<\/td>\n<\/tr>\n<tr class=\"row-24\">\n\t<td class=\"column-1\"><a href=\"#pau\">Pau D&#8217;Arco (rul til)<\/a><\/td><td class=\"column-2\">Urteekstrakt<\/td><td class=\"column-3\">Forstyrrer kr\u00e6ftcellers energi-metabolisme og DNA-reparation (Lapachol).<\/td><td class=\"column-4\">Ingen specifik data.<\/td><td class=\"column-5\">Prim\u00e6rt pr\u00e6klinisk.<\/td><td class=\"column-6\">Kan v\u00e6re toksisk. Kr\u00e6ver forsigtighed.<\/td>\n<\/tr>\n<tr class=\"row-25\">\n\t<td class=\"column-1\"><a href=\"#probiotika\">Probiotika (rul til)<\/a><\/td><td class=\"column-2\">Bakteriekulturer<\/td><td class=\"column-3\">Modulerer tarmflora og dermed immunforsvaret. Kan reducere bivirkninger.<\/td><td class=\"column-4\">Immunterapi, pr\u00e6biotika (fibre).<\/td><td class=\"column-5\">Meget st\u00e6rk og voksende evidens, is\u00e6r ifm. immunterapi.<\/td><td class=\"column-6\">Stamme-specifik virkning. V\u00e6lg et bredspektret produkt.<\/td>\n<\/tr>\n<tr class=\"row-26\">\n\t<td class=\"column-1\"><a href=\"#quercetin\">Quercetin (rul til)<\/a><\/td><td class=\"column-2\">Flavonoid<\/td><td class=\"column-3\">Anti-inflammatorisk, antioxidant, h\u00e6mmer PI3K\/Akt.<\/td><td class=\"column-4\">Vitamin C (synergistisk antioxidant effekt), EGCG.<\/td><td class=\"column-5\">St\u00e6rk pr\u00e6klinisk evidens.<\/td><td class=\"column-6\">D\u00e5rlig optagelighed alene.<\/td>\n<\/tr>\n<tr class=\"row-27\">\n\t<td class=\"column-1\"><a href=\"#resveratrol\">Resveratrol (rul til)<\/a><\/td><td class=\"column-2\">Polyfenol<\/td><td class=\"column-3\">Sirtuin-aktivator, anti-inflammatorisk.<\/td><td class=\"column-4\">Quercetin, andre polyfenoler.<\/td><td class=\"column-5\">St\u00e6rk pr\u00e6klinisk evidens.<\/td><td class=\"column-6\">Biotilg\u00e6ngelighed er en udfordring.<\/td>\n<\/tr>\n<tr class=\"row-28\">\n\t<td class=\"column-1\"><a href=\"#selen\">Selen (rul til)<\/a><\/td><td class=\"column-2\">Mineral<\/td><td class=\"column-3\">Vigtig for antioxidant-enzymer og immunfunktion.<\/td><td class=\"column-4\">Vitamin E.<\/td><td class=\"column-5\">St\u00e6rk evidens for vigtigheden af tilstr\u00e6kkelige niveauer.<\/td><td class=\"column-6\">For meget er giftigt. Skal doseres pr\u00e6cist.<\/td>\n<\/tr>\n<tr class=\"row-29\">\n\t<td class=\"column-1\"><a href=\"#sort-valnoed\">Sort Valn\u00f8d (rul til)<\/a><\/td><td class=\"column-2\">Urte-ekstrakt<\/td><td class=\"column-3\">Pro-oxidativ og cytotoksisk. Inducerer apoptose via ROS-dannelse.<\/td><td class=\"column-4\">Teoretisk med andre pro-oxidative terapier.<\/td><td class=\"column-5\">Prim\u00e6rt pr\u00e6klinisk. Begr\u00e6nset human data.<\/td><td class=\"column-6\">ADVARSEL: Potent stof. Skal bruges med ekstrem forsigtighed.<\/td>\n<\/tr>\n<tr class=\"row-30\">\n\t<td class=\"column-1\"><a href=\"#sulforaphane\">Sulforaphane (rul til)<\/a><\/td><td class=\"column-2\">Plantestof<\/td><td class=\"column-3\">HDAC-h\u00e6mmer, aktiverer Nrf2, rammer kr\u00e6ftstamceller.<\/td><td class=\"column-4\">DIM\/I3C, Gr\u00f8n te (EGCG).<\/td><td class=\"column-5\">St\u00e6rk pr\u00e6klinisk evidens.<\/td><td class=\"column-6\">Findes i broccoli-spirer.<\/td>\n<\/tr>\n<tr class=\"row-31\">\n\t<td class=\"column-1\"><a href=\"#turkey-tail\">Turkey Tail (rul til)<\/a><\/td><td class=\"column-2\">Svampeekstrakt<\/td><td class=\"column-3\">Immun-modulerende (PSK\/PSP).<\/td><td class=\"column-4\">Kemoterapi, str\u00e5lebehandling (forbedrer immunrespons).<\/td><td class=\"column-5\">Meget st\u00e6rk evidens, is\u00e6r fra Japan.<\/td><td class=\"column-6\">Meget sikker.<\/td>\n<\/tr>\n<tr class=\"row-32\">\n\t<td class=\"column-1\"><a href=\"#vitamin-c\">Vitamin C (oralt\/ kapsler\/ tabletter) (rul til)<\/a><\/td><td class=\"column-2\">Vitamin<\/td><td class=\"column-3\">Kraftig antioxidant. St\u00f8tter immunforsvaret og kollagen-dannelse.<\/td><td class=\"column-4\">Kraftig antioxidant. Essentiel co-faktor for immun-funktion (T-celler\/NK-celler), epigenetisk regulering (TET-enzymer) og cellers respons p\u00e5 iltmangel (hypoxi).<\/td><td class=\"column-5\">Essentielt n\u00e6ringsstof. Ingen evidens for direkte anti-kr\u00e6ft effekt i oral form.<\/td><td class=\"column-6\">Virker ikke pro-oxidant som IV C. Kontroversielt i h\u00f8je doser under aktiv kemo\/str\u00e5ling (ligesom NAC).<\/td>\n<\/tr>\n<tr class=\"row-33\">\n\t<td class=\"column-1\"><a href=\"#vitamin-d\">Vitamin D (rul til)<\/a><\/td><td class=\"column-2\">Vitamin\/Hormon<\/td><td class=\"column-3\">Regulerer celledeling og immunfunktion.<\/td><td class=\"column-4\">Vitamin K2.<\/td><td class=\"column-5\">Meget st\u00e6rk epidemiologisk og klinisk evidens.<\/td><td class=\"column-6\">Kr\u00e6ver blodpr\u00f8ve for korrekt dosering.<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<!-- #tablepress-3 from cache -->\n\n\n<p class=\"wp-block-paragraph\"><strong>Oversigt 2:<\/strong> Her finder du en tabel for <a href=\"https:\/\/jegharkraeft.dk\/kosttilskud-grupperet\/\">Kosttilskud<\/a>. Denne kan benyttes til at sl\u00e5 et specifikt stof op og hurtigt f\u00e5 et overordnet indtryk af dets virkningsmekanisme, evidens-niveau og evt. bem\u00e6rkninger.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Forts\u00e6ttes&#8230;<\/strong><a href=\"https:\/\/jegharkraeft.dk\/dr-vogl\"><\/a><\/p>\n\n\n\n<p class=\"has-custom-menu-links-color has-text-color has-link-color wp-elements-78958270cc4840b7bdca48105c79180e wp-block-paragraph\"><strong><a href=\"#menu\" data-type=\"internal\" data-id=\"#diagnose\">(Til menu)<\/a><\/strong><\/p>\n\n\n\n<p class=\"has-text-align-center wp-block-paragraph\"><mark style=\"background-color:rgba(0, 0, 0, 0)\" class=\"has-inline-color has-custom-menu-links-color\">\u2764<\/mark><\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Hvad du l\u00e6ser p\u00e5 <\/strong><em><strong>Jeg har Kr\u00e6ft<\/strong><\/em><strong> er ikke en anbefaling. S\u00f8g kompetent vejledning.<\/strong><\/p>\n<\/div>\n<\/div>\n\n\n\n<div class=\"wp-block-group alignfull is-style-default has-global-padding is-layout-constrained wp-container-core-group-is-layout-b040ace0 wp-block-group-is-layout-constrained has-background\" style=\"margin-top:0;margin-bottom:0;padding-top:var(--wp--preset--spacing--60);padding-right:var(--wp--preset--spacing--20);padding-bottom:var(--wp--preset--spacing--60);padding-left:var(--wp--preset--spacing--20);background-image:url(&apos;https:\/\/jegharkraeft.dk\/wp-content\/uploads\/2025\/06\/Pathways4.jpg&apos;);background-position:44% 36%;background-size:cover;\">\n<div class=\"gb-element-4761890b\">\n<h2 class=\"wp-block-heading\" id=\"links\"><span class=\"ez-toc-section\" id=\"Metaboliske_strategier_Links\"><\/span>Metaboliske strategier<br>Links<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p class=\"has-custom-menu-links-color has-text-color has-link-color wp-elements-78958270cc4840b7bdca48105c79180e wp-block-paragraph\"><strong><a href=\"#menu\" data-type=\"internal\" data-id=\"#diagnose\">(Til menu)<\/a><\/strong><\/p>\n\n\n\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Links\"><\/span>Links<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<h4 class=\"wp-block-heading\">Alment<\/h4>\n\n\n\n<p class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-07411234abfb1e0188b3e2e01094a662 wp-block-paragraph\"><a href=\"https:\/\/www.dagensmedicin.dk\/specialistomrader\/diabetes\/dansk-forskning-metabolisk-kontrol-boer-vaere-et-maal-ved-behandling-af-kraeft\/\" target=\"_blank\" rel=\"noopener\">Dansk forskning: Metabolisk kontrol b\u00f8r v\u00e6re et m\u00e5l ved behandling af kr\u00e6ft<\/a> (Dagens Medicin, 2023)<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Indhold: Fokus p\u00e5 stofskifte: Kr\u00e6ftceller \u00e6ndrer kroppens stofskifte for at skaffe sig energi. M\u00e5let med strategien: Forskning s\u00f8ger at manipulere de metaboliske processer for at begr\u00e6nse kr\u00e6ftcellernes v\u00e6kst. Fordele for l\u00e6seren: Strategien sigter mod at stabilisere stofskiftet og mindske risikoen for komplikationer.<br><\/li>\n<\/ul>\n\n\n\n<h3 class=\"wp-block-heading\" id=\"repurposed-drugs\"><span class=\"ez-toc-section\" id=\"Repurposed_drugs\"><\/span>Repurposed drugs<span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<h4 class=\"wp-block-heading has-custom-sort-tekst-color has-text-color has-link-color wp-elements-8cb689adcd43e52b43186c18e2fdd72a\" id=\"benzimidazoler\">1. <a href=\"https:\/\/jegharkraeft.dk\/vermox\/\">Benzimidazoler<\/a> (Mebendazol\/ Fenbendazol)<\/h4>\n\n\n\n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-2973a59d12c94bf2feeb1d1772c6aa2f\"><strong>Link 1:<\/strong><a href=\"https:\/\/www.rjptonline.org\/HTMLPaper.aspx?Journal=Research%20Journal%20of%20Pharmacy%20and%20Technology;PID=2025-18-4-23\" target=\"_blank\" rel=\"noreferrer noopener\"> Repurposing of Mebendazole as an Anticancer Agent: A Review<\/a> (Research Journal of Pharmacy and Technology, 2025)\n<ul class=\"wp-block-list\">\n<li><strong>Relevans:<\/strong> Dette er en nyere oversigtsartikel, der opsummerer mebendazols virkningsmekanismer, herunder hvordan det stopper celledeling, forhindrer dannelse af blodkar (angiogenese) og fremkalder programmeret celled\u00f8d (apoptose) i en lang r\u00e6kke kr\u00e6ftformer.<\/li>\n<\/ul>\n<\/li>\n\n\n\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-53b47d47ef6dc65ca453a53f54ced4d7\"><strong>Link 2:<\/strong><a href=\"https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC3158014\/\" target=\"_blank\" rel=\"noreferrer noopener\"> Antiparasitic mebendazole shows survival benefit in 2 preclinical models of glioblastoma multiforme<\/a> (Neuro-Oncology via PMC, 2011)\n<ul class=\"wp-block-list\">\n<li><strong>Relevans:<\/strong> Et specifikt og meget citeret pr\u00e6klinisk studie, der viser, hvordan b\u00e5de fenbendazol og mebendazol har effekt mod glioblastom (hjernekr\u00e6ft) i dyremodeller, prim\u00e6rt ved at forstyrre cellernes mikrotubuli-struktur.<\/li>\n<\/ul>\n<\/li>\n\n\n\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-197c6aaf64fa000f6ae9b024ffdf633f\"><strong>Link 3:<\/strong> <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/39851541\/\" target=\"_blank\" rel=\"noopener\">Mebendazole Exerts Anticancer Activity in Ovarian Cancer Cell Lines via Novel Girdin-Mediated AKT\/IKK\u03b1\/\u03b2\/NF-\u03baB Signaling Axis<\/a> (PubMed, 2025)\n<ul class=\"wp-block-list\">\n<li><strong>Relevans:<\/strong> Mebendazol (MBZ) h\u00e6mmer v\u00e6kst, migration og kr\u00e6ftstamceller i \u00e6ggestokkr\u00e6ftceller ved at forstyrre cytoskelettet og blokere Akt\/NF-\u03baB pathways. Det inducerer cellecyklus-arrest og apoptose, hvilket g\u00f8r det til en lovende behandling.<\/li>\n<\/ul>\n<\/li>\n\n\n\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-066b23c10c7f48be07900ea866b5508f\"><strong>Link 4: <\/strong><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/39566281\/\" target=\"_blank\" rel=\"noopener\">Transcriptome analysis displays new molecular insights into the mechanisms of action of Mebendazole in gastric cancer cells<\/a> (PubMed, 2024)\n<ul class=\"wp-block-list\">\n<li><strong>Relevans:<\/strong> Unders\u00f8gelsen viser, at Mebendazol (MBZ) p\u00e5virker genudtryk i mavekr\u00e6ftceller, is\u00e6r ved at \u00e6ndre histon- og inflammationsgener. Det kan have epigenetiske og immunologiske virkninger, hvilket kan forbedre patienters prognose. Flere studier er n\u00f8dvendige for at forst\u00e5 mekanismerne bedre.<\/li>\n<\/ul>\n<\/li>\n\n\n\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-e37a708ddd9998caacec4921a3a29900\"><strong>Link 5:<\/strong> <a href=\"https:\/\/www.frontiersin.org\/journals\/chemistry\/articles\/10.3389\/fchem.2024.1541846\/full\" target=\"_blank\" rel=\"noreferrer noopener\">Design, synthesis, and apoptotic antiproliferative action of new benzimidazole\/1,2,3-triazole hybrids as EGFR inhibitors<\/a> (Frontiers in Chemistry, 2024)\n<ul class=\"wp-block-list\">\n<li><strong>Relevans:<\/strong> Dette studie beskriver udviklingen af nye benzimidazol-baserede stoffer (hybrider), der viser st\u00e6rk effekt som EGFR-h\u00e6mmere. EGFR er en velkendt og vigtig signalvej i mange kr\u00e6ftformer, og resultaterne viste, at de nye stoffer havde en potent antiproliferativ effekt, der i nogle tilf\u00e6lde overgik standardbehandlingen erlotinib.<\/li>\n<\/ul>\n<\/li>\n\n\n\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-60ae7c4f32319fd5d32467da8e9ee58e\"><strong>Link 6:<\/strong> <a href=\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC10052731\/\" target=\"_blank\" rel=\"noopener\">Metabolic Reprogramming and Potential Therapeutic Targets in Lymphoma<\/a> (National Institutes of Health, 2023) \n<ul class=\"wp-block-list\">\n<li><strong>Indhold:<\/strong> En systematisk gennemgang af, hvordan lymfomceller oml\u00e6gger deres stofskifte (fokus p\u00e5 h\u00f8j glukoseoptagelse og deregulerede glykolyse-enzymer). Artiklen underbygger relevansen af at blokere glykolyse som en terapeutisk strategi, hvilket er centralt for is\u00e6r Burkitt&#8217;s Lymfom og DLBCL.<\/li>\n<\/ul>\n<\/li>\n\n\n\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-6ce7631f22a662b1de16402686925eb5\"><strong>Link 7:<\/strong> <a href=\"https:\/\/www.nature.com\/articles\/s41392-020-00213-8\" target=\"_blank\" rel=\"noopener\">Overcoming cancer therapeutic bottleneck by drug repurposing<\/a> (Nature, 2020) \n<ul class=\"wp-block-list\">\n<li><strong>Indhold:<\/strong> En autoritativ oversigtsartikel, der diskuterer drug repurposing som strategi til at overvinde terapeutisk modstandsdygtighed (bottleneck). Artiklen underst\u00f8tter relevansen af Mebendazole ved at beskrive, hvordan det reducerer GLI1-ekspression, hvilket er en mekanisme, der er relevant for v\u00e6ksth\u00e6mning i kr\u00e6ftceller.<\/li>\n<\/ul>\n<\/li>\n\n\n\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-034e6aa2f809760ae1ee1b8a7a74928a\"><strong>Link 8:<\/strong> <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/29225688\/\" target=\"_blank\" rel=\"noopener\">Repurposing Drugs in Oncology (ReDO)\u2014chloroquine and hydroxychloroquine as anti-cancer agents<\/a> (National Institutes of Health, 2017) \n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-ddac59a29d4f8818122eda509589400e\"><strong>Indhold:<\/strong> Oversigtsartikel fra ReDO-projektet, der bekr\u00e6fter, at Hydroxychloroquine (HCQ) har bredspektrede effekter, herunder autofagi-h\u00e6mning, p53-aktivering og p\u00e5virkning af tumormikromilj\u00f8et.<\/li>\n<\/ul>\n<\/li>\n\n\n\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-2709638ab9f08c205033cf4c7378888f\"><strong>Link 9: <\/strong><a href=\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC6769799\/?fbclid=IwY2xjawO7uchicmlkETFEbDBJa0gyVzV5YXNiSXhYc3J0YwZhcHBfaWQQMjIyMDM5MTc4ODIwMDg5MgABHr9JiWo5d6stsZ4qNZWyds8mw4Q7jswrdhe2KA-A4r35gLsxmqXsIGtrI3Kv&amp;brid=5-Px0OZgVALgqmqBS7rbQg\" target=\"_blank\" rel=\"noopener\">Mebendazole as a Candidate for Drug Repurposing in Oncology: An Extensive Review of Current Literature<\/a> (PubMed, 2019)\n<ul class=\"wp-block-list\">\n<li><strong>Indhold:<\/strong> Gennemgang af hvordan mebendazol kan anvendes til at bek\u00e6mpe resistente kr\u00e6ftceller og h\u00e6mme spredning, b\u00e5de som selvst\u00e6ndig behandling og i synergi med kemoterapi.<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">Binyrebarkkr\u00e6ft:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-fe49ddd9e88734b458e60d6986da4a8f\"><strong>Link 10:<\/strong> <a href=\"https:\/\/www.esmoopen.com\/article\/S2059-7029(23)01179-1\/fulltext\" target=\"_blank\" rel=\"noopener\">Repurposing existing therapies for adrenal cancer<\/a> (ESMO Open, 2023)\n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-7766eaa404f429313e2a18245b2c6903\"><strong>Indhold:<\/strong> Et videnskabeligt abstract, der beskriver en metode til at identificere eksisterende, godkendte l\u00e6gemidler, der kan genanvendes mod binyrebarkkr\u00e6ft. Studiet anvender genetiske analyser til at udpege medicin, der potentielt kan ramme sygdommens specifikke svagheder.<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">Bl\u00e6rekr\u00e6ft og Urinlederkr\u00e6ft:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-689895889c6f1ccd8cdf78e5ebdef320\"><strong>Link 11:<\/strong> <a href=\"https:\/\/www.frontiersin.org\/journals\/pharmacology\/articles\/10.3389\/fphar.2025.1631419\/full\" target=\"_blank\" rel=\"noopener\">Critical dysregulated signaling pathways in drug resistance: highlighting the repositioning of mebendazole for cancer therapy<\/a> (Frontiers in Pharmacology, 2025)\n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-2f6b6fdf1bb02dfcf676b70fb3e7f1ce\"><strong>Indhold:<\/strong> En videnskabelig oversigtsartikel, der beskriver Mebendazols potentiale til at overvinde medicinresistens. Artiklen gennemg\u00e5r, hvordan stoffet rammer flere signalveje samtidig ved at h\u00e6mme tumorens blodforsyning, fremme celled\u00f8d og blokere celledeling.<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">Hjernekr\u00e6ft:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-19b84a7dfb299850bff03a9c8cba68e1\"><strong>Link 12:<\/strong> <a href=\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC12256405\/\" target=\"_blank\" rel=\"noopener\">The therapeutic potential of repurposed mebendazole, alone or in combination, against brain tumors<\/a> (PMC, 2025)\n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-115c1154ca3a57aff8a2009ee877957f\"><strong>Indhold:<\/strong> En videnskabelig gennemgang, der beskriver mebendazols potentiale mod hjernetumorer. Artiklen fremh\u00e6ver stoffets evne til at krydse blod-hjerne-barrieren og dets virkning mod kr\u00e6ftceller, enten alene eller i kombination med anden behandling.<\/li>\n<\/ul>\n<\/li>\n\n\n\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-e94df230d5fe7b80e4209d3a8132bd6e\"><strong>Link 13:<\/strong> <a href=\"https:\/\/academic.oup.com\/noa\/article\/7\/1\/vdaf066\/8097633\" target=\"_blank\" rel=\"noopener\">Repurposing the anthelmintic drug mebendazole in combination with radiotherapy<\/a> (Oxford Academic, 2025)\n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-278709297babf9b141a54fc2248b8477\"><strong>Indhold:<\/strong> Et helt nyt studie, der p\u00e5viser mebendazols evne til at stoppe celledeling (antiproliferativ effekt) i gliom-modeller. Unders\u00f8gelsen belyser virkningen ved celle-cyklus stop, hvilket er centralt for at bremse tumorv\u00e6kst.<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">Myelomatose\/ Knoglemarvskr\u00e6ft &amp; Nyrekr\u00e6ft:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-85ce8ded8b1414d6ba8cef2ee59988bd\"><strong>Link 14:<\/strong> <a href=\"https:\/\/www.frontiersin.org\/journals\/pharmacology\/articles\/10.3389\/fphar.2025.1631419\/full\" target=\"_blank\" rel=\"noopener\">Critical dysregulated signaling pathways in drug resistance: highlighting the repositioning of mebendazole for cancer therapy<\/a> (Frontiers in Pharmacology, 2025)\n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-5004a38f1de55d727e464181e70bd562\"><strong>Indhold:<\/strong> En videnskabelig oversigtsartikel, der beskriver Mebendazols virkningsmekanismer, herunder inaktivering af overlevelsesproteinet Bcl-2. Artiklen gennemg\u00e5r, hvordan stoffet kan genanvendes til kr\u00e6ftbehandling for at overvinde resistens og fremme celled\u00f8d ved at blokere vitale signalveje.<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">Prostatakr\u00e6ft:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-d3c51de922665f99adcfeefbcd21f2e3\"><strong>Link 15:<\/strong> <a href=\"https:\/\/apps.dtic.mil\/sti\/citations\/ADA545657\" target=\"_blank\" rel=\"noopener\">Benzimidazole as Novel Therapy for Hormone-Refractory Prostate Cancer <\/a>(dtic.mil, 2011)\n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-b3c6aabc0548c64baa34c7ed92007d2e\"><strong>Indhold:<\/strong> Rapport, der viser, at Benzimidazol-behandling forl\u00e6nger overlevelsestiden for mus med prostatakr\u00e6ft-metastaser og h\u00e6mmer v\u00e6ksten af prostatakr\u00e6ftceller. Dette underst\u00f8tter stoffets rolle som anti-metastatisk middel ved at h\u00e6mme Mikrotubuli (cellens skelet).<\/li>\n<\/ul>\n<\/li>\n\n\n\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-de604a1d2ce1caf65810f71dd1ac016e\"><strong>Link 16:<\/strong> <a href=\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC9978992\/\" target=\"_blank\" rel=\"noopener\">Benzimidazole and its derivatives as cancer therapeutics<\/a> (National Institutes of Health, 2022)\n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-a81b00563a4407c421b4e2d2aee236ab\"><strong>Indhold:<\/strong> Oversigtsartikel, der beskriver Benzimidazolers bioaktivitet som potente anticancer-midler. Artiklen validerer, at stofferne virker ved at h\u00e6mme mikrotubuli (cellens skelet) og fremkalde celled\u00f8d, hvilket er kernestrategien mod metastatisk prostatakr\u00e6ft.<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Tilbage til:<\/strong> <a href=\"#skema-01\"><mark style=\"background-color:rgba(0, 0, 0, 0)\" class=\"has-inline-color has-custom-menu-links-color\">Oversigtsskema for Repurposed drugs<\/mark><\/a><\/p>\n\n\n\n<h4 class=\"wp-block-heading\" id=\"celecoxib\">1.A <a href=\"https:\/\/jegharkraeft.dk\/celecoxib\/\">Celecoxib<\/a><\/h4>\n\n\n\n<p class=\"wp-block-paragraph\">Binyrebarkkr\u00e6ft:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-f17edebfad33fdb58167d2852b6f46fc\"><strong>Link 1:<\/strong> <a href=\"https:\/\/academic.oup.com\/jes\/article\/8\/Supplement_1\/bvae163.228\/7812225\" target=\"_blank\" rel=\"noopener\">Luteinizing Hormone\/Human Chorionic Gonadotropin Receptor and Cyclooxygenase-2 Expression in Adrenocortical Carcinoma<\/a> (Oxford Academic, 2024) \n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-c2399206137ef607c18d89def9005205\"><strong>Indhold: <\/strong>Et videnskabeligt studie, der unders\u00f8ger v\u00e6vspr\u00f8ver fra binyrebarkkr\u00e6ft. Resultaterne viser, at COX-2 enzymet findes i st\u00f8rstedelen af b\u00e5de de prim\u00e6re tumorer og i metastaserne, hvilket leverer det biologiske grundlag for at behandle med en COX-2 h\u00e6mmer.<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">Bl\u00e6rekr\u00e6ft og Urinlederkr\u00e6ft:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-fbf425c1fcb4de393d28b6eb8937917f\"><strong>Link 2:<\/strong> <a href=\"https:\/\/www.google.com\/search?q=Celecoxib+Synergistically+Enhances+MLN4924-Induced+Cytotoxicity+via+AKT+and+ERK+Pathways+in+Human+Urothelial+Carcinoma+(ResearchGate%2C+2022)&amp;rlz=1C1ONGR_enDK1116DK1116&amp;oq=Celecoxib+Synergistically+Enhances+MLN4924-Induced+Cytotoxicity+via+AKT+and+ERK+Pathways+in+Human+Urothelial+Carcinoma+(ResearchGate%2C+2022)&amp;gs_lcrp=EgZjaHJvbWUyBggAEEUYOdIBBzM1N2owajSoAgCwAgA&amp;sourceid=chrome&amp;ie=UTF-8\" target=\"_blank\" rel=\"noopener\">Celecoxib Synergistically Enhances MLN4924-Induced Cytotoxicity via AKT and ERK Pathways in Human Urothelial Carcinoma<\/a> (PubMed, 2022)\n<ul class=\"wp-block-list\">\n<li><strong>Indhold:<\/strong> Forskning, der demonstrerer, hvordan Celecoxib (COX-2 h\u00e6mmer) forst\u00e6rker effekten af anden behandling ved at lukke ned for overlevelses-signalerne AKT og ERK i urotheliale kr\u00e6ftceller.<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">Myelomatose\/ Knoglemarvskr\u00e6ft:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-412a5ded2df17fc82d5ce5c59abd3aa3\"><strong>Link 3:<\/strong> <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/16247750\/\" target=\"_blank\" rel=\"noopener\">Overexpression of cyclooxygenase-2 in multiple myeloma: association with reduced survival<\/a> (PubMed, 2005) \n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-7e65fecae632de5dac0af64521fe74a8\"><strong>Indhold:<\/strong> Et n\u00f8glestudie, der fastsl\u00e5r, at COX-2 enzymet ofte er overudtrykt i myelomatose og er forbundet med d\u00e5rligere overlevelse. Det underst\u00f8tter brugen af COX-2 h\u00e6mmere som Celecoxib til at bremse sygdommen.<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">Nyrekr\u00e6ft:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-9bb76d34f5c8d357e9059c6b3b84469d\"><strong>Link 4:<\/strong> <a href=\"https:\/\/www.frontiersin.org\/journals\/pharmacology\/articles\/10.3389\/fphar.2025.1691392\/full\" target=\"_blank\" rel=\"noopener\">Celecoxib in oncology: targeting the COX-2\/PGE 2 axis to prevent cancer progression<\/a> (Frontiers, 2025)\n<ul class=\"wp-block-list\">\n<li><strong>Indhold:<\/strong> En videnskabelig oversigtsartikel, der beskriver, hvordan Celecoxib h\u00e6mmer COX-2 og PGE2-signalvejen. Artiklen forklarer, at dette reducerer udtrykket af v\u00e6kstfaktoren VEGF, hvilket stopper dannelsen af nye blodkar (angiogenese) og dermed bremser tumorv\u00e6kst og spredning.<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Tilbage til:<\/strong> <a href=\"#skema-01\"><mark style=\"background-color:rgba(0, 0, 0, 0)\" class=\"has-inline-color has-custom-menu-links-color\">Oversigtsskema for Repurposed drugs<\/mark><\/a><\/p>\n\n\n\n<h4 class=\"wp-block-heading\" id=\"desloratadin\">2. <a href=\"https:\/\/jegharkraeft.dk\/desloratadin-krestine-mildin\/\">Desloratadin<\/a><\/h4>\n\n\n\n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-f2c091f680db8fb2b23e25d09622391f\"><strong>Link 1:<\/strong> <a href=\"https:\/\/www.sciencedirect.com\/science\/article\/pii\/S2352396416302572\" target=\"_blank\" rel=\"noopener\">Repurposing Cationic Amphiphilic Antihistamines for Cancer Treatment<\/a> (Science Direct, 2016)\n<ul class=\"wp-block-list\">\n<li><strong>Relevans:<\/strong> Et registerstudie viste, at visse antihistaminer (som loratadin) var forbundet med lavere d\u00f8delighed hos patienter med fremskreden lungekr\u00e6ft (NSCLC). Effekten var st\u00e6rkest, n\u00e5r det blev givet sammen med kemoterapi, da stofferne viste sig at \u00f8ge kr\u00e6ftcellers f\u00f8lsomhed over for behandlingen.<\/li>\n<\/ul>\n<\/li>\n\n\n\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-84f7c57e6bb0feab9c903c3c7add764e\"><strong>Link 2: <\/strong><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/32459128\/\" target=\"_blank\" rel=\"noopener\">Desloratadine and loratadine stand out among common H<sub>1<\/sub>-antihistamines for association with improved breast cancer survival<\/a> (PubMed, 2020)\n<ul class=\"wp-block-list\">\n<li><strong>Relevans:<\/strong> Forskere anbefaler kliniske fors\u00f8g med de sikre antihistaminer desloratadin og loratadin som en potentiel behandling mod brystkr\u00e6ft.<\/li>\n<\/ul>\n<\/li>\n\n\n\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-04eb3880971aa209770c1512f27188b3\"><strong>Link 3:<\/strong> <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/39672344\/\" target=\"_blank\" rel=\"noopener\">Desloratadine mitigates hepatocellular carcinoma in rats: Possible contribution of TLR4\/MYD88\/NF-\u03baB pathway<\/a> (PubMed, 2025)\n<ul class=\"wp-block-list\">\n<li><strong>Relevans:<\/strong> Desloratadin kan beskytte leveren og reducere inflammation i leverkr\u00e6ft hos rotter ved at modulere inflammationsveje og have antioxidative virkninger, hvilket g\u00f8r det til en potentiel behandling for HCC.<\/li>\n<\/ul>\n<\/li>\n\n\n\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-da732b9d0927c8ba463695483c8c136d\"><strong>Link 4:<\/strong> <a href=\"https:\/\/www.mdpi.com\/2072-6694\/16\/24\/4253\" target=\"_blank\" rel=\"noreferrer noopener\">H1 Antihistamines\u2014Promising Candidates for Repurposing in the Context of the Development of New Therapeutic Approaches to Cancer Treatment<\/a> (Cancers, 2024)\n<ul class=\"wp-block-list\">\n<li><strong>Relevans:<\/strong> En nyere oversigtsartikel, der fremh\u00e6ver potentialet i antihistaminer. Studiet n\u00e6vner specifikt, at desloratadin var effektivt i alle unders\u00f8gte immunogene kr\u00e6fttyper (bl.a. mave, bugspytkirtel, tyktarm, bryst og lunge), hvilket underst\u00f8tter dets rolle i at modulere immunresponset mod kr\u00e6ft.<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Tilbage til:<\/strong> <a href=\"#skema-01\"><mark style=\"background-color:rgba(0, 0, 0, 0)\" class=\"has-inline-color has-custom-menu-links-color\">Oversigtsskema for Repurposed drugs<\/mark><\/a><\/p>\n\n\n\n<h4 class=\"wp-block-heading\" id=\"dipyridamol\">3. <a href=\"https:\/\/jegharkraeft.dk\/dipyridamol\/\">Dipyridamol<\/a><\/h4>\n\n\n\n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-2e509692e64923f0286505275aae82ee\"><strong>Link 1:<\/strong><a href=\"https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC7654221\/\" target=\"_blank\" rel=\"noreferrer noopener\"> Dipyridamole prevents triple-negative breast-cancer progression<\/a> (Clinical &amp; Experimental Metastasis, 2013)\n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-3b996d7b754f992f85ab2c333bc54d6c\"><strong>Relevans:<\/strong> Et st\u00e6rkt pr\u00e6klinisk studie, der viser, hvordan dipyridamol b\u00e5de h\u00e6mmer v\u00e6ksten af den prim\u00e6re tumor og dannelsen af metastaser i en model af trippel-negativ brystkr\u00e6ft, bl.a. ved at p\u00e5virke immunmilj\u00f8et i tumoren.<\/li>\n<\/ul>\n<\/li>\n\n\n\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-e3ca67198b024bbcf01f1143503c2fb2\"><strong>Link 2:<\/strong><a href=\"https:\/\/www.google.com\/search?q=https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC5209474\/\" target=\"_blank\" rel=\"noreferrer noopener\"> <\/a><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/28077994\/\" target=\"_blank\" rel=\"noopener\">Reverse screening approach to identify potential anti-cancer targets of dipyridamole<\/a> (PubMed, 2016)\n<ul class=\"wp-block-list\">\n<li><strong>Relevans:<\/strong> Forskere har brugt computermodeller til at afd\u00e6kke, hvorfor l\u00e6gemidlet Dipyridamol (DIP) forst\u00e6rker effekten af kemoterapi som 5-fluorouracil (5-FU). Studiet forudsiger, at Dipyridamol virker ved at blokere det enzym (DPD), der normalt nedbryder kemoterapien. Dette kan forklare, hvorfor kemoterapien bliver mere effektiv og har f\u00e6rre bivirkninger.<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">Hudkr\u00e6ft:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-0c5fd2cfe63444afddd283651c7879ab\"><strong>Link 3:<\/strong> <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/38540310\/\" target=\"_blank\" rel=\"noopener\">Repurposing of the Cardiovascular Drug Statin for the Treatment of Cancers: Efficacy of Statin-Dipyridamole Combination Treatment in Melanoma Cell Lines<\/a> (PubMed, 2024)\n<ul class=\"wp-block-list\">\n<li><strong>Relevans:<\/strong> Kombination af statin og dipyridamol kan forbedre behandling af melanom ved at reducere cellev\u00e6kst, is\u00e6r sammen med BRAF-h\u00e6mmeren vemurafenib.<\/li>\n<\/ul>\n<\/li>\n\n\n\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-0aab1223951a203ac00242fc15725b5f\"><strong>Link 4:<\/strong> <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/37666675\/\" target=\"_blank\" rel=\"noopener\">PRUNE1 (located on chromosome 1q21.3) promotes multiple myeloma with 1q21 Gain by enhancing the links between purine and mitochondrion<\/a> (PubMed, 2023)\n<ul class=\"wp-block-list\">\n<li><strong>Relevans:<\/strong> Denne unders\u00f8gelse viser bl.a., at dipyridamol effektivt kan h\u00e6mme proliferation af MM-celler med h\u00f8jt PRUNE1-udtryk b\u00e5de in vitro og in vivo, hvilket \u00e5bner nye muligheder for behandling af denne patientgruppe.<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Tilbage til:<\/strong> <a href=\"#skema-01\"><mark style=\"background-color:rgba(0, 0, 0, 0)\" class=\"has-inline-color has-custom-menu-links-color\">Oversigtsskema for Repurposed drugs<\/mark><\/a><\/p>\n\n\n\n<h4 class=\"wp-block-heading\" id=\"disulfiram\">4. <a href=\"https:\/\/jegharkraeft.dk\/disulfiram\/\">Disulfiram<\/a> (Antabus)<\/h4>\n\n\n\n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-b967219ef429ccee1262c4148e20ac05\"><strong>Link 1:<\/strong> <a href=\"https:\/\/www.mdpi.com\/2072-6694\/12\/1\/138\" target=\"_blank\" rel=\"noreferrer noopener\">Disulfiram\/Copper Induces Antitumor Activity against Both Nasopharyngeal Cancer Cells and Cancer-Associated Fibroblasts<\/a> (Cancers, 2020)\n<ul class=\"wp-block-list\">\n<li><strong>Relevans:<\/strong> Denne artikel beskriver, hvordan kombinationen af disulfiram og kobber (DSF\/Cu) virker dr\u00e6bende p\u00e5 b\u00e5de kr\u00e6ftceller og de omkringliggende &#8220;hj\u00e6lper-celler&#8221; (fibroblaster) via oxidativt stress og ferroptose.<\/li>\n<\/ul>\n<\/li>\n\n\n\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-3129e8aa076535b88d7106fc2e7cfc08\"><strong>Link 2:<\/strong><a href=\"https:\/\/journals.plos.org\/plosone\/article?id=10.1371\/journal.pone.0251957\" target=\"_blank\" rel=\"noreferrer noopener\"> Disulfiram and copper combination therapy targets NPL4, cancer stem cells and extends survival in a medulloblastoma model<\/a> (PLOS ONE, 2021)\n<ul class=\"wp-block-list\">\n<li><strong>Relevans:<\/strong> Dette studie underbygger p\u00e5standen om, at disulfiram rammer kr\u00e6ftstamceller. Det viser, hvordan DSF\/Cu specifikt rammer stamcelle-mark\u00f8rer som ALDH og forl\u00e6nger overlevelsen i en model af en hjernetumor.<\/li>\n<\/ul>\n<\/li>\n\n\n\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-a566adeadd85d84633de99345b583d60\"><strong>Link 3:<\/strong> <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/40491359\/\" target=\"_blank\" rel=\"noopener\">DDTC-Cu(I) Nano-MOF Induces Ferroptosis by Targeting SLC7A11\/GPX4 Signal in Colorectal Cancer<\/a> (PubMed, 2025)\n<ul class=\"wp-block-list\">\n<li><strong>Relevans:<\/strong> Denne unders\u00f8gelse viser, at nanomedicinen Cu-BTC@DDTC, hvor disulfiram (DSF) er omdannet til sin metabolit, diethyldithiocarbamate (DDTC), indlejret i en metal-organic framework, har st\u00e6rk antitumoraktivitet ved at h\u00e6mme cellev\u00e6kst, migration og invasion. Den virker ved at inducere ferroptose gennem SLC7A11\/GPX4-pathwayet, hvilket g\u00f8r den til et lovende alternativ i kr\u00e6ftbehandling via genbrug af eksisterende l\u00e6gemidler.<\/li>\n<\/ul>\n<\/li>\n\n\n\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-146e60f0ebc77abe407c7b255bdec6d8\"><strong>Link 4:<\/strong> <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/40850194\/\" target=\"_blank\" rel=\"noopener\">Employing a drug repurposing strategy to identify B-cell lymphoma-2 (BCL-2) inhibitors with anticancer potential: An in silico and in vitro based study<\/a> (National Institutes of Health, 2025) \n<ul class=\"wp-block-list\">\n<li>Indhold: Beskriver brugen af drug repurposing til at identificere stoffer, der specifikt kan h\u00e6mme BCL-2-proteinet. Dette validerer den strategi, der anvendes i skemaet, hvor Disulfiram (som rammer stamceller og proteiner) bruges mod Follikul\u00e6rt Lymfom, der er BCL-2-drevet.<\/li>\n<\/ul>\n<\/li>\n\n\n\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-9d739e9af80986b0295b23770ff2cbb7\"><strong>Link 5:<\/strong> <a href=\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC5295448\/\" target=\"_blank\" rel=\"noopener\">Targeting ALDH1A1 by disulfiram\/copper complex inhibits non-small cell lung cancer recurrence driven by ALDH-positive cancer stem cells<\/a> (National Institutes of Health, 2016) \n<ul class=\"wp-block-list\">\n<li><strong>Indhold:<\/strong> Et studie, der specifikt viser, hvordan Disulfiram\/kobber-komplekset m\u00e5lrettet h\u00e6mmer ALDH1A1-positive kr\u00e6ftstamceller. Dette underst\u00f8tter Disulfirams H\u00f8j relevans (2) i Triple Negativ og Metaplastisk brystkr\u00e6ft, da disse subtyper ofte er afh\u00e6ngige af ALDH-enzymet for overlevelse.<\/li>\n<\/ul>\n<\/li>\n\n\n\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-622abe78f1c6419a7cf457d6695371c2\"><strong>Link 6:<\/strong> <a href=\"https:\/\/www.sciencedirect.com\/science\/article\/abs\/pii\/S0024320524006234\" target=\"_blank\" rel=\"noopener\">ALDH and cancer stem cells: Pathways, challenges, and therapeutic opportunities <\/a>(ScienceDirect.com, 2024) \n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-bd3ed2fad98c49414e2e28baf0f0af91\"><strong>Indhold:<\/strong> Oversigtsartikel, der beskriver ALDH-enzymerne som en central mark\u00f8r og driver for kr\u00e6ftstamceller (CSCs). Artiklen validerer, at ALDH-enheder spiller en rolle i CSC-progression og kan for\u00e5rsage resistens over for behandling.<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">Binyrebarkkr\u00e6ft:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-0eaa9b846fd311c4a6ae5cfa2e342b2f\"><strong>Link 7:<\/strong> <a href=\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC8334864\/\" target=\"_blank\" rel=\"noopener\">Cancer Stemness Associated With Prognosis and the Immune Microenvironment in Adrenocortical Carcinoma<\/a> (National Institutes of Health, 2021)\n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-764af7a06fba0400a4ca41bb35cb0683\"><strong>Indhold: <\/strong>Et videnskabeligt studie, der identificerer kr\u00e6ftstamceller som en afg\u00f8rende faktor for resistens og tilbagefald ved binyrebarkkr\u00e6ft. Artiklen understreger behovet for nye strategier, der specifikt rammer disse cellers egenskaber (stemness), da standardbehandling ofte kommer til kort over for netop denne celletype.<\/li>\n<\/ul>\n<\/li>\n\n\n\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-510cab3db4147f7cb15ed8f381bb4416\"><strong>Link 8:<\/strong> <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/38779454\/\" target=\"_blank\" rel=\"noopener\">Pharmacogenomic analysis in adrenocortical carcinoma reveals genetic features associated with mitotane sensitivity and potential therapeutics <\/a>(PubMed, 2024) \n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-a49099eb02a695e9597e98eb89e8e298\"><strong>Indhold:<\/strong> Et videnskabeligt studie, der gennem omfattende l\u00e6gemiddel-screening identificerer Disulfiram som en effektiv behandling mod binyrebarkkr\u00e6ftceller. Unders\u00f8gelsen fremh\u00e6ver Disulfiram som en st\u00e6rk kandidat til genanvendelse (repurposing), is\u00e6r til at ramme de kr\u00e6ftformer, der udviser f\u00f8lsomhed over for specifikke metaboliske p\u00e5virkninger.<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">Bl\u00e6rekr\u00e6ft og Urinvejskr\u00e6ft:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-6b7601a602482fb56d9d1dd7075e726c\"><strong>Link 9:<\/strong> <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/31673101\/\" target=\"_blank\" rel=\"noopener\">Systematic chemical screening identifies disulfiram as a repurposed drug that enhances sensitivity to cisplatin in bladder cancer<\/a> (PubMed, 2019) \n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-032286a7ab3e7be67c2f4e43b5d11ff4\"><strong>Indhold:<\/strong> Et n\u00f8glestudie, der identificerer Disulfiram som en effektiv kandidat til at bryde resistens over for kemoterapien Cisplatin i bl\u00e6rekr\u00e6ft. Mekanismen involverer blokering af pumper, der ellers smider medicinen ud af cellen.<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">Bugspytkirtelkr\u00e6ft:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-be76fcf7c9432ad5efbb45669e946f2f\"><strong>Link 10:<\/strong> <a href=\"https:\/\/mednexus.org\/doi\/10.1097\/CM9.0000000000002909\" target=\"_blank\" rel=\"noopener\">Disulfiram: A novel repurposed drug for cancer therapy<\/a> (MedNexus, 2024)\n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-31e6407fa197d1fffde835f7cbdd6371\"><strong>Indhold:<\/strong> En helt ny oversigtsartikel fra 2024, der opsummerer de mekanismer, hvorved Disulfiram (i kombination med kobber) bek\u00e6mper kr\u00e6ft. Artiklen fokuserer is\u00e6r p\u00e5 stoffets evne til at skabe oxidativt stress (ROS) inde i kr\u00e6ftcellerne og dermed h\u00e6mme deres v\u00e6kst.<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">Hjernekr\u00e6ft:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-ffff0c778b48f4e7efd81b5a55f42334\"><strong>Link 10A:<\/strong> <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/38275022\/\" target=\"_blank\" rel=\"noopener\">Disulfiram: A novel repurposed drug for cancer therapy<\/a> (PMC, 2024)\n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-9a5320ca17ca332e0552042ae5e41b33\"><strong>Indhold:<\/strong> En videnskabelig gennemgang der beskriver disulfirams mekanismer mod kr\u00e6ft, herunder evnen til at ramme kr\u00e6ftstamceller, h\u00e6mme NF-kB og omvende resistens over for kemoterapi. Artiklen fremh\u00e6ver stoffets potentiale som repurposed drug.<\/li>\n<\/ul>\n<\/li>\n\n\n\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-01b47038512db239002d34636e437006\"><strong>Link 11:<\/strong> <a href=\"https:\/\/www.frontiersin.org\/journals\/pharmacology\/articles\/10.3389\/fphar.2022.933655\/full\" target=\"_blank\" rel=\"noopener\">Disulfiram in glioma: Literature review of drug repurposing<\/a> (Frontiers in Pharmacology, 2022)\n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-3222aec95a7aaadcfdb23946fa4570d2\"><strong>Indhold:<\/strong> En videnskabelig gennemgang, der beskriver disulfirams potentiale mod gliomer. Artiklen fokuserer p\u00e5 stoffets evne til at overvinde resistens og ramme kr\u00e6ftstamceller, hvilket g\u00f8r det til en lovende kandidat til genanvendelse (repurposing).<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">Knoglekr\u00e6ft:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-5016001b82388501cdb4a71685e2396a\"><strong>Link 12:<\/strong> <a href=\"https:\/\/europepmc.org\/article\/med\/30046395\" target=\"_blank\" rel=\"noopener\">Disulfiram reduces metastatic osteosarcoma tumor burden in vitro and in vivo<\/a> (Europe PMC, 2018)\n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-b056eb83e6f722b3444f56c2f101bac1\"><strong>Indhold:<\/strong> Et studie der viser, at Disulfiram (Antabus) fungerer som en h\u00e6mmer af ALDH-enzymet og effektivt reducerer spredning (metastase) af osteosarkom-celler. Resultaterne bekr\u00e6fter stoffets potentiale til at bremse sygdommen b\u00e5de i laboratoriefors\u00f8g og i levende organismer.<\/li>\n<\/ul>\n<\/li>\n\n\n\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-8a2a576807bae4ed298b20fe157c8584\"><strong>Link 13:<\/strong> <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/36765727\/\" target=\"_blank\" rel=\"noopener\">Exploiting the Stemness and Chemoresistance Transcriptome of Ewing Sarcoma to Identify Candidate Therapeutic Targets and Drug-Repurposing Candidates<\/a> (PubMed Central, 2023)\n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-81af6f50db1d170c2f7c34014f88f821\"><strong>Indhold:<\/strong> Et der unders\u00f8ger strategier til at ramme de resistente stamceller i Ewings Sarkom. Studiet identificerer specifikke s\u00e5rbarheder og peger p\u00e5 repurposed drugs som en effektiv vej til at blokere disse cellers overlevelse og forhindre tilbagefald.<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">Myelomatose\/ Knoglemarvskr\u00e6ft:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-ab82e427d39cbbcf0525bab359762245\"><strong>Link 14:<\/strong> <a href=\"https:\/\/www.nature.com\/articles\/nature25016\" target=\"_blank\" rel=\"noopener\">Alcohol-abuse drug disulfiram targets cancer via p97 segregase adapter NPL4<\/a> (Nature, 2017)\n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-c6beade27e8ae57d15bacb317815342d\"><strong>Indhold:<\/strong> Et meget anerkendt studie, der afd\u00e6kker disulfirams virkningsmekanisme: Det blokerer cellens evne til at h\u00e5ndtere protein-affald (via p97\/NPL4 pathway). Da myelomatose-celler producerer enorme m\u00e6ngder protein, er de ekstremt s\u00e5rbare over for denne blokering.<\/li>\n<\/ul>\n<\/li>\n\n\n\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-a3d3f467f42121a17661b1c00b1bb936\"><strong>Link 15:<\/strong> <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/30427223\/\" target=\"_blank\" rel=\"noopener\">The power of proteasome inhibition in multiple myeloma <\/a>(PubMed, 2018)\n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-5f97e95e822c8bd1701633616e644b87\"><strong>Indhold:<\/strong> En oversigtsartikel, der beskriver, hvorfor proteasom-h\u00e6mning er rygraden i myelomatose-behandling, og hvordan stoffer som disulfiram kan bidrage til denne effekt.<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">Nyrekr\u00e6ft:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-78ca8b877a6d3b213ecb9135b769893b\"><strong>Link 16:<\/strong> <a href=\"https:\/\/www.sciencedirect.com\/science\/article\/abs\/pii\/S0014299923006246\" target=\"_blank\" rel=\"noopener\">Overcoming the compensatory increase in NRF2 induced oxidative stress via the synergistic action of disulfiram\/copper in renal cell carcinoma <\/a>(ScienceDirect, 2023)\n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-0558ddb17f984dc641636473598dfcfd\"><strong>Indhold:<\/strong> Et nyere studie, der demonstrerer, at kombinationen af Disulfiram og kobber effektivt reducerer levedygtigheden af nyrekr\u00e6ftceller. Artiklen viser, at behandlingen h\u00e6mmer cellernes evne til at invadere og migrere (sprede sig) og samtidig forstyrrer de mekanismer, cellerne bruger til at opretholde resistens.<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Tilbage til:<\/strong> <a href=\"#skema-01\"><mark style=\"background-color:rgba(0, 0, 0, 0)\" class=\"has-inline-color has-custom-menu-links-color\">Oversigtsskema for Repurposed drugs<\/mark><\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><\/p>\n\n\n\n<h4 class=\"wp-block-heading has-custom-sort-tekst-color has-text-color has-link-color wp-elements-580709a4061b2c8bccc257193bb4a0ee\" id=\"doxycyclin\">5. <a href=\"https:\/\/jegharkraeft.dk\/doxycyclin\/\">Doxycyclin<\/a><\/h4>\n\n\n\n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-23446902e4dd30fffdc3437564b4e188\"><strong>Link 1:<\/strong> <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/40273927\/\" target=\"_blank\" rel=\"noopener\">Matrix metalloproteinase 9 implication during colorectal carcinogenesis. Effect of doxycycline<\/a> (PubMed, 2025)\n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-15fc16b189a47936b7bfd0504fd33c5b\"><strong>Relevans:<\/strong> Overekspression af MMP9 opst\u00e5r tidligt under kolorektal carcinogenese, og doxycyklin kan kontrollere den patologiske omdannelse af colonmucosa til ACF-kluster ved at formindske MMP9-aktiviteten.<\/li>\n<\/ul>\n<\/li>\n\n\n\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-1b58b3aeb3c9c37eac1cc3070ee6429b\"><strong>Link 2:<\/strong><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/30364293\/\" target=\"_blank\" rel=\"noopener\"> Doxycycline, an Inhibitor of Mitochondrial Biogenesis, Effectively Reduces Cancer Stem Cells (CSCs) in Early Breast Cancer Patients: A Clinical Pilot Study<\/a> (PubMed, 2018)\n<ul class=\"wp-block-list\">\n<li><strong>Relevans:<\/strong> Et pilotstudie p\u00e5 brystkr\u00e6ftpatienter viser, at antibiotikummet doxycyclin ser ud til at kunne fjerne de aggressive kr\u00e6ftstamceller (CSC). Dette blev m\u00e5lt ved et fald i de kendte stamcelle-mark\u00f8rer (CD44 og ALDH1). Selvom resultaterne er lovende, er st\u00f8rre studier n\u00f8dvendige for at bekr\u00e6fte fundet.<\/li>\n<\/ul>\n<\/li>\n\n\n\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-4d8c45d07c57317d5d42cde45563d664\"><strong>Link 3:<\/strong><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/31002656\/\" target=\"_blank\" rel=\"noopener\"> Doxycycline, Azithromycin and Vitamin C (DAV): A potent combination therapy for targeting mitochondria and eradicating cancer stem cells (CSCs)<\/a> (PubMed, 2019)\n<ul class=\"wp-block-list\">\n<li><strong>Relevans:<\/strong> En kombination af to antibiotika (Doxycyclin og Azithromycin) og C-vitamin virker som en &#8220;metabolisk f\u00e6lde&#8221;, der i laboratoriefors\u00f8g stoppede over 90% af brystkr\u00e6ftstamcellers v\u00e6kst ved at lamme deres energiproduktion.<\/li>\n<\/ul>\n<\/li>\n\n\n\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-7342df477572baff5dfabecb9eab504a\"><strong>Link 4:<\/strong> <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/40284400\/\" target=\"_blank\" rel=\"noopener\">The Impact of Doxycycline as an Adjunctive Therapy on Prostate-Specific Antigen, Quality of Life, and Cognitive Function in Metastatic Prostate Cancer Patients: A Phase II Randomized Controlled Trial <\/a>(PubMed, 2025)\n<ul class=\"wp-block-list\">\n<li><strong>Relevans:<\/strong> Doxycyklin kan hj\u00e6lpe ved metastatisk prostatakr\u00e6ft ved at s\u00e6nke PSA og forbedre livskvalitet. Yderligere st\u00f8rre studier er n\u00f8dvendige for at bekr\u00e6fte dette.<\/li>\n<\/ul>\n<\/li>\n\n\n\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-c7abcd82be04c52882a6c73c63c48fae\"><strong>Link 5:<\/strong> <a href=\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC11719974\/\" target=\"_blank\" rel=\"noreferrer noopener\">Doxycycline Restores Gemcitabine Sensitivity in Preclinical Models of Multidrug-Resistant Intrahepatic Cholangiocarcinoma<\/a> (Cancers, 2025)\n<ul class=\"wp-block-list\">\n<li><strong>Relevans:<\/strong> Et meget relevant pr\u00e6klinisk studie, der viser, at doxycyclin kan overvinde resistens over for kemoterapien gemcitabin i intrahepatisk galdegangskr\u00e6ft (iCCA). Kombinationen af doxycyclin og gemcitabin f\u00f8rte til markant reduceret tumorv\u00e6kst i dyremodeller, bl.a. ved at inducere apoptose og ramme kr\u00e6ftstamcellerne.<\/li>\n<\/ul>\n<\/li>\n\n\n\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-ba67210ffb480eacdbb05a82bd54c4c3\"><strong>Link 6:<\/strong> <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/34644207\/\" target=\"_blank\" rel=\"noopener\">Doxycycline sensitizes renal cell carcinoma to chemotherapy by preferentially inhibiting mitochondrial translation<\/a> (PubMed, 2021)\n<ul class=\"wp-block-list\">\n<li><strong>Indhold:<\/strong> Dette studie viser, at doxycyclin kan g\u00f8re nyrekr\u00e6ftceller mere f\u00f8lsomme over for kemoterapi. Mekanismen er, at doxycyclin specifikt h\u00e6mmer kr\u00e6ftcellernes mitokondrier (cellens kraftv\u00e6rker), hvilket forstyrrer deres energiproduktion og g\u00f8r dem mere s\u00e5rbare over for den celleskade, som kemoterapien for\u00e5rsager.<\/li>\n<\/ul>\n<\/li>\n\n\n\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-1b08fc305df4a113aeada9ab56e44e51\"><strong>Link 7:<\/strong> <a href=\"https:\/\/www.mdpi.com\/1422-0067\/20\/1\/229\" target=\"_blank\" rel=\"noopener\">Targeting Mitochondria for Treatment of Chemoresistant Ovarian Cancer<\/a> (MDPI, 2019)\n<ul class=\"wp-block-list\">\n<li><strong>Indhold:<\/strong> En artikel, der specifikt beskriver, hvordan man kan angribe kr\u00e6ftcellernes kraftv\u00e6rker (mitokondrier) for at bek\u00e6mpe resistent \u00e6ggestokkr\u00e6ft \u2013 pr\u00e6cis den mekanisme, Doxycyclin bruger.<\/li>\n<\/ul>\n<\/li>\n\n\n\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-679a9688bbc823b14e81cb21d3908264\"><strong>Link 8:<\/strong><a href=\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC10052731\/\" target=\"_blank\" rel=\"noopener\"> Metabolic Reprogramming and Potential Therapeutic Targets in Lymphoma<\/a> (National Institutes of Health, 2023)\n<ul class=\"wp-block-list\">\n<li><strong>Indhold:<\/strong> En systematisk gennemgang af, hvordan lymfomceller oml\u00e6gger deres stofskifte (fokus p\u00e5 h\u00f8j glukoseoptagelse og deregulerede glykolyse-enzymer). Artiklen underbygger relevansen af at blokere glykolyse som en terapeutisk strategi, hvilket er centralt for is\u00e6r Burkitt&#8217;s Lymfom og DLBCL. Dog n\u00e6vnes Doxycyclin ikke direkte i artiklen.<\/li>\n<\/ul>\n<\/li>\n\n\n\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-ab0209817864244511c885754b88b536\"><strong>Link 9:<\/strong><a href=\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC6995629\/\" target=\"_blank\" rel=\"noopener\"> Metformin: The Answer to Cancer in a Flower? Current Knowledge and Future Prospects of Metformin as an Anti-Cancer Agent in Breast Cancer<\/a> (National Institutes of Health, 2019)\n<ul class=\"wp-block-list\">\n<li><strong>Indhold:<\/strong> En oversigtsartikel, der beskriver, hvordan kombinationsstrategier er n\u00f8dvendige mod aggressivt B-celle lymfom. Artiklen underst\u00f8tter relevansen af at kombinere midler (som Metformin og Doxycyclin), der blokerer mTORC1-signalvejen og relaterede v\u00e6kstmekanismer.<\/li>\n<\/ul>\n<\/li>\n\n\n\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-9e193398742205f3cc13fca7fa66ecbb\"><strong>Link 10:<\/strong> <a href=\"https:\/\/www.sciencedirect.com\/science\/article\/pii\/S0304419X25001921\" target=\"_blank\" rel=\"noopener\">Unraveling the role of mitochondrial dynamics in cancer eradication: a review<\/a> (ScienceDirect.com, 2025)\n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-428cb5e113182ce33131a9def5d29705\"><strong>Indhold:<\/strong> Oversigtsartikel, der beskriver, hvordan mitokondriel dynamik er en s\u00e5rbarhed for kr\u00e6ftceller. Artiklen validerer, at targeting af mitokondrier repr\u00e6senterer en terapeutisk strategi for at eliminere kr\u00e6ftstamceller.<\/li>\n<\/ul>\n<\/li>\n\n\n\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-109eff8f63a576205c8df177347f2085\"><strong>Link 11:<\/strong> <a href=\"https:\/\/www.sciencedirect.com\/science\/article\/pii\/S0009279723004179\" target=\"_blank\" rel=\"noopener\">Hydroxychloroquine: Key therapeutic advances and mechanistic insights for cancer<\/a> (ScienceDirect.com, 2023)\n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-cfad4a68a8ab9bfef6122c90f175203d\"><strong>Indhold:<\/strong> Oversigtsartikel, der beskriver Hydroxychloroquine (HCQ) som et lovende anticancermiddel, der kan bek\u00e6mpe kr\u00e6ft gennem autofagi-h\u00e6mning. Artiklen underst\u00f8tter HCQ&#8217;s Hovedstrategi (1) mod resistens, da autofagi er den prim\u00e6re flugtvej.<\/li>\n<\/ul>\n<\/li>\n\n\n\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-d07d7e35ab3ef9a441ead257a706cb35\"><strong>Link 12:<\/strong> <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/26512779\/\" target=\"_blank\" rel=\"noopener\">Doxycycline reverses epithelial-to-mesenchymal transition and suppresses the proliferation and metastasis of lung cancer cells<\/a> (Oncotarget, 2015)\n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-b3f7022ca30f3ce9c84b173e815dd4cf\"><strong>Indhold:<\/strong> Studie, der viser, at Doxycyclin h\u00e6mmer celledeling, metastase og vender epithelial-to-mesenchymal transition (EMT), hvilket er en essentiel mekanisme for EGFR-resistente stamceller.<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">Binyrebarkkr\u00e6ft:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-5186c6912d738bafad49d35c4d8faf2b\"><strong>Link 13:<\/strong> <a href=\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC7503725\/\" target=\"_blank\" rel=\"noopener\">Targeting the Mitochondrial Metabolic Network: A Promising Strategy for Cancer Treatment<\/a> (National Institutes of Health, 2020)\n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-793b8afb490094e97a6265a1b2e9a6c5\"><strong>Indhold:<\/strong> En videnskabelig oversigtsartikel, der beskriver strategien ved at ramme kr\u00e6ftcellers mitokondrier. Artiklen fremh\u00e6ver Doxycyklin som en af de mest lovende kandidater til at blokere mitokondriel funktion og dermed kv\u00e6le energitilf\u00f8rslen til tumorer med h\u00f8jt stofskifte.<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">Blodkr\u00e6ft:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-b1f284728a0c9bfc88502fc250108583\"><strong>Link 14:<\/strong> <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/34704521\/\" target=\"_blank\" rel=\"noopener\">Targeting mitochondrial metabolism in acute myeloid leukemia<\/a> (PubMed, 2022)\n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-2891f8d7f71b65f8c7de68f8f23e6ee3\"><strong>Indhold:<\/strong> Et studie der analyserer betydningen af kr\u00e6ftcellers energifabrikker (mitokondrier) for overlevelsen af leuk\u00e6mi-stamceller. Forskningen underbygger strategien om at anvende stoffer som Doxycyclin til at h\u00e6mme mitokondriel proteinsyntese og dermed fjerne energiforsyningen til de mest aggressive celler.<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">Hjernekr\u00e6ft:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-a0a849db7d59dea1138cca57fdad916b\"><strong>Link 15:<\/strong> <a href=\"https:\/\/www.researchgate.net\/publication\/26527272_Anti-Tumor_Effect_of_Doxycycline_on_Glioblastoma_Cells\" target=\"_blank\" rel=\"noopener\">Anti-Tumor Effect of Doxycycline on Glioblastoma Cells<\/a> (ResearchGate, 2007)\n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-ecfc03eab390daf18161a0dfab72b09c\"><strong>Indhold:<\/strong> Et nyere studie, der unders\u00f8ger doxycyclins effekt p\u00e5 glioblastom-celler. Resultaterne bekr\u00e6fter, at stoffet virker som en h\u00e6mmer af matrix metalloproteinaser (MMP&#8217;er), hvilket er afg\u00f8rende for at forhindre kr\u00e6ftcellerne i at invadere det omkringliggende hjernev\u00e6v.<\/li>\n<\/ul>\n<\/li>\n\n\n\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-1aee67175f3059279b7cc67dfbabc66d\"><strong>Link 16:<\/strong> <a href=\"https:\/\/www.mdpi.com\/2673-6284\/14\/2\/28\" target=\"_blank\" rel=\"noopener\">Matrix Metalloproteinases in Glioma: Drivers of Invasion<\/a> (MDPI, 2025)\n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-27c8f24dc996760b2bb195c1f15c1aa5\"><strong>Indhold:<\/strong> En nyere oversigtsartikel, der identificerer matrix metalloproteinaser (MMP) som centrale drivere for invasion ved gliom. Teksten diskuterer doxycyclins rolle som en MMP-h\u00e6mmer i fors\u00f8get p\u00e5 at bremse denne spredning.<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">Knoglekr\u00e6ft:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-48b88edc3e726a02e73329248f8c05df\"><strong>Link 17:<\/strong> <a href=\"https:\/\/europepmc.org\/article\/med\/36027697\" target=\"_blank\" rel=\"noopener\">Doxycycline inhibits the progression of metastases in early-stage osteosarcoma<\/a> (Europe PMC, 2022)\n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-0fe1e81349d1cdb1fff4f152fcd2c62f\"><strong>Indhold: <\/strong>Et studie der dokumenterer Doxycyclins evne til at h\u00e6mme spredning af osteosarkom. Artiklen beskriver, hvordan stoffet nedregulerer de enzymer (MMP) og v\u00e6kstfaktorer (VEGF), som kr\u00e6ftcellerne bruger til at invadere v\u00e6v og danne blodkar, hvilket bekr\u00e6fter dets potentiale til at bremse sygdomsudviklingen.<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">Myelomatose\/ Knoglemarvskr\u00e6ft:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-15896aec9c52959843e1bb27bfaeed9f\"><strong>Link 18:<\/strong> <a href=\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC11431705\/\" target=\"_blank\" rel=\"noopener\">Doxycycline Plus Bortezomib-Containing Regimens for the Treatment of Light-Chain Amyloidosis <\/a>(PubMed, MDPI, 2024)\n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-2394318f8496da251dffc2da0766e6ce\"><strong>Indhold:<\/strong> Et nyt studie, der viser, at doxycyclin kan forbedre behandlingen af AL amyloidose (en tilstand t\u00e6t besl\u00e6gtet med myelomatose). Doxycyclin h\u00e6mmer dannelsen af skadelige protein-fibriller og beskytter organerne.<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">Nyrekr\u00e6ft:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-70395164b928ba4a138d1f29ed80aaf4\"><strong>Link 19:<\/strong> <a href=\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC8521774\/\" target=\"_blank\" rel=\"noopener\">Doxycycline sensitizes renal cell carcinoma to cisplatin via inhibiting mitochondrial DNA translation<\/a> (PubMed, 2021)\n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-0d79511c496e0d0afc3902f061df55f4\"><strong>Indhold:<\/strong> Et videnskabeligt studie, der viser, at Doxycyklin h\u00e6mmer dannelsen af mitokondrie-DNA i nyrekr\u00e6ftceller. Dette forstyrrer cellernes energiproduktion (respiration) og g\u00f8r dem samtidig markant mere f\u00f8lsomme over for kemoterapi (cisplatin), hvilket underst\u00f8tter strategien om at ramme kr\u00e6ftcellernes metabolisme.<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n\n\n\n<p class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-6159f05db2d82389bd0a895fb83b5de1 wp-block-paragraph\"><strong>Tilbage til:<\/strong> <a href=\"#skema-01\"><mark style=\"background-color:rgba(0, 0, 0, 0)\" class=\"has-inline-color has-custom-menu-links-color\">Oversigtsskema for Repurposed drugs<\/mark><\/a><\/p>\n\n\n\n<h4 class=\"wp-block-heading has-custom-sort-tekst-color has-text-color has-link-color wp-elements-d9a81b4439ae9b136c7db7e2eb187718\" id=\"aspirin\">6. <a href=\"https:\/\/jegharkraeft.dk\/aspirin\/\">Hjertemagnyl<\/a> (Aspirin)<\/h4>\n\n\n\n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-67d25ca6d2f335824ee94bb6c541cde7\"><strong>Link 1:<\/strong><a href=\"https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC8426031\/\" target=\"_blank\" rel=\"noreferrer noopener\"> Aspirin and cancer survival: a systematic review and meta-analyses of 118 observational studies of aspirin and 18 cancers<\/a> (British Journal of Cancer, 2021)\n<ul class=\"wp-block-list\">\n<li><strong>Relevans:<\/strong> En meget stor og omfattende oversigtsartikel (meta-analyse), der samler data fra 118 studier. Den konkluderer, at der er en overbevisende sammenh\u00e6ng mellem regelm\u00e6ssig brug af aspirin og forbedret overlevelse for en lang r\u00e6kke kr\u00e6ftformer, is\u00e6r tarmkr\u00e6ft.<\/li>\n<\/ul>\n<\/li>\n\n\n\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-382df02aaadf58a506ceb946f56e0e7d\"><strong>Link 2: <\/strong><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/39825684\/\" target=\"_blank\" rel=\"noopener\">Long-term use of low-dose aspirin for cancer prevention: A 20-year longitudinal cohort study of 1,506,525 Hong Kong residents <\/a>(PubMed, 2025)\n<ul class=\"wp-block-list\">\n<li><strong>Relevans:<\/strong> Langvarig lavdosis aspirin (over 10 \u00e5r) reducerer risikoen for kr\u00e6ft, is\u00e6r lunge-, bryst- og tyktarmskr\u00e6ft, samt kr\u00e6ftrelateret d\u00f8delighed. Effekten er st\u00e6rkere med l\u00e6ngere brug og kan starte allerede fra 40-\u00e5rs alderen.<\/li>\n<\/ul>\n<\/li>\n\n\n\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-ecf6eb7c7059a639fe3add85094f69b8\"><strong>Link 3:<\/strong><a href=\"https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC7729916\/\" target=\"_blank\" rel=\"noreferrer noopener\"> Mechanisms of Colorectal Cancer Prevention by Aspirin\u2014A Literature Review and Perspective on the Role of COX-Dependent and -Independent Pathways<\/a> (Cancers, 2020)\n<ul class=\"wp-block-list\">\n<li><strong>Relevans:<\/strong> Denne artikel g\u00e5r i dybden med <em>hvordan<\/em> aspirin virker. Den forklarer den velkendte COX-h\u00e6mmende (anti-inflammatoriske) mekanisme, men diskuterer ogs\u00e5 nyere forskning i COX-uafh\u00e6ngige mekanismer, hvilket underbygger, hvorfor aspirin har s\u00e5 bred en virkning.<\/li>\n<\/ul>\n<\/li>\n\n\n\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-c908c9b0118bfe66cfc484107b6f6cc0\"><strong>Link 4:<\/strong> <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/40141362\/\" target=\"_blank\" rel=\"noopener\">Prolonged Low-Dose Administration of FDA-Approved Drugs for Non-Cancer Conditions: A Review of Potential Targets in Cancer Cells<\/a> (PubMed, 2025)\n<ul class=\"wp-block-list\">\n<li><strong>Relevans:<\/strong> Selvom FDA-godkendte l\u00e6gemidler som aspirin og metformin kan s\u00e6nke kr\u00e6ftforekomsten, er de pr\u00e6cise mekanismer endnu uklare. Langvarig lavdosis behandling kan potentielt forebygge metastaser hos udvalgte patienter.<\/li>\n<\/ul>\n<\/li>\n\n\n\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-1904145cc9c38fb81a13d0153a1c2784\"><strong>Link 5:<\/strong> <a href=\"https:\/\/www.cancernetwork.com\/view\/aspirin-does-not-limit-recurrence-improve-survival-in-crc-liver-metastases\" target=\"_blank\" rel=\"noreferrer noopener\">Aspirin Does Not Limit Recurrence, Improve Survival in CRC Liver Metastases<\/a> (Journal of Clinical Oncology, 2025)\n<ul class=\"wp-block-list\">\n<li><strong>Relevans:<\/strong> Et stort, randomiseret, placebo-kontrolleret fase 3-studie (ASAC-studiet) viste overraskende, at en lav dosis aspirin <strong>ikke<\/strong> forbedrede den sygdomsfri overlevelse eller den samlede overlevelse hos patienter med levermetastaser fra tyktarmskr\u00e6ft. Dette er et vigtigt, nyt resultat, der udfordrer tidligere observationelle data for denne specifikke patientgruppe.<\/li>\n<\/ul>\n<\/li>\n\n\n\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-a9a405852703ba39788911afc15ea32b\"><strong>Link 5:<\/strong><a href=\"https:\/\/www.nature.com\/articles\/s41388-021-02170-0\" target=\"_blank\" rel=\"noopener\"> Blockade of beta-adrenergic receptors reduces cancer growth and enhances the response to anti-CTLA4 therapy by modulating the tumor <\/a>(Nature, 2022)\n<ul class=\"wp-block-list\">\n<li><strong>Indhold:<\/strong> En videnskabelig artikel, der bekr\u00e6fter, at blokering af beta-adrenerge receptorer (Propranolol) reducerer kr\u00e6ftv\u00e6kst og forbedrer effekten af immunterapi. Dette underst\u00f8tter Propranolols Hovedstrategi (1)-status i Inflammatorisk Brystkr\u00e6ft (IBC) og metastatisk sygdom, hvor stress- og immunmodulering er afg\u00f8rende.<\/li>\n<\/ul>\n<\/li>\n\n\n\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-868b67bfe47104c1c281966b4458d0ed\"><strong>Link 6:<\/strong> <a href=\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC10452867\/\" target=\"_blank\" rel=\"noopener\">BRAF Mutations in Melanoma: Biological Aspects and Therapeutic Approaches<\/a> (National Institutes of Health, 2023) \n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-e064667540e39d2a1e21a14daad09eb7\"><strong>Indhold:<\/strong> Oversigtsartikel, der beskriver, at kombinationsbehandlinger sigter mod at h\u00e6mme forskellige transduktionsveje, der er kritiske for kr\u00e6ftcellers overlevelse. Dette validerer den overordnede strategi i skemaet om at angribe b\u00e5de MAPK og alternative veje for at forhindre resistens.<\/li>\n<\/ul>\n<\/li>\n\n\n\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-b58cc39b0ba1e4e94a1b8d7404df67b8\"><strong>Link 7:<\/strong> <a href=\"https:\/\/www.dovepress.com\/aspirin-in-cancer-therapy-pharmacology-and-nanotechnology-advances-peer-reviewed-fulltext-article-IJN\" target=\"_blank\" rel=\"noopener\">Repurposing Aspirin as a Potent Anti-Cancer Agent<\/a> (Dove Medical Press, 2025) \n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-796adb2cb68f1a1b439d3f3a4e37d93a\"><strong>Indhold:<\/strong> Oversigtsartikel, der beskriver Aspirins evne til at h\u00e6mme COX-2 og derved ikke blot reducere inflammation, men ogs\u00e5 forstyrre tumorfremmende signalveje involveret i kr\u00e6ftudvikling. Dette validerer Hovedstrategi (1) i den inflammationsdrevne KRAS-muterede kr\u00e6ft.<\/li>\n<\/ul>\n<\/li>\n\n\n\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-0ac88bf5c28e58b5e4e1351552514d49\"><strong>Link 8: <\/strong><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/24057048\/\" target=\"_blank\" rel=\"noopener\">The hexacarbonyldicobalt derivative of aspirin acts as a CO-releasing NSAID on malignant mesothelioma cells<\/a> (National Institutes of Health, 2013)<strong> <\/strong>\n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-4e6203fc61254a9ab842a8f0b0e0eda1\"><strong>Indhold:<\/strong> Studie, der viser, at et derivat af Aspirin virker som en CO-frigivende NSAID, der er mere potent end cisplatin i at h\u00e6mme cellev\u00e6kst i mesotheliomceller ved at h\u00e6mme det anti-apoptotiske protein NF-\u03baB.<\/li>\n<\/ul>\n<\/li>\n\n\n\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-4267814011c502704394b8faeb308be7\"><strong>Link 9:<\/strong> <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/17132819\/\" target=\"_blank\" rel=\"noopener\">Aspirin activates the NF-kappaB signalling pathway and induces apoptosis in intestinal neoplasia in two in vivo models of human colorectal cancer<\/a> (Oxford Academic, 2007) \n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-fc06155e51f2a45b3c456d1bcd3c37b7\"><strong>Indhold:<\/strong> Studie, der viser, at Aspirin modulerer NF-\u03baB-signalvejen og fremmer celled\u00f8d i tarmkr\u00e6ftceller i dyremodeller. Dette validerer Aspirins Hovedstrategi (1) mod den inflammatoriske driver.<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">Bugspytkirtelkr\u00e6ft:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-c3681f04d029007654b2f7bb9d744593\"><strong>Link 10:<\/strong> <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/40242424\/\" target=\"_blank\" rel=\"noopener\">Long-term aspirin use influences the probability of distant metastases and operability in patients with pancreatic ductal adenocarcinoma<\/a> (NIH, PubMed, 2025) \n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-f4313b215763eb5d4e84b2f7158fbda9\"><strong>Indhold:<\/strong> Et klinisk studie, der unders\u00f8ger effekten af l\u00e6ngerevarende brug af hjertemagnyl (aspirin) hos patienter med bugspytkirtelkr\u00e6ft. Resultaterne viser, at patienter, der tog aspirin, havde en signifikant lavere risiko for at have fjernmetastaser ved diagnosetidspunktet, og at flere var egnede til operation, hvilket underbygger stoffets evne til at bremse sygdommens spredning.<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">Galdebl\u00e6re- og Galdevejskr\u00e6ft:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-146bc7afb47caedaf83d1f35760ffd78\"><strong>Link 11:<\/strong> <a href=\"https:\/\/www.researchgate.net\/publication\/349936495_Aspirin_and_Statin_Use_and_the_Risk_of_Gallbladder_Cancer\" target=\"_blank\" rel=\"noopener\">Aspirin and Statin Use and the Risk of Gallbladder Cancer <\/a>(ResearchGate, 2025) \n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-6813748139e1384a5a4ec29d490a2956\"><strong>Indhold:<\/strong> Et nyt studie, der evaluerer sammenh\u00e6ngen mellem statinbrug og risikoen for galdebl\u00e6rekr\u00e6ft. Resultaterne viser, at statiner (is\u00e6r i kombination med aspirin) er forbundet med en st\u00e6rkt reduceret risiko for at udvikle sygdommen, hvilket underst\u00f8tter deres potentiale til at h\u00e6mme kr\u00e6ftudvikling i galdevejene.<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">Mavekr\u00e6ft:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-c235e365c4586fbfebc9c48fbce9153c\"><strong>Link 12:<\/strong> <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/40945236\/\" target=\"_blank\" rel=\"noopener\">Aspirin use associated with a decreased risk of gastric cancer<\/a> (PubMed\/Cancer Epidemiology, 2025)\n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-a893b3bd7eca14bc1d79484dbbefdaa0\"><strong>Indhold:<\/strong> Et nyt studie fra 2025, der underbygger aspirins rolle i forebyggelse og behandling af mavekr\u00e6ft. Resultaterne viser en signifikant nedsat risiko for sygdommen, hvilket st\u00f8tter teorien om aspirins anti-inflammatoriske og kr\u00e6fth\u00e6mmende virkning i maves\u00e6kken.<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">Myelomatose\/ Knoglemarvskr\u00e6ft:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-1364687311e683149aa424f455b85cf8\"><strong>Link 13:<\/strong> <a href=\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC8825752\/\" target=\"_blank\" rel=\"noopener\">Regular Aspirin Use and Mortality in Multiple Myeloma<\/a> (National Institutes of Health, 2021) \n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-1267680638d93de8a8d70c0e1a759bdc\"><strong>Indhold: <\/strong>En videnskabelig artikel, der unders\u00f8ger effekten af aspirin hos patienter med myelomatose. Studiet fremh\u00e6ver, at blodfortyndende behandling er afg\u00f8rende for patienter, der modtager immunmodulerende medicin (f.eks. lenalidomid), da disse \u00f8ger risikoen for blodpropper. Samtidig peger data p\u00e5 en sammenh\u00e6ng mellem aspirin-brug og reduceret d\u00f8delighed.<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">Tarmkr\u00e6ft:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-3eb64aced66f3e0f0dff92b0b75284f7\"><strong>Link 14:<\/strong> <a href=\"https:\/\/www.nejm.org\/doi\/full\/10.1056\/NEJMoa2504650\" target=\"_blank\" rel=\"noopener\">Low-Dose Aspirin for PI3K-Altered Localized Colorectal Cancer<\/a> (New England Journal of Medicine, 2025)\n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-b710692752929c0580d3357fe19cc8a9\"><strong>Indhold:<\/strong> Et klinisk studie, der unders\u00f8ger effekten af lavdosis aspirin hos patienter med tarmkr\u00e6ft. Resultaterne indikerer, at aspirin reducerer risikoen for tilbagefald, is\u00e6r hos patienter med genetiske \u00e6ndringer i PI3K-signalvejen, hvilket underst\u00f8tter en m\u00e5lrettet brug af stoffet.<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n\n\n\n<p class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-6159f05db2d82389bd0a895fb83b5de1 wp-block-paragraph\"><strong>Tilbage til:<\/strong> <a href=\"#skema-01\"><mark style=\"background-color:rgba(0, 0, 0, 0)\" class=\"has-inline-color has-custom-menu-links-color\">Oversigtsskema for Repurposed drugs<\/mark><\/a><\/p>\n\n\n\n<h4 class=\"wp-block-heading has-custom-sort-tekst-color has-text-color has-link-color wp-elements-5b071a2468367fc111e426c8d4e693a6\" id=\"hydroxychloroquin\">7. <a href=\"https:\/\/jegharkraeft.dk\/plaquenil-ivermectin\/\">Hydroxychloroquin<\/a><\/h4>\n\n\n\n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-fdbde484a50d9b633a15b1ae9ace89f3\"><strong>Link 1:<\/strong> <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/40185322\/\" target=\"_blank\" rel=\"noopener\">The imidazoline I<sub>2<\/sub>&nbsp;receptor agonist 2-BFI enhances cytotoxic activity of hydroxychloroquine by modulating oxidative stress, energy-related metabolism and autophagic influx in human colorectal adenocarcinoma cell lines<\/a> (PubMed, 2025)\n<ul class=\"wp-block-list\">\n<li><strong>Relevans:<\/strong> Et nyt studie viser, at stoffet 2-BFI (en imidazoline I2-receptor agonist) markant forst\u00e6rker den celledr\u00e6bende effekt af autofagi-h\u00e6mmeren hydroxychloroquin (HCQ) mod tarmkr\u00e6ftceller. Kombinationen virker ved at skabe \u00f8get oxidativt stress og forstyrre kr\u00e6ftcellernes stofskifte og overlevelsesmekanismer.<\/li>\n<\/ul>\n<\/li>\n\n\n\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-e791d047bf2fc3dc3c519ce954fa3ff4\"><strong>Link 2:<\/strong><a href=\"https:\/\/www.upmc.com\/media\/news\/030922-malaria-drug-chemotherapy\" target=\"_blank\" rel=\"noreferrer noopener\"> Malaria Drug Could Combat Chemotherapy-Resistant Head and Neck Cancers<\/a> (UPMC, 2022)\n<ul class=\"wp-block-list\">\n<li><strong>Relevans:<\/strong> Dette er en letforst\u00e5elig opsummering af et studie, der viser et helt konkret eksempel p\u00e5, hvordan hydroxychloroquin bruges til at overvinde kemo-resistens. Det forklarer, hvordan stoffet kan &#8220;gen-sensibilisere&#8221; kr\u00e6ftceller, s\u00e5 kemoterapien virker igen.<\/li>\n<\/ul>\n<\/li>\n\n\n\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-746c8e1ce9ec47dff904e80d31646254\"><strong>Link 3: <\/strong><a href=\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC6406467\/\" target=\"_blank\" rel=\"noopener\">Therapeutic Modulation of Autophagy in Leukaemia and Lymphoma<\/a> (National Institutes of Health, 2019) \n<ul class=\"wp-block-list\">\n<li><strong>Indhold:<\/strong> En oversigtsartikel, der fokuserer p\u00e5 autofagiens rolle i udviklingen af b\u00e5de leuk\u00e6mi og lymfom. Artiklen beskriver, hvordan blokering af denne cellul\u00e6re overlevelsesmekanisme er en terapeutisk strategi i blodkr\u00e6ft, hvilket underst\u00f8tter relevansen af Hydroxychloroquin i alle lymfom-kolonner.<\/li>\n<\/ul>\n<\/li>\n\n\n\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-287239d7fd4975026cccf500c5c51055\"><strong>Link 4: <\/strong><a href=\"https:\/\/pubs.acs.org\/doi\/10.1021\/acsptsci.4c00545\" target=\"_blank\" rel=\"noopener\">Harnessing Drug Repurposing to Combat Breast Cancer by Targeting Altered Metabolism and EMT<\/a> (ACS Publications, 2024)\n<ul class=\"wp-block-list\">\n<li><strong>Indhold:<\/strong> En ny oversigtsartikel (2024), der specifikt validerer strategien for Doxycyclin og Hydroxychloroquin ved at fokusere p\u00e5 metabolisk reprogrammering og targeting af stamcelle-egenskaber i brystkr\u00e6ft. Dette underst\u00f8tter Hovedstrategi (1)-status for begge midler i metaplastisk brystkr\u00e6ft.<\/li>\n<\/ul>\n<\/li>\n\n\n\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-5d9a4ebc15a35b19d3275ca6bdaf86dd\"><strong>Link 5: <\/strong><a href=\"https:\/\/www.sciencedirect.com\/science\/article\/pii\/S0304419X25001921\" target=\"_blank\" rel=\"noopener\">Unraveling the role of mitochondrial dynamics in cancer eradication: a review<\/a> (ScienceDirect.com, 2025)\n<ul class=\"wp-block-list\">\n<li><strong>Indhold:<\/strong> Oversigtsartikel, der beskriver, hvordan mitokondriel dynamik er en s\u00e5rbarhed for kr\u00e6ftceller. Artiklen validerer, at targeting af mitokondrier repr\u00e6senterer en terapeutisk strategi for at eliminere kr\u00e6ftstamceller.<\/li>\n<\/ul>\n<\/li>\n\n\n\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-31e65724eb5708dc03095fbd2a7cf3d6\"><strong>Link 6:<\/strong> <a href=\"https:\/\/www.sciencedirect.com\/science\/article\/pii\/S0009279723004179\" target=\"_blank\" rel=\"noopener\">Hydroxychloroquine: Key therapeutic advances and mechanistic insights for cancer<\/a> (ScienceDirect.com, 2023) \n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-cfad4a68a8ab9bfef6122c90f175203d\"><strong>Indhold:<\/strong> Oversigtsartikel, der beskriver Hydroxychloroquine (HCQ) som et lovende anticancermiddel, der kan bek\u00e6mpe kr\u00e6ft gennem autofagi-h\u00e6mning. Artiklen underst\u00f8tter HCQ&#8217;s Hovedstrategi (1) mod resistens, da autofagi er den prim\u00e6re flugtvej.<\/li>\n<\/ul>\n<\/li>\n\n\n\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-ef91e192740b2cb90032aaba4493e243\"><strong>Link 7:<\/strong> <a href=\"https:\/\/www.frontiersin.org\/journals\/chemistry\/articles\/10.3389\/fchem.2022.837987\/full\" target=\"_blank\" rel=\"noopener\">Combining EGFR-TKI With SAHA Overcomes EGFR-TKI-Acquired Resistance by Reducing the Protective Autophagy in Non-Small Cell Lung Cancer<\/a> (Frontiers, 2022) \n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-becaac0c5b2c55d3a67dd9d831af6c56\"><strong>Indhold:<\/strong> Studie, der konkluderer, at den tumorh\u00e6mmende effekt af EGFR-TKI&#8217;er forst\u00e6rkes markant, n\u00e5r man h\u00e6mmer autofagi med en autofagi-h\u00e6mmer. Resultatet bekr\u00e6fter, at autofagi er en central resistensmekanisme, der skal blokeres (hvilket Hydroxychloroquin og andre autofagi-h\u00e6mmere g\u00f8r).<\/li>\n<\/ul>\n<\/li>\n\n\n\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-c7eca79e261e6802729983d60f77c3d0\"><strong>Link 8:<\/strong> <a href=\"https:\/\/www.nature.com\/articles\/s41420-023-01631-7\" target=\"_blank\" rel=\"noopener\">The role and implication of autophagy in cholangiocarcinoma<\/a> (Nature, 2023) \n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-2b27b807edc22bb2552bf60edcc20b83\"><strong>Indhold:<\/strong> Oversigtsartikel, der underst\u00f8tter Hydroxychloroquins (1) Hovedstrategi. Artiklen beskriver den terapeutiske strategi om at h\u00e6mme autofagi, en central overlevelsesmekanisme, som mesotheliomceller er st\u00e6rkt afh\u00e6ngige af.<\/li>\n<\/ul>\n<\/li>\n\n\n\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-01ad10a4543dcfc51dfea07437545481\"><strong>Link 9:<\/strong> <a href=\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC4540424\/\" target=\"_blank\" rel=\"noopener\">Autophagy Correlates with the Therapeutic Responsiveness of Malignant Pleural Mesothelioma in 3D Models<\/a> (National Institutes of Health (NIH), 2015) \n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-91283078d5956d1a40c5e4b2c4590a65\"><strong>Indhold:<\/strong> Et fundamentalt studie, der viser, at autofagi spiller en central rolle i mesotheliomcellers respons p\u00e5 behandling. Dette underst\u00f8tter, at Hydroxychloroquins blokering af autofagi er en Hovedstrategi (1) mod overlevelsesmekanismerne i Mesotheliom.<\/li>\n<\/ul>\n<\/li>\n\n\n\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-0614a61bd748a5b20dda89bc571f4b36\"><strong>Link 10:<\/strong> <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/29225688\/\" target=\"_blank\" rel=\"noopener\">Repurposing Drugs in Oncology (ReDO)\u2014chloroquine and hydroxychloroquine as anti-cancer agents<\/a> (National Institutes of Health, 2017) \n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-ddac59a29d4f8818122eda509589400e\"><strong>Indhold:<\/strong> Oversigtsartikel fra ReDO-projektet, der bekr\u00e6fter, at Hydroxychloroquine (HCQ) har bredspektrede effekter, herunder autofagi-h\u00e6mning, p53-aktivering og p\u00e5virkning af tumormikromilj\u00f8et.<\/li>\n<\/ul>\n<\/li>\n\n\n\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-84024f1b96d06378d3498274af699843\"><strong>Link 11:<\/strong> <a href=\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC9040713\/\" target=\"_blank\" rel=\"noopener\">Role of mTOR through Autophagy in Esophageal Cancer Stemness<\/a> (PMC &#8211; NIH, 2022) \n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-e84f81432fffd66671267272ea8845be\"><strong>Indhold:<\/strong> Unders\u00f8gelse af kr\u00e6ftstamceller (CSCs) i spiser\u00f8rskr\u00e6ft, der viser, at h\u00e6mning af cellens affaldssystem (autofagi) reducerer stamcelleegenskaberne. Dette validerer Hydroxychloroquins Hovedstrategi ved at angribe overlevelsesmekanismer uafh\u00e6ngigt af kemoterapi.<\/li>\n<\/ul>\n<\/li>\n\n\n\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-2bb56b11f0f3d38f06c43ae6ffda78af\"><strong>Link 12:<\/strong> <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/27463016\/\" target=\"_blank\" rel=\"noopener\">Vorinostat and hydroxychloroquine improve immunity and inhibit autophagy in metastatic colorectal cancer<\/a> (PubMed, 2016) \n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-987600680bcea29b07c2e0733a215255\"><strong>Indhold:<\/strong> Studie, der viser, at Hydroxychloroquine (HCQ) og andre midler forbedrer immuniteten og h\u00e6mmer autofagi i tarmkr\u00e6ft.<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">Bl\u00e6rekr\u00e6ft og Urinvejskr\u00e6ft:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-cd3a2d1fa73a5ca1e8a033704c50fe7c\"><strong>Link 13:<\/strong> <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/28433067\/\" target=\"_blank\" rel=\"noopener\">Chloroquine and hydroxychloroquine inhibit bladder cancer cell growth by targeting basal autophagy and enhancing apoptosis<\/a> (ResearchGate, 2017) \n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-417a04dda216aa36cec8ae3597317267\"><strong>Indhold:<\/strong> Unders\u00f8gelse, der bekr\u00e6fter, at blokering af autofagi (cellens genbrugssystem) med Hydroxychloroquin h\u00e6mmer v\u00e6ksten af bl\u00e6rekr\u00e6ftceller og \u00f8ger deres f\u00f8lsomhed over for stress.<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">Prostatakr\u00e6ft:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-ff218a395207be511f0989172ce3c161\"><strong>Link 14:<\/strong> <a href=\"https:\/\/www.researchgate.net\/publication\/315983908_Autophagic_cell_death_with_hydroxychloroquine_in_patients_with_hormone-dependent_prostate-specific_antigen_progression_after_local_therapy_for_prostate_cancer\" target=\"_blank\" rel=\"noopener\">Autophagic cell death with hydroxychloroquine in patients with hormone-dependent prostate-specific antigen progression after local therapy for prostate cancer<\/a> (ResearchGate, 2017\/2025)\n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-2772121ece94cb03a15e064344c406c1\"><strong>Indhold:<\/strong> Studie, der underst\u00f8tter Hydroxychloroquins rolle i prostatakr\u00e6ft. Unders\u00f8gelsen bekr\u00e6fter, at kr\u00e6ftceller bruger autofagi som overlevelsesmekanisme, og at HCQ har aktivitet ved at blokere denne proces i prostataceller.<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">Galdebl\u00e6re- og Galdevejskr\u00e6ft:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-5b5b0615f727534b77c655de871830ab\"><strong>Link 15: <\/strong><a href=\"https:\/\/www.researchgate.net\/publication\/354510577_Hydroxychloroquine_Induces_Apoptosis_in_Cholangiocarcinoma_via_Reactive_Oxygen_Species_Accumulation_Induced_by_Autophagy_Inhibition\" target=\"_blank\" rel=\"noopener\">Hydroxychloroquin Induces Apoptosis in Cholangiocarcinoma via Reactive Oxygen Species Accumulation<\/a> (ResearchGate, 2025)\n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-29a1781f667be4d6f779b809acb9a346\"><strong>Indhold:<\/strong> Et studie der dokumenterer, hvordan hydroxychloroquin (HCQ) virker mod galdevejskr\u00e6ft. Resultaterne viser, at stoffet effektivt blokerer autofagi (cellens genbrugssystem) og dermed skaber en ophobning af stress (ROS), der tvinger kr\u00e6ftcellerne til at d\u00f8.<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">Glioblastom:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-71f45fb3af1ca63d32043c26aed07235\"><strong>Link 16:<\/strong> <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/37569432\/\" target=\"_blank\" rel=\"noopener\">Autophagy Inhibition via Hydroxychloroquine or 3-Methyladenine Enhances Chemotherapy-Induced Apoptosis in Neuro-Blastoma and Glioblastoma<\/a> (PubMed, MDPI, 2023)\n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-4dc1d7df034bf0e3eef946e90eea0db1\"><strong>Indhold:<\/strong> Studie, der validerer Hydroxychloroquins (1) Hovedstrategi. Unders\u00f8gelsen viser, at h\u00e6mning af Autofagi med HCQ forst\u00e6rker celled\u00f8d og oxidativt stress i glioblastomceller.<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">Binyrebarkkr\u00e6ft:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-4a4ddbce703fd88b37c38a3c2c3a7526\"><strong>Link 17:<\/strong> <a href=\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC9373848\/\" target=\"_blank\" rel=\"noopener\">Modulation of Autophagy in Adrenal Tumors<\/a> (National Institutes of Health, 2022) \n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-761a985a7687feea820cac6c16df5db4\"><strong>Indhold:<\/strong> En videnskabelig unders\u00f8gelse, der dokumenterer, hvordan standardbehandlingen Mitotane aktiverer autofagi i binyrebarktumorer. Artiklen beskriver, at denne &#8220;selv-spisende&#8221; proces fungerer som en overlevelsesmekanisme for kr\u00e6ftcellerne, og at blokering af autofagi derfor kan v\u00e6re en strategi til at \u00f8ge behandlingens effektivitet.<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">Bugspytkirtelkr\u00e6ft:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-939900ee7807054539b41ddf06eb216b\"><strong>Link 18:<\/strong> <a href=\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC12567078\/\" target=\"_blank\" rel=\"noopener\">Autophagy: a novel target in order to overcome drug resistance in cancer<\/a> (National Institutes of Health, 2025)\n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-20c5e2f98c244628e0ffa237cbe640f8\"><strong>Indhold:<\/strong> En helt ny videnskabelig gennemgang, der bekr\u00e6fter strategien med at bruge autofagi-h\u00e6mmere (som Hydroxychloroquin) til at nedbryde kr\u00e6ftcellers forsvar. Artiklen konkluderer, at denne blokering er afg\u00f8rende for at overvinde den resistens, kr\u00e6ftceller ofte udvikler mod kemoterapi, og dermed g\u00f8re standardbehandlingen effektiv igen.<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">Hjernekr\u00e6ft:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-06f9b9c6f6ff93dbc4d6c0649fbf9951\"><strong>Link 19: <\/strong><a href=\"https:\/\/www.researchgate.net\/publication\/336011978_Hydroxychloroquine_potentiates_the_anti-cancer_effect_of_bevacizumab_on_glioblastoma_via_the_inhibition_of_autophagy\" target=\"_blank\" rel=\"noopener\">Hydroxychloroquine potentiates the anti-cancer effect of bevacizumab on glioblastoma via the inhibition of autophagy<\/a> (ResearchGate, 2019)\n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-3bc81b9a177dbff15c9beceac5a39819\"><strong>Indhold:<\/strong> Et studie, der viser, at Hydroxychloroquine h\u00e6mmer autofagi og lysosomal funktion i glioblastom-celler. Dette blokerer cellens genbrugssystem og forst\u00e6rker effekten af anden behandling ved at \u00f8ge cellestress.<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">Myelomatose\/ Knoglemarvskr\u00e6ft:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-19acc74350ae57e42c5e9d2c2cea7dd9\"><strong>Link 20:<\/strong> <a href=\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC5342593\/\" target=\"_blank\" rel=\"noopener\">Hydroxychloroquine potentiates carfilzomib toxicity towards myeloma cells<\/a> (PMC, 2017) \n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-72fb8ef441f5a9b87216cbff2a937254\"><strong>Indhold:<\/strong> Forskning, der viser, at hydroxychloroquin forst\u00e6rker effekten af moderne proteasom-h\u00e6mmere (Carfilzomib) ved at blokere autofagi. N\u00e5r b\u00e5de proteasomet og autofagien er blokeret, har kr\u00e6ftcellen ingen steder at g\u00f8re af sit affald og d\u00f8r.<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">Nyrekr\u00e6ft:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-763c687e32822b8cf40c57a78a839e63\"><strong>Link 21:<\/strong> <a href=\"https:\/\/www.mdpi.com\/2072-6694\/12\/5\/1185\" target=\"_blank\" rel=\"noopener\">Therapeutic Targeting of Autophagy for Renal Cell Carcinoma <\/a>(MDPI, 2020)\n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-f3d7ba9acef4a163e30a930940d9a614\"><strong>Indhold:<\/strong> En videnskabelig artikel, der unders\u00f8ger autofagi som et terapeutisk m\u00e5l i nyrekr\u00e6ft. Artiklen forklarer, hvordan h\u00e6mning af autofagi blokerer en central genbrugsproces, som kr\u00e6ftceller udnytter til at overleve stress, hvilket g\u00f8r dem mere modtagelige for behandling.<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">Spytkirtel- og N\u00e6sekr\u00e6ft:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-688620ad86f09f9cc8c1cd749b5b7940\"><strong>Link 22:<\/strong> <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/33319639\/\" target=\"_blank\" rel=\"noopener\">Autophagy and salivary gland cancer: A putative target for therapeutic intervention<\/a> (National Institutes of Health, 2020)\n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-d7d366cffd581b2e841d5f8c788774cc\"><strong>Indhold:<\/strong> En videnskabelig gennemgang, der fokuserer p\u00e5 autofagi (cellens genbrugssystem) i spytkirtelkr\u00e6ft. Artiklen underbygger strategien om at manipulere denne proces (f.eks. med hydroxychloroquin) for at g\u00f8re kr\u00e6ftcellerne s\u00e5rbare over for behandling, da de ofte er afh\u00e6ngige af autofagi for at overleve.<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">\u00c6ggestokkr\u00e6ft:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-22755a049f2cb8b54ba54690957d38a3\"><strong>Link 23:<\/strong> <a href=\"https:\/\/jhoonline.biomedcentral.com\/articles\/10.1186\/s13045-020-01000-2\" target=\"_blank\" rel=\"noopener\">Targeting autophagy to overcome drug resistance in ovarian cancer<\/a> (Journal of Hematology &amp; Oncology, 2020)\n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-384736e1d12bcf738895e5fd28b25a12\"><strong>Indhold:<\/strong> En videnskabelig gennemgang, der fokuserer p\u00e5 autofagi (cellens genbrugssystem) som en n\u00f8glefaktor i resistens ved \u00e6ggestokkr\u00e6ft. Artiklen underbygger strategien om at bruge klorokin\/hydroxychloroquin til at blokere denne overlevelsesmekanisme og dermed g\u00f8re kr\u00e6ftcellerne s\u00e5rbare over for behandling igen.<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">\u00d8jenkr\u00e6ft:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-2c8d4a0e94ac50096444eede77d4111d\"><strong>Link 24:<\/strong> <a href=\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC10886749\/\" target=\"_blank\" rel=\"noopener\">The Role of Autophagy in Human Uveal Melanoma and Targeted Therapy<\/a> (National Institutes of Health, 2024)\n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-4692433cbaf2f5c4d5ac655d170bd45a\"><strong>Indhold:<\/strong> En videnskabelig gennemgang, der unders\u00f8ger autofagis rolle i moderm\u00e6rkekr\u00e6ft i \u00f8jet. Artiklen beskriver, hvordan kr\u00e6ftcellerne bruger denne proces til at overleve stress, og hvordan m\u00e5lrettet h\u00e6mning kan v\u00e6re en effektiv strategi for at bremse sygdommen.<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n\n\n\n<p class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-6159f05db2d82389bd0a895fb83b5de1 wp-block-paragraph\"><strong>Tilbage til:<\/strong> <a href=\"#skema-01\"><mark style=\"background-color:rgba(0, 0, 0, 0)\" class=\"has-inline-color has-custom-menu-links-color\">Oversigtsskema for Repurposed drugs<\/mark><\/a><\/p>\n\n\n\n<h4 class=\"wp-block-heading has-custom-sort-tekst-color has-text-color has-link-color wp-elements-c6eda4b854e26dc16aafb6f43ef2e535\" id=\"ivermectin\">8. <a href=\"https:\/\/jegharkraeft.dk\/plaquenil-ivermectin\/\">Ivermectin<\/a><\/h4>\n\n\n\n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-e236071a8fba460aa197c667308fac6a\"><strong>Link 1:<\/strong><a href=\"https:\/\/www.sciencedirect.com\/science\/article\/pii\/S1043661820315152\" target=\"_blank\" rel=\"noreferrer noopener\"> Ivermectin, a potential anticancer drug derived from an antiparasitic agent<\/a> (Science Direct, 2021)\n<ul class=\"wp-block-list\">\n<li><strong>Relevans:<\/strong> Denne artikel giver en bred oversigt over de mange foresl\u00e5ede anti-kr\u00e6ft mekanismer for ivermectin. Den n\u00e6vner bl.a. effekten p\u00e5 Hippo-, Akt\/mTOR- og WNT-signalvejene, hvilket underbygger stoffets alsidighed.<\/li>\n<\/ul>\n<\/li>\n\n\n\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-a8237135716e70e719422117ea70afcd\"><strong>Link 2:<\/strong><a href=\"https:\/\/www.embopress.org\/doi\/full\/10.15252\/emmm.201404084\" target=\"_blank\" rel=\"noreferrer noopener\"> The river blindness drug Ivermectin and related macrocyclic lactones inhibit WNT-TCF pathway responses in human cancer<\/a> (EMBO Molecular Medicine, 2014)\n<ul class=\"wp-block-list\">\n<li><strong>Relevans:<\/strong> Et meget specifikt studie, der bekr\u00e6fter, at ivermectin er en effektiv blokker af WNT-signalvejen, som er en fundamental og ofte overaktiv signalvej i mange kr\u00e6ftformer, herunder tarm- og brystkr\u00e6ft.<\/li>\n<\/ul>\n<\/li>\n\n\n\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-fa0989211a0022fbfd2af9b0614a6cc6\"><strong>Link 3:<\/strong> <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/40174264\/\" target=\"_blank\" rel=\"noopener\">Targeting EGFR\/PI3K\/AKT\/mTOR and Bax\/Bcl-2\/caspase3 pathways with ivermectin mediates its anticancer effects against urethane-induced non-small cell lung cancer in BALB\/c mice<\/a> (PubMed, 2025)\n<ul class=\"wp-block-list\">\n<li><strong>Relevans:<\/strong> Et nyt dyrestudie viser, at l\u00e6gemidlet ivermectin har en st\u00e6rk anti-kr\u00e6ft effekt p\u00e5 ikke-sm\u00e5cellet lungekr\u00e6ft (NSCLC). Studiet konkluderer, at ivermectin virker ved at blokere den centrale v\u00e6kst-signalvej (EGFR\/PI3K\/AKT\/mTOR), hvilket f\u00f8rer til \u00f8get celled\u00f8d og h\u00e6mmet tumorv\u00e6kst.<\/li>\n<\/ul>\n<\/li>\n\n\n\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-d892155054bb882dd0001dcf7bd68259\"><strong>Link 4:<\/strong> <a href=\"https:\/\/link.springer.com\/article\/10.1007\/s12672-025-03190-y\" target=\"_blank\" rel=\"noopener\">Therapeutic potential of natural compounds in targeting WNT, Notch, and Hedgehog signaling pathways<\/a> (Springer, 2025) \n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-f73bc3f3dc884ce8e0070d4bb445df4d\"><strong>Indhold:<\/strong> Oversigtsartikel, der beskriver, hvordan naturlige stoffer kan forstyrre de kritiske WNT, Notch og Hedgehog-signalveje. Dette underst\u00f8tter den h\u00f8je relevans for midler som Ivermectin, Resveratrol og EGCG i metaplastisk kr\u00e6ft, der er afh\u00e6ngig af stamcelle-signalering.<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">Binyrebarkkr\u00e6ft:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-28bea0e88746cc9596b6bfdb82407a28\"><strong>Link 5:<\/strong> <a href=\"https:\/\/www.sciencedirect.com\/science\/article\/pii\/S2405844024120208\" target=\"_blank\" rel=\"noopener\">Blocking the WNT\/\\beta-catenin pathway in cancer treatment and drug resistance<\/a> (ScienceDirect, 2024)\n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-3ad4ccbeb83102c3bd722e5f9a34777a\"><strong>Indhold:<\/strong> En videnskabelig artikel, der gennemg\u00e5r strategier for at blokere Wnt-signalvejen i kr\u00e6ftbehandling. Studiet fremh\u00e6ver, at Ivermectin effektivt h\u00e6mmer denne signalvej, hvilket reducerer kr\u00e6ftcellernes evne til at sprede sig og modvirker de mekanismer, der ellers driver tumorv\u00e6kst.<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">Bl\u00e6rekr\u00e6ft og Urinlederkr\u00e6ft:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-ad8a1fcf227d03de5ed77d58cc592a55\"><strong>Link 6:<\/strong> <a href=\"https:\/\/www.medsci.org\/v19p1567\" target=\"_blank\" rel=\"noopener\">Ivermectin induces cell cycle arrest and caspase-dependent apoptosis in human urothelial carcinoma cells <\/a>(International Journal of Medical Sciences, 2022) \n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-ae0a8c9f263a8dd428aae16de2eae981\"><strong>Indhold:<\/strong> Et studie, der viser, at Ivermectin kan standse cellecyklus og fremtvinge celled\u00f8d (apoptose) i urotheliale kr\u00e6ftceller, hvilket g\u00f8r det til en relevant kandidat i behandlingen.<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">Hudkr\u00e6ft:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-a4be53ae21213ecadf88377147b34842\"><strong>Link 7:<\/strong> <a href=\"https:\/\/www.mdpi.com\/1424-8247\/18\/10\/1459\" target=\"_blank\" rel=\"noopener\">Ivermectin as an Alternative Anticancer Agent: A Review of Current Evidence<\/a> (MDPI, 2025)\n<ul class=\"wp-block-list\">\n<li><strong>Indhold:<\/strong> En videnskabelig gennemgang, der unders\u00f8ger Ivermectins potentiale som en alternativ kr\u00e6ftbehandling. Artiklen fremh\u00e6ver stoffets evne til at h\u00e6mme kr\u00e6ftv\u00e6kst og spredning ved at p\u00e5virke flere centrale signalveje, herunder Wnt-vejen, hvilket underst\u00f8tter dets anvendelse som et celledr\u00e6bende middel.<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">Livmoderkr\u00e6ft:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-b0ef1194b57c34e9294df623f923815d\"><strong>Link 8:<\/strong> <a href=\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC9641399\/\" target=\"_blank\" rel=\"noopener\">Ivermectin inhibits tumor metastasis by regulating the Wnt\/\u03b2-catenin signaling pathway<\/a> (PubMed Central, 2022)\n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-a3e43afef636fcca4918c5db34c241fd\"><strong>Indhold: <\/strong>Et studie der dokumenterer, hvordan ivermectin effektivt kan h\u00e6mme spredning (metastase) ved at blokere Wnt-signalvejen. Da denne signalvej er en central driver for aggressive former af livmoderkr\u00e6ft, underst\u00f8tter studiet stoffets potentiale til at bremse sygdommens udvikling.<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">Myelomatose\/ Knoglemarvskr\u00e6ft:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-3c4e42a0880b7b4faad2b7e47c85a0ca\"><strong>Link 9: <\/strong><a href=\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC10823940\/\" target=\"_blank\" rel=\"noopener\">Gene signatures to therapeutics: Assessing the potential of ivermectin against t(4;14) multiple myeloma<\/a> (National Institutes of Health, 2024) \n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-aaf3e7d720adde4751574b320eec2ca4\"><strong>Indhold: <\/strong>Et videnskabeligt studie, der unders\u00f8ger ivermectins potentiale mod en specifik og aggressiv undertype af myelomatose (t(4;14)). Forskerne identificerer specifikke gen-signaturer og p\u00e5viser, at ivermectin effektivt kan h\u00e6mme kr\u00e6ftcellev\u00e6kst og fremprovokere celled\u00f8d via signalveje som NF-\u03baB.<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">Nyrekr\u00e6ft:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-605e377a7cd0548e900fa68ea827fff1\"><strong>Link 10:<\/strong> <a href=\"https:\/\/www.sciencedirect.com\/science\/article\/abs\/pii\/S0006291X1731656X\" target=\"_blank\" rel=\"noopener\">Antibiotic ivermectin preferentially targets renal cancer through inducing mitochondrial dysfunction and oxidative damage<\/a> (ScienceDirect, 2017)\n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-0a67228cc77e0b26af12c2578bbd9dfc\"><strong>Indhold: <\/strong>Et videnskabeligt studie, der p\u00e5viser, at Ivermectin rammer nyrekr\u00e6ftceller m\u00e5lrettet ved at skabe dysfunktion i mitokondrierne. Artiklen dokumenterer, hvordan dette f\u00f8rer til oxidativ stress og reduceret energiproduktion, hvilket resulterer i celled\u00f8d.<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n\n\n\n<p class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-6159f05db2d82389bd0a895fb83b5de1 wp-block-paragraph\"><strong>Tilbage til:<\/strong> <a href=\"#skema-01\"><mark style=\"background-color:rgba(0, 0, 0, 0)\" class=\"has-inline-color has-custom-menu-links-color\">Oversigtsskema for Repurposed drugs<\/mark><\/a><\/p>\n\n\n\n<h4 class=\"wp-block-heading has-custom-sort-tekst-color has-text-color has-link-color wp-elements-90cb3a0ef9517d9d6cc47f5246a0a695\" id=\"ldn\">9. <a href=\"https:\/\/jegharkraeft.dk\/ldn\/\">Low-dose Naltrexone<\/a> (LDN)<\/h4>\n\n\n\n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-40b10a6d7e00dc0ae16e482773dcf547\"><strong>Link 1:<\/strong><a href=\"https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC10968813\/\" target=\"_blank\" rel=\"noreferrer noopener\"> Low-Dose Naltrexone as an Adjuvant in Combined Anticancer Therapy<\/a> (Cancers, 2024)\n<ul class=\"wp-block-list\">\n<li><strong>Relevans:<\/strong> En ny oversigtsartikel, der i detaljer forklarer den prim\u00e6re hypotese: At LDN midlertidigt blokerer kroppens &#8220;Opioid Growth Factor receptor (OGFr)&#8221;, hvilket f\u00e5r kroppen til at kompensere ved at producere flere endorfiner og enkefaliner. Disse virker immun-modulerende og kan h\u00e6mme kr\u00e6ftcellers v\u00e6kst.<\/li>\n<\/ul>\n<\/li>\n\n\n\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-657b11b004447faefc2c8cb82a402e28\"><strong>Link 2:<\/strong><a href=\"https:\/\/www.google.com\/search?q=https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC3494420\/\" target=\"_blank\" rel=\"noreferrer noopener\"> <\/a><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/21807817\/\" target=\"_blank\" rel=\"noopener\">Low-Dose Naltrexone Targets the Opioid Growth Factor Receptor to Inhibit Cell Proliferation in Triple-Negative Breast Cancer<\/a> (PubMed, 2011)\n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-ad74957e2a1fccd1047d42d2919bedfe\"><strong>Relevans:<\/strong> Denne artikel viser, hvordan LDN h\u00e6mmer triple-negativ brystkr\u00e6ft via OGFr-blokade og immunmodulation.<\/li>\n<\/ul>\n<\/li>\n\n\n\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-4d7ad7f5bf339dd3d7cca4cb99e3736f\"><strong>Link 3:<\/strong> <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/38539570\/\" target=\"_blank\" rel=\"noopener\">Low-Dose Naltrexone as an Adjuvant in Combined Anticancer Therapy<\/a> (PubMed, 2025)\n<ul class=\"wp-block-list\">\n<li><strong>Relevans:<\/strong> Low-dose naltrexon (LDN) blokkerer OGFr-receptoren, hvilket \u00f8ger OGF-syntesen, der h\u00e6mmer kr\u00e6ftudvikling. Studier viser, at LDN kan hj\u00e6lpe med at inaktivere kr\u00e6ftcellev\u00e6kst, uden direkte at v\u00e6re cytotoksisk, og det kan bruges som supplement til kr\u00e6ftbehandling.<\/li>\n<\/ul>\n<\/li>\n\n\n\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-9841ab7420888ea6aa053337e958939d\"><strong>Link 4:<\/strong> <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/29885638\/\" target=\"_blank\" rel=\"noopener\">Low-dose naltrexone (LDN): A promising treatment in immune-related diseases and cancer therapy<\/a> (PubMed, 2018)\n<ul class=\"wp-block-list\">\n<li><strong> Indhold:<\/strong> Artiklen gennemg\u00e5r, hvordan LDN i lave doser kan fungere som en immunmodulator ved autoimmune sygdomme og kr\u00e6ft. Forskningen viser, at LDN binder sig til opioidreceptorer p\u00e5 immunceller, hvilket potentielt kan lindre symptomer ved mentale lidelser og regulere kroppens immunrespons.<\/li>\n<\/ul>\n<\/li>\n\n\n\n<li><\/li>\n<\/ul>\n\n\n\n<p class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-b1654d2539b0214f484c2560219251f9 wp-block-paragraph\"><strong>Tilbage til:<\/strong> <a href=\"#skema-01\"><mark style=\"background-color:rgba(0, 0, 0, 0)\" class=\"has-inline-color has-custom-menu-links-color\">Oversigtsskema for Repurposed drugs<\/mark><\/a><\/p>\n\n\n\n<h4 class=\"wp-block-heading\">0. <a href=\"#benzimidazoler\">Mebendazol <\/a>&#8211; Se under <a href=\"#benzimidazoler\">Benzomidazoler<\/a><\/h4>\n\n\n\n<h4 class=\"wp-block-heading\">0. <a href=\"#melatonin\">Melatonin<\/a> &#8211; Se under Kosttilskud<\/h4>\n\n\n\n<h4 class=\"wp-block-heading has-custom-sort-tekst-color has-text-color has-link-color wp-elements-dcffee8817a23f6916ba5f0813da4c84\" id=\"metformin\">10. <a href=\"https:\/\/jegharkraeft.dk\/metformin\/\">Metformin<\/a><\/h4>\n\n\n\n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-ac2a8ce9c2f573c140d9b544251f7897\"><strong>Link 1:<\/strong><a href=\"https:\/\/academic.oup.com\/abbs\/article\/50\/2\/133\/4371596?login=false\" target=\"_blank\" rel=\"noopener\"> Metformin as an anti-cancer agent: actions and mechanisms targeting cancer stem cells<\/a> (Oxford Academic 2017)\n<ul class=\"wp-block-list\">\n<li><strong>Relevans:<\/strong> Metformin, en udbredt diabetesmedicin, har vist sig at virke mod kr\u00e6ft ved at forstyrre cellernes stofskifte og blokere centrale v\u00e6kstveje som mTOR. Forskningen fokuserer is\u00e6r p\u00e5 dets evne til at ramme de modstandsdygtige kr\u00e6ftstamceller, der driver spredning og tilbagefald, og det unders\u00f8ges derfor som supplerende behandling til mange kr\u00e6fttyper.<\/li>\n<\/ul>\n<\/li>\n\n\n\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-f07f24fe13306983e22e677fc84a9fdc\"><strong>Link 2:<\/strong><a href=\"https:\/\/www.google.com\/search?q=https:\/\/translational-medicine.biomedcentral.com\/articles\/10.1186\/s12967-020-02348-1\" target=\"_blank\" rel=\"noreferrer noopener\"> <\/a><a href=\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC10286395\/\" target=\"_blank\" rel=\"noopener\">Metformin and cancer hallmarks: shedding new lights on therapeutic repurposing<\/a> (PubMed, 2023)\n<ul class=\"wp-block-list\">\n<li><strong>Relevans:<\/strong> Metformin, en sikker og billig diabetesmedicin, har vist sig at neds\u00e6tte kr\u00e6ftrisiko og -d\u00f8delighed. Dets anti-kr\u00e6ft effekt menes at virke p\u00e5 to m\u00e5der: <strong>indirekte<\/strong>, ved at forbedre kroppens generelle stofskifte ved at s\u00e6nke blodsukker og insulin, og <strong>direkte<\/strong>, ved ogs\u00e5 at angribe kr\u00e6ftcellernes egen energioms\u00e6tning uafh\u00e6ngigt heraf.<\/li>\n<\/ul>\n<\/li>\n\n\n\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-6cfef8b97b33223baee0c2ed275df1da\"><strong>Link 3:<\/strong> <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/40466285\/\" target=\"_blank\" rel=\"noopener\">An exploration of molecular signaling in drug reprocessing for Oral Squamous Cell Carcinoma<\/a> (PubMed, 2025)\n<ul class=\"wp-block-list\">\n<li><strong>Relevans:<\/strong> Metformin er et af de kendte repurposed l\u00e6gemidler med dokumenteret anticancer-effekt, is\u00e6r i behandling af oral squamous cell carcinoma (OSCC). Det virker gennem forskellige molekyl\u00e6re signalveje, hvilket g\u00f8r det til et v\u00e6rdifuldt supplement i cancerterapi. Anvendelsen af eksisterende medicin som metformin kan fremskynde behandlingsudviklingen og forbedre patientudfaldet.<\/li>\n<\/ul>\n<\/li>\n\n\n\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-d287af7f5d1823d9eef94071c055dbc7\"><strong>Link 4:<\/strong> <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/40471105\/\" target=\"_blank\" rel=\"noopener\">Metformin Enhances PD-L1 Inhibitor Efficacy in Ovarian Cancer by Modulating the Immune Microenvironment and RBMS3 Expression<\/a> (PubMed, 2025)\n<ul class=\"wp-block-list\">\n<li><strong>Relevans: <\/strong>Metformin kan styrke immunforsvaret i ovariecancer ved at \u00f8ge CD8+ T-celler og reducere PD-L1. N\u00e5r det bruges sammen med PD-L1-h\u00e6mmere, forbedres behandlingen, men RBMS3 er vigtig for denne effekt. Kombinationsbehandling kan forbedre resultaterne mod ovariecancer.<\/li>\n<\/ul>\n<\/li>\n\n\n\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-9f0fa41d6541e7f7daea5a7dfbb0cfc9\"><strong>Link 5:<\/strong> <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/40252335\/\" target=\"_blank\" rel=\"noopener\">Neratinib and metformin: A novel therapeutic approach against HER2-Positive Breast Cancer<\/a> (PubMed, 2025)\n<ul class=\"wp-block-list\">\n<li><strong>Relevans:<\/strong> Kombinationen af neratinib og metformin reducerer cancercelle-v\u00e6kst, forstyrrer cellecyklus, h\u00e6mmer invasion og angiogenese i HER2-positiv brystkr\u00e6ft. De p\u00e5virker ogs\u00e5 flere vigtige signalveje og co-udtrykker HER2 og IGF-1R. Samlet set kan denne kombination v\u00e6re en lovende behandling.<\/li>\n<\/ul>\n<\/li>\n\n\n\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-4af29f4b274bd977987008b10aaa46c1\"><strong>Link 6:<\/strong> <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/40216262\/\" target=\"_blank\" rel=\"noopener\">The multifaceted role of agents counteracting metabolic syndrome: A new hope for gastrointestinal cancer therapy<\/a> (PubMed, 2025)\n<ul class=\"wp-block-list\">\n<li><strong>Relevans:<\/strong> Metabolisk syndrom \u00f8ger risikoen for kr\u00e6ft, is\u00e6r i mave-tarm-kanalen. Medicin som metformin og statiner kan forebygge kr\u00e6ft og forbedre prognosen. Dette \u00e5bner muligheder for at bruge disse l\u00e6gemidler i nye kombinationsbehandlinger mod GI-cancer, hvilket kan forbedre behandlingsresultaterne.<\/li>\n<\/ul>\n<\/li>\n\n\n\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-971a7fd5bfba00cd2df733dbde32851e\"><strong>Link 7:<\/strong> <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/24172091\/\" target=\"_blank\" rel=\"noopener\">The effects of metformin on ovarian cancer: a systematic review <\/a>(PubMed, 2013)\n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-fc65711003cfe6a1ca8fb1894ccc3cbe\"><strong>Indhold:<\/strong> Denne systematiske gennemgang samler resultaterne fra adskillige studier. Konklusionen er, at Metformin, is\u00e6r n\u00e5r det kombineres med kemoterapi, er associeret med forbedret overlevelse hos patienter med \u00e6ggestokkr\u00e6ft.<\/li>\n<\/ul>\n<\/li>\n\n\n\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-cfa7c3107bc857461bdccc18589eaa8b\"><strong>Link 8:<\/strong> <a href=\"https:\/\/www.mdpi.com\/1648-9144\/61\/6\/1021\" target=\"_blank\" rel=\"noopener\">Metformin: A Dual-Role Player in Cancer Treatment and Prevention: A Comprehensive Systematic Review and Meta-Analysis <\/a>(MDPI, Cancers, 2024)\n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-f0d1e5ca58121d59e56b6ea679415152\"><strong>Indhold:<\/strong> Denne meta-analyse af 112 studier viser, at metformin er forbundet med en markant lavere kr\u00e6ftrisiko og en reduceret d\u00f8delighed hos kr\u00e6ftpatienter. Resultaterne underst\u00f8tter dets potentiale som et supplement til standardbehandling p\u00e5 tv\u00e6rs af flere kr\u00e6ftformer.<\/li>\n<\/ul>\n<\/li>\n\n\n\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-d19e1a557521d9396ec6130a9d4e9ad1\"><strong>Link 9: <\/strong><a href=\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC12087300\/\" target=\"_blank\" rel=\"noopener\">Targeting Cancer Stem Cells and Hedgehog Pathway by Metformin and Cisplatin Combination in Ovarian Cancer<\/a> (PMC, 2025)\n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-b783b345b0163d1f7c54f352a4d3e671\"><strong>Indhold:<\/strong> Et laboratoriestudie, der viser pr\u00e6cis, hvordan metformin og en type platin-baseret kemoterapi (cisplatin) arbejder sammen om at fremkalde programmeret celled\u00f8d (apoptose) i kr\u00e6ftceller fra \u00e6ggestokkene.<\/li>\n<\/ul>\n<\/li>\n\n\n\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-40276d2b4aaf80bfa63daadf0b9d3e34\"><strong>Link 10:<\/strong> <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/40105683\/\" target=\"_blank\" rel=\"noopener\">Tolerability, safety and feasibility of metformin combined with chemoradiotherapy in patients with locally advanced cervical cancer: A phase II, randomized study<\/a> (PubMed, 2025)\n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-eb85c454c635fa385660f13477c8bb30\"><strong>Indhold:<\/strong> Viser, at det er sikkert og muligt at kombinere metformin med kemo\/str\u00e5ler i en lignende patientgruppe (gyn\u00e6kologisk kr\u00e6ft).<\/li>\n<\/ul>\n<\/li>\n\n\n\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-11f787f9ad3e754d99d7ad4cecd355d0\"><strong>Link 11:<\/strong> <a href=\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC7497683\/\" target=\"_blank\" rel=\"noopener\">Phase I study of metformin in combination with carboplatin\/paclitaxel chemotherapy in patients with advanced epithelial ovarian cancer <\/a>(PubMed, 2020)\n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-7a069d986b07704c594fc10dd5affee0\"><strong>Indhold:<\/strong> Et sikkerhedsstudie, der fastsl\u00e5r den rette dosis og bekr\u00e6fter, at det er sikkert at kombinere metformin med netop Carboplatin-baseret kemoterapi.<\/li>\n<\/ul>\n<\/li>\n\n\n\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-1a60659a1b1ac4ff6c013791f25ff6ab\"><strong>Link 12:<\/strong> <a href=\"https:\/\/www.researchgate.net\/publication\/388848700_Metformin_for_patients_with_advanced_stage_ovarian_cancer_A_randomized_phase_II_placebo-controlled_trial\" target=\"_blank\" rel=\"noopener\">Metformin for patients with advanced stage ovarian cancer: A randomized phase II placebo-controlled trial <\/a>(Research Gate, 2025)\n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-0a9125ffaa9b12641941ec6ba9bb1d88\"><strong>Indhold:<\/strong> Et studie af h\u00f8j kvalitet, der bekr\u00e6fter metformins effekt hos patienter med fremskreden \u00e6ggestokkr\u00e6ft.<\/li>\n<\/ul>\n<\/li>\n\n\n\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-745407c4d298cf74001fa4053fdafbf6\"><strong>Link 13:<\/strong> <a href=\"https:\/\/www.sciencedirect.com\/science\/article\/pii\/S193652332500169X\" target=\"_blank\" rel=\"noopener\">The clinical potentials of combining paclitaxel-based chemotherapy regimen with metformin in cancer treatment: A systematic review and Meta-analysis<\/a> (Science Direct, 2025)\n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-0a78766b0234130fb027e57b5c822bbf\"><strong>Indhold:<\/strong> En oversigtsartikel, der samler viden om metformins positive effekt sammen med en type kemoterapi (Taxol\/Paclitaxel), som patienten tidligere har f\u00e5et.<\/li>\n<\/ul>\n<\/li>\n\n\n\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-32d809046ff055fab401958ba3e62e17\"><strong>Link 14:<\/strong> <a href=\"https:\/\/www.frontiersin.org\/journals\/oncology\/articles\/10.3389\/fonc.2023.1176885\/full\" target=\"_blank\" rel=\"noopener\">Efficacy and safety of metformin in combination with chemotherapy in cancer patients without diabetes: systematic review and meta-analysis<\/a> (Frontiers, 2023)\n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-bcf39a3481fb1abe8c98b5e2c4446491\"><strong>Indhold:<\/strong> En oversigtsartikel, der bekr\u00e6fter, at metformin er effektivt og sikkert for kr\u00e6ftpatienter, der ikke har diabetes i forvejen \u2013 pr\u00e6cis som i dette tilf\u00e6lde.<\/li>\n<\/ul>\n<\/li>\n\n\n\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-92c6dbbd7d71bcc103de1f9f8db3162d\"><strong>Link 15:<\/strong> <a href=\"https:\/\/www.cancer.gov\/news-events\/press-releases\/2024\/vipor-combination-therapy-b-cell-lymphoma\" target=\"_blank\" rel=\"noopener\">Five-drug combination targets aggressive B-cell lymphomas<\/a> (National Cancer Institute, 2024) \n<ul class=\"wp-block-list\">\n<li><strong>Indhold:<\/strong> Fokuserer p\u00e5 DLBCL (Diffust storcellet B-celle lymfom). Artiklen beskriver, hvordan en kombination af fem stoffer m\u00e5lrettet blokerer flere molekyl\u00e6re signalveje samtidigt, hvilket denne aggressive kr\u00e6ftform er afh\u00e6ngig af for at overleve. Dette validerer strategien i skemaet.<\/li>\n<\/ul>\n<\/li>\n\n\n\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-5d08d220066708a0599759fe595c694b\"><strong>Link 16:<\/strong> <a href=\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC6995629\/\" target=\"_blank\" rel=\"noopener\">Metformin: The Answer to Cancer in a Flower? Current Knowledge and Future Prospects of Metformin as an Anti-Cancer Agent in Breast Cancer<\/a> (National Institutes of Health, 2019) \n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-b895f2794cdf11245c4c318206ef332e\"><strong>Indhold:<\/strong> En oversigtsartikel, der diskuterer Metformins brede anticancer-effekter. Artiklen underst\u00f8tter Metformins Hovedstrategi (1)-graduering i DLBCL ved at beskrive, hvordan det h\u00e6mmer mTORC1-signalvejen og undertrykker v\u00e6ksten i aggressivt B-celle lymfom. Dette validerer den overordnede kombinationsstrategi med andre midler.<\/li>\n<\/ul>\n<\/li>\n\n\n\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-fd3a751761d45b1230dbd4a7f88b7915\"><strong>Link 17:<\/strong><a href=\"https:\/\/www.sciencedirect.com\/science\/article\/pii\/S0304419X25001921\" target=\"_blank\" rel=\"noopener\"> Unraveling the role of mitochondrial dynamics in cancer eradication: a review<\/a> (ScienceDirect.com, 2025)\n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-428cb5e113182ce33131a9def5d29705\"><strong>Indhold:<\/strong> Oversigtsartikel, der beskriver, hvordan mitokondriel dynamik er en s\u00e5rbarhed for kr\u00e6ftceller. Artiklen validerer, at targeting af mitokondrier repr\u00e6senterer en terapeutisk strategi for at eliminere kr\u00e6ftstamceller.<\/li>\n<\/ul>\n<\/li>\n\n\n\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-38ad4ec90c82cd6d2848c4e6918ac72f\"><strong>Link 18:<\/strong> <a href=\"https:\/\/www.nature.com\/articles\/s41419-024-07077-8\" target=\"_blank\" rel=\"noopener\">Targeted therapy of cancer stem cells: inhibition of mTOR signaling pathway<\/a> (Nature, 2024) \n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-4a4d42bbda827b7a34af0b8a82cbe1c2\"><strong>Indhold: <\/strong>Oversigtsartikel, der beskriver, at Metformin h\u00e6mmer mTOR-vejen ved at aktivere AMPK. Dette validerer Metformins Hovedstrategi (1) mod resistens, da h\u00e6mning af mTOR er den mest almindelige m\u00e5de at omg\u00e5 resistens p\u00e5 i BRAF-muterede celler.<\/li>\n<\/ul>\n<\/li>\n\n\n\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-8d67f54edc1bf6436925c357bff3d810\"><strong>Link 19:<\/strong> <a href=\"https:\/\/www.nature.com\/articles\/s41598-025-87537-z\" target=\"_blank\" rel=\"noopener\">Metformin inhibits the growth of SCLC cells by inducing autophagy and apoptosis via the suppression of EGFR and AKT signalling<\/a> (Nature, 2025) \n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-6cac701017cee1ae1f6afc6071693eb9\"><strong>Indhold:<\/strong> Studie, der beskriver, hvordan Metformin kan genoprette f\u00f8lsomheden i NSCLC-celler over for EGFR-h\u00e6mmere ved at h\u00e6mme EGFR\/PI3K-signalvejen. Dette validerer Metformins Hovedstrategi (1) mod resistens.<\/li>\n<\/ul>\n<\/li>\n\n\n\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-c2df44684bb40a6e2c8ede2ec76b027b\"><strong>Link 20:<\/strong> <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/33537296\/\" target=\"_blank\" rel=\"noopener\">Metformin Induces Apoptosis and Inhibits Notch1 in Malignant Pleural Mesothelioma Cells<\/a> (National Institutes of Health, 2021) \n<ul class=\"wp-block-list\">\n<li><strong>Indhold:<\/strong> Studie, der validerer Metformins (1) Hovedstrategi. Artiklen beskriver, hvordan Metformin h\u00e6mmer proliferation, forst\u00e6rker celled\u00f8d og h\u00e6mmer Notch1-signalvejen i lungehindekr\u00e6ftceller.<\/li>\n<\/ul>\n<\/li>\n\n\n\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-f7f596cdecdc76746b75a252e1734aca\"><strong>Link 21:<\/strong> <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/38474224\/\" target=\"_blank\" rel=\"noopener\">Metformin in Esophageal Carcinoma: Exploring Molecular Mechanisms and Therapeutic Insights<\/a> (PMC &#8211; NIH, 2024) \n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-2a20784aaf79ef042da721d4c7319e5a\"><strong>Indhold:<\/strong> En systematisk analyse, der gennemg\u00e5r Metformins indflydelse p\u00e5 spiser\u00f8rskr\u00e6ft. Artiklen fokuserer p\u00e5 de molekyl\u00e6re mekanismer, herunder h\u00e6mning af mTOR-signalvejen og AMPK-aktivering, som er centrale for at bremse v\u00e6ksten.<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">Prostatakr\u00e6ft:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-3835f2566001c32c5a823e898359c761\"><strong>Link 22:<\/strong> <a href=\"https:\/\/www.researchgate.net\/publication\/353954015_Metformin_exerts_anti-AR-negative_prostate_cancer_activity_via_AMPKautophagy_signaling_pathway\" target=\"_blank\" rel=\"noopener\">Metformin exerts anti-AR-negative prostate cancer activity via AMPK\/autophagy signaling pathway<\/a> (ResearchGate, 2021) \n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-c051697d6a13f3aa4be94a6307d2091f\"><strong>Indhold:<\/strong> Studie, der viser, at Metformin ud\u00f8ver en anti-cancer effekt ved at inducere autofagi og h\u00e6mme AMPK\/mTOR-signalvejen i hormon-uafh\u00e6ngig prostatakr\u00e6ft (AR-negativ).<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">Analkr\u00e6ft:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-c4d86dbce14672005b2f9bb04e8f6d93\"><strong>Link 23:<\/strong> <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/33809480\/\" target=\"_blank\" rel=\"noopener\">Metabolic Reprogramming in Cancer: Role of HPV 16 Variants<\/a><strong> <\/strong>(PMC, 2021) <\/li>\n\n\n\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-280b743e953c7e8c809cd26747b29ca6\"><strong>Indhold:<\/strong> En videnskabelig oversigtsartikel, der beskriver, hvordan HPV 16-proteinerne E6 og E7 (som er den prim\u00e6re \u00e5rsag til analkr\u00e6ft) fremmer kr\u00e6ftcellers metaboliske oml\u00e6gning (Warburg-effekten) for at d\u00e6kke deres energibehov.<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">Binyrebarkkr\u00e6ft:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-6b8291d86172ec5fd80b063f7a137a00\"><strong>Link 24:<\/strong> <a href=\"http:\/\/Metformin Inhibit Cell Proliferation and Secretion Function of Adrenocortical Carcinoma H295R Cells (Semantic Scholar, 2020) Indhold: Et videnskabeligt studie, der dokumenterer metformins effekt p\u00e5 binyrebarkkr\u00e6ftceller. Resultaterne viser, at stoffet virker dosis-afh\u00e6ngigt ved b\u00e5de at bremse celledelingen og reducere udskillelsen af hormonerne kortisol og aldosteron, hvilket er s\u00e6rligt relevant for patienter med hormonproducerende tumorer.\">Metformin Inhibit Cell Proliferation and Secretion Function of Adrenocortical Carcinoma H295R Cells<\/a> (Semantic Scholar, 2020) \n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-f3c8e2e2d79ef104b2088663640955d6\"><strong>Indhold:<\/strong> Et videnskabeligt studie, der dokumenterer metformins effekt p\u00e5 binyrebarkkr\u00e6ftceller. Resultaterne viser, at stoffet virker dosis-afh\u00e6ngigt ved b\u00e5de at bremse celledelingen og reducere udskillelsen af hormonerne kortisol og aldosteron, hvilket er s\u00e6rligt relevant for patienter med hormonproducerende tumorer.<\/li>\n<\/ul>\n<\/li>\n\n\n\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-61ecb1787da27a113f1b99e78a240ca6\"><strong>Link 25:<\/strong> <a href=\"https:\/\/link.springer.com\/article\/10.1186\/s12964-025-02115-0\" target=\"_blank\" rel=\"noopener\">Emerging role of IGF1R and IR expression and localisation in adrenocortical carcinoma<\/a> (Springer Nature, Cell Communication and Signaling, 2025) \n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-c3f9c836f51955627ef8229dce5a8000\"><strong>Indhold: <\/strong>En videnskabelig artikel, der bekr\u00e6fter, at v\u00e6kstfaktoren IGF-2 er overudtrykt i 90% af alle tilf\u00e6lde af binyrebarkkr\u00e6ft. Studiet beskriver, hvordan denne faktor driver kr\u00e6ftcellernes deling via specifikke receptorer, hvilket underbygger relevansen af at anvende behandling, der d\u00e6mper disse v\u00e6kstsignaler.<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">Blodkr\u00e6ft:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-7be952904188be47b699fdec7aead0e9\"><strong>Link 26:<\/strong> <a href=\"https:\/\/www.mdpi.com\/2218-273X\/13\/2\/250\" target=\"_blank\" rel=\"noopener\">Action Mechanism of Metformin and Its Application in Hematological Malignancies<\/a> (MDPI, 2023)\n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-7c7d81e359dd0e4fc792bb1e0763fd05\"><strong>Indhold:<\/strong> En videnskabelig gennemgang, der kortl\u00e6gger metformins potentiale som behandling mod blodkr\u00e6ft. Artiklen beskriver de molekyl\u00e6re mekanismer, herunder aktivering af AMPK og h\u00e6mning af mTOR, som kan bremse kr\u00e6ftcellers deling og overlevelse i sygdomme som leuk\u00e6mi og lymfom.<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">Bl\u00e6rekr\u00e6ft og Urinvejskr\u00e6ft:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-2cc76c30f38f92d52d0f3a7809673233\"><strong>Link 27:<\/strong> <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/41063036\/\" target=\"_blank\" rel=\"noopener\">Metformin as an anti-cancer agent against bladder cancer acts via PD-L1 downregulation<\/a> (ResearchGate, 2025) \n<ul class=\"wp-block-list\">\n<li><strong>Indhold:<\/strong> Helt ny forskning fra oktober 2025, der viser, at Metformin ikke kun virker metabolisk, men ogs\u00e5 kan g\u00f8re kr\u00e6ftcellerne mere synlige for immunsystemet ved at nedregulere &#8220;skjoldet&#8221; PD-L1.<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">Galdebl\u00e6re- og Galdevejskr\u00e6ft:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-1880af8fb2c35fa1d656420c27d649fd\"><strong>Link 28:<\/strong> <a href=\"https:\/\/www.researchgate.net\/publication\/360390820_T088_IMPACT_OF_METFORMIN_ON_THE_INCIDENCE_OF_HUMAN_CHOLANGIOCARCINOMA_IN_DIABETIC_PATIENTS_A_SYSTEMATIC_REVIEW_AND_META-ANALYSIS\" target=\"_blank\" rel=\"noopener\">Impact of metformin on the incidence of human cholangiocarcinoma in diabetic patients: a systematic review and meta-analysis<\/a> (ResearchGate, 2025)\n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-8442718040e792d985bc0f65891c89c8\"><strong>Indhold:<\/strong> En systematisk gennemgang og meta-analyse, der unders\u00f8ger metformins effekt p\u00e5 galdevejskr\u00e6ft. Studiet finder, at metformin-brug er associeret med en markant lavere risiko for at udvikle sygdommen og reducerer tumorens aggressivitet ved at h\u00e6mme mTOR-signalvejen og regulere cellecyklus.<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">Glioblastom:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-3b2af6047bfdd2f42a991524a084dc16\"><strong>Link 29:<\/strong> <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/31952173\/\" target=\"_blank\" rel=\"noopener\">Metformin as Potential Therapy for High-Grade Glioma<\/a> (NIH, 2020)\n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-106772774409fe38f91038296bfc04dc\"><strong>Indhold:<\/strong> Oversigtsartikel, der validerer Metformins (1) Hovedstrategi mod GBM. Artiklen bekr\u00e6fter, at stoffet h\u00e6mmer v\u00e6kstvejen PI3K\/Akt\/mTOR og kan forbedre overlevelse hos patienter med h\u00f8jmaligne gliomer.<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">Bugspytkirtelkr\u00e6ft:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-a7acfe99295bc4b29d19bdf3885d6e9d\"><strong>Link 30:<\/strong> <a href=\"https:\/\/www.sciencedirect.com\/science\/article\/pii\/S0753332225007012\" target=\"_blank\" rel=\"noopener\">From basics to clinics: New opportunities for metformin in pancreatic cancer <\/a>(ScienceDirect, 2025)\n<ul class=\"wp-block-list\">\n<li><strong>Indhold:<\/strong> En helt ny videnskabelig artikel, der unders\u00f8ger sammenh\u00e6ngen mellem stofskiftesygdomme og bugspytkirtelkr\u00e6ft. Artiklen gennemg\u00e5r den nyeste viden fra b\u00e5de grundforskning og kliniske fors\u00f8g for at identificere nye muligheder for at anvende Metformin som behandling, s\u00e6rligt med fokus p\u00e5 dets evne til at p\u00e5virke kr\u00e6ftens stofskifte.<\/li>\n<\/ul>\n<\/li>\n\n\n\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-2530abf1f1cf1aab7a7194fc8ed99860\"><strong>Link 31:<\/strong> <a href=\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC10950617\/\" target=\"_blank\" rel=\"noopener\">Metformin and pancreatic neuroendocrine tumors: A systematic review and meta-analysis<\/a> (World Journal of Gastroenterology, 2024)\n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-98c2ab5ab6fb078f17b273149ff238fa\"><strong>Indhold:<\/strong> Analyse der unders\u00f8ger effekten af diabetesmedicinen Metformin p\u00e5 neuroendokrine tumorer i bugspytkirtlen (PNETs). Studiet konkluderer, at metformin kan have en beskyttende effekt og potentielt forbedre overlevelsen ved at h\u00e6mme v\u00e6kstsignaler som mTOR, hvilket g\u00f8r det til en lovende supplerende strategi.<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">Hals- og Mundhulekr\u00e6ft:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-9c12ffc5017f3e13f42394def21f3085\"><strong>Link 32:<\/strong> <a href=\"https:\/\/www.mdpi.com\/2077-0383\/12\/19\/6195\" target=\"_blank\" rel=\"noopener\">Preventive and Therapeutic Effect of Metformin in Head and Neck Cancer: A Systematic Review<\/a> (MDPI, 2023)\n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-7dcf51d85873bde660b03accd34e8e53\"><strong>Indhold:<\/strong> En videnskabelig gennemgang, der unders\u00f8ger metformins potentiale som b\u00e5de forebyggende og behandlende middel ved hoved-halskr\u00e6ft. Analysen konkluderer, at patienter kan opn\u00e5 en overlevelsesfordel ved brug af stoffet, sandsynligvis p\u00e5 grund af dets evne til at regulere cellernes energistofskifte og h\u00e6mme v\u00e6kstsignaler.<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">Hjernekr\u00e6ft:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-f4903e8bcbffcaedca7a85667fc22aea\"><strong>Link 33:<a href=\"https:\/\/www.sciencedirect.com\/science\/article\/pii\/S1936523325000543\" target=\"_blank\" rel=\"noopener\"> <\/a><\/strong><a href=\"https:\/\/www.sciencedirect.com\/science\/article\/pii\/S1936523325000543\" target=\"_blank\" rel=\"noopener\">Metformin and glioma: Targeting metabolic dysregulation for effective therapy<\/a> (ScienceDirect, 2025)\n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-6bda4a877e5453febf79b97ba724ec05\"><strong>Indhold:<\/strong> En videnskabelig gennemgang, der unders\u00f8ger metformins potentiale som behandling af gliom. Artiklen fokuserer p\u00e5, hvordan midlet kan ramme den metaboliske ubalance (dysregulering), som kr\u00e6ftcellerne er afh\u00e6ngige af for at vokse.<\/li>\n<\/ul>\n<\/li>\n\n\n\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-217ea492f69a1d3dd11dff4a5ff7b73c\"><strong>Link 34:<\/strong> <a href=\"https:\/\/clinicaltrials.gov\/study\/NCT07226453\" target=\"_blank\" rel=\"noopener\">Target Validation and Efficacy of Metformin in Patients With Posterior Fossa Ependymoma<\/a> (ClinicalTrials.gov, 2025)\n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-2cc04c06b997cb736cadb032a87b6ec6\"><strong>Indhold:<\/strong> Et klinisk studie fra 2025, der unders\u00f8ger effekten af metformin til behandling af tilbagevendende ependymom i baghovedet (PFA). Studiet bygger p\u00e5 evidens om, at metformin kan p\u00e5virke de metaboliske og epigenetiske mekanismer, der driver denne specifikke tumortype.<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">Hudkr\u00e6ft:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-d7b18a8488db7792575744b666a2ee49\"><strong>Link 35:<\/strong> <a href=\"https:\/\/www.researchgate.net\/publication\/392094011_Metformin_-A_New_Frontier_in_Skin_Cancer_Pharmacotherapy\" target=\"_blank\" rel=\"noopener\">Metformin &#8211; A New Frontier in Skin Cancer Pharmacotherapy<\/a> (ResearchGate, 2025)\n<ul class=\"wp-block-list\">\n<li><strong>Indhold: <\/strong>En videnskabelig gennemgang, der analyserer Metformins potentiale som behandling mod hudkr\u00e6ft. Artiklen konkluderer, at stoffet kan have en bred virkning ved at h\u00e6mme centrale kr\u00e6ft-signalveje (som PI3K\/Akt\/mTOR) og forstyrre kr\u00e6ftcellernes energiforsyning (mitokondrierne), hvilket underst\u00f8tter dets potentiale som en effektiv metabolisk behandling.<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">Livmoderhalskr\u00e6ft:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-801d728b7b6c389700d364e4bca55f52\"><strong>Link 36:<\/strong> <a href=\"https:\/\/www.mdpi.com\/2218-273X\/13\/6\/950\" target=\"_blank\" rel=\"noopener\">Potential Mechanisms of Metformin-Induced Apoptosis in HeLa Cells<\/a> (MDPI, 2023)\n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-2c142e7a77db9f3b554152e32316ad09\"><strong>Indhold:<\/strong> En videnskabelig artikel, der unders\u00f8ger metformins direkte evne til at bek\u00e6mpe livmoderhalskr\u00e6ftceller (HeLa). Studiet konkluderer, at metformin virker ved at h\u00e6mme kr\u00e6ftcellernes deling og fremme programmeret celled\u00f8d (apoptose), hvilket underst\u00f8tter stoffets potentiale som en selvst\u00e6ndig behandling.<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">Mavekr\u00e6ft:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-4d1ee3879d2b36b437acf819389697aa\"><strong>Link 37:<\/strong> <a href=\"https:\/\/www.researchgate.net\/publication\/373538533_Metformin_A_New_Inhibitor_of_the_Wnt_Signaling_Pathway_in_Cancer\" target=\"_blank\" rel=\"noopener\">A New Inhibitor of the Wnt Signaling Pathway in Cancer<\/a> (ResearchGate, 2023)\n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-8d446bf4351ee9791ee34d7ac393150d\"><strong>Indhold:<\/strong> Et studie der dokumenterer, hvordan metformin h\u00e6mmer v\u00e6kst og spredning i kr\u00e6ftceller. Artiklen fokuserer p\u00e5 stoffets evne til at blokere Wnt-signalvejen og regulere cellernes energistofskifte via AMPK-aktivering, hvilket bekr\u00e6fter dets potentiale som en metabolisk behandling.<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">Myelomatose\/ Knoglemarvskr\u00e6ft:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-8717ac34068f852357a90ebe7dffe416\"><strong>Link 38:<\/strong> <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/25305450\/\" target=\"_blank\" rel=\"noopener\">Metformin displays anti-myeloma activity and synergistic effect with dexamethasone<\/a> (PubMed, 2014) \n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-9f7740cbcc567424d6a0e55256b933b9\"><strong>Indhold:<\/strong> Et studie, der viser, at metformin h\u00e6mmer v\u00e6ksten af myelomatose-celler ved at stoppe cellecyklus og inducere apoptose. Det virker synergistisk med binyrebarkhormon (dexamethason), som er standardbehandling.<\/li>\n<\/ul>\n<\/li>\n\n\n\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-16606fa6165d9a85c0e879f94fd1839b\"><strong>Link 39:<\/strong> <a href=\"https:\/\/link.springer.com\/article\/10.1186\/s12967-023-04263-8\" target=\"_blank\" rel=\"noopener\">Metformin and cancer hallmarks: shedding new lights on therapeutic implications<\/a> (Journal of Translational Medicine, 2023) \n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-99dc6a99b9306c9ec43a15083500bcf9\"><strong>Indhold:<\/strong> En videnskabelig oversigtsartikel, der gennemg\u00e5r metformins virkning p\u00e5 kr\u00e6ftceller. Artiklen fremh\u00e6ver specifikt, at stoffet udviser aktivitet mod myelomatose og skaber en synergi med dexamethason, hvilket forst\u00e6rker effekten af denne standardbehandling.<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">Nyrekr\u00e6ft:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-7cc3f189b5d1743c13aa8e6b1f4476dc\"><strong>Link 40:<\/strong> <a href=\"https:\/\/www.researchgate.net\/publication\/332264952_Metformin_Induces_Different_Responses_in_Clear_Cell_Renal_Cell_Carcinoma_Caki_Cell_Lines\" target=\"_blank\" rel=\"noopener\">Metformin Induces Different Responses in Clear Cell Renal Cell Carcinoma<\/a> (ResearchGate, 2019)\n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-0d59cdb23c2e24db0e27c3989bdda86f\"><strong>Indhold:<\/strong> Et videnskabeligt studie, der unders\u00f8ger metformins effekt p\u00e5 nyrekr\u00e6ft. Resultaterne viser, at metformin d\u00e6mper det s\u00e6rlige protein, der fungerer som kr\u00e6ftcellernes &#8220;ilt-sensor&#8221;. N\u00e5r dette protein undertrykkes, mister kr\u00e6ftcellerne deres vigtigste overlevelsesmekanisme og evnen til at vokse.<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">Tarmkr\u00e6ft:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-2733fb15504715e84cefaefebda9c3b1\"><strong>Link 41:<\/strong> <a href=\"https:\/\/link.springer.com\/article\/10.1007\/s12672-025-03905-1\" target=\"_blank\" rel=\"noopener\">Metformin&#8217;s multifaceted role in colorectal cancer<\/a> (Springer, 2025)\n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-7e51b594d6c111edab3b8b15e2d59707\"><strong>Indhold:<\/strong> En videnskabelig artikel, der belyser metformins mangefacetterede rolle ved tarmkr\u00e6ft. Artiklen beskriver, hvordan stoffet kan undertrykke resistens hos kr\u00e6ftstamceller over for behandling, hvilket er afg\u00f8rende for at forhindre tilbagefald og spredning (metastase).<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">Livmoderkr\u00e6ft:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-5e22e611e34844b01d8b1d7f7cf2ac6d\"><strong>Link 42:<\/strong> <a href=\"https:\/\/www.archivesofmedicalscience.com\/Evaluation-of-the-impact-of-diabetes-mellitus-on-endometrial-cancer-risk-an-updated,196001,0,2.html\" target=\"_blank\" rel=\"noopener\">Metformin and endometrial cancer: an updated meta-analysis of case-control studies<\/a> (Archives of Medical Science, 2024)\n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-45b357a3ea37b3f38b25f0a990b19e92\"><strong>Indhold:<\/strong> En omfattende analyse, der bekr\u00e6fter metformins beskyttende virkning mod livmoderkr\u00e6ft. Studiet viser en tydelig sammenh\u00e6ng, hvor brugen af metformin er forbundet med en nedsat risiko for sygdommen, hvilket underst\u00f8tter strategien om at regulere blodsukker og insulin for at h\u00e6mme kr\u00e6ftv\u00e6kst.<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">Spytkirtel- N\u00e6sekr\u00e6ft:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-7dd8a6f2778426e7dd837c65ecf491c9\"><strong>Link 43:<\/strong> <a href=\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC9017546\/\" target=\"_blank\" rel=\"noopener\">A potential protective effect of metformin in adenoid cystic carcinoma<\/a> (National Institutes of Health, 2020)\n<ul class=\"wp-block-list\">\n<li><strong>Indhold:<\/strong> Et klinisk studie der unders\u00f8ger metformins virkning p\u00e5 adenoid cystic carcinoma (ACC). Resultaterne viser, at patienter, der tog metformin, havde en signifikant lavere risiko for tilbagefald og l\u00e6ngere sygdomsfri overlevelse, hvilket tilskrives stoffets evne til at h\u00e6mme v\u00e6kstsignaler og bremse celledeling.<\/li>\n<\/ul>\n<\/li>\n\n\n\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-22a62c2dd57bfae5a8c463fa9ac493e1\"><strong>Link 44:<\/strong> <a href=\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC10136714\/\" target=\"_blank\" rel=\"noopener\">The Association between Metformin and the Cancer-Specific Mortality Rate in Nasopharyngeal Cancer Patients: Real-World Evidence<\/a> (National Institutes of Health, 2023)\n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-5dae567b104415f3cc198230616d4b83\"><strong>Indhold:<\/strong> Et studie der unders\u00f8ger sammenh\u00e6ngen mellem brug af metformin og d\u00f8delighed hos patienter med n\u00e6sesv\u00e6lgskr\u00e6ft. Resultaterne indikerer, at metformin kan reducere den kr\u00e6ftspecifikke d\u00f8delighed, hvilket underst\u00f8tter dets potentiale som en effektiv del af behandlingen.<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">Vulva- og Skedekr\u00e6ft:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-e0e46f108aabfba0862ab99003c698cc\"><strong>Link 45:<\/strong> <a href=\"https:\/\/www.mdpi.com\/2077-0383\/14\/20\/7258\" target=\"_blank\" rel=\"noopener\">Biological Anti-Tumoral Mechanisms of Metformin in Head and Neck Squamous Cell Carcinomas<\/a> (MDPI, 2025)\n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-ad40095758668ec7ef6d75d1f8827a08\"><strong>Indhold:<\/strong> En systematisk gennemgang, der analyserer metformins virkning p\u00e5 planocellul\u00e6rt karcinom. Da vulva- og skedekr\u00e6ft er af samme celletype, underbygger studiet, hvordan stoffet kan h\u00e6mme tumorv\u00e6kst og spredning ved at p\u00e5virke cellernes energistofskifte og bremse celledeling.<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">\u00c6ggestokkr\u00e6ft:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-967b29a0a0ac0c57e78c39030a8a56c4\"><strong>Link 46:<\/strong> <a href=\"https:\/\/atm.amegroups.org\/article\/view\/42993\/html\" target=\"_blank\" rel=\"noopener\">Metformin and ovarian cancer: the evidence<\/a> (Annals of Translational Medicine, 2020)\n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-f5e2b7f0fa9100ffdd698e03325885c8\"><strong>Indhold:<\/strong> En videnskabelig gennemgang, der samler evidensen for metformins effekt ved \u00e6ggestokkr\u00e6ft. Artiklen konkluderer, at stoffet har klare effekter, der g\u00f8r kr\u00e6ftcellerne mere f\u00f8lsomme over for behandling, og at det fungerer som en effektiv h\u00e6mmer af dannelsen af nye blodkar (angiogenese).<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n\n\n\n<p class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-f847ae3ed7387b4bb5d21191ec3814ab wp-block-paragraph\">\u00d8jenkr\u00e6ft: <\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-520fa146fe491bf8f7a09d1f1ac17901\"><strong>Link 47:<\/strong> <a href=\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC4215581\/\" target=\"_blank\" rel=\"noopener\">Effects of metformin on retinoblastoma growth in vitro and in vivo<\/a> (National Institutes of Health, 2014)\n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-f432257c3414882e1d34a8f44d21684c\"><strong>Indhold:<\/strong> Et studie der dokumenterer metformins effekt p\u00e5 retinoblastom (b\u00f8rne-\u00f8jenkr\u00e6ft). Det viser, at stoffet kan bremse celledeling og h\u00e6mme kr\u00e6ftens v\u00e6kst b\u00e5de i cellestudier og dyremodeller, hvilket underst\u00f8tter dets potentiale som en metabolisk behandling.<\/li>\n<\/ul>\n<\/li>\n\n\n\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-7fae6e7f562ee2ce91d5558a871746c7\"><strong>Link 48:<\/strong> <a href=\"https:\/\/www.sciencedirect.com\/science\/article\/pii\/S1936523325000543\" target=\"_blank\" rel=\"noopener\">Metformin and glioma: Targeting metabolic dysregulation for enhanced therapeutic outcomes<\/a> (Science Direct, 2025)\n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-3c4939ed05c97895104b6369ab7d1746\"><strong>Indhold:<\/strong> En videnskabelig gennemgang, der unders\u00f8ger metformins potentiale som behandling af neurale tumorer. Artiklen beskriver, hvordan stoffet rammer metabolisk dysregulering og h\u00e6mmer v\u00e6kstveje, hvilket er mekanismer, der er overf\u00f8rbare til andre kr\u00e6ftformer i nervesystemet som f.eks. retinoblastom i \u00f8jet.<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n\n\n\n<p class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-40bf9c0ec30d3a4bc8843a91fa3c87de wp-block-paragraph\"><strong><strong>Tilbage til:<\/strong> <a href=\"#skema-01\"><mark style=\"background-color:rgba(0, 0, 0, 0)\" class=\"has-inline-color has-custom-menu-links-color\">Oversigtsskema for Repurposed drugs<\/mark><\/a><\/strong><\/p>\n\n\n\n<h4 class=\"wp-block-heading has-custom-sort-tekst-color has-text-color has-link-color wp-elements-01a926f7978cbe9cbd5cd29be4777e6d\" id=\"propranolol\">11. <a href=\"https:\/\/jegharkraeft.dk\/propranolol\/\">Propranolol<\/a><\/h4>\n\n\n\n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-3c7435254c17405eb4657992e84ee54a\"><strong>Link 1:<\/strong> <a href=\"https:\/\/www.authorea.com\/users\/498160\/articles\/579001-repurposing-propranolol-to-improve-cancer-therapy-in-clinic-where-are-we\" target=\"_blank\" rel=\"noopener\">Repurposing propranolol to improve cancer therapy in clinic: where are we?<\/a> (Authorea, 2022)\n<ul class=\"wp-block-list\">\n<li><strong>Relevans:<\/strong> Betablokkeren propranolol, der allerede er genanvendt til behandling af visse tumorer, viser sig i stigende grad at v\u00e6re en sikker og lovende strategi mod mange forskellige kr\u00e6ftformer.<\/li>\n<\/ul>\n<\/li>\n\n\n\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-3a59fa2634e7ac284a5c274b3f622cd0\"><strong>Link 2:<\/strong><a href=\"https:\/\/ecancer.org\/en\/journal\/article\/680-repurposing-drugs-in-oncology-redo-propranolol-as-an-anti-cancer-agent\" target=\"_blank\" rel=\"noopener\"> Repurposing Drugs in Oncology (ReDO)\u2014Propranolol as an anti-cancer agent<\/a> (eCancer Medical Science, 2016)\n<ul class=\"wp-block-list\">\n<li><strong>Relevans:<\/strong> Betablokkeren propranolol viser lovende anti-kr\u00e6ft effekt ved at h\u00e6mme cellev\u00e6kst og spredning, is\u00e6r den der kan opst\u00e5 efter operation, og unders\u00f8ges nu i en r\u00e6kke kliniske fors\u00f8g.<\/li>\n<\/ul>\n<\/li>\n\n\n\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-c31008449266e1ce576af0a5b76ef09e\"><strong>Link 3: <\/strong><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/40361395\/\" target=\"_blank\" rel=\"noopener\">Propranolol and Capecitabine Synergy on Inducing Ferroptosis in Human Colorectal Cancer Cells: Potential Implications in Cancer Therapy<\/a> (PubMed, 2025)\n<ul class=\"wp-block-list\">\n<li><strong>Relevans:<\/strong> Disse resultater tyder p\u00e5, at PRO kan v\u00e6re en lovende tilf\u00f8jelsesbehandling sammen med CAP mod kolorektal kr\u00e6ft, is\u00e6r i HT-29 celler med B-RAF V600E-mutation.<\/li>\n<\/ul>\n<\/li>\n\n\n\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-843af6cdbaee72dd3e0b614863c733ed\"><strong>Link 4:<\/strong> <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/38857055\/\" target=\"_blank\" rel=\"noopener\">Role of transforming growth factor-\u03b21 pathway in angiogenesis induced by chronic stress in colorectal cancer <\/a>(PubMed, 2024)\n<ul class=\"wp-block-list\">\n<li><strong>Relevans: <\/strong>Resultaterne viser, at NE p\u00e5virker tumorets dannelse af nye blodkar og, at TGF-\u03b21 er vigtig i denne proces. Stress kan derfor sv\u00e6kke effektiviteten af anti-angiogenerende behandling, da en bestemt signalvej involverer \u03b2-AR, TGF-\u03b21, HIF-1\u03b1 og VEGF.<\/li>\n<\/ul>\n<\/li>\n\n\n\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-1e410e39d2879d7c003ad8f7f309444b\"><strong>Link 5:<\/strong> <a href=\"https:\/\/www.nature.com\/articles\/s41388-021-02170-0\" target=\"_blank\" rel=\"noopener\">Blockade of beta-adrenergic receptors reduces cancer growth and enhances the response to anti-CTLA4 therapy by modulating the tumor <\/a>(Nature, 2022) \n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-c7ec07729e7735982a7cc43599feeae3\"><strong>Indhold:<\/strong> En videnskabelig artikel, der bekr\u00e6fter, at blokering af beta-adrenerge receptorer (Propranolol) reducerer kr\u00e6ftv\u00e6kst og forbedrer effekten af immunterapi. Dette underst\u00f8tter Propranolols Hovedstrategi (1)-status i Inflammatorisk Brystkr\u00e6ft (IBC) og metastatisk sygdom, hvor stress- og immunmodulering er afg\u00f8rende.<\/li>\n<\/ul>\n<\/li>\n\n\n\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-868b67bfe47104c1c281966b4458d0ed\"><strong>Link 6:<\/strong> <a href=\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC10452867\/\" target=\"_blank\" rel=\"noopener\">BRAF Mutations in Melanoma: Biological Aspects and Therapeutic Approaches<\/a> (National Institutes of Health, 2023) \n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-e064667540e39d2a1e21a14daad09eb7\"><strong>Indhold:<\/strong> Oversigtsartikel, der beskriver, at kombinationsbehandlinger sigter mod at h\u00e6mme forskellige transduktionsveje, der er kritiske for kr\u00e6ftcellers overlevelse. Dette validerer den overordnede strategi i skemaet om at angribe b\u00e5de MAPK og alternative veje for at forhindre resistens.<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">Binyrebarkkr\u00e6ft:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-2e198c66328cc3adeeda275969067c25\"><strong>Link 7:<\/strong> <a href=\"https:\/\/www.mdpi.com\/1422-0067\/21\/21\/7958\" target=\"_blank\" rel=\"noopener\">Neurobiology of Cancer: The Role of \\beta-Adrenergic Receptor Signaling in Cancer<\/a> (MDPI, 2020)\n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-5b8fa9877ea7336d8c6de4fdff469b51\"><strong>Indhold:<\/strong> En videnskabelig oversigtsartikel, der kortl\u00e6gger, hvordan kroppens stress-signaler (beta-adrenerg signalering) direkte fremmer dannelsen af nye blodkar (angiogenese) og tumorv\u00e6kst. Da binyren er stress-systemets centrum, underbygger studiet relevansen af at blokere disse signaler med propranolol for at bremse sygdomsprogressionen.<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">Hudkr\u00e6ft:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-5fce203e76c9248b4e244978c866268a\"><strong>Link 8:<\/strong><a href=\"https:\/\/link.springer.com\/article\/10.1007\/s00432-025-06262-2\" target=\"_blank\" rel=\"noopener\"> Does propranolol have a role in cancer treatment? <\/a>(Springer, 2025)\n<ul class=\"wp-block-list\">\n<li><strong>Indhold:<\/strong> En videnskabelig artikel, der gennemg\u00e5r evidensen for, at betablokkeren propranolol kan forbedre udfaldet af kr\u00e6ftbehandling. Artiklen fremh\u00e6ver, at stoffet ser ud til at kunne neds\u00e6tte risikoen for tilbagefald, hvilket underst\u00f8tter strategien om at d\u00e6mpe stress-signaler og h\u00e6mme de mekanismer, der driver kr\u00e6ftv\u00e6kst.<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">Nyrekr\u00e6ft:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-c57906c21c39823ce654dd3183ac6de4\"><strong>Link 9:<\/strong> <a href=\"https:\/\/www.nature.com\/articles\/s41388-021-02170-0\" target=\"_blank\" rel=\"noopener\">Blockade of beta-adrenergic receptors reduces cancer growth and metastasis<\/a> (Nature, 2022) \n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-b002747cb1a572661e723ff8dffbc63c\"><strong>Indhold: <\/strong>En videnskabelig artikel, der beskriver, hvordan betablokkere (specifikt propranolol) d\u00e6mper kroppens stress-signaler. Studiet forklarer, at behandlingen derved reducerer tumorens evne til at danne nye blodkar (angiogenese) og \u00e6ndrer tumormilj\u00f8et, s\u00e5 immunsystemet bedre kan bek\u00e6mpe kr\u00e6ftcellerne.<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">Prostatakr\u00e6ft:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-93d4963b64d44fd70ecd666ff9ef7a49\"><strong>Link 10:<\/strong> <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/27641328\/\" target=\"_blank\" rel=\"noopener\">Beta-adrenergic signaling promotes tumor angiogenesis and prostate cancer progression through HDAC2-mediated suppression of thrombospondin-1<\/a> (PubMed, 2017) \n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-3502d2772b62d27544c80d2a10d94666\"><strong>Indhold:<\/strong> Et videnskabeligt studie, der dokumenterer, hvordan kronisk stress og beta-adrenerg signalering direkte fremmer udviklingen af prostatakr\u00e6ft. Forskningen viser, at stresshormoner stimulerer dannelsen af nye blodkar (angiogenese), hvilket giver tumoren n\u00e6ring til at vokse og sprede sig.<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n\n\n\n<p class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-6159f05db2d82389bd0a895fb83b5de1 wp-block-paragraph\"><strong>Tilbage til:<\/strong> <a href=\"#skema-01\"><mark style=\"background-color:rgba(0, 0, 0, 0)\" class=\"has-inline-color has-custom-menu-links-color\">Oversigtsskema for Repurposed drugs<\/mark><\/a><\/p>\n\n\n\n<h4 class=\"wp-block-heading has-custom-sort-tekst-color has-text-color has-link-color wp-elements-d4e2c352a548c0ca35ef9212635290eb\" id=\"statiner\">12. <a href=\"https:\/\/jegharkraeft.dk\/statiner\/\">Statiner<\/a><\/h4>\n\n\n\n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-0434d8eee1c6e881ec7140601b159e57\"><strong>Link 1:<\/strong><a href=\"https:\/\/www.google.com\/search?q=https:\/\/www.nature.com\/articles\/s41571-021-00534-7\" target=\"_blank\" rel=\"noreferrer noopener\"> <\/a><a href=\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC12116307\/\" target=\"_blank\" rel=\"noopener\">The role of statins in the regulation of breast and colorectal cancer and future directions<\/a> (PubMed, 2025)\n<ul class=\"wp-block-list\">\n<li><strong>Relevans:<\/strong> Kolesterols\u00e6nkende medicin (statiner) viser potentiale mod is\u00e6r bryst- og tarmkr\u00e6ft ved at blokere den vigtige Mevalonat-v\u00e6kstvej. De kliniske resultater er dog usikre og afh\u00e6nger sandsynligvis af den specifikke type statin, dosis og behandlingstid, hvilket kr\u00e6ver mere forskning.<\/li>\n<\/ul>\n<\/li>\n\n\n\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-3fdc9d887522eb1e000140a781eb070e\"><strong>Link 2:<\/strong><a href=\"https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC10296752\/\" target=\"_blank\" rel=\"noreferrer noopener\"> <\/a><a href=\"https:\/\/jitc.bmj.com\/content\/11\/1\/e005940\" target=\"_blank\" rel=\"noopener\">Statin drugs enhance responses to immune checkpoint blockade in head and neck cancer models<\/a> (Journal for ImmunoTherapy of Cancer, 2023)\n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-9a2d94fd9c68438051a437cf6319d85a\"><strong>Relevans:<\/strong> Disse resultater tyder p\u00e5, at statiner fortjener yderligere unders\u00f8gelse som veltolererede, prisvenlige l\u00e6gemidler, der kan forbedre responset p\u00e5 PD-1 checkpoint-blokade og andre immunterapier mod hoved- og halspladecellekarcinom (HNSCC).<\/li>\n<\/ul>\n<\/li>\n\n\n\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-b28067b4fec910880d438cf4751f4395\"><strong>Link 3:<\/strong> <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/40452015\/\" target=\"_blank\" rel=\"noopener\">Cholesterol-induced colorectal cancer progression and its mitigation through gut microbiota remodeling and simvastatin treatment<\/a> (PubMed, 2025)\n<ul class=\"wp-block-list\">\n<li><strong>Relevans:<\/strong> H\u00f8jt serumkolesterol kan fremme kolorektal kr\u00e6ft, mens forbedring af tarmbakterier med Lactobacillus og cholesterol-s\u00e6nkende behandlinger som Simvastatin kan hj\u00e6lpe med at bremse tumorv\u00e6kst og styrke immunforsvaret. Cholesterolstyring er derfor vigtig i CRC-behandling.<\/li>\n<\/ul>\n<\/li>\n\n\n\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-a0578898120ec157c7ce96a2f0ce3c4d\"><strong>Link 4:<\/strong> <a href=\"https:\/\/www.ejog.org\/article\/S0301-2115(21)00556-X\/abstract\" target=\"_blank\" rel=\"noopener\">Association between statin use and the risk, prognosis, and mortality of gynecologic cancer: a systematic review and meta-analysis<\/a> (European Journal of Obstetrics and Gynecology, 2022)\n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-99ab63ae3b79dff49982b60c84125d3a\"><strong>Indhold:<\/strong> Denne meta-analyse fra 2022 samler data fra 43 studier. Konklusionen er, at brug af statiner er forbundet med en lavere risiko for at udvikle gyn\u00e6kologisk kr\u00e6ft, herunder kr\u00e6ft i \u00e6ggestokkene. Analysen indikerer desuden en mulig sammenh\u00e6ng mellem statinbrug og forbedret prognose.<\/li>\n<\/ul>\n<\/li>\n\n\n\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-7d2ceb1dbd68eeffde77aa26fedc7daa\"><strong>Link 5:<\/strong> <a href=\"https:\/\/www.researchgate.net\/publication\/7300955_Anti-Cancer_Therapy_Targeting_the_Mevalonate_Pathway\" target=\"_blank\" rel=\"noopener\">Anti-Cancer Therapy: Targeting the Mevalonate Pathway<\/a> (ResearchGate, 2025)\n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-432a2b316b91bc4fff2609c4f5f92c16\"><strong>Indhold:<\/strong> Denne oversigtsartikel forklarer, hvorfor Mevalonate-signalvejen er et s\u00e5rbart m\u00e5l i mange kr\u00e6ftformer. Den beskriver, hvordan signalvejen er afg\u00f8rende for kr\u00e6ftcellers v\u00e6kst og overlevelse, og hvordan statiner kan udnytte denne s\u00e5rbarhed ved at blokere processen.<\/li>\n<\/ul>\n<\/li>\n\n\n\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-880bb05b517ee78c2df8489f980db3c7\"><strong>Link 6:<\/strong> <a href=\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC9695805\/\" target=\"_blank\" rel=\"noopener\">Statins as Repurposed Drugs in Gynecological Cancer: A Review<\/a> (PubMed, 2022)\n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-d27c83abc74e5ad99cd6922851a756bf\"><strong>Indhold:<\/strong> En oversigtsartikel, der beskriver rationalet for at bruge statiner ved gyn\u00e6kologiske kr\u00e6ftformer.<\/li>\n<\/ul>\n<\/li>\n\n\n\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-7b82e06b1f1083482cc7f866f3d73802\"><strong>Link 7:<\/strong> <a href=\"https:\/\/www.researchgate.net\/publication\/385555366_Statin_use_and_ovarian_cancer_Outcomes\" target=\"_blank\" rel=\"noopener\">Statin use and ovarian cancer Outcomes<\/a> (Research Gate, 2024)\n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-18e2f63fd1e8b50ae5cd1161891f9740\"><strong>Indhold:<\/strong> Et studie, der unders\u00f8ger, hvordan brug af statiner p\u00e5virker prognosen og overlevelsen for patienter med \u00e6ggestokkr\u00e6ft.<\/li>\n<\/ul>\n<\/li>\n\n\n\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-e3adae2130e11c2dfd067ba79ec76aec\"><strong>Link 8:<\/strong> <a href=\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC7661422\/\" target=\"_blank\" rel=\"noopener\">Efficacy and safety profile of statins in patients with cancer: a systematic review of randomised controlled trials <\/a>(PubMed, 2020)\n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-1af43655ec5e1d630be70a101fcc6cb9\"><strong>Indhold:<\/strong> En systematisk gennemgang af de bedste studier (randomiserede), der bekr\u00e6fter statiners sikkerhedsprofil hos kr\u00e6ftpatienter.<\/li>\n<\/ul>\n<\/li>\n\n\n\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-103edf4fc3b884a7f2c794e4a2e633c9\"><strong>Link 9:<\/strong> <a href=\"https:\/\/www.mdpi.com\/1424-8247\/14\/5\/470\" target=\"_blank\" rel=\"noopener\">Statin as a Potential Chemotherapeutic Agent: Current Updates as a Monotherapy, Combination Therapy, and Treatment for Anti-Cancer Drug Resistance<\/a> (MDPI, 2021)\n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-cc452cc35bcaacf0fb64d0a6942ed1e4\"><strong>Indhold:<\/strong> En oversigtsartikel, der beskriver, hvordan statiner virker mod kr\u00e6ft, b\u00e5de alene og i kombination med kemo.<\/li>\n<\/ul>\n<\/li>\n\n\n\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-a9677b5fe3b753f6d2a3f3c119a500b2\"><strong>Link 11:<\/strong> <a href=\"https:\/\/karger.com\/ort\/article-abstract\/48\/7-8\/414\/924164\/Effect-of-Statin-Use-on-Survival-Outcomes-in?redirectedFrom=fulltext\" target=\"_blank\" rel=\"noopener\">Effect of Statin Use on Survival Outcomes in Patients Diagnosed with Epithelial Ovarian Cancer<\/a> (Karger, Oncology Research and Treatment, 2025)\n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-424663f01a8288acdc5a1b0e8894198a\"><strong>Indhold:<\/strong> Et studie, der specifikt forbinder brug af statiner med bedre overlevelse hos patienter med \u00e6ggestokkr\u00e6ft.<\/li>\n<\/ul>\n<\/li>\n\n\n\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-be4ba296136fe80aad65f4513df205fb\"><strong>Link 12:<\/strong> <a href=\"https:\/\/www.nature.com\/articles\/cddis201344\" target=\"_blank\" rel=\"noopener\">HMG-CoA reductase inhibitors induce apoptosis of lymphoma cells<\/a> (Nature, 2013) \n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-7dbb0f522b66e8e0b13b0781fca6b09c\"><strong>Indhold:<\/strong> Et studie, der specifikt unders\u00f8ger Statiner (HMG-CoA reduktase-h\u00e6mmere) i lymfomceller. Artiklen bekr\u00e6fter, at Statiner inducerer celled\u00f8d (apoptose), og at dette skyldes h\u00e6mning af Mevalonat-vejen, hvilket er den mekanisme, der er angivet i skemaets graduering.<\/li>\n<\/ul>\n<\/li>\n\n\n\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-db4426697c8d0105464b68c540b571a7\"><strong>Link 13:<\/strong> <a href=\"https:\/\/www.nature.com\/articles\/s41420-023-01784-5\" target=\"_blank\" rel=\"noopener\">Cholesterol metabolism and colorectal cancer: the plot thickens<\/a> (Nature, 2024) \n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-b64c4e5f2af92c5c0dfb575de058e2ea\"><strong>Indhold:<\/strong> Artiklen beskriver den \u00f8gede ekspression af Mevalonat- og kolesterol-metabolisme i BRAF-muteret tarmkr\u00e6ft. Dette validerer Statins Hovedstrategi (1), da de h\u00e6mmer denne vej, som er kritisk for BRAF-signaleringens funktion.<\/li>\n<\/ul>\n<\/li>\n\n\n\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-c4af5deae7a2323b946167269c3f641a\"><strong>Link 14:<\/strong> <a href=\"https:\/\/www.spandidos-publications.com\/10.3892\/ol.2022.13407\" target=\"_blank\" rel=\"noopener\">Tumor metabolic reprogramming in lung cancer progression<\/a> (Spandidos Publications, 2022) \n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-2cc7f36316dfa232fcdbc50c930bed6c\"><strong>Indhold:<\/strong> Oversigtsartikel, der opsummerer de abnormale \u00e6ndringer i metabolismen af glukose, fedt og aminosyrer i lungekr\u00e6ft, samt de underliggende molekyl\u00e6re mekanismer.<\/li>\n<\/ul>\n<\/li>\n\n\n\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-0863c8b63015ff8f2828f0b4d21a908a\"><strong>Link 15:<\/strong> <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/33110390\/\" target=\"_blank\" rel=\"noopener\">Pleiotropic use of Statins as non-lipid-lowering drugs<\/a> (International Journal of Biological Sciences, 2020) \n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-4a4b83950f4da8fc44c9dc4c81bb9f5e\"><strong>Indhold:<\/strong> Oversigtsartikel, der beskriver Statins bredspektrede effekter. Artiklen bekr\u00e6fter, at Statiner blokerer Mevalonat-vejen og reducerer derved produktionen af Coenzym Q10 (Ubiquinone), hvilket validerer behovet for Q10-supplementering i strategien.<\/li>\n<\/ul>\n<\/li>\n\n\n\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-68799a2de8631cbab8fa6069e6074f20\"><strong>Link 16:<\/strong> <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/33358111\/\" target=\"_blank\" rel=\"noopener\">Targeting the Mevalonate Pathway in Cancer<\/a> (National Institutes of Health, 2021) \n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-3cb78bbcd35dc57f862502a3e286aa9b\"><strong>Indhold:<\/strong> Oversigtsartikel, der beskriver Mevalonat-vejens rolle i talrige cellul\u00e6re processer, der underst\u00f8tter kr\u00e6ftv\u00e6kst. Artiklen validerer, at h\u00e6mning af vejen med Statiner forstyrrer proteinernes lipid-ankre, hvilket er kritisk for RAS-proteinernes (KRAS\/NRAS) funktion.<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">Binyrebarkkr\u00e6ft:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-c23fa10bd8fa16d725ff6d37acc822ec\"><strong>Link 17:<\/strong> <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/32546662\/\" target=\"_blank\" rel=\"noopener\">Statins Reduce Intratumor Cholesterol Affecting Adrenocortical Carcinoma Growth<\/a> (National Institutes of Health, 2020) \n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-0c2f60811e68da9f44f3de119c49fe96\"><strong>Indhold: <\/strong>Et videnskabeligt studie, der unders\u00f8ger effekten af statiner p\u00e5 binyrebarkkr\u00e6ft. Resultaterne viser, at statiner effektivt s\u00e6nker kolesterolniveauet inde i selve tumoren. Da disse kr\u00e6ftceller er storforbrugere af kolesterol til b\u00e5de v\u00e6kst og signalering, h\u00e6mmer behandlingen tumorens udvikling markant.<\/li>\n<\/ul>\n<\/li>\n\n\n\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-d37e0d134373876d91b10889657a950c\"><strong>Link 18:<\/strong> <a href=\"https:\/\/www.sciencedirect.com\/science\/article\/abs\/pii\/S0890623815300307\" target=\"_blank\" rel=\"noopener\">Simvastatin decreases steroid production in the H295R cell line and decreases steroids and FSH in female rats<\/a> (ScienceDirect, 2015) \n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-77c24e45a4c87228c09879f54e85c80a\"><strong>Indhold:<\/strong> Et laboratoriestudie, der dokumenterer, at simvastatin direkte h\u00e6mmer binyrebarkkr\u00e6ftcellers evne til at producere hormoner (steroidogenese). Resultaterne viser, at statiner reducerer produktionen af kortisol og andre steroider ved at gribe ind i cellernes interne kolesterol-syntese, hvilket er centralt for de funktionelle tumorer.<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">Blodkr\u00e6ft:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-d5da2bb060325c67924cfed54bb25125\"><strong>Link 19:<\/strong> <a href=\"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-025-15038-3\" target=\"_blank\" rel=\"noopener\">Impact of statin use on survival and adverse events in patients<\/a> (BMC Cancer, 2025)\n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-237faa742939fe2738658b2ee4f52787\"><strong>Indhold:<\/strong> En systematisk gennemgang og meta-analyse, der unders\u00f8ger virkningen af statiner p\u00e5 overlevelsen hos kr\u00e6ftpatienter. Studiet samler den nyeste evidens og indikerer, at brugen af statiner kan have en positiv effekt p\u00e5 overlevelsesraterne ved forskellige kr\u00e6ftformer, herunder blodkr\u00e6ft, hvilket underst\u00f8tter potentialet som supplerende behandling.<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">Prostatakr\u00e6ft:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-e4d92e048ff3d2704f8b30901af5464a\"><strong>Link 20:<\/strong> <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/38396837\/\" target=\"_blank\" rel=\"noopener\">Prostate Cancer and the Mevalonate Pathway<\/a> (PubMed, 2024)\n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-745a08137236eb221ff2cf18de9645ad\"><strong>Indhold:<\/strong> Oversigtsartikel, der beskriver, hvordan dysregulering af lipidmetabolismen (fedtstofskiftet) er en overlevelsesstrategi for prostatakr\u00e6ft. Artiklen validerer, at Statiner virker ved at h\u00e6mme Mevalonat-vejen og derved forstyrre cellev\u00e6ksten og signalering.<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">Glioblastom:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-aa32b4ffdd01c399f7f0ad5e848f0577\"><strong>Link 21:<\/strong> <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/37569432\/\" target=\"_blank\" rel=\"noopener\">Activation of the Mevalonate Pathway in Response to Anti-cancer Treatments Drives Glioblastoma Recurrences Through Activation of Rac-1<\/a> (PubMed Central, 2023)\n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-da0d19b4e41481290545b8d28cc9d80a\"><strong>Indhold:<\/strong> Studie, der viser, at Mevalonat-vejen er en kritisk flugtvej for glioblastom. Artiklen validerer, at Statiner kan udnytte denne metaboliske s\u00e5rbarhed for at h\u00e6mme tumoren og forbedre overlevelsen.<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">Bugspytkirtelkr\u00e6ft:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-d50c546ffc41787efa318d4e5883a4f6\"><strong>Link 22:<\/strong> <a href=\"https:\/\/www.mdpi.com\/2072-6694\/15\/19\/4787\" target=\"_blank\" rel=\"noopener\">Unraveling the Anticancer Potential of Statins: Mechanisms and Clinical Significance <\/a>(MDPI, 2023)\n<ul class=\"wp-block-list\">\n<li><strong>Indhold:<\/strong> En ny videnskabelig gennemgang fra 2023, der analyserer statiners potentiale som kr\u00e6ftbehandling. Artiklen fremh\u00e6ver kliniske studier, der viser en sammenh\u00e6ng mellem brug af statiner og reduceret kr\u00e6ftrisiko, mindre aggressive tumorer ved diagnose og forbedret overlevelse, hvilket underst\u00f8tter deres rolle som et repurposed drug.<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">Hals- og Mundhulekr\u00e6ft:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-5754a6444ae2746073d5b1d380feb0b1\"><strong>Link 23:<\/strong> <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/39645545\/\" target=\"_blank\" rel=\"noopener\">Post-diagnosis statin use and survival among head and neck squamous cell carcinoma patients<\/a> (National Institutes of Health, 2025)\n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-123c2f8570ea7e56663808dad4fdf66c\"><strong>Indhold:<\/strong> Et studie der unders\u00f8ger sammenh\u00e6ngen mellem brug af statiner efter diagnosen og overlevelse hos patienter med hoved-halskr\u00e6ft. Resultaterne indikerer, at l\u00e6ngerevarende brug af statiner er forbundet med en forbedret overlevelse, hvilket underst\u00f8tter stoffets potentiale i behandlingen.<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">Hjernekr\u00e6ft:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-fb11ef937f2382963093eccfb0c16084\"><strong>Link 24:<\/strong> <a href=\"https:\/\/www.spandidos-publications.com\/10.3892\/ol.2025.15213\" target=\"_blank\" rel=\"noopener\">Investigation into the synergistic effect of atorvastatin<\/a> (Spandidos Publications, 2025)\n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-52bcedb1ca72817fb3bf22714777274f\"><strong>Indhold:<\/strong> En unders\u00f8gelse der beskriver, hvordan atorvastatin kan virke synergistisk med anden behandling mod glioblastom. Resultaterne indikerer, at statiner kan bidrage til en forbedret overlevelse ved at p\u00e5virke tumorcellernes v\u00e6kstvilk\u00e5r.<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">Hudkr\u00e6ft:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-a56df814520e5505d82939976f7293df\"><strong>Link 25:<\/strong> <a href=\"https:\/\/www.jidonline.org\/article\/S0022-202X(20)32413-1\/fulltext\" target=\"_blank\" rel=\"noopener\">Computational Drug Repositioning Identifies Statins as a Novel Therapy for Melanoma Metastasis<\/a> (Journal of Investigative Dermatology, 2021)\n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-c91646d18d090299d66907a0bf2d8157\"><strong>Indhold:<\/strong> Et studie der identificerer statiner som en potentiel behandling mod spredning af moderm\u00e6rkekr\u00e6ft. Resultaterne viser at patienter der tog statiner p\u00e5 diagnosetidspunktet havde en signifikant lavere risiko for metastaser hvilket underst\u00f8ttes af analyser der viser at stoffet p\u00e5virker gener involveret i spredning.<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">Knoglekr\u00e6ft:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-d42174506d96c180c823425fcc9a1986\"><strong>Link 26:<\/strong> <a href=\"https:\/\/www.frontiersin.org\/journals\/pharmacology\/articles\/10.3389\/fphar.2023.1188926\/full\" target=\"_blank\" rel=\"noopener\">New insights into the therapeutic potentials of statins in cancer therapy<\/a> (Frontiers, 2023)\n<ul class=\"wp-block-list\">\n<li><strong>Indhold:<\/strong> En videnskabelig artikel fra 2023, der fremh\u00e6ver statiners potentiale til at forhindre spredning til knoglerne (skeletmetastaser). Studiet viser, hvordan behandling med statiner kan h\u00e6mme specifikke mark\u00f8rer p\u00e5 kr\u00e6ftstamceller og dermed g\u00f8re det sv\u00e6rere for kr\u00e6ften at etablere sig i knoglev\u00e6vet.<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">Mavekr\u00e6ft:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-c15a24f1dbf67d126d7d1ab3f8474a4d\"><strong>Link 27:<\/strong> <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/35685487\/\" target=\"_blank\" rel=\"noopener\">Statins Are Associated with Improved Survival of Patients with Gastric Cancer: A Systematic Review and Meta-Analysis<\/a> (PubMed, 2022)\n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-b20f90a882539dbb41b2344b98035c50\"><strong>Indhold:<\/strong> En stor systematisk gennemgang og meta-analyse, der bekr\u00e6fter, at brugen af statiner er forbundet med en forbedret overlevelse hos patienter med mavekr\u00e6ft. Studiet konkluderer, at statiner kan v\u00e6re en v\u00e6rdifuld tilf\u00f8jelse til behandlingen.<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">Myelomatose\/ Knoglemarvskr\u00e6ft:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-bd3a5364eb824422aec3490b113a19c0\"><strong>Link 28:<\/strong> <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/32141627\/\" target=\"_blank\" rel=\"noopener\">Statin use is associated with improved survival in multiple myeloma: A Swedish population-based study<\/a> (PubMed, 2020) \n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-dc17b241ed9bf12c0b53ce9b7547354d\"><strong>Indhold: <\/strong>Et stort befolkningsstudie med over 4000 patienter, der viser, at brug af statiner er forbundet med en markant bedre overlevelse ved myelomatose. Dette underst\u00f8tter strategien om at bruge statiner som supplement.<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">Nyrekr\u00e6ft:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-7277b57b85e8d851de307c16d99b3c9f\"><strong>Link 29:<\/strong> <a href=\"https:\/\/www.cancertreatmentreviews.com\/article\/S0305-7372(16)30134-7\/abstract\" target=\"_blank\" rel=\"noopener\">Statin use and kidney cancer survival outcomes<\/a> (Cancer Treatment Reviews, 2017)\n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-6c21f2e5f482f95746011cfa520e5581\"><strong>Indhold:<\/strong> En videnskabelig meta-analyse, der gennemg\u00e5r data fra flere studier. Konklusionen er, at brug af statiner (kolesterols\u00e6nkende medicin) er signifikant forbundet med en bedre overlevelse hos patienter med nyrekr\u00e6ft, b\u00e5de hvad ang\u00e5r kr\u00e6ftspecifik og generel overlevelse.<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">Tarmkr\u00e6ft:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-5329665f98eb1e06a6fc2078518a2fdc\"><strong>Link 30:<\/strong> <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/30149418\/\" target=\"_blank\" rel=\"noopener\">Statins and colorectal cancer: A systematic review<\/a> (PubMed, 2020)\n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-57e4ac546859707159f4e56c013cd6c3\"><strong>Indhold:<\/strong> En systematisk gennemgang, der viser, at statin-brug er forbundet med bedre overlevelse ved tarmkr\u00e6ft. Artiklen peger p\u00e5, at statiner kan h\u00e6mme spredning (metastase) og g\u00f8re kr\u00e6ftcellerne mere f\u00f8lsomme over for anden behandling.<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">Livmoderkr\u00e6ft:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-7d2dd9b1a4167918c84054cfb28aff26\"><strong>Link 31:<\/strong> <a href=\"https:\/\/www.ejog.org\/article\/S0301-2115(21)00556-X\/abstract\" target=\"_blank\" rel=\"noopener\">Association between statin use and the risk, prognosis of gynecologic cancers<\/a> (European Journal of Obstetrics and Gynecology, 2022)\n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-d58c7820a026cc5a04b17dfd45661a07\"><strong>Indhold:<\/strong> En systematisk gennemgang og meta-analyse, der unders\u00f8ger sammenh\u00e6ngen mellem statinbrug og prognosen for gyn\u00e6kologiske kr\u00e6ftformer. Resultaterne viser, at brugen af statiner er forbundet med en lavere d\u00f8delighed, hvilket underst\u00f8tter strategien om at h\u00e6mme kr\u00e6ftv\u00e6kst ved at blokere Mevalonat-vejen.<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">\u00c6ggestokkr\u00e6ft:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-be0614d3ea9488e77db1028be1dd10e5\"><strong>Link 32:<\/strong> <a href=\"https:\/\/www.ejog.org\/article\/S0301-2115(21)00556-X\/abstract\" target=\"_blank\" rel=\"noopener\">Association between statin use and the risk, prognosis of gynecologic cancers<\/a> (European Journal of Obstetrics and Gynecology, 2022)\n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-d58c7820a026cc5a04b17dfd45661a07\"><strong>Indhold:<\/strong> En systematisk gennemgang og meta-analyse, der unders\u00f8ger sammenh\u00e6ngen mellem statinbrug og prognosen for gyn\u00e6kologiske kr\u00e6ftformer. Resultaterne viser, at brugen af statiner er forbundet med en lavere d\u00f8delighed, hvilket underst\u00f8tter strategien om at h\u00e6mme kr\u00e6ftv\u00e6kst ved at blokere Mevalonat-vejen.<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">\u00d8jenkr\u00e6ft:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-01f60ca3e5bc7e48d18f41128071d321\"><strong>Link 33:<\/strong> <a href=\"https:\/\/www.mdpi.com\/2072-6694\/15\/3\/886\" target=\"_blank\" rel=\"noopener\">Cerivastatin Synergizes with Trametinib and Enhances Its Efficacy in Uveal Melanoma<\/a> (MDPI, 2023)\n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-63f01779579c1f31d8690f9c20aa4c12\"><strong>Indhold:<\/strong> Et studie der unders\u00f8ger effekten af et statin (cerivastatin) mod moderm\u00e6rkekr\u00e6ft i \u00f8jet. Resultaterne viser, at statiner ved at blokere Mevalonat-vejen kan h\u00e6mme v\u00e6kstsignalerne og potentielt forbedre overlevelsen ved metastatisk sygdom.<\/li>\n<\/ul>\n<\/li>\n\n\n\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-4c154df9803571155af692a18208b333\"><strong>Link 34:<\/strong> <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/38126027\/\" target=\"_blank\" rel=\"noopener\">Driver mutations in GNAQ and GNA11 genes as potential targets for precision immunotherapy in uveal melanoma patients<\/a> (PubMed, 2023)\n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-f461d29e47549d9584bab3b5b76f7a90\"><strong>Indhold:<\/strong> Et studie der unders\u00f8ger de specifikke mutationer (GNAQ\/GNA11), der driver uvealt melanom. Artiklen bekr\u00e6fter, at disse genetiske fejl er centrale for sygdommen og kan fungere som m\u00e5l for pr\u00e6cisionsbehandling, hvilket underst\u00f8tter strategien om at ramme de signalveje, som mutationerne aktiverer.<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Tilbage til:<\/strong> <a href=\"#skema-01\"><mark style=\"background-color:rgba(0, 0, 0, 0)\" class=\"has-inline-color has-custom-menu-links-color\">Oversigtsskema for Repurposed drugs<\/mark><\/a><\/p>\n\n\n\n<h4 class=\"wp-block-heading\"><a href=\"#benzimidazoler\">Vermox<\/a> &#8211; Se under <a href=\"#benzimidazoler\">Benzimidazoler<\/a><\/h4>\n\n\n\n<h3 class=\"wp-block-heading\" id=\"kosttilskud\"><span class=\"ez-toc-section\" id=\"Kosttilskud\"><\/span>Kosttilskud<span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<h4 class=\"wp-block-heading has-custom-sort-tekst-color has-text-color has-link-color wp-elements-79224285b9d9f5f638e632e90dff328b\" id=\"ahcc\">1. <a href=\"https:\/\/jegharkraeft.dk\/ahcc\/\">AHCC (Active Hexose Correlated Compound)<\/a><\/h4>\n\n\n\n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-ca3120b35d8cc811a6707e8c4269ae17\"><strong>Link 1:<\/strong><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/28440968\/\" target=\"_blank\" rel=\"noopener\"> The effects of Active Hexose Correlated Compound (AHCC) on the frequency of CD4+ and CD8+ T cells in patients with epithelial ovarian cancer or peritoneal cancer<\/a> (PubMed, 2017)\n<ul class=\"wp-block-list\">\n<li><strong>Relevans:<\/strong> Dette kliniske studie p\u00e5 mennesker viser, hvordan AHCC kan styrke immunforsvaret hos kr\u00e6ftpatienter ved at \u00f8ge antallet af vigtige T-celler (immunceller), hvilket underbygger p\u00e5standen om &#8220;generel immunst\u00f8tte&#8221;.<\/li>\n<\/ul>\n<\/li>\n\n\n\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-b49c3842dcedff43e1ceedadce2398f9\"><strong>Link 2:<\/strong><a href=\"https:\/\/www.sciencedirect.com\/science\/article\/pii\/S0022316622092148\" target=\"_blank\" rel=\"noopener\"> <\/a><a href=\"hhttps:\/\/pubmed.ncbi.nlm.nih.gov\/38140397\/\" target=\"_blank\" rel=\"noopener\">Active Hexose-Correlated Compound Shows Direct and Indirect Effects against Chronic Lymphocytic Leukemia<\/a> (PubMed 2023)\n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-151b8b24aee70647199087e9dc87d77e\"><strong>Relevans:<\/strong> Svampeekstraktet AHCC viser i nye studier en dobbelt effekt mod Kronisk Lymfatisk Leuk\u00e6mi (CLL), da det b\u00e5de dr\u00e6ber kr\u00e6ftcellerne direkte og fjerner de &#8220;hj\u00e6lper-celler&#8221;, som er afg\u00f8rende for kr\u00e6ftens overlevelse.<\/li>\n<\/ul>\n<\/li>\n\n\n\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-7d8674ca9aa47060952f518da7952362\"><strong>Link 3:<\/strong> <a href=\"https:\/\/www.nature.com\/articles\/s41419-024-06641-6\" target=\"_blank\" rel=\"noopener\">Dietary factors and their influence on immunotherapy strategies in oncology: a comprehensive review<\/a> (Nature, 2024) \n<ul class=\"wp-block-list\">\n<li><strong>Indhold:<\/strong> En oversigtsartikel der beskriver, hvordan specifikke kostkomponenter (f.eks. fedtsyrer og n\u00e6ringsstoffer) kan forbedre immunterapi ved at modulere immunresponset. Artiklen er relevant, fordi den validerer, at kosttilskud (herunder dette) har en immunmodulerende effekt og p\u00e5virker den inflammatoriske del af kr\u00e6ftmilj\u00f8et.<\/li>\n<\/ul>\n<\/li>\n\n\n\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-891889cb6d5fcc75c040cb5feaf1c8ba\"><strong>Link 4:<\/strong> <a href=\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC10452867\/\" target=\"_blank\" rel=\"noopener\">BRAF Mutations in Melanoma: Biological Aspects and Therapeutic Approaches<\/a> (National Institutes of Health, 2023) \n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-e064667540e39d2a1e21a14daad09eb7\"><strong>Indhold:<\/strong> Oversigtsartikel, der beskriver, at kombinationsbehandlinger sigter mod at h\u00e6mme forskellige transduktionsveje, der er kritiske for kr\u00e6ftcellers overlevelse. Dette validerer den overordnede strategi i skemaet om at angribe b\u00e5de MAPK og alternative veje for at forhindre resistens.<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">Livmoderhalskr\u00e6ft:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-6142db4825623d8b45cc9d623e51464d\"><strong>Link 5:<\/strong> <a href=\"https:\/\/www.mdpi.com\/1648-9144\/61\/4\/622\" target=\"_blank\" rel=\"noopener\">Evaluation of the Efficacy of Active Hexose Correlated Compound (AHCC) Supplementation<\/a> (MDPI, 2025) \n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-3ad5fad4f0cf3fd62e9412e4bc23ce1a\"><strong>Indhold:<\/strong> Et studie der unders\u00f8ger effekten af AHCC-tilskud p\u00e5 vedvarende HPV-infektioner. Resultaterne indikerer, at tilskuddet kan underst\u00f8tte immunforsvaret og bidrage til at rense infektionen, hvilket er den prim\u00e6re strategi for at fjerne \u00e5rsagen til celleforandringerne.<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">Vulva- og Skedekr\u00e6ft:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-368d5b2b44a6d58368501fe69897a754\"><strong>Link 6:<\/strong> <a href=\"https:\/\/www.nature.com\/articles\/d42473-020-00414-3\" target=\"_blank\" rel=\"noopener\">AHCC, a mushroom culture extract to boost immune defence<\/a> (Nature, (2022)) \n<ul class=\"wp-block-list\">\n<li><strong>Indhold:<\/strong> En artikel fra det anerkendte tidsskrift Nature, der beskriver AHCC&#8217;s potentiale som et immun-st\u00f8ttende supplement. Artiklen fokuserer p\u00e5, hvordan ekstraktet kan hj\u00e6lpe immunforsvaret med at bek\u00e6mpe Human Papillomavirus (HPV), hvilket er den prim\u00e6re \u00e5rsag til celleforandringer i vulva og skede.<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n\n\n\n<p class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-d0ca7c5a5b992e20ec1e0ccfec68ebc4 wp-block-paragraph\"><strong>Tilbage til:<\/strong> <a href=\"#skema-02\"><mark style=\"background-color:rgba(0, 0, 0, 0)\" class=\"has-inline-color has-custom-menu-links-color\">Oversigtsskema for Kosttilskud<\/mark><\/a><\/p>\n\n\n\n<h4 class=\"wp-block-heading has-custom-sort-tekst-color has-text-color has-link-color wp-elements-5cb5582e884f7ee190f87c66f5fd0dc9\" id=\"alfa-liponsyre\">2. <a href=\"https:\/\/jegharkraeft.dk\/alfa-liponsyre\/\">Alfa-liponsyre<\/a> (ALA)<\/h4>\n\n\n\n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-7bbae35c3f749e660644309527d1688c\"><strong>Link 1:<\/strong><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/40327992\/\" target=\"_blank\" rel=\"noopener\"> Alpha lipoic acid modulates metabolic reprogramming in breast cancer stem cells enriched 3D spheroids by targeting phosphoinositide 3-kinase: In silico and in vitro insights<\/a> (PubMed, 2025)\n<ul class=\"wp-block-list\">\n<li><strong>Relevans:<\/strong> Dette studie viser, at alfa-liponsyre (LA) kan ramme de aggressive brystkr\u00e6ftstamceller ved at blokere den vigtige PI3K\/Akt\/mTOR-signalvej. Dette forstyrrer kr\u00e6ftcellernes stofskifte og g\u00f8r dem markant mere f\u00f8lsomme over for kemoterapi som doxorubicin.<\/li>\n<\/ul>\n<\/li>\n\n\n\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-99c3442d95453d4b891589255904e158\"><strong>Link 2:<\/strong> <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/39694075\/\" target=\"_blank\" rel=\"noopener\">Anticancer effects of alpha-lipoic acid, a potent organosulfur compound by modulating matrix metalloproteinases and apoptotic markers in osteosarcoma MG-63 cells<\/a> (PubMed, 2025)\n<ul class=\"wp-block-list\">\n<li><strong>Relevans:<\/strong> Et nyt laboratoriestudie viser, at alfa-liponsyre (ALA) har en st\u00e6rk effekt mod den aggressive knoglekr\u00e6ft osteosarkom. Resultaterne viste, at ALA b\u00e5de forhindrer kr\u00e6ftcellerne i at sprede sig (metastasere) og aktiverer programmeret celled\u00f8d (apoptose) i dem.<\/li>\n<\/ul>\n<\/li>\n\n\n\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-48bea936f0664c7edadecca94029db70\"><strong>Link 3:<\/strong> <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/39199143\/\" target=\"_blank\" rel=\"noreferrer noopener\">The Multifaceted Role of Alpha-Lipoic Acid in Cancer Prevention, Occurrence, and Treatment<\/a> (Antioxidants, 2024)\n<ul class=\"wp-block-list\">\n<li><strong>Relevans:<\/strong> Denne oversigtsartikel fra juli 2024 opsummerer den nyeste viden om ALA. Den fremh\u00e6ver, at mens ALA fungerer som en antioxidant i normale celler, udviser det pro-oxidative (kr\u00e6ftbek\u00e6mpende) egenskaber i kr\u00e6ftcellers unikke milj\u00f8. Artiklen diskuterer ogs\u00e5 ALA&#8217;s rolle i nanomedicin og potentialet til at ramme kr\u00e6ftstamceller.<\/li>\n<\/ul>\n<\/li>\n\n\n\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-f2be1e3c20721f50b55070b1c6ecfcf6\"><strong>Link 4:<\/strong> <a href=\"https:\/\/www.spandidos-publications.com\/10.3892\/ol.2022.13407\" target=\"_blank\" rel=\"noopener\">Tumor metabolic reprogramming in lung cancer progression<\/a> (Spandidos Publications, 2022) \n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-2cc7f36316dfa232fcdbc50c930bed6c\"><strong>Indhold:<\/strong> Oversigtsartikel, der opsummerer de abnormale \u00e6ndringer i metabolismen af glukose, fedt og aminosyrer i lungekr\u00e6ft, samt de underliggende molekyl\u00e6re mekanismer.<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Tilbage til:<\/strong> <a href=\"#skema-02\"><mark style=\"background-color:rgba(0, 0, 0, 0)\" class=\"has-inline-color has-custom-menu-links-color\">Oversigtsskema for Kosttilskud<\/mark><\/a><\/p>\n\n\n\n<h4 class=\"wp-block-heading\" id=\"apigenin\">3. <a href=\"https:\/\/jegharkraeft.dk\/apigenin\/\">Apigenin<\/a><\/h4>\n\n\n\n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-318565fed7511f9db4599253e4a0e347\"><strong>Link 1:<\/strong><a href=\"https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC5791748\/\" target=\"_blank\" rel=\"noreferrer noopener\">Apigenin as a promising molecule for cancer prevention<\/a> (Pharmaceutical Research, 2017)\n<ul class=\"wp-block-list\">\n<li><strong>Relevans:<\/strong> En detaljeret oversigtsartikel, der beskriver apigenins brede anti-kr\u00e6ft effekter, herunder dets evne til at stoppe celledeling, inducere apoptose og h\u00e6mme angiogenese (dannelse af blodkar).<\/li>\n<\/ul>\n<\/li>\n\n\n\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-a7fdecb9354a14c2b1520ed01c41c2ce\"><strong>Link 2:<\/strong> <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/40440759\/\" target=\"_blank\" rel=\"noopener\">Apigenin and doxorubicin loaded zeolitic imidazole frameworks for triple-combination therapy of breast cancer <\/a>(PubMed, 2025)\n<ul class=\"wp-block-list\">\n<li><strong>Relevans:<\/strong> Forskningsstudiet udviklede en nanobehandling, der kombinerer en glycolyseh\u00e6mmer (apigenin) med kemoterapi (doxorubicin) i en speciel carrier (ZIF-90). Denne metode m\u00e5lretter kr\u00e6ftceller, is\u00e6r ved at udnytte deres specifikke milj\u00f8, og kombinerer hypertermi, kemoterapi og energih\u00e6mning. Resultater viser, at denne triple-behandling er mere effektiv end enkeltbehandlinger, hvilket kan forbedre kr\u00e6ftbehandlinger fremover.<\/li>\n<\/ul>\n<\/li>\n\n\n\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-9988aa66eaee6de58bc19febfaf74f5e\"><strong>Link 3:<\/strong> <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/40063738\/\" target=\"_blank\" rel=\"noopener\">Molecular insights into the antineoplastic potential of apigenin and its derivatives: paving the way for nanotherapeutic innovations<\/a> (PubMed, 2025)\n<ul class=\"wp-block-list\">\n<li><strong>Relevans:<\/strong> Apigenin er en plantebaseret flavonoid med kr\u00e6ftbek\u00e6mpende egenskaber, der kan p\u00e5virke kr\u00e6ftceller og reducere tumorv\u00e6kst. Dog g\u00f8r dets h\u00f8je hydrofobicitet og ukoncentrerede spredning det sv\u00e6rt at bruge i medicin.<\/li>\n<\/ul>\n<\/li>\n\n\n\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-ce5f417058312ee9aae5333e9f56825c\"><strong>Link 4:<\/strong> <a href=\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC11386296\/\" target=\"_blank\" rel=\"noreferrer noopener\">Potential therapeutic effects of apigenin for colorectal adenocarcinoma: A systematic review and meta\u2010analysis<\/a> (Phytotherapy Research, 2024)\n<ul class=\"wp-block-list\">\n<li><strong>Relevans:<\/strong> En systematisk gennemgang og meta-analyse, der konkluderer, at apigenin kan betragtes som et muligt supplerende middel i behandlingen af tyktarmskr\u00e6ft. Resultaterne viste, at apigenin reducerer cellers levedygtighed, inducerer apoptose og cellecyklus-stop samt mindsker tumorst\u00f8rrelse i pr\u00e6kliniske modeller.<\/li>\n<\/ul>\n<\/li>\n\n\n\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-b863259fc030ad8ae02eb1ded7743b44\"><strong>Link 5: <\/strong><a href=\"https:\/\/www.nature.com\/articles\/s41392-020-0110-5\" target=\"_blank\" rel=\"noopener\">Targeting cancer stem cell pathways for cancer therapy<\/a> (Nature, 2020)\n<ul class=\"wp-block-list\">\n<li><strong>Indhold:<\/strong> Oversigtsartikel, der opsummerer de prim\u00e6re faktorer og signalveje, der regulerer udviklingen af kr\u00e6ftstamceller (CSCs). Artiklen underst\u00f8tter, at CSCs er n\u00f8gledrivere for resistens og validerer de mange strategier i skemaet, der sigter mod at blokere CSC-veje.<\/li>\n<\/ul>\n<\/li>\n\n\n\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-d4a4d27c8af3ffd55ad119218498a235\"><strong>Link 6:<\/strong> <a href=\"https:\/\/www.nature.com\/articles\/s41598-025-87537-z\" target=\"_blank\" rel=\"noopener\">Metformin inhibits the growth of SCLC cells by inducing autophagy and apoptosis via the suppression of EGFR and AKT signalling<\/a> (Nature, 2025) \n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-6cac701017cee1ae1f6afc6071693eb9\"><strong>Indhold:<\/strong> Studie, der beskriver, hvordan Metformin kan genoprette f\u00f8lsomheden i NSCLC-celler over for EGFR-h\u00e6mmere ved at h\u00e6mme EGFR\/PI3K-signalvejen. Dette validerer Metformins Hovedstrategi (1) mod resistens.<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Tilbage til:<\/strong> <a href=\"#skema-02\"><mark style=\"background-color:rgba(0, 0, 0, 0)\" class=\"has-inline-color has-custom-menu-links-color\">Oversigtsskema for Kosttilskud<\/mark><\/a><\/p>\n\n\n\n<h4 class=\"wp-block-heading\" id=\"artemisinin\">4. <a href=\"https:\/\/jegharkraeft.dk\/artemisia\/\">Artemisinin<\/a> \/ Artesunat<\/h4>\n\n\n\n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-489dafe8867a43d41979b61fd012d72d\"><strong>Link 1:<\/strong> <a href=\"https:\/\/advanced.onlinelibrary.wiley.com\/doi\/abs\/10.1002\/adbi.202300086\" target=\"_blank\" rel=\"noopener\">Therapeutical Utilization and Repurposing of Artemisinin and Its Derivatives: A Narrative Review<\/a> (Advanced Biology, 2023)\n<ul class=\"wp-block-list\">\n<li><strong>Relevans:<\/strong> Artemisinin og dets derivater bruges prim\u00e6rt mod malaria, men har ogs\u00e5 potentiale til behandling af virusinfektioner, autoimmune sygdomme og kr\u00e6ft. Forskning fokuserer p\u00e5 at optimere brugen af disse l\u00e6gemidler til andre sygdomme, og fremtidig forskning b\u00f8r udvikle mere effektive derivater og kombinationer.<\/li>\n<\/ul>\n<\/li>\n\n\n\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-93f373dfa99be6c1e229021f0d8170ee\"><strong>Link 2:<\/strong> <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/40410249\/\" target=\"_blank\" rel=\"noopener\">Inhibition activity of Artemisia vulgaris L. on Bhas 42 cell transformation<\/a> (PubMed, 2025)\n<ul class=\"wp-block-list\">\n<li><strong>Relevans:<\/strong> Unders\u00f8gelsen viste, at Artemisia vulgaris-ekstrakt kan h\u00e6mme celleomdannelse, som er en vigtig del af kr\u00e6ftudvikling. Det kan reducere antallet af kr\u00e6ftlignende celler i laboratoriefors\u00f8g, men der kr\u00e6ves mere forskning for at forst\u00e5 mekanismerne endnu bedre.<\/li>\n<\/ul>\n<\/li>\n\n\n\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-eab88f363bd1922a499ed78119a12130\"><strong>Link 3:<\/strong> <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/40398524\/\" target=\"_blank\" rel=\"noopener\">Biotransformation of artemisinin by human intestinal fungi and cytotoxicity against breast cancer cells of its metabolites<\/a> (PubMed, 2025)\n<ul class=\"wp-block-list\">\n<li><strong>Relevans:<\/strong> Forskning viser, at menneskelige tarmfungi kan omdanne artemisinin til nye stoffer, hvor nogle har bedre kr\u00e6fth\u00e6mmende egenskaber end artemisinin selv. Dette \u00e5bner muligheder for at bruge tarmfloraen til at forbedre medicinsk behandling mod kr\u00e6ft og malaria.<\/li>\n<\/ul>\n<\/li>\n\n\n\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-2a8528ae0a9a42aec47584724743cae6\"><strong>Link 4:<\/strong> <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/40224969\/\" target=\"_blank\" rel=\"noopener\">Scoparone suppresses proliferation and cell cycle of hepatocellular carcinoma cells via inhibiting AKT\/GSK-3\u03b2\/cyclin D1 signaling pathway<\/a> (PubMed, 2025)\n<ul class=\"wp-block-list\">\n<li><strong>Relevans:<\/strong> Scoparone kan h\u00e6mme v\u00e6kst, migration og invasion af leverkr\u00e6ftceller ved at p\u00e5virke cellernes v\u00e6kstcyklus, is\u00e6r ved at reducere nogle vigtige cellecykelgener og proteiner. Dets effekt kan delvist modvirkes ved at aktivere AKT-signalvejen.<\/li>\n<\/ul>\n<\/li>\n\n\n\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-0e100af8fa80eda8ee69daa2f95da28b\"><strong>Link 5:<\/strong> <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/39941696\/\" target=\"_blank\" rel=\"noopener\">Exploring the Therapeutic Potential of&nbsp;<em>Artemisia<\/em>&nbsp;and&nbsp;<em>Salvia<\/em>&nbsp;Genera in Cancer, Diabetes, and Cardiovascular Diseases: A Short Review of Clinical Evidence<\/a> (PubMed, 2025)\n<ul class=\"wp-block-list\">\n<li><strong>Relevans:<\/strong> Studier viser, at planter som Artemisia og Salvia har potentiale til at hj\u00e6lpe med fedme-relaterede sygdomme som diabetes, hjertesygdomme og kr\u00e6ft. Selvom nogle plantestoffer viser lovende resultater, mangler der stadig st\u00e6rk klinisk dokumentation, hvilket kr\u00e6ver mere grundig forskning for at kunne anvende dem sikkert i behandling.<\/li>\n<\/ul>\n<\/li>\n\n\n\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-b8c2a716efb3780f9008178d720a0a37\"><strong>Link 6:<\/strong> <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/39876565\/\" target=\"_blank\" rel=\"noopener\">Isolation and spectroscopic characterization of anticancer phytochemicals from&nbsp;<em>Artemisia laciniata<\/em>: a combined experimental and theoretical investigation using ADMET analysis and in silico molecular docking simulation against key cancer targets<\/a> (PubMed, 2025)\n<ul class=\"wp-block-list\">\n<li><strong>Relevans:<\/strong> Artemisia laciniata indeholder potent antitumorstoffer, der kan p\u00e5virke forskellige kr\u00e6fttyper. Flere af de isolerede forbindelser viste st\u00e6rk kr\u00e6fth\u00e6mmende aktivitet, og nogle har potentiale til at m\u00e5lrette kr\u00e6ftrelaterede proteiner, hvilket kan hj\u00e6lpe med udvikling af nye kr\u00e6ftbehandlinger.<\/li>\n<\/ul>\n<\/li>\n\n\n\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-e0e54fc5a7d1ca57d728447b99c38641\"><strong>Link 7:<\/strong> <a href=\"https:\/\/www.leicester-ozone.co.uk\/post\/the-power-of-artemisinin-and-high-dose-iv-vitamin-c-in-integrative-cancer-care?fbclid=IwY2xjawO7t8ticmlkETFEbDBJa0gyVzV5YXNiSXhYc3J0YwZhcHBfaWQQMjIyMDM5MTc4ODIwMDg5MgABHhNNAsS0BbNZ8CRMG3FnJvbnGEkBsMkK_xnXOdLl81g6bLGGbnAp8H8UXBnH&amp;brid=-cht4BRO1hheZWpUn8pPUQ\" target=\"_blank\" rel=\"noopener\">The Power of Artemisinin and High-Dose IV Vitamin C in Integrative Cancer Care<\/a> (Leicester Ozone Clinic, 2025)\n<ul class=\"wp-block-list\">\n<li><strong>Indhold:<\/strong> (Fra privat klinik &#8211; ikke uvildig, men god forklaring) Artiklen gennemg\u00e5r det synergistiske potentiale i at kombinere artemisinin med h\u00f8jdosis IV C-vitamin. Ved at udnytte kr\u00e6ftcellers h\u00f8je jernindhold skabes en kraftig oxidativ stressreaktion, der m\u00e5lrettet kan sv\u00e6kke kr\u00e6ftceller og g\u00f8re dem mere modtagelige for konventionel behandling.<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">Blodkr\u00e6ft:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-dd7d439b1ed817377248a7e57d3c2c62\"><strong>Link 8:<\/strong> <a href=\"https:\/\/www.nature.com\/articles\/s41420-023-01371-8\" target=\"_blank\" rel=\"noopener\">Dihydroartemisinin-induced ferroptosis in acute myeloid leukemia<\/a> (Nature, 2023)\n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-5ce64a8ff7f5ded30b75fcea0501f697\"><strong>Indhold:<\/strong> Et studie publiceret i Nature, der dokumenterer, hvordan et derivat af artemisinin (DHA) effektivt kan dr\u00e6be celler fra akut myeloid leuk\u00e6mi (AML). Studiet bekr\u00e6fter, at mekanismen er ferroptose (jern-afh\u00e6ngig celled\u00f8d), og at behandlingen specifikt rammer kr\u00e6ftcellernes afh\u00e6ngighed af jern, hvilket underst\u00f8tter dets potentiale som en m\u00e5lrettet metabolisk strategi.<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">Hals- og Mundhulekr\u00e6ft:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-48d63dbd6876b9c51e06f337721549e4\"><strong>Link 9:<\/strong> <a href=\"https:\/\/www.spandidos-publications.com\/10.3892\/br.2024.1839\" target=\"_blank\" rel=\"noopener\">Advances in ferroptosis in head and neck cancer<\/a> (Spandidos Publications, 2024)\n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-f3798c458bbfff206c809be7e276d45b\"><strong>Indhold:<\/strong> En videnskabelig gennemgang der beskriver, hvordan artemisinin og dets derivater kan udl\u00f8se ferroptose (jern-afh\u00e6ngig celled\u00f8d) i hoved-halskr\u00e6ftceller. Artiklen forklarer, hvordan denne mekanisme kan bruges til at overvinde resistens over for anden behandling.<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">Livmoderhalskr\u00e6ft:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-423370c8552f0d71778bead24eaeccdb\"><strong>Link 10:<\/strong> <a href=\"https:\/\/www.mdpi.com\/1420-3049\/29\/16\/3886\" target=\"_blank\" rel=\"noopener\">Artemisinin and Its Derivatives as Potential Anticancer Agents<\/a> (MDPI, 2024)\n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-6a57ace48f002204b8d818f4916b9278\"><strong>Indhold:<\/strong> En omfattende videnskabelig gennemgang fra 2024, der kortl\u00e6gger artemisinins potentiale mod forskellige kr\u00e6ftformer. Artiklen beskriver detaljeret, hvordan stoffet inducerer celled\u00f8d via oxidativt stress og ferroptose, og bekr\u00e6fter dets effektivitet over for resistente cellelinjer, hvilket g\u00f8r det til en relevant strategi.<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">Lungekr\u00e6ft og leverkr\u00e6ft:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-b54e1f6b7fe9b88c80e06ea8b9106b44\"><strong>Link 11:<\/strong> <a href=\"https:\/\/digitalcommons.pcom.edu\/research_day\/research_day_GA_2025\/researchGA2025\/10\/\" target=\"_blank\" rel=\"noreferrer noopener\">Combination Therapy in Cancer Treatment: The Role of Artemisinin as an Adjuvant and the Integration of Nanotechnology for Enhanced Efficacy<\/a> (Konferenceabstrakt, 2025)\n<ul class=\"wp-block-list\">\n<li><strong>Relevans:<\/strong> Denne oversigt fremh\u00e6ver, at de prim\u00e6re begr\u00e6nsninger for artemisinin (d\u00e5rlig vandopl\u00f8selighed og biotilg\u00e6ngelighed) kan overvindes ved hj\u00e6lp af nanoteknologi (f.eks. liposomer, miceller). Artemisinin-nanoformuleringer viser signifikant forbedret levering og \u00f8get celledr\u00e6bende effekt i forskellige kr\u00e6ftmodeller, herunder lunge- og leverkr\u00e6ft.<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">Lymfom:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-07fc7c50f9732dd7599e57b0b5933d0c\"><strong>Link 12: <\/strong><a href=\"https:\/\/www.nature.com\/articles\/s41419-020-03144-y\" target=\"_blank\" rel=\"noopener\">Targeting BCL-2 in B-cell malignancies and overcoming resistance <\/a>(Nature, 2020)\n<ul class=\"wp-block-list\">\n<li><strong>Indhold:<\/strong> En autoritativ oversigtsartikel, der bekr\u00e6fter, at h\u00e6mning af BCL-2-familien er en rationel terapeutisk strategi for lymfomer og andre B-celle maligniteter. Artiklen diskuterer, hvordan BCL-2-afh\u00e6ngige tilstande (som f.eks. Follikul\u00e6rt Lymfom) behandles ved at genoprette cellens evne til at d\u00f8 (apoptose).<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">Prostatakr\u00e6ft:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-dea1230e4f11f0c14223f6df9cf9e3d6\"><strong>Link 13:<\/strong> <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/31114026\/\" target=\"_blank\" rel=\"noopener\">Artemisinin compounds sensitize cancer cells to ferroptosis by regulating iron homeostasis<\/a> (PubMed, 2020)\n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-9819581cf407ee0244915dc3f886cd33\"><strong>Indhold:<\/strong> Studie, der forklarer Artemisinins virkningsmekanisme: Det sensibiliserer kr\u00e6ftceller for Ferroptose (jern-afh\u00e6ngig celled\u00f8d) ved at regulere jernmetabolismen. Dette validerer den Hovedstrategi (1), der er rettet mod Ferroptose i aggressive tumorer.<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">Glioblastom:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-5a5e5cfed76204e910215cfa369857c2\"><strong>Link 14:<\/strong> <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/32452511\/\" target=\"_blank\" rel=\"noopener\">Dihydroartemisinin initiates ferroptosis in glioblastoma through GPX4 inhibition<\/a> (PMC &#8211; NIH, 2020)\n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-d94219c816fc4cab15eefb3349ef12f2\"><strong>Indhold: <\/strong>Studie, der validerer strategien for Artemisinin\/Ferroptose. Artiklen forklarer, at Dihydroartemisinin (Artemisinin) initierer Ferroptose (jern-afh\u00e6ngig celled\u00f8d) i glioblastomceller.<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">Spytkirtel- og N\u00e6sekr\u00e6ft:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-4eccf63d45b6024dc72bbcd4e6ceac00\"><strong>Link 15:<\/strong> <a href=\"https:\/\/www.spandidos-publications.com\/10.3892\/or.2024.8782\" target=\"_blank\" rel=\"noopener\">Natural products targeting ferroptosis pathways in cancer<\/a> (Spandidos Publications, 2024)\n<ul class=\"wp-block-list\">\n<li><strong>Indhold:<\/strong> En videnskabelig gennemgang fra 2024, der beskriver hvordan naturstoffer som artemisinin kan udl\u00f8se ferroptose (jern-afh\u00e6ngig celled\u00f8d). Artiklen fremh\u00e6ver specifikt effekten p\u00e5 n\u00e6sesv\u00e6lgskr\u00e6ftceller, hvilket underst\u00f8tter strategien om at bruge denne mekanisme til at dr\u00e6be kr\u00e6ftceller, der ellers er modstandsdygtige.<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">Vulva- og Skedekr\u00e6ft:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-debecacb83d457b21a5301bea8cb9c74\"><strong>Link 16:<\/strong> <a href=\"https:\/\/www.ijbs.com\/v21p0075.pdf\" target=\"_blank\" rel=\"noopener\">Artemisinin Suppressed Melanoma Recurrence and Metastasis<\/a> (International Journal of Biological Sciences, 2025)\n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-76e6912a9eeafd771f14a5f560df3652\"><strong>Indhold:<\/strong> Et videnskabeligt studie, der dokumenterer artemisinins evne til at undertrykke tilbagefald og spredning (metastase) af moderm\u00e6rkekr\u00e6ft. Resultaterne underst\u00f8tter stoffets potentiale som en strategi mod aggressive kr\u00e6ftformer, hvor risikoen for spredning er h\u00f8j.<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Tilbage til:<\/strong> <a href=\"#skema-02\"><mark style=\"background-color:rgba(0, 0, 0, 0)\" class=\"has-inline-color has-custom-menu-links-color\">Oversigtsskema for Kosttilskud<\/mark><\/a><\/p>\n\n\n\n<h4 class=\"wp-block-heading\" id=\"astragalus\">5. <a href=\"https:\/\/jegharkraeft.dk\/astragalus\/\">Astragalus<\/a><\/h4>\n\n\n\n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-8f38b17b8090ffa91207d0ad25ca2840\"><strong>Link 1:<\/strong> <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/40233474\/\" target=\"_blank\" rel=\"noopener\">Chinese herbal extract Astragalus radix potentiates human ovarian cancer cell cytotoxicity by aggravated ROS production and apoptosis<\/a> (PubMed, 2025)\n<ul class=\"wp-block-list\">\n<li><strong>Relevans:<\/strong> Astragalus radix (en kinesisk urt) viser st\u00e6rke kr\u00e6ftbek\u00e6mpende egenskaber mod \u00e6ggestokkr\u00e6ftceller i laboratoriefors\u00f8g, hvilket tyder p\u00e5, at den kan bruges som supplement eller alternativ behandling. Mere forskning er n\u00f8dvendig for at teste dens effekt og sikkerhed i levende organismer og kliniske studier.<\/li>\n<\/ul>\n<\/li>\n\n\n\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-9dcbedc53f4e0242d27685e17af88ef4\"><strong>Link 2:<\/strong> <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/40020348\/\" target=\"_blank\" rel=\"noopener\">Effect of Astragalus polysaccharide combined with cisplatin on exhaled volatile organic compounds as biomarkers for lung cancer and its anticancer mechanism<\/a> (PubMed, 2025)\n<ul class=\"wp-block-list\">\n<li><strong>Relevans:<\/strong> Astragalus polysaccharider (APS) kan forbedre behandlingen af lungekr\u00e6ft ved at styrke immunsystemet og \u00f8ge effekten af cisplatin. Det p\u00e5virker kr\u00e6ftmetabolismen og kan spores via \u00e6ndringer i luftens VOC&#8217;er, hvilket kan bruges til at overv\u00e5ge behandlingens effektivitet.<\/li>\n<\/ul>\n<\/li>\n\n\n\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-7c4430f2d9817ef72a834329dedf5ba2\"><strong>Link 3:<\/strong> <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/40318719\/\" target=\"_blank\" rel=\"noopener\">Astragalus polysaccharides inhibits tumor proliferation and enhances cisplatin sensitivity in bladder cancer by regulating the PI3K\/AKT\/FoxO1 axis<\/a> (PubMed, 2025)\n<ul class=\"wp-block-list\">\n<li><strong>Relevans:<\/strong> Astragalus polysaccharid (APS) kan \u00f8ge f\u00f8lsomheden over for cisplatin i bl\u00e6rekr\u00e6ft ved at h\u00e6mme cellev\u00e6kst, fremme celled\u00f8d og modulere tumormilj\u00f8et, hvilket kan hj\u00e6lpe med at overvinde resistens mod behandlingen.<\/li>\n<\/ul>\n<\/li>\n\n\n\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-a483327d7737427e1b8c4f16dcb4c277\"><strong>Link 4:<\/strong> <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/40208321\/\" target=\"_blank\" rel=\"noopener\">Efficacy and safety of astragalus polysaccharides in patients with malignant tumors: A systematic review and meta-analysis<\/a> (PubMed, 2025)\n<ul class=\"wp-block-list\">\n<li><strong>Relevans:<\/strong> En gennemgang af 31 kliniske fors\u00f8g viser, at Astragalus polysaccharid (APS) kan forbedre behandlingseffekten, styrke immunforsvaret og v\u00e6re sikkert for kr\u00e6ftpatienter. Det kan derfor v\u00e6re en lovende tilf\u00f8jelse i kr\u00e6ftbehandling, men mere forskning p\u00e5 specifikke kr\u00e6fttyper er n\u00f8dvendig.<\/li>\n<\/ul>\n<\/li>\n\n\n\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-d1a8d912cb73fe75562dcba8f24a4609\"><strong>Link 5:<\/strong> <a href=\"https:\/\/www.frontiersin.org\/journals\/pharmacology\/articles\/10.3389\/fphar.2025.1585697\/full\" target=\"_blank\" rel=\"noreferrer noopener\">Bioactive components and clinical potential of Astragalus species<\/a> (Frontiers in Pharmacology, 2025)\n<ul class=\"wp-block-list\">\n<li><strong>Relevans:<\/strong> En meget ny oversigtsartikel (maj 2025), der opsummerer forskningen fra 2020-2025. Den bekr\u00e6fter de bioaktive stoffers (polysaccharider, flavonoider, saponiner) immunmodulerende, antioxidante og antitumor-effekter og opfordrer til fremtidige kliniske fors\u00f8g for at validere potentialet.<\/li>\n<\/ul>\n<\/li>\n\n\n\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-5d4a817ec0ef5dccedad7e0b4c245ad0\"><strong>Link 5:<\/strong><a href=\"https:\/\/www.nature.com\/articles\/s41419-024-06641-6\" target=\"_blank\" rel=\"noopener\"> Dietary factors and their influence on immunotherapy strategies in oncology: a comprehensive review<\/a> (Nature, 2024)\n<ul class=\"wp-block-list\">\n<li><strong>Indhold:<\/strong> En oversigtsartikel der beskriver, hvordan specifikke kostkomponenter (f.eks. fedtsyrer og n\u00e6ringsstoffer) kan forbedre immunterapi ved at modulere immunresponset. Artiklen er relevant, fordi den validerer, at kosttilskud (herunder dette) har en immunmodulerende effekt og p\u00e5virker den inflammatoriske del af kr\u00e6ftmilj\u00f8et.<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Tilbage til:<\/strong> <a href=\"#skema-02\"><mark style=\"background-color:rgba(0, 0, 0, 0)\" class=\"has-inline-color has-custom-menu-links-color\">Oversigtsskema for Kosttilskud<\/mark><\/a><\/p>\n\n\n\n<h4 class=\"wp-block-heading\" id=\"berberin\">6. <a href=\"https:\/\/jegharkraeft.dk\/berberin\/\">Berberin<\/a><\/h4>\n\n\n\n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-bba77b1c218e50624740592b944d6984\"><strong>Link 1:<\/strong> <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/40473844\/\" target=\"_blank\" rel=\"noopener\">Investigating the impact of berberine on autophagy-mediated drug resistance in chronic lymphocytic leukemia tumor cells<\/a> (PubMed, 2025)\n<ul class=\"wp-block-list\">\n<li><strong>Relevans:<\/strong> Berberine kan reducere autophagy- og resistensmark\u00f8rer i blodceller hos B-CLL-patienter, hvilket viser potentiale som behandling. Yderligere kliniske studier er n\u00f8dvendige for at bekr\u00e6fte dens effekt i behandling af B-CLL.<\/li>\n<\/ul>\n<\/li>\n\n\n\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-2b631435c5123b26509cdb3d4f60f678\"><strong>Link 2:<\/strong> <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/40258505\/\" target=\"_blank\" rel=\"noopener\">Coptidis rhizoma and berberine as anti-cancer drugs: A 10-year updates and future perspectives<\/a> (PubMed, 2025)\n<ul class=\"wp-block-list\">\n<li><strong>Relevans:<\/strong> Berberine, et naturligt stof fra Coptidis Rhizoma, har bred kr\u00e6ftbek\u00e6mpende effekt ved at forhindre v\u00e6kst, sprede sig, fremme celled\u00f8d og forbedre behandlinger. Nye teknologier og AI kan hj\u00e6lpe med at optimere brugen af berberine i kr\u00e6ftforebyggelse og behandling.<\/li>\n<\/ul>\n<\/li>\n\n\n\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-ae008220553c4da355ca9fb2b865c480\"><strong>Link 3:<\/strong> <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/40252400\/\" target=\"_blank\" rel=\"noopener\">Berberine inhibits metastasis of ovarian cancer by blocking lipid metabolism, alleviating aging of adipose tissue and increasing tumor infiltrating immune cells<\/a> (PubMed, 2025)\n<ul class=\"wp-block-list\">\n<li><strong>Relevans:<\/strong> Berberine kan h\u00e6mme v\u00e6kst og spredning af \u00e6ggestokkr\u00e6ft ved at p\u00e5virke fedtstofskifte og forbedre immunforsvarets infiltration i tumorer, hvilket kan hj\u00e6lpe ved avanceret sygdom med peritoneal spredning og v\u00e6skeansamling.<\/li>\n<\/ul>\n<\/li>\n\n\n\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-581bb6ebbe8e9e47f47ebed9fca621b5\"><strong>Link 4:<\/strong> <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/39755832\/\" target=\"_blank\" rel=\"noopener\">Berberine restrains non-small cell lung cancer cell growth, invasion and glycolysis via inactivating the SPC25\/NUF2 pathway<\/a> (PubMed, 2025)\n<ul class=\"wp-block-list\">\n<li><strong>Relevans:<\/strong> Berberine kan h\u00e6mme v\u00e6kst, invasion og energiproduktion i ikke-sm\u00e5cellet lungekr\u00e6ft ved at reducere SPC25, som samarbejder med NUF2. Dette \u00e5bner nye muligheder for m\u00e5lrettet behandling af NSCLC.<\/li>\n<\/ul>\n<\/li>\n\n\n\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-d166cfc56ed464989abf138f622a972a\"><strong>Link 5:<\/strong> <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/40155519\/\" target=\"_blank\" rel=\"noopener\">Berberine diminishes the malignant progression of non-small cell lung cancer cells by targeting CDCA5 and CCNA2<\/a> (PubMed, 2025)\n<ul class=\"wp-block-list\">\n<li><strong>Relevans:<\/strong> Berberine kan forhindre aggressiv v\u00e6kst i NSCLC ved at p\u00e5virke CDCA5 og CCNA2, hvilket g\u00f8r disse til lovende m\u00e5l i behandlingen.<\/li>\n<\/ul>\n<\/li>\n\n\n\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-de04576f909023772cabe6201cd0fef8\"><strong>Link 6:<\/strong> <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/33354502\/\" target=\"_blank\" rel=\"noopener\">Berberine diminishes cancer cell PD-L1 expression and facilitates antitumor immunity&nbsp;<em>via<\/em>&nbsp;inhibiting the deubiquitination activity of CSN5 <\/a>(PubMed, 2020)\n<ul class=\"wp-block-list\">\n<li><strong>Relevans:<\/strong> Berberin (BBR) h\u00e6mmer PD-L1 ved at fremme dets nedbrydning, hvilket \u00f8ger immunforsvarets evne til at bek\u00e6mpe kr\u00e6ft. Det fungerer som en sm\u00e5-molekyle checkpoint-inhibitor.<\/li>\n<\/ul>\n<\/li>\n\n\n\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-e3a55019bcb1f13491a1de262be6b8eb\"><strong>Link 7:<\/strong> <a href=\"https:\/\/www.researchgate.net\/publication\/387371192_A_Comprehensive_Review_Highlighting_the_Prospects_of_Phytonutrient_Berberine_as_an_Anticancer_Agent\" target=\"_blank\" rel=\"noreferrer noopener\">A Comprehensive Review Highlighting the Prospects of Phytonutrient Berberine as an Anticancer Agent<\/a> (Journal of Biochemical and Molecular Toxicology, 2025)\n<ul class=\"wp-block-list\">\n<li><strong>Relevans:<\/strong> En omfattende gennemgang fra 2025, der positionerer berberin som et alsidigt, multi-m\u00e5lrettet stof mod kr\u00e6ft. Artiklen bekr\u00e6fter dets evne til at h\u00e6mme cellev\u00e6kst, inducere apoptose, bremse angiogenese og modulere tumormikromilj\u00f8et i bl.a. lever-, lunge- og tyktarmskr\u00e6ft.<\/li>\n<\/ul>\n<\/li>\n\n\n\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-06b1bb4e8c7fa834c3e8df7a7812c1b4\"><strong>Link 8:<\/strong><a href=\"https:\/\/www.cancer.gov\/news-events\/press-releases\/2024\/vipor-combination-therapy-b-cell-lymphoma\" target=\"_blank\" rel=\"noopener\"> Five-drug combination targets aggressive B-cell lymphomas<\/a> (National Cancer Institute, 2024)\n<ul class=\"wp-block-list\">\n<li><strong>Indhold:<\/strong> Fokuserer p\u00e5 DLBCL (Diffust storcellet B-celle lymfom). Artiklen beskriver, hvordan en kombination af fem stoffer m\u00e5lrettet blokerer flere molekyl\u00e6re signalveje samtidigt, hvilket denne aggressive kr\u00e6ftform er afh\u00e6ngig af for at overleve. Dette validerer strategien i skemaet.<\/li>\n<\/ul>\n<\/li>\n\n\n\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-086176296b6492cde6e73f4083a8302d\"><strong>Link 9:<\/strong><a href=\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC10052731\/\" target=\"_blank\" rel=\"noopener\"> Metabolic Reprogramming and Potential Therapeutic Targets in Lymphoma<\/a> (National Institutes of Health, 2023)\n<ul class=\"wp-block-list\">\n<li><strong>Indhold:<\/strong> En systematisk gennemgang af, hvordan lymfomceller oml\u00e6gger deres stofskifte (fokus p\u00e5 h\u00f8j glukoseoptagelse og deregulerede glykolyse-enzymer). Artiklen underbygger relevansen af at blokere glykolyse som en terapeutisk strategi, hvilket er centralt for is\u00e6r Burkitt&#8217;s Lymfom og DLBCL.<\/li>\n<\/ul>\n<\/li>\n\n\n\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-a634580b58f1dc9bd63f0318c1e8545c\"><strong>Link 10:<\/strong> <a href=\"https:\/\/www.nature.com\/articles\/s41419-024-07077-8\" target=\"_blank\" rel=\"noopener\">Targeted therapy of cancer stem cells: inhibition of mTOR signaling pathway<\/a> (Nature, 2024) \n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-4a4d42bbda827b7a34af0b8a82cbe1c2\"><strong>Indhold: <\/strong>Oversigtsartikel, der beskriver, at Metformin h\u00e6mmer mTOR-vejen ved at aktivere AMPK. Dette validerer Metformins Hovedstrategi (1) mod resistens, da h\u00e6mning af mTOR er den mest almindelige m\u00e5de at omg\u00e5 resistens p\u00e5 i BRAF-muterede celler.<\/li>\n<\/ul>\n<\/li>\n\n\n\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-ae136c5ff9fe62081e3ccf3ffdc9ad7b\"><strong>Link 11:<\/strong> <a href=\"https:\/\/www.nature.com\/articles\/s41598-025-87537-z\" target=\"_blank\" rel=\"noopener\">Metformin inhibits the growth of SCLC cells by inducing autophagy and apoptosis via the suppression of EGFR and AKT signalling<\/a> (Nature, 2025)\n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-6cac701017cee1ae1f6afc6071693eb9\"><strong>Indhold:<\/strong> Studie, der beskriver, hvordan Metformin kan genoprette f\u00f8lsomheden i NSCLC-celler over for EGFR-h\u00e6mmere ved at h\u00e6mme EGFR\/PI3K-signalvejen. Dette validerer Metformins Hovedstrategi (1) mod resistens.<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">Binyrebarkkr\u00e6ft:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-ef4bcbee3c11f6da8228045b87ed6cce\"><strong>Link 12:<\/strong> <a href=\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC4955188\/\" target=\"_blank\" rel=\"noopener\">Berberine inhibits androgen synthesis by interaction with aldo-keto reductase 1C3<\/a> (National Institutes of Health, 2015) \n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-31d7314f5fb84a902752f31d73de66bb\"><strong>Indhold:<\/strong> Et videnskabeligt studie, der dokumenterer, at berberin h\u00e6mmer dannelsen af hormoner (androgener). Resultaterne viser, at stoffet reducerer hormonproduktionen dosis-afh\u00e6ngigt, hvilket underst\u00f8tter strategien om at bruge berberin til at d\u00e6mpe de funktionelle tumorer, der producerer overskydende hormoner.<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">Bl\u00e6rekr\u00e6ft og Urinlederkr\u00e6ft:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-07b66e4e60401b3ad72589a48fc184ec\"><strong>Link 13:<\/strong> <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/33887260\/\" target=\"_blank\" rel=\"noopener\">Berberine suppresses bladder cancer cell proliferation by inhibiting JAK1-STAT3 signaling<\/a> (PubMed, 2021)\n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-35f17adc7cebe52f2565cbb8eba3f252\"><strong>Indhold:<\/strong> Et studie, der viser, hvordan Berberin h\u00e6mmer v\u00e6ksten i bl\u00e6rekr\u00e6ftceller ved at blokere JAK1-STAT3 signalvejen. Dette er en vigtig mekanisme for at stoppe celledeling og spredning.<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">Bugspytkirtelkr\u00e6ft:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-a54255c242e3f3cd974dab85ba1cc25e\"><strong>Link 14:<\/strong> <a href=\"https:\/\/www.sciencedirect.com\/science\/article\/pii\/S2666978125000212\" target=\"_blank\" rel=\"noopener\">Berberine loaded glyceryl monooleate nanoparticles exhibited potent intrinsic anticancer activity against pancreatic cancer therapy: In vitro and in silico studies <\/a>(ResearchGate\/Elsevier, 2025)\n<ul class=\"wp-block-list\">\n<li><strong>Indhold:<\/strong> Et studie der unders\u00f8ger berberins effekt p\u00e5 bugspytkirtelkr\u00e6ft. Studiet bekr\u00e6fter, at berberin har en st\u00e6rk evne til at h\u00e6mme kr\u00e6ftcellers v\u00e6kst og inducere celled\u00f8d ved at ramme mitokondrierne (energifabrikkerne) og blokere vigtige v\u00e6kst-signalveje som AKT.<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">Galdebl\u00e6re- og Galdevejskr\u00e6ft:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-7e865cd17395f5b21e14565597622174\"><strong>Link 15:<\/strong> <a href=\"https:\/\/www.nature.com\/articles\/s41598-025-11480-2\" target=\"_blank\" rel=\"noopener\">Berberine hydrochloride inhibits the proliferation and metastasis of gallbladder cancer cells<\/a> (Nature, 2025)\n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-85de0e596b8c366c01f6a5c12030598e\"><strong>Indhold:<\/strong> Et studie der dokumenterer berberins effekt p\u00e5 galdebl\u00e6rekr\u00e6ft. Resultaterne viser, at stoffet effektivt h\u00e6mmer kr\u00e6ftcellernes v\u00e6kst, spredning (metastase) og invasion, samt fremmer celled\u00f8d, hvilket bekr\u00e6fter dets potentiale som en metabolisk strategi.<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">Hjernekr\u00e6ft:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-434ee229e127eeff4568679f88a4e425\"><strong>Link 16:<\/strong> <a href=\"https:\/\/e-century.us\/files\/ijcem\/12\/1\/ijcem0080342.pdf\" target=\"_blank\" rel=\"noopener\">Berberine inhibits cell growth via Wnt\/beta-catenin signaling pathway <\/a>(International Journal of Clinical and Experimental Medicine, 2019)\n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-318ce80ee5b79236df63dae7d379d9d6\"><strong>Indhold:<\/strong> Et studie, der p\u00e5viser, hvordan Berberin undertrykker v\u00e6ksten i gliom-celler ved at blokere Wnt\/beta-catenin signalvejen. Dette underst\u00f8tter strategien om at bruge Berberin til at h\u00e6mme denne specifikke pathway ved oligodendrogliom.<\/li>\n<\/ul>\n<\/li>\n\n\n\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-d17f075228cd0205b92b542ce642a02f\"><strong>Link 17:<\/strong> <a href=\"https:\/\/www.sciencedirect.com\/science\/article\/abs\/pii\/S1875536423603917\" target=\"_blank\" rel=\"noopener\">Berberine targets the electron transport chain complex I and reveals the landscape of OXPHOS dependency in IDH1 mutation<\/a> (ScienceDirect, 2023)\n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-a8fbc6079ba0ed10f60c4ff8d30f342a\"><strong>Indhold:<\/strong> Et studie, der kortl\u00e6gger, hvordan Berberin specifikt rammer energiproduktionen (mitokondrierne) i celler med IDH1-mutation. Resultaterne giver en videnskabelig forklaring p\u00e5, hvorfor IDH-muterede kr\u00e6ftceller er s\u00e6rligt s\u00e5rbare over for Berberins metaboliske blokering.<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">Livmoderkr\u00e6ft: <\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-c4fa0213aae1068c5493705b25b29cef\"><strong>Link 18:<\/strong> <a href=\"http:\/\/Berberine inhibits the development of endometrial cancer (PubMed, 2022) Indhold: Et videnskabeligt studie, der dokumenterer, at berberin kan h\u00e6mme udviklingen af livmoderkr\u00e6ft. Resultaterne viser, at stoffet virker ved at blokere specifikke signalveje involveret i inflammation (COX-2), hvilket bekr\u00e6fter dets potentiale til at bremse kr\u00e6ftv\u00e6kst.\">Berberine inhibits the development of endometrial cancer<\/a> (PubMed, 2022)\n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-69617c960321bc952fc77b3b8151fc8d\"><strong>Indhold:<\/strong> Et videnskabeligt studie, der dokumenterer, at berberin kan h\u00e6mme udviklingen af livmoderkr\u00e6ft. Resultaterne viser, at stoffet virker ved at blokere specifikke signalveje involveret i inflammation (COX-2), hvilket bekr\u00e6fter dets potentiale til at bremse kr\u00e6ftv\u00e6kst.<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">Myelomatose\/ Knoglemarvskr\u00e6ft:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-c8226409029d5086d967876fa48ae4f8\"><strong>Link 19: <\/strong><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/24843889\/\" target=\"_blank\" rel=\"noopener\">Berberine induces apoptosis in human multiple myeloma cell line U266 through hypomethylation of p53 promoter<\/a> (PubMed, 2014)\n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-741a61579b5ac179d9d31ceeafc68b83\"><strong>Indhold:<\/strong> Et studie, der viser, hvordan Berberin kan &#8220;t\u00e6nde&#8221; for kroppens eget kr\u00e6ft-bremse-gen (p53) ved at \u00e6ndre DNA-methyleringen i myelomatose-celler. Dette f\u00f8rer til \u00f8get celled\u00f8d.<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">Nyrekr\u00e6ft:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-e1676fdce0b7340b5c0539e4c49dace3\"><strong>Link 20:<\/strong> <a href=\"https:\/\/www.sciencedirect.com\/science\/article\/pii\/S1043661825001677\" target=\"_blank\" rel=\"noopener\">Coptidis rhizoma and berberine as anti-cancer drugs<\/a> (ScienceDirect, 2025)\n<ul class=\"wp-block-list\">\n<li><strong>Indhold:<\/strong> En videnskabelig artikel, der dokumenterer berberins evne til at h\u00e6mme invasion og migration i nyrekr\u00e6ftceller. Studiet beskriver, hvordan stoffet virker ved at nedregulere METTL3-udtrykket, hvilket er afg\u00f8rende for at reducere kr\u00e6ftcellernes evne til at sprede sig og danne metastaser.<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Tilbage til:<\/strong> <a href=\"#skema-02\"><mark style=\"background-color:rgba(0, 0, 0, 0)\" class=\"has-inline-color has-custom-menu-links-color\">Oversigtsskema for Kosttilskud<\/mark><\/a><\/p>\n\n\n\n<h4 class=\"wp-block-heading\" id=\"boswellia\">7. <a href=\"https:\/\/jegharkraeft.dk\/boswellia\/\">Boswellia<\/a> (Frankincense)<\/h4>\n\n\n\n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-66b78908b0515ac5a56c8ecc511755ec\"><strong>Link 1:<\/strong> <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/40284420\/\" target=\"_blank\" rel=\"noopener\">Anti-Tumor Potential of Frankincense Essential Oil and Its Nano-Formulation in Breast Cancer: An In Vivo and In Vitro Study<\/a> (PubMed, 2025)\n<ul class=\"wp-block-list\">\n<li><strong>Relevans:<\/strong> Frankincense-olie og dens nanoforbindelse kan reducere brystkr\u00e6ftcellers v\u00e6kst, spredning og overlevelse b\u00e5de i laboratoriefors\u00f8g og i mus, hvilket viser potentiel for nye behandlinger, is\u00e6r som orale pr\u00e6parater.<\/li>\n<\/ul>\n<\/li>\n\n\n\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-b97b75120571bcc56f45a9bdba8aa68a\"><strong>Link 2:<\/strong> <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/39993542\/\" target=\"_blank\" rel=\"noopener\">Boswellia Serrata for Cerebral Radiation Necrosis After Radiosurgery for Brain Metastases<\/a> (PubMed, 2025)\n<ul class=\"wp-block-list\">\n<li><strong>Relevans:<\/strong> Boswellia serrata kan v\u00e6re en sikker og effektiv behandling for hjernens radiationsnecrose efter stereotaktisk behandling, med mange patienter, der oplever forbedring uden store bivirkninger. Yderligere forskning er n\u00f8dvendig for at bekr\u00e6fte dens effekt.<\/li>\n<\/ul>\n<\/li>\n\n\n\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-fc7e3ba95877626393e7f0612350b8ca\"><strong>Link 3:<\/strong> <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/39841429\/\" target=\"_blank\" rel=\"noopener\">Boswellic acid exerts anti-tumor effect in oral squamous cell carcinoma by inhibiting PI3K\/AKT1 mediated signaling pathway <\/a>(PubMed, 2025)\n<ul class=\"wp-block-list\">\n<li><strong>Relevans:<\/strong> Boswellic acid kan h\u00e6mme v\u00e6kst og fremme celled\u00f8d i mundhulekr\u00e6ftceller ved at stoppe cellecyklus og blokere energiproduktion, hvilket g\u00f8r det til et lovende behandlingspotentiale. Yderligere forskning er n\u00f8dvendig for at udvikle det til klinisk brug.<\/li>\n<\/ul>\n<\/li>\n\n\n\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-fce565a9127eed404741bf338a5bce92\"><strong>Link 4:<\/strong> <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/40271498\/\" target=\"_blank\" rel=\"noopener\">Anti-cancer effects of frankincense methanolic extract on brain metastatic breast cancer cells<\/a> (PubMed, 2025)\n<ul class=\"wp-block-list\">\n<li><strong>Relevans:<\/strong> Frankincense-udtr\u00e6k er effektivt til at dr\u00e6be og fremkalde celled\u00f8d i hjernemetastaserende brystkr\u00e6ftceller, hvilket g\u00f8r det til en lovende behandling mod kr\u00e6ft, der spreder sig til hjernen.<\/li>\n<\/ul>\n<\/li>\n\n\n\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-79513e14660eabfa20ea691e1d9f4ca1\"><strong>Link 5:<\/strong> <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/39819155\/\" target=\"_blank\" rel=\"noopener\">Synergistic Effect of HAD-B1 and Osimertinib Against Gefitinib Resistant HCC827 Non-Small Cell Lung Cancer Cells <\/a>(PubMed, 2025)\n<ul class=\"wp-block-list\">\n<li><strong>Relevans:<\/strong> Kombinationen af osimertinib og naturl\u00e6gemidlet HAD-B1 kan effektivt dr\u00e6be resistente ikke-sm\u00e5cellet lungekr\u00e6ft ved at h\u00e6mme v\u00e6kstsignaler og fremkalde celled\u00f8d, hvilket viser potentiale for en kombinationsbehandling.<\/li>\n<\/ul>\n<\/li>\n\n\n\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-c0a35c67c119eba35cb5447aac1d0c3e\"><strong>Link 6:<\/strong> <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/38194131\/\" target=\"_blank\" rel=\"noopener\">The anti-proliferative effects of a frankincense extract in a window of opportunity phase ia clinical trial for patients with breast cancer<\/a> (PubMed, 2024)\n<ul class=\"wp-block-list\">\n<li><strong>Relevans:<\/strong> Boswellia serrata kan reducere kr\u00e6ftcellev\u00e6kst i brystkr\u00e6ft uden alvorlige bivirkninger, hvilket g\u00f8r det til en lovende behandling at unders\u00f8ge yderligere.<\/li>\n<\/ul>\n<\/li>\n\n\n\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-19e7bde625881b5bfa9640660f77eb06\"><strong>Link 7:<\/strong><a href=\"https:\/\/www.nature.com\/articles\/s41419-024-06641-6\" target=\"_blank\" rel=\"noopener\"> Dietary factors and their influence on immunotherapy strategies in oncology: a comprehensive review<\/a> (Nature, 2024)\n<ul class=\"wp-block-list\">\n<li><strong>Indhold:<\/strong> En oversigtsartikel der beskriver, hvordan specifikke kostkomponenter (f.eks. fedtsyrer og n\u00e6ringsstoffer) kan forbedre immunterapi ved at modulere immunresponset. Artiklen er relevant, fordi den validerer, at kosttilskud (boswellia) har en immunmodulerende effekt og p\u00e5virker den inflammatoriske del af kr\u00e6ftmilj\u00f8et.<\/li>\n<\/ul>\n<\/li>\n\n\n\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-21a38cde4f81cce1e4f0828b4386508d\"><strong>Link 8:<\/strong> <a href=\"https:\/\/www.dovepress.com\/aspirin-in-cancer-therapy-pharmacology-and-nanotechnology-advances-peer-reviewed-fulltext-article-IJN\" target=\"_blank\" rel=\"noopener\">Repurposing Aspirin as a Potent Anti-Cancer Agent<\/a> (Dove Medical Press, 2025) \n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-796adb2cb68f1a1b439d3f3a4e37d93a\"><strong>Indhold:<\/strong> Oversigtsartikel, der beskriver Aspirins evne til at h\u00e6mme COX-2 og derved ikke blot reducere inflammation, men ogs\u00e5 forstyrre tumorfremmende signalveje involveret i kr\u00e6ftudvikling. Dette validerer Hovedstrategi (1) i den inflammationsdrevne KRAS-muterede kr\u00e6ft.<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">Hjernekr\u00e6ft:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-729af672307fac2f80c771f562c41505\"><strong>Link 9:<\/strong> <a href=\"https:\/\/europepmc.org\/article\/med\/31096725\" target=\"_blank\" rel=\"noopener\">A novel lecithin-based delivery form of Boswellic acids<\/a> (Europe PMC, 2019) \n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-1aff99c67773ff309a0575322c9b83aa\"><strong>Indhold:<\/strong> Et klinisk pilotstudie, der unders\u00f8ger en ny, optimeret leveringsform af boswelliasyrer som komplement\u00e6r behandling. Studiet bekr\u00e6fter effekten p\u00e5 cerebralt \u00f8dem (v\u00e6skeophobning), hvilket underst\u00f8tter den anti-inflammatoriske virkningsmekanisme i hjernen. <\/li>\n<\/ul>\n<\/li>\n\n\n\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-ee4fe18a6206a23d2bf4c060c6b97969\"><strong>Link 10:<\/strong> <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/10894362\/\" target=\"_blank\" rel=\"noopener\">Boswellic acids inhibit glioma growth: a new treatment option? <\/a>(ResearchGate, 2020) \n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-d491d41af47ae76247d5085f92095321\">Indhold: En artikel, der unders\u00f8ger boswelliasyrers evne til at h\u00e6mme v\u00e6kst (proliferation) og inducere celled\u00f8d (apoptose) i hjerne-tumorer. Resultaterne indikerer en direkte anticancer-effekt udover den kendte anti-inflammatoriske virkning.<\/li>\n<\/ul>\n<\/li>\n\n\n\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-95d519afca86a954b957166009e7360e\"><strong>Link 11:<\/strong> <a href=\"https:\/\/www.mdpi.com\/2072-6694\/17\/14\/2321\" target=\"_blank\" rel=\"noopener\">New Approach for Enhancing Survival in Glioblastoma Patients: A Longitudinal Pilot Study on Integrative Oncology<\/a> (MDPI, 2025) \n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-4261cb69b020b1ab57f3aa85bf2cffa4\"><strong>Indhold:<\/strong> Et nyt pilotstudie, der viser forbedret overlevelse hos glioblastom-patienter behandlet med en kombination af Boswellia, curcumin og polydatin sidel\u00f8bende med standardbehandling. Studiet fremh\u00e6ver reduktion af \u00f8dem og f\u00e6rre bivirkninger.<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Tilbage til:<\/strong> <a href=\"#skema-02\"><mark style=\"background-color:rgba(0, 0, 0, 0)\" class=\"has-inline-color has-custom-menu-links-color\">Oversigtsskema for Kosttilskud<\/mark><\/a><\/p>\n\n\n\n<h4 class=\"wp-block-heading\" id=\"cats-claw\">8. <a href=\"https:\/\/jegharkraeft.dk\/cats-claw-tomentosa\/\">Cat&#8217;s Claw<\/a> (Uncaria tomentosa)<\/h4>\n\n\n\n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-ac3931f1e28b694be57e9cb5f1f45659\"><strong>Link 1:<\/strong> <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/40438596\/\" target=\"_blank\" rel=\"noopener\">Cytotoxic effect of different&nbsp;<em>Uncaria tomentosa<\/em>&nbsp;(cat&#8217;s claw) extracts, fractions on normal and cancer cells: a systematic review<\/a> (PubMed, 2025)\n<ul class=\"wp-block-list\">\n<li><strong>Relevans:<\/strong> Urtedraget U. tomentosa (cats claw) har lovende kr\u00e6ftbek\u00e6mpende egenskaber, men behovet for standardisering og yderligere forskning er vigtigt for at bekr\u00e6fte dens terapeutiske potentiale.<\/li>\n<\/ul>\n<\/li>\n\n\n\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-9688fc08cd613b311d2a9fdfe2570409\"><strong>Link 2:<\/strong> <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/33670520\/\" target=\"_blank\" rel=\"noopener\">Treatment with&nbsp;<em>Uncaria tomentosa<\/em>&nbsp;Promotes Apoptosis in B16-BL6 Mouse Melanoma Cells and Inhibits the Growth of B16-BL6 Tumours<\/a> (PubMed, 2021)\n<ul class=\"wp-block-list\">\n<li><strong>Relevans<\/strong>: Uncaria tomentosa (cats claw) har st\u00e6rk kr\u00e6fth\u00e6mmende effekt b\u00e5de i laboratoriefors\u00f8g og i mus, hvor den reducerer tumorv\u00e6kst, celleproliferation og blodkvalitet, hvilket g\u00f8r den til en lovende naturlig kr\u00e6ftbehandling.<\/li>\n<\/ul>\n<\/li>\n\n\n\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-fdfbf48dde7019474b22cc216349c78c\"><strong>Link 3:<\/strong> <a href=\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC12116528\/\" target=\"_blank\" rel=\"noreferrer noopener\">Cytotoxic effect of different Uncaria tomentosa (cat\u2019s claw) extracts, fractions on normal and cancer cells: a systematic review<\/a> (Systematic Reviews, 2025)\n<ul class=\"wp-block-list\">\n<li><strong>Relevans:<\/strong> En systematisk gennemgang (opdateret til januar 2025), der samler den pr\u00e6kliniske evidens for Cat&#8217;s Claws kr\u00e6fth\u00e6mmende effekter. Gennemgangen bekr\u00e6fter stoffets potentiale, men understreger behovet for standardisering af ekstrakter for at kunne bestemme, hvilke specifikke bestanddele der er mest effektive mod bestemte kr\u00e6fttyper.<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Tilbage til:<\/strong> <a href=\"#skema-02\"><mark style=\"background-color:rgba(0, 0, 0, 0)\" class=\"has-inline-color has-custom-menu-links-color\">Oversigtsskema for Kosttilskud<\/mark><\/a><\/p>\n\n\n\n<h4 class=\"wp-block-heading\" id=\"q10\">9. <a href=\"https:\/\/jegharkraeft.dk\/q10\/\">Coenzym Q10<\/a><\/h4>\n\n\n\n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-ee49590b4a02e6c9001fd239d3a388a8\"><strong>Link 1:<\/strong> <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/39862484\/\" target=\"_blank\" rel=\"noopener\">Radioprotective effects of coenzyme Q10 on X-ray radiation-induced intestinal damage via oxidative stress and apoptosis<\/a> (PubMed, 2025)\n<ul class=\"wp-block-list\">\n<li><strong>Relevans<\/strong>: CoQ10 reducerede skader p\u00e5 tolvfingertarmen, oxidativt stress og celled\u00f8d (apoptose), som var for\u00e5rsaget af r\u00f8ntgenstr\u00e5ling, og havde dermed en str\u00e5lebeskyttende effekt.<\/li>\n<\/ul>\n<\/li>\n\n\n\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-8e8f0880989e7d085fafaecf4cea39aa\"><strong>Link 2:<\/strong> <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/39765895\/\" target=\"_blank\" rel=\"noopener\">Vitamins, Coenzyme Q10, and Antioxidant Strategies to Improve Oocyte Quality in Women with Gynecological Cancers: A Comprehensive Review<\/a> (PubMed, 2024)\n<ul class=\"wp-block-list\">\n<li><strong>Relevans:<\/strong> Vitaminer og antioxidanter som D3, C, E og CoQ10 kan forbedre \u00e6gcellekvaliteten hos kvinder med gyn\u00e6kologiske kr\u00e6ftformer, hvilket underst\u00f8tter fertilitetsbevarelse og assisteret reproduktion. Mere forskning er n\u00f8dvendig for at fastl\u00e6gge effektive doser og behandlinger.<\/li>\n<\/ul>\n<\/li>\n\n\n\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-ba445a2a1ed6f6c3b0899dd94a1d8fdc\"><strong>Link 3:<\/strong> <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/40005071\/\" target=\"_blank\" rel=\"noopener\">Coenzyme Q<sub>10<\/sub>&nbsp;as an Inhibitor of Effector Release from One-Electron-Reduced Bioreductive Anticancer Prodrugs<\/a> (PubMed, 2025)\n<ul class=\"wp-block-list\">\n<li><strong>Relevans:<\/strong> I hypoxic tumoromr\u00e5der kan prodrug-radikalanioner frigive kr\u00e6ftbehandlingseffekter uden betydelig h\u00e6mning af deres nedbrydning, is\u00e6r hvis UQ-syntesen h\u00e6mmes, hvilket kan forbedre behandlingseffektiviteten mod iltfattige cancerceller.<\/li>\n<\/ul>\n<\/li>\n\n\n\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-b0b2f91e24138008ce66e9c8bdda8fa8\"><strong>Link 4:<\/strong> <a href=\"https:\/\/www.unipd.it\/news\/reducing-breast-cancer-aggression-coenzyme-q10\" target=\"_blank\" rel=\"noreferrer noopener\">Reducing breast cancer aggression with coenzyme Q10<\/a> (Nature Communications, 2024)\n<ul class=\"wp-block-list\">\n<li><strong>Relevans:<\/strong> Et banebrydende studie, der viser, at tabet af enzymet UBIAD1 (som producerer CoQ10) er forbundet med de mest aggressive, metastatiske former for triple-negativ brystkr\u00e6ft. Forskerne viste i dyremodeller, at administration af CoQ10 begr\u00e6nsede kr\u00e6ftcellernes aggressivitet og forhindrede dannelsen af lungemetastaser.<\/li>\n<\/ul>\n<\/li>\n\n\n\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-e2d7ad2dba623a76b66bbed4cf3dd7b7\"><strong>Link 5:<\/strong> <a href=\"https:\/\/www.nature.com\/articles\/s41420-023-01784-5\" target=\"_blank\" rel=\"noopener\">Cholesterol metabolism and colorectal cancer: the plot thickens<\/a> (Nature, 2024) \n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-b64c4e5f2af92c5c0dfb575de058e2ea\"><strong>Indhold:<\/strong> Artiklen beskriver den \u00f8gede ekspression af Mevalonat- og kolesterol-metabolisme i BRAF-muteret tarmkr\u00e6ft. Dette validerer Statins Hovedstrategi (1), da de h\u00e6mmer denne vej, som er kritisk for BRAF-signaleringens funktion.<\/li>\n<\/ul>\n<\/li>\n\n\n\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-27a578082a50ef6b8617a1fd91f3b39d\"><strong>Link 6:<\/strong> <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/33110390\/\" target=\"_blank\" rel=\"noopener\">Pleiotropic use of Statins as non-lipid-lowering drugs<\/a> (International Journal of Biological Sciences, 2020) \n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-4a4b83950f4da8fc44c9dc4c81bb9f5e\"><strong>Indhold:<\/strong> Oversigtsartikel, der beskriver Statins bredspektrede effekter. Artiklen bekr\u00e6fter, at Statiner blokerer Mevalonat-vejen og reducerer derved produktionen af Coenzym Q10 (Ubiquinone), hvilket validerer behovet for Q10-supplementering i strategien.<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Tilbage til:<\/strong> <a href=\"#skema-02\"><mark style=\"background-color:rgba(0, 0, 0, 0)\" class=\"has-inline-color has-custom-menu-links-color\">Oversigtsskema for Kosttilskud<\/mark><\/a><\/p>\n\n\n\n<h4 class=\"wp-block-heading\" id=\"curcumin\">10. <a href=\"https:\/\/jegharkraeft.dk\/gurkemeje-curcumin\/\">Curcumin<\/a><\/h4>\n\n\n\n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-473805125b9f6e183c9ea6be66217ff5\"><strong>Link 1:<\/strong> <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/40300310\/\" target=\"_blank\" rel=\"noopener\">Single molecule recognition of CD95 receptors on the surface of HepG2 cells under the curcumin<\/a> (PubMed, 2025)\n<ul class=\"wp-block-list\">\n<li><strong>Relevans:<\/strong> Curcumin \u00f8ger b\u00e5de antallet og styrken af CD95-receptorer p\u00e5 leverkr\u00e6ftceller, hvilket kan fremme apoptosis og \u00e5bne muligheder for nye behandlinger ved hepatocellul\u00e6rt karcinom.<\/li>\n<\/ul>\n<\/li>\n\n\n\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-df2eab75253a332b723aeb997b21e6a8\"><strong>Link 2:<\/strong> <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/40228427\/\" target=\"_blank\" rel=\"noopener\">Enhanced cancer therapy using modified magnetic \u03b1-Fe<sub>2<\/sub>O<sub>3<\/sub>\/Fe<sub>3<\/sub>O<sub>4<\/sub>nanorods: Dual role in curcumin delivery and ferroptosis induction <\/a>(PubMed, 2025)\n<ul class=\"wp-block-list\">\n<li><strong>Relevans:<\/strong> Det udviklede nanomateriale med magnetiske egenskaber forbedrer curcuminets levering til leverkr\u00e6ftceller, \u00f8ger dets effektivitet, mindsker skadelig effekt p\u00e5 normale celler og kan bruges til m\u00e5lrettet behandling af leverkr\u00e6ft.<\/li>\n<\/ul>\n<\/li>\n\n\n\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-900de40712fdc8f076b0078c94e243d6\"><strong>Link 3:<\/strong> <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/40315643\/\" target=\"_blank\" rel=\"noopener\">Curcuminoids WM03 inhibits ovarian cancer cisplatin-resistant cells proliferation and reverses cisplatin resistance by targeting DYRK2<\/a> (PubMed, 2025)\n<ul class=\"wp-block-list\">\n<li><strong>Relevans:<\/strong> Det nye curcumin-derivat, WM03, er betydeligt mere effektivt end almindelig curcumin til at h\u00e6mme v\u00e6kst, migration og invasivitet i resistente ovariecancerceller. Det virker ved at m\u00e5lrette enzymet DYRK2, hvilket g\u00f8r det til et lovende nyt l\u00e6gemiddel til behandling af cisplatin-resistente ovariecancer.<\/li>\n<\/ul>\n<\/li>\n\n\n\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-4673d3b09637ad862cb310916305c13c\"><strong>Link 4:<\/strong> <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/40484145\/\" target=\"_blank\" rel=\"noopener\">Co-embedding of curcumin and gold nanoparticles with ZIF-8 nanoparticles for the treatment of liver cancer and its impact on metabolomics<\/a> (PubMed, 2025)\n<ul class=\"wp-block-list\">\n<li><strong>Relevans:<\/strong> Det nye nanobaserede l\u00e6gemiddelsystem, Cur\/Au@ZIF-8, forbedrer levering og frigivelse af curcumin i leveren, hvilket \u00f8ger dens kr\u00e6ftbek\u00e6mpende effekt. Det virker ved at h\u00e6mme tumorv\u00e6kst og p\u00e5virke fedtsyremetabolisme, hvilket kan bidrage til fremtidige cancerbehandlinger.<\/li>\n<\/ul>\n<\/li>\n\n\n\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-58449369acaf57dc344f82fdf95635ed\"><strong>Link 5:<\/strong> <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/40471501\/\" target=\"_blank\" rel=\"noopener\">Curcumin inhibits IFN-\u03b3 induced PD-L1 expression via reduction of STAT1 Phosphorylation in A549 non-small cell lung cancer cells<\/a> (PubMed, 2025)\n<ul class=\"wp-block-list\">\n<li><strong>Relevans:<\/strong> Curcumin kan forbedre immunterapier ved at h\u00e6mme tumorforsvarsmekanismer og styrke kroppens evne til at bek\u00e6mpe ikke-sm\u00e5cellet lungekr\u00e6ft, hvilket g\u00f8r det til et lovende supplement i cancerbehandling.<\/li>\n<\/ul>\n<\/li>\n\n\n\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-c079554d5cb84d564bcabe792c980c61\"><strong>Link 6:<\/strong> <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/40464979\/\" target=\"_blank\" rel=\"noopener\">Curcumin protects extracellular matrix to maintain microenvironmental stability inhibiting colon cancer metastasis through HPSE\/IL-6\/STAT5 axis<\/a> (PubMed, 2025)\n<ul class=\"wp-block-list\">\n<li><strong>Relevans:<\/strong> Curcumin h\u00e6mmer kolorektalcancercellers v\u00e6kst og spredning ved at nedregulere enzymet HPSE gennem non-codende RNAs, hvilket blokerer IL-6\/STAT5-signaler og kan bruges til nye kr\u00e6ftbehandlinger.<\/li>\n<\/ul>\n<\/li>\n\n\n\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-0fa8c1db0c0056127a4f067cd8ee644c\"><strong>Link 7:<\/strong> <a href=\"https:\/\/www.mdpi.com\/1422-0067\/26\/2\/799\" target=\"_blank\" rel=\"noopener\">Re-Sensitization of Resistant Ovarian Cancer SKOV3\/CDDP Cells to Cisplatin by a Curcumin Pre-treatment Therapeutic Strategy<\/a> (MDPI, 2025)\n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-9749164064e183f0114d418f88d0cdb8\"><strong>Indhold:<\/strong> Et studie, der specifikt viser, hvordan forbehandling med curcumin kan genoprette f\u00f8lsomheden over for platin-baseret kemoterapi i resistente kr\u00e6ftceller fra \u00e6ggestokkene. Dette sker ved at h\u00e6mme centrale overlevelsessignalveje, som kr\u00e6ftcellerne bruger til at modst\u00e5 behandling.<\/li>\n<\/ul>\n<\/li>\n\n\n\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-55900f02c5bded5474d01f59798b3e7d\"><strong>Link 8:<\/strong> <a href=\"https:\/\/www.intechopen.com\/chapters\/1215903\" target=\"_blank\" rel=\"noopener\">Curcumin in Cancer Therapy: Mechanisms, Delivery Systems, and Clinical Applications<\/a> (IntechOpen, 2025)\n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-b974696813f9e96f7106cc9767945ae7\"><strong>Indhold:<\/strong> En oversigtsartikel, der samler beviser for curcumins evne til at &#8220;sensibilisere&#8221; (g\u00f8re f\u00f8lsom) kr\u00e6ftceller over for en bred vifte af standardbehandlinger, herunder kemo- og str\u00e5leterapi, og dermed forbedre behandlingens effektivitet.<\/li>\n<\/ul>\n<\/li>\n\n\n\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-764b5c935901fe65d23b80117bae83a4\"><strong>Link 9:<\/strong> <a href=\"https:\/\/pdf.sciencedirectassets.com\/271153\/1-s2.0-S1040842821X00108\/1-s2.0-S104084282100130X\/am.pdf?X-Amz-Security-Token=IQoJb3JpZ2luX2VjEBYaCXVzLWVhc3QtMSJHMEUCIQD7epkSwoqP%2FvOgibUMECtrkQCCy1D99QL2%2FUQIuwvDKwIgNqiNvB4p9y%2BpHQ1xbgGwSSoDtcwO3oAnZTdR6vHq4msqvAUIjv%2F%2F%2F%2F%2F%2F%2F%2F%2F%2FARAFGgwwNTkwMDM1NDY4NjUiDFNOm1sHY925uPeHMyqQBQqufV7N0vbbA%2BRoWG%2BipyKqsHXDo5O92Sku0XQz%2Fl47zL%2F8feN4DID1LH8Vg1qK%2FQiAtzN%2B0bPTHsZvcgTsr5TCnMXmbs7v1f3x%2BwQCui6mn7mzAPOxaKy2IN8YcOBbx2GPmF%2F5DZWVZYblFgX8pNCcIagTSvbcTog4F0%2B66v%2FiwnYMyGs1fo6hR%2B1nYgrgrGJeSKVDmPhQ8n%2Bq16WKF4kGd1i5da%2FR5DP5OwRYykBcGGrVIE4QpPJTHqXrxena%2BSDZNdTAtgsvsBCY70qIP4uFZ%2BeYS%2FfsVppFcaX6bxBy7wW5aj2d54Ni9aX%2FW1C%2B%2BSYVz4n%2BZz6BMFh5SpPSoNeGdKR89ZJz8F2R8VlhvMuHuKYlQ8MIjl2A2BGxbetI6fKRD8mUVk3eMM4DcrPscK6ZpZyYtcxR0ZJ3N9IuefIqGxuyons1UWNHLg5CciSNjPdgfqJ%2F9NmkEYWANEltzMhG8FcLOsPDoX%2B4MxxlIS%2FiQ6cQJqgQc54erfw0VJmjcKiFHeG4WvFY0yA1pWtTkqPxmmUYyvDpIVsN%2F3Y7O%2BFDqr6wQrlt%2F3AwP%2Fz8Qp7c7ir89E0pDP0pb3vtSwgkIgcPhnX7ADAueeTjDRm13n3aQk0E5a3dcRLcgjtd33EXoUUBxP1L8NDAsjqjdJCxyBwUbkowx%2BDFSUF7Si3kvHdvpjHcWvmyIAqe6yRmTSv1WE68BkfAuXwSuvFPt8j6oHmFk9zj2Yywt7EdL9RADaLy%2FUBzYOyJvqvMdsY0CmLS8F9YlFqs%2FTab%2B5bh2NQrd4XWfOWDlw8rkzdZ8%2BRl1e5S1HVfq2d2%2B9qX0%2FyTGTqZ%2BzM3YPnCVTdD0yoltBqqiGpDdOo4pWNPuUIa7wPYckfrMITEpcYGOrEBWmZq8QB8oAM4glHcymuZhiY0YDRXP3z247uF6kAnLOHHLzvIjPqIAKfKyaPmk98Er9MVky55R247MFaAB0dx4rAIAwKToLUAO%2FpIXb0uddYeJTW7ob04anUDCXVUSpW53iJ7onBV3DQt4NDUutDVXSfv1RKHba4Rjqxbcb0UvyZ7Z50pFWefZ4Mcl6iGREr1MGt1mHBJLnwLItDMkdyql8QYh5zEcHlQDpIUn%2BqSPF6k&amp;X-Amz-Algorithm=AWS4-HMAC-SHA256&amp;X-Amz-Date=20250916T141645Z&amp;X-Amz-SignedHeaders=host&amp;X-Amz-Expires=300&amp;X-Amz-Credential=ASIAQ3PHCVTYT262LADW%2F20250916%2Fus-east-1%2Fs3%2Faws4_request&amp;X-Amz-Signature=3dfc7da9f61833657323950d68433a8e66b3f93c501e11338a305f7baad48263&amp;hash=c5eb8554eab3439cd47642771d3c926f2892bcbc33a1e90aef70f0a125063a51&amp;host=68042c943591013ac2b2430a89b270f6af2c76d8dfd086a07176afe7c76c2c61&amp;pii=S104084282100130X&amp;tid=pdf-addf9351-13e7-447b-aefa-2303f637f001&amp;sid=9627816e9d084448a04b1fd-cb62e3a70a5bgxrqb&amp;type=client\" target=\"_blank\" rel=\"noopener\">Review Article: Potential Cytochrome P450-mediated pharmacokinetic interactions between herbs, food, and dietary supplements and cancer treatments.<\/a> (Science Direct, pdf., 2021)\n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-0585194234e84417d8dca9afa0274ce4\"><strong>Indhold:<\/strong> En central oversigtsartikel, der diskuterer pr\u00e6cis den risiko for interaktion via leverenzymer (CYP450), som var en bekymring.<\/li>\n<\/ul>\n<\/li>\n\n\n\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-425a545177c4b569a44b42266e961f15\"><strong>Link 10:<\/strong> <a href=\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC6770025\/\" target=\"_blank\" rel=\"noopener\">Bioactivity of Curcumin on the Cytochrome P450 Enzymes of the Steroidogenic Pathway<\/a> (PubMed, 2019)\n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-c11cbc4d6d893dbe828ae23d68eb9c5a\"><strong>Indhold:<\/strong> Et studie, der g\u00e5r i dybden med, hvordan curcumin specifikt p\u00e5virker disse leverenzymer.<\/li>\n<\/ul>\n<\/li>\n\n\n\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-063f03b44b5e8c9affea3205bfeb35f8\"><strong>Link 11:<\/strong> <a href=\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC6277549\/\" target=\"_blank\" rel=\"noopener\">Preventive Effect of Curcumin Against Chemotherapy-Induced Side-Effects<\/a> (PubMed, Frontiers, 2018)\n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-693fce33eef3a3c09339f48f1ace68dc\"><strong>Indhold:<\/strong> Viser, at curcumin kan beskytte mod bivirkninger fra kemoterapi.<\/li>\n<\/ul>\n<\/li>\n\n\n\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-cc7237a62a6890d7f800c9fabaeac6ce\"><strong>Link 12:<\/strong> <a href=\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC8464730\/\" target=\"_blank\" rel=\"noopener\">The Role of Curcumin in Cancer Treatment<\/a> (PubMed, 2021)\n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-98d769c1962aff2afb1750d3954a2f9c\"><strong>Indhold:<\/strong> En bred oversigtsartikel, der sandsynligvis d\u00e6kker curcumins grundl\u00e6ggende virkningsmekanismer, pr\u00e6klinisk evidens og dets generelle anvendelse i kliniske sammenh\u00e6nge.<\/li>\n<\/ul>\n<\/li>\n\n\n\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-168f4008dd750239ff484056b9d293e8\"><strong>Link 13:<\/strong> <a href=\"https:\/\/www.researchgate.net\/publication\/354876847_Curcumin_supplementation_in_the_treatment_of_patients_with_cancer_a_systematic_review\" target=\"_blank\" rel=\"noopener\">Curcumin supplementation in the treatment of patients with cancer: a systematic review<\/a> (Research Gate, 2021)\n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-caac60014a9950619395d9929a0a8d75\"><strong>Indhold:<\/strong> En systematisk gennemgang \u2013 en st\u00e6rk form for evidens \u2013 der specifikt analyserer resultater fra kliniske studier, hvor patienter har f\u00e5et curcumin som supplement til deres kr\u00e6ftbehandling.<\/li>\n<\/ul>\n<\/li>\n\n\n\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-008ae1f006aff20b786f3e3592146fba\"><strong>Link 14:<\/strong> <a href=\"https:\/\/link.springer.com\/article\/10.1007\/s00228-024-03764-9\" target=\"_blank\" rel=\"noopener\">Curcumin as a complementary treatment in oncological therapy: a systematic review<\/a> (Springer, 2025)\n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-a11d034011f747f4bacdcb3139817be1\"><strong>Indhold:<\/strong> Ligeledes en systematisk gennemgang, men med et specifikt fokus p\u00e5 curcumins rolle som <em>komplement\u00e6r<\/em> behandling. Det vil sige, hvordan det virker <em>sammen med<\/em> standardbehandlinger som kemoterapi for at forbedre effekten og\/eller reducere bivirkninger.<\/li>\n<\/ul>\n<\/li>\n\n\n\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-6d46353fae77c30770c38f2065e977b4\"><strong>Link 15:<\/strong> <a href=\"https:\/\/www.sciencedirect.com\/science\/article\/pii\/S0944711320300507\" target=\"_blank\" rel=\"noopener\">Efficacy and safety of curcumin in combination with paclitaxel in patients with advanced, metastatic breast cancer: A comparative, randomized, double-blind, placebo-controlled clinical trial <\/a>(Science Direct, 2020)\n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-ef8ad36210c1bfbe95b8bb3f6a78ae19\"><strong>Indhold:<\/strong> Et klinisk studie af h\u00f8j kvalitet, der bekr\u00e6fter, at kombinationen af curcumin og kemoterapi er b\u00e5de effektiv og sikker.<\/li>\n<\/ul>\n<\/li>\n\n\n\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-4444e42f26362549323b86cf3660df9b\"><strong>Link 16:<\/strong> <a href=\"https:\/\/www.frontiersin.org\/journals\/oncology\/articles\/10.3389\/fonc.2024.1438040\/full\" target=\"_blank\" rel=\"noopener\">Curcumin as a novel therapeutic candidate for cancer: can this natural compound revolutionize cancer treatment?<\/a> (Frontiers, 2024)\n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-72e1eabc1205067fb8c5fc98563cd880\"><strong>Indhold:<\/strong> En fremadskuende oversigtsartikel, der sandsynligvis fokuserer p\u00e5 curcumins fremtidige potentiale, herunder nye leveringsmetoder (f.eks. nanopartikler) for at forbedre optageligheden og nye opdagede virkningsmekanismer.<\/li>\n<\/ul>\n<\/li>\n\n\n\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-624268dbf489d1544f520f254a4d70e6\"><strong>Link 17:<\/strong> <a href=\"https:\/\/www.mdpi.com\/2072-6694\/16\/14\/2580\" target=\"_blank\" rel=\"noopener\">The Bright Side of Curcumin: A Narrative Review of Its Therapeutic Potential in Cancer Management<\/a> (MDPI, 2024)\n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-0af0eec6091b421eeb2b763851d5f00b\"><strong>Indhold:<\/strong> En narrativ gennemgang, der fokuserer p\u00e5 de positive aspekter af curcumin inden for &#8220;cancer management&#8221;. Dette d\u00e6kker bredt over b\u00e5de behandling, forebyggelse af bivirkninger og forbedring af livskvalitet under et sygdomsforl\u00f8b.<\/li>\n<\/ul>\n<\/li>\n\n\n\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-b8f180a54aedd1cdc0b7b3800ec78026\"><strong>Link 18:<\/strong> <a href=\"https:\/\/www.researchgate.net\/publication\/375786914_Curcumin_supplementation_prevents_cisplatin-induced_nephrotoxicity_a_randomized_double-blinded_and_placebo-controlled_trial\" target=\"_blank\" rel=\"noopener\">Curcumin supplementation prevents cisplatin-induced nephrotoxicity: a randomized, double-blinded, and placebo-controlled trial<\/a> (Research Gate, 2023)\n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-f208b3af58b7978ff96d6c41d6e12438\"><strong>Indhold:<\/strong> Et klinisk studie, der viser, at curcumin beskytter nyrerne mod skader fra platin-baseret kemo (som er i familie med Carboplatin).<\/li>\n<\/ul>\n<\/li>\n\n\n\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-005df855bc68a33a13ff499fe14ef6da\"><strong>Link 19:<\/strong><a href=\"https:\/\/www.cancer.gov\/news-events\/press-releases\/2024\/vipor-combination-therapy-b-cell-lymphoma\" target=\"_blank\" rel=\"noopener\"> Five-drug combination targets aggressive B-cell lymphomas<\/a> (National Cancer Institute, 2024)\n<ul class=\"wp-block-list\">\n<li><strong>Indhold:<\/strong> Fokuserer p\u00e5 DLBCL (Diffust storcellet B-celle lymfom). Artiklen beskriver, hvordan en kombination af fem stoffer m\u00e5lrettet blokerer flere molekyl\u00e6re signalveje samtidigt, hvilket denne aggressive kr\u00e6ftform er afh\u00e6ngig af for at overleve. Dette validerer strategien i skemaet.<\/li>\n<\/ul>\n<\/li>\n\n\n\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-390dbb5ad222a2379b48edb79cd73516\"><strong>Link 20:<\/strong> <a href=\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC10927384\/\" target=\"_blank\" rel=\"noopener\">Curcumin in treatment of hematological cancers<\/a> (National Institutes of Health, 2024) \n<ul class=\"wp-block-list\">\n<li><strong>Indhold:<\/strong> En ny oversigtsartikel (2024), der specifikt underbygger relevansen af Curcumin og Quercetin i Hodgkin&#8217;s Lymfom (HL). Artiklen beskriver, hvordan begge stoffer inducerer celled\u00f8d ved at h\u00e6mme den centrale v\u00e6kstvej NF-\u03baB (som HL er afh\u00e6ngig af) og STAT3.<\/li>\n<\/ul>\n<\/li>\n\n\n\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-6598f1c541de34b67ecd8f0774cc14c8\"><strong>Link 21:<\/strong> <a href=\"https:\/\/mednexus.org\/doi\/10.1016\/j.cpt.2025.02.006\" target=\"_blank\" rel=\"noopener\">Phytoconstituents as emerging therapeutics for breast cancer <\/a>(ScienceDirect.com, Med Nexus, 2025) \n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-9d574382477e77c722e335809f3320fe\"><strong>Indhold:<\/strong> En meget ny oversigtsartikel, der beskriver plantestoffer som Curcumin og Resveratrol som fremspirende terapeutiske midler mod brystkr\u00e6ft. Artiklen underst\u00f8tter synergien ved at vise, hvordan disse stoffer reducerer tumorst\u00f8rrelse, h\u00e6mmer cellemigration og undertrykker metastase.<\/li>\n<\/ul>\n<\/li>\n\n\n\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-cc65278209c77c470bfe9096023a7a8a\"><strong>Link 22:<\/strong> <a href=\"https:\/\/www.nature.com\/articles\/s41392-020-0110-5\" target=\"_blank\" rel=\"noopener\">Targeting cancer stem cell pathways for cancer therapy<\/a> (Nature, 2020) \n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-60b7fda163ca99a234bb3624c3a5f904\"><strong>Indhold:<\/strong> Oversigtsartikel, der opsummerer de prim\u00e6re faktorer og signalveje, der regulerer udviklingen af kr\u00e6ftstamceller (CSCs). Artiklen underst\u00f8tter, at CSCs er n\u00f8gledrivere for resistens og validerer de mange strategier i skemaet, der sigter mod at blokere CSC-veje.<\/li>\n<\/ul>\n<\/li>\n\n\n\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-5b184476a9835e7c25ad6f6a1219da44\"><strong>Link 23:<\/strong> <a href=\"https:\/\/www.sciencedirect.com\/science\/article\/pii\/S209517792100071X\" target=\"_blank\" rel=\"noopener\">Phytochemicals targeting NF-\u03baB signaling: Potential anti-inflammatory and anti-cancer agents<\/a> (ScienceDirect.com, 2022) \n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-c2be5fe82b306694d403be2f85ce2e52\"><strong>Indhold:<\/strong> Oversigtsartikel, der beskriver, at Curcumin udviser anticancer-aktivitet ved at h\u00e6mme NF-\u03baB p65-proteinets transkriptionelle aktivitet. Dette validerer Curcumins relevans mod b\u00e5de den prim\u00e6re MAPK\/ERK-vej og den inflammatoriske NF-kB-vej i melanom.<\/li>\n<\/ul>\n<\/li>\n\n\n\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-549a0534bf3f750f9fc7d583ae2d13f9\"><strong>Link 24:<\/strong> <a href=\"https:\/\/onlinelibrary.wiley.com\/doi\/full\/10.1002\/fsn3.70829\" target=\"_blank\" rel=\"noopener\">Curcumin and Resveratrol as Dual Modulators of the STAT3 Pathway in Lung Cancer: A Comprehensive Review<\/a> (Wiley Online Library, 2025) \n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-760e54f82176ccf9c291adf0b6359a54\"><strong>Indhold:<\/strong> Oversigtsartikel, der viser, at Curcumin h\u00e6mmer STAT3-signalvejen i lungekr\u00e6ftceller, hvilket leder til en 40-60% reduktion i tumorst\u00f8rrelse og en afbrydelse af kommunikationen med tumormikromilj\u00f8et. Dette validerer Curcumins Hovedstrategi (1) mod den inflammationsdrevne KRAS-subtype.<\/li>\n<\/ul>\n<\/li>\n\n\n\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-d36613ad4cf7e01012315e546ed50ba2\"><strong>Link 25:<\/strong> <a href=\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC3951553\/\" target=\"_blank\" rel=\"noopener\">Curcumin: A Double Hit on Malignant Mesothelioma &#8211; PMC<\/a> (National Institutes of Health, 2014) \n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-f54688a33a37a7ed63ffeb6de68361ec\"><strong>Indhold:<\/strong> Studie, der validerer Curcumins (1) Hovedstrategi mod Mesotheliom. Artiklen beskriver, at Curcumin har en dobbelt effekt p\u00e5 mesotheliomceller ved at h\u00e6mme NF-\u03baB og inducere celled\u00f8d (pyroptose).<\/li>\n<\/ul>\n<\/li>\n\n\n\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-6efb0757b5b76e07adcff4a1ff4cd203\"><strong>Link 26:<\/strong> <a href=\"https:\/\/www.frontiersin.org\/journals\/pharmacology\/articles\/10.3389\/fphar.2022.1058070\/full\" target=\"_blank\" rel=\"noopener\">The Therapeutic and Preventive Efficacy of Curcumin and Its Derivatives in Esophageal Cancer<\/a> (Frontiers, 2022) \n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-ce41ccf156e0e572d05fce79c96ece7f\"><strong>Indhold:<\/strong> Oversigtsartikel, der d\u00e6kker Curcumins anticancer-effekt i spiser\u00f8rskr\u00e6ft. Artiklen beskriver, hvordan Curcumin ud\u00f8ver sin effekt ved at downregulere NF-\u03baB-signalvejen, h\u00e6mme inflammation og angribe pro-oncogene pathways.<\/li>\n<\/ul>\n<\/li>\n\n\n\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-74513433343d54732981b509870a31e4\"><strong>Link 27:<\/strong> <a href=\"https:\/\/www.researchgate.net\/publication\/324047343_Curcumin_Suppresses_Colorectal_Cancer_Growth_and_Metastasis_by_Inhibiting_NF-kB_Activity\" target=\"_blank\" rel=\"noopener\">Curcumin Suppresses Colorectal Cancer Growth and Metastasis by Inhibiting NF-\u03baB Activity<\/a> (ResearchGate, 2018) \n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-a1bcec1cf2d9df341618520c704637dd\"><strong>Indhold:<\/strong> Studie, der validerer Curcumins Hovedstrategi (1). Artiklen beskriver, hvordan Curcumin h\u00e6mmer NF-\u03baB-aktiviteten, hvilket undertrykker v\u00e6kst og metastase i tarmkr\u00e6ftceller.<\/li>\n<\/ul>\n<\/li>\n\n\n\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-7593d051928e5f106b851558da8c059a\"><strong>Link 28:<\/strong> <a href=\"https:\/\/www.sciencedirect.com\/science\/article\/pii\/S209517792100071X\" target=\"_blank\" rel=\"noopener\">Phytochemicals targeting NF-\u03baB signaling: Potential anti-inflammatory and anti-cancer agents<\/a> (ScienceDirect.com, 2022)\n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-c2be5fe82b306694d403be2f85ce2e52\"><strong>Indhold:<\/strong> Oversigtsartikel, der beskriver, at Curcumin udviser anticancer-aktivitet ved at h\u00e6mme NF-\u03baB p65-proteinets transkriptionelle aktivitet. Dette validerer Curcumins relevans mod b\u00e5de den prim\u00e6re MAPK\/ERK-vej og den inflammatoriske NF-kB-vej i melanom.<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">Binyrebarkkr\u00e6ft<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-0a0d47973ce335ddc2e032ff74c8d5ff\"><strong>Link 29:<\/strong> <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/33907586\/\" target=\"_blank\" rel=\"noopener\">Curcumin induces apoptosis and inhibits the growth of adrenocortical carcinoma: Identification of potential candidate genes and pathways by transcriptome analysis<\/a> (National Institutes of Health, 2021) \n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-316cb36d9d85eaeda2ff1afe2ac0fb75\"><strong>Indhold:<\/strong> Et videnskabeligt studie, der bekr\u00e6fter curcumins evne til at bremse v\u00e6ksten af binyrebarkkr\u00e6ft. Resultaterne viser, at stoffet aktiverer specifikke stress-signalveje (JNK og p38 MAPK) inde i kr\u00e6ftcellerne, hvilket fremtvinger programmeret celled\u00f8d (apoptose).<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">Bl\u00e6rekr\u00e6ft og Urinvejskr\u00e6ft:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-3040dea879e3a3625bb4226387fb16fe\"><strong>Link 30:<\/strong> <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/38273747\/\" target=\"_blank\" rel=\"noopener\">Curcumin Inhibits Bladder Cancer by Inhibiting Invasion via AKT\/MMP14 Pathway<\/a> (PubMed, 2024) \n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-453efd739ec3a6ae8400584bf7589a1c\"><strong>Indhold:<\/strong> Et nyt studie, der kortl\u00e6gger, hvordan Curcumin forhindrer bl\u00e6rekr\u00e6ft i at sprede sig (invasion) ved at h\u00e6mme enzymet MMP14. Resultaterne underst\u00f8tter brugen af Curcumin mod aggressive, invasive former.<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">Bugspytkirtelkr\u00e6ft:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-a71947495438e2227e5d0526937d7bf4\"><strong>Link 31:<\/strong> <a href=\"https:\/\/www.sciencedirect.com\/science\/article\/abs\/pii\/S0045206825001440\" target=\"_blank\" rel=\"noopener\">Insights into curcumin&#8217;s anticancer activity in pancreatic cancer <\/a>(ScienceDirect, 2025)\n<ul class=\"wp-block-list\">\n<li><strong>Indhold:<\/strong> En ny videnskabelig unders\u00f8gelse, der belyser curcumins potentiale mod bugspytkirtelkr\u00e6ft. Artiklen fokuserer specifikt p\u00e5, hvordan stoffet regulerer tumorens mikromilj\u00f8 og h\u00e6mmer aktiveringen af de celler, der danner det t\u00e6tte arv\u00e6v (stroma), hvilket reducerer tumorens aggressivitet og evne til at sprede sig.<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">Galdebl\u00e6re- og Galdevejskr\u00e6ft:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-c17093d9a23077c2abdf32a966ec43fd\"><strong>Link 32:<\/strong> <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/41020838\/\" target=\"_blank\" rel=\"noopener\">Revisiting Curcumin in Cancer Therapy: Recent Insights into Molecular Mechanisms<\/a> (PubMed Central, 2025)\n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-64242cbdc39e898938ee7be9ea725d56\"><strong>Indhold:<\/strong> En omfattende gennemgang fra 2025, der kortl\u00e6gger curcumins virkningsmekanismer mod kr\u00e6ft. Artiklen fremh\u00e6ver, hvordan stoffet specifikt kan h\u00e6mme v\u00e6kstsignaler (Wnt\/\u03b2-catenin, mTOR) og inducere celled\u00f8d i galdevejskr\u00e6ftceller, samt d\u00e6mpe den inflammation, der ofte driver sygdommen.<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">Hjernekr\u00e6ft:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-28dd9a041f694c5a6d81a7fd0e0b7dc0\"><strong>Link 33:<\/strong> <a href=\"https:\/\/www.mdpi.com\/2076-3921\/14\/3\/351\" target=\"_blank\" rel=\"noopener\">Potential of Curcumin and Its Analogs in Glioblastoma Treatment<\/a> (MDPI, 2025)\n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-c99f7f475fe47314e8609536f8faa402\"><strong>Indhold:<\/strong> En oversigtsartikel der beskriver curcumins evne til at h\u00e6mme v\u00e6kst, migration og invasion i hjernetumorer gennem regulering af oxidativt stress og signalveje. Resultaterne underst\u00f8tter brugen af curcumin som en del af strategien mod aggressive hjernecancerformer.<\/li>\n<\/ul>\n<\/li>\n\n\n\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-514d1ba949fa5a2f6ebfaa6c4d7101d3\"><strong>Link 34: <\/strong><a href=\"https:\/\/www.sciencedirect.com\/science\/article\/pii\/S0955286323002164\" target=\"_blank\" rel=\"noopener\">Regulation of the Notch signaling pathway by natural products<\/a> (ScienceDirect, 2023)\n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-371b7fd1fe8fa32c5df0f8959f38f701\"><strong>Indhold:<\/strong> En gennemgang af, hvordan naturstoffer som curcumin regulerer Notch-signalvejen i forskellige kr\u00e6ftformer. Artiklen beskriver de specifikke mekanismer, hvorved stoffet kan blokere denne signalvej og dermed h\u00e6mme tumorudvikling.<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">Hoved- og Mundhulekr\u00e6ft:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-5fc9198e573c58199c3f1ce3d04e3e39\"><strong>Link 35:<\/strong> <a href=\"https:\/\/www.sciencedirect.com\/science\/article\/pii\/S0753332222009490\" target=\"_blank\" rel=\"noopener\">Role of curcumin in selected head and neck lesions<\/a> (ScienceDirect, 2022)\n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-fdf78027d22581b96f3db1000e628bee\"><strong>Indhold:<\/strong> En videnskabelig artikel, der opsummerer viden om curcumins effekt p\u00e5 sygdomme i hoved-hals-regionen, herunder planocellul\u00e6rt karcinom. Den beskriver, hvordan stoffet kan h\u00e6mme tumorv\u00e6kst og reducere inflammation i slimhinderne, hvilket underst\u00f8tter dets anvendelse i denne sammenh\u00e6ng.<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">Knoglekr\u00e6ft: <\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-c1ae204d6d04286428289d73e71eb0f6\"><strong>Link 36:<\/strong> <a href=\"https:\/\/journals.sagepub.com\/doi\/full\/10.1177\/03946320241308082\" target=\"_blank\" rel=\"noopener\">Curcumin suppresses metastasis, invasion, and proliferation<\/a> (Sage Journals, 2024)\n<ul class=\"wp-block-list\">\n<li><strong>Indhold:<\/strong> Et studie fra 2024, der dokumenterer curcumins evne til at h\u00e6mme spredning (metastase) og v\u00e6kst af knoglekr\u00e6ftceller. Artiklen beskriver, hvordan stoffet virker ved at nedregulere specifikke signalveje (EGFR\/Src), der ellers driver kr\u00e6ftens udvikling og evne til at invadere nyt v\u00e6v.<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">Livmoderhalskr\u00e6ft:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-16aa0451fbf33ddd81d1819956d7ae1b\"><strong>Link 37:<\/strong> <a href=\"https:\/\/www.sciencedirect.com\/science\/article\/pii\/S0753332223003785\" target=\"_blank\" rel=\"noopener\">Basic research on curcumin in cervical cancer<\/a> (ScienceDirect, 2023)\n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-ecc950de1d56e1f69a06b4ff860340f5\"><strong>Indhold:<\/strong> En videnskabelig artikel, der analyserer curcumins effekter mod livmoderhalskr\u00e6ft. Den fremh\u00e6ver, at stoffet virker ved at fremkalde programmeret celled\u00f8d (apoptose) og h\u00e6mme tumorcellernes deling, hvilket bekr\u00e6fter potentialet som en del af behandlingen.<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">Mavekr\u00e6ft:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-b137bd3f458e96ac3846801bee29cf1d\"><strong>Link 38:<\/strong> <a href=\"https:\/\/www.mdpi.com\/1420-3049\/30\/1\/3\" target=\"_blank\" rel=\"noopener\">Resveratrol, Piceatannol, Curcumin, and Quercetin as Therapeutic Targets in Gastric Cancer<\/a> (MDPI, 2025)\n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-0bce2f2bd5d69f3d31e7e949d270aa5f\"><strong>Indhold:<\/strong> En helt ny gennemgang fra 2025, der samler evidensen for Curcumin og andre polyfenoler mod mavekr\u00e6ft. Artiklen fremh\u00e6ver Curcumins evne til at h\u00e6mme spredning, inducere celled\u00f8d og blokere centrale signalveje som NF-kB og Wnt.<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">Myelomatose\/ Knoglemarvskr\u00e6ft:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-b3919bbfc15a23e95d8760f2036a1188\"><strong>Link 39:<\/strong> <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/29987021\/\" target=\"_blank\" rel=\"noopener\">Ancient drug curcumin impedes 26S proteasome activity by direct inhibition of dual-specificity tyrosine-regulated kinase 2<\/a> (PubMed, 2018) \n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-c949011c4fe3fe65a44d3c2ca0fd2358\"><strong>Indhold:<\/strong> Banebrydende forskning, der viser, at Curcumin virker som en naturlig proteasom-h\u00e6mmer (samme mekanisme som Velcade\/Bortezomib). Det skaber en synergieffekt, der stresser kr\u00e6ftcellerne til d\u00f8de.<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">Nyrekr\u00e6ft: <\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-1e6385e0aac32a593eb130cdfce462d4\"><strong>Link 40:<\/strong> <a href=\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC8986413\/\" target=\"_blank\" rel=\"noopener\">Curcumin Inhibits the Proliferation of Renal Cancer 786-O Cells and Induces Apoptosis via the MTOR Signaling Pathway <\/a>(National Institutes of Health, 2022)\n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-81e67f70b17ac771fafaa9774ecf46c4\"><strong>Indhold: <\/strong>Et videnskabeligt studie, der dokumenterer, at curcumin h\u00e6mmer v\u00e6kst, migration og invasion i nyrekr\u00e6ftceller. Resultaterne viser, at dette sker ved specifikt at blokere mTOR-signalvejen, hvilket samtidig aktiverer programmeret celled\u00f8d (apoptose).<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">Tarmkr\u00e6ft:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-5dd46bf4c64b9fc9e9ee924895dbf344\"><strong>Link 41:<\/strong> <a href=\"https:\/\/onlinelibrary.wiley.com\/doi\/full\/10.1002%2Fptr.8220\" target=\"_blank\" rel=\"noopener\">Curcumin and its anti\u2010colorectal cancer potential<\/a> (Wiley Online Library, 2024)\n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-e9c91a38e9d04941adb93960dadeeb72\"><strong>Indhold:<\/strong> En videnskabelig gennemgang, der kortl\u00e6gger curcumins potentiale mod tarmkr\u00e6ft. Artiklen beskriver, hvordan stoffet kan bek\u00e6mpe kr\u00e6ftceller ved at p\u00e5virke en lang r\u00e6kke af de signalveje, der styrer cellernes v\u00e6kst og overlevelse, hvilket bekr\u00e6fter dets brede virkningsmekanisme.<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">Spytkirtel- og N\u00e6sekr\u00e6ft:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-87078c3e874fa823e358c90d0509bc2a\"><strong>Link 42:<\/strong> <a href=\"https:\/\/www.nature.com\/articles\/s41598-024-77294-w\" target=\"_blank\" rel=\"noopener\">Curcumin derivative C210 induces Epstein\u2013Barr virus lytic reactivation<\/a> (Nature, 2024)\n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-9a20ab1c0174da3fd4a16140269be997\"><strong>Indhold:<\/strong> Et videnskabeligt studie, der demonstrerer, hvordan stoffer baseret p\u00e5 curcumin kan tvinge det latente Epstein-Barr virus til at blive aktivt igen. Denne mekanisme f\u00e5r kr\u00e6ftcellerne i n\u00e6sesv\u00e6lget til at d\u00f8, da de ikke kan overleve virus-aktiveringen, hvilket underst\u00f8tter en specifik antiviral strategi mod kr\u00e6ften.<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">\u00c6ggestokkr\u00e6ft:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-693539d7fa5b928e5f079c8c44a0c80c\"><strong>Link 43:<\/strong> <a href=\"https:\/\/www.frontiersin.org\/journals\/pharmacology\/articles\/10.3389\/fphar.2022.1014933\/full\" target=\"_blank\" rel=\"noopener\">Curcumin enhances the anti-cancer efficacy in ovarian cancer <\/a>(Frontiers in Oncology, 2023)\n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-5fea744b44f0215949b62ce2699f51ae\"><strong>Indhold:<\/strong> Et studie fra 2023, der dokumenterer curcumins virkning p\u00e5 \u00e6ggestokkr\u00e6ft. Forskningen viser, at stoffet kan h\u00e6mme tumorv\u00e6kst og fremme celled\u00f8d ved at regulere specifikke signalveje, hvilket underst\u00f8tter dets potentiale som metabolisk behandling.<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">Vulva- og Skedekr\u00e6ft:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-1ad4733a07209ed801ef36a1ae232960\"><strong>Link 44:<\/strong> <a href=\"https:\/\/virologyj.biomedcentral.com\/articles\/10.1186\/s12985-025-02738-2\" target=\"_blank\" rel=\"noopener\">Curcumin nanoemulsion suppresses HPV oncogenes and induces apoptosis<\/a> (Virology Journal, 2025)\n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-942f037fdae198f002e6a75a369de1cc\"><strong>Indhold:<\/strong> Et studie der dokumenterer curcumins evne til at undertrykke de kr\u00e6ftfremkaldende HPV-gener og inducere celled\u00f8d (apoptose). Resultaterne bekr\u00e6fter, at stoffet effektivt kan ramme de virus-drevne mekanismer, der er centrale for udviklingen af kr\u00e6ft i de nedre k\u00f8nsorganer.<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">\u00d8jenkr\u00e6ft: <\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-e6a619485407ea3f19eb5a8b4e65ab23\"><strong>Link 45:<\/strong> <a href=\"https:\/\/cjeo-journal.org\/inhibitory-effect-of-curcumin-on-malignant-biological-behavior-and-wnt-%CE%B2-catenin-pathway-of-uveal-melanoma-cells\/\" target=\"_blank\" rel=\"noopener\">Inhibitory effect of curcumin on malignant biological behavior and Wnt\/\u03b2-catenin pathway of uveal melanoma cells<\/a> (CJEO Journal, 2024)\n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-913f9f2fb862d68bb03da84fd98b7111\"><strong>Indhold:<\/strong> En unders\u00f8gelse der dokumenterer curcumins evne til at h\u00e6mme v\u00e6kst, spredning og invasion ved moderm\u00e6rkekr\u00e6ft i \u00f8jet. Resultaterne peger p\u00e5, at stoffet virker ved at blokere Wnt-signalvejen, hvilket reducerer tumorcellernes overlevelse og fremmer celled\u00f8d.<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Tilbage til:<\/strong> <a href=\"#skema-02\"><mark style=\"background-color:rgba(0, 0, 0, 0)\" class=\"has-inline-color has-custom-menu-links-color\">Oversigtsskema for Kosttilskud<\/mark><\/a><\/p>\n\n\n\n<h4 class=\"wp-block-heading\" id=\"dim\">11. <a href=\"https:\/\/jegharkraeft.dk\/dim-indol-3-carbinol\/\">DIM<\/a><a href=\"https:\/\/jegharkraeft.dk\/indol-3-carbinol\/\"> <\/a>\/<a href=\"https:\/\/jegharkraeft.dk\/indol-3-carbinol\/\"> I3C<\/a> (Indol-3-Carbinol)<\/h4>\n\n\n\n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-fcce27dccc586cdf462c0c406c369dbf\"><strong>Link 1:<\/strong> <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/40318812\/\" target=\"_blank\" rel=\"noopener\">Integrating structure-activity relationships, computational approaches, and experimental validation to unlock the therapeutic potential of indole-3-carbinol and its derivatives<\/a> (PubMed, 2025)\n<ul class=\"wp-block-list\">\n<li><strong>Relevans:<\/strong> Indole-3-carbinol (I3C) fra korsblomstrede gr\u00f8ntsager har potentiale til kr\u00e6ftforebyggelse og behandling. Molekyl\u00e6re \u00e6ndringer, is\u00e6r i dimers som DIM, p\u00e5virker dens effektivitet, og kombination med andre behandlinger kan forbedre resultaterne. Fremtiden ligger i avanceret computeranalyser og forbedret levering for at udvikle nye I3C-baserede terapier.<\/li>\n<\/ul>\n<\/li>\n\n\n\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-57e10303a97c26baec37085d81d3affa\"><strong>Link 2:<\/strong> <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/40476854\/\" target=\"_blank\" rel=\"noopener\">Treatment Interventions for Usual-Type Vulvar Intraepithelial Neoplasia: A Systematic Review and Meta-analysis<\/a> (PubMed, 2025)\n<ul class=\"wp-block-list\">\n<li><strong>Relevans:<\/strong> Imiquimod 5% er en effektiv behandling for uventet intraepitelial neoplasi (uVIN), hvilket er en forstadie til kr\u00e6ft i slimhinderne, og resultaterne er tilsvarende kirurgi. Cidofovir 1% er ogs\u00e5 et godt alternativ. Mindre invasiv behandling er fordelagtigt ved multifokale eller omfattende l\u00e6sioner, men kombination af medicinske og kirurgiske metoder er endnu ikke unders\u00f8gt.<\/li>\n<\/ul>\n<\/li>\n\n\n\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-7cc90f697db4b72541d06dfe1b3a0730\"><strong>Link 3:<\/strong> <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/40215823\/\" target=\"_blank\" rel=\"noopener\">Indole-3-carbinol inhibits PD-L1-mediated immune evasion in hepatocellular carcinoma via suppressing NF-\u03baB p105 Ubiquitination<\/a> (PubMed, 2025)\n<ul class=\"wp-block-list\">\n<li><strong>Relevans:<\/strong> Indole-3-carbinol (I3C) kan forhindre leverkr\u00e6ft i at undg\u00e5 kroppens immunforsvar ved at h\u00e6mme en vigtig signalvej, hvilket \u00e5bner muligheder for nye immunbehandlinger.<\/li>\n<\/ul>\n<\/li>\n\n\n\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-5d5e5fa24afaaac9abc9ceba4a9dd2b2\"><strong>Link 4:<\/strong> <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/39985695\/\" target=\"_blank\" rel=\"noopener\">Indole-3-carbinol prevented tumor progression and potentiated PD1ab therapy by upregulating PTEN in colorectal cancer<\/a> (PubMed, 2025)\n<ul class=\"wp-block-list\">\n<li><strong>Relevans:<\/strong> Indole-3-carbinol (I3C) kan h\u00e6mme kolorektalanceres v\u00e6kst ved at \u00f8ge PTEN-genes aktivitet uden at skade vitale organer, og det kan forbedre effekten af immunterapi, hvilket g\u00f8r det til en lovende kandidat til kr\u00e6ftbehandling.<\/li>\n<\/ul>\n<\/li>\n\n\n\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-3cf7635154f4b5b85f39e8dd4b850f19\"><strong>Link 5: <\/strong><a href=\"https:\/\/www.nature.com\/articles\/s41419-020-03144-y\" target=\"_blank\" rel=\"noopener\">Targeting BCL-2 in B-cell malignancies and overcoming resistance <\/a>(Nature, 2020)\n<ul class=\"wp-block-list\">\n<li><strong>Indhold:<\/strong> En autoritativ oversigtsartikel, der bekr\u00e6fter, at h\u00e6mning af BCL-2-familien er en rationel terapeutisk strategi for lymfomer og andre B-celle maligniteter. Artiklen diskuterer, hvordan BCL-2-afh\u00e6ngige tilstande (som f.eks. Follikul\u00e6rt Lymfom) behandles ved at genoprette cellens evne til at d\u00f8 (apoptose).<\/li>\n<\/ul>\n<\/li>\n\n\n\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-38081175bea65f0aaaa08152eb1d59df\"><strong>Link 6:<\/strong> <a href=\"https:\/\/cancerci.biomedcentral.com\/articles\/10.1186\/s12935-023-03031-4\" target=\"_blank\" rel=\"noopener\">3,3\u2032-Diindolylmethane and indole-3-carbinol: potential chemopreventive agents<\/a> (Cancer Cell International, 2023) \n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-004470285ba877e8109c1553f72e08d0\"><strong>Indhold:<\/strong> En oversigtsartikel, der beskriver, hvordan DIM og I3C (som stammer fra korsblomstrede gr\u00f8ntsager) kan tilbyde beskyttelse mod hormonafh\u00e6ngige kr\u00e6ftformer. Artiklen validerer DIM \/ I3C&#8217;s Hovedstrategi (1)-status i hormonf\u00f8lsom brystkr\u00e6ft ved at fokusere p\u00e5 deres rolle i \u00f8strogen-metabolisme.<\/li>\n<\/ul>\n<\/li>\n\n\n\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-762922f4eec556ed5062fda7de97a5f1\"><strong>Link 7:<\/strong> <a href=\"https:\/\/www.nature.com\/articles\/s41419-024-07077-8\" target=\"_blank\" rel=\"noopener\">Targeted therapy of cancer stem cells: inhibition of mTOR signaling pathway<\/a> (Nature, 2024) \n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-4a4d42bbda827b7a34af0b8a82cbe1c2\"><strong>Indhold: <\/strong>Oversigtsartikel, der beskriver, at Metformin h\u00e6mmer mTOR-vejen ved at aktivere AMPK. Dette validerer Metformins Hovedstrategi (1) mod resistens, da h\u00e6mning af mTOR er den mest almindelige m\u00e5de at omg\u00e5 resistens p\u00e5 i BRAF-muterede celler.<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Tilbage til:<\/strong> <a href=\"#skema-02\"><mark style=\"background-color:rgba(0, 0, 0, 0)\" class=\"has-inline-color has-custom-menu-links-color\">Oversigtsskema for Kosttilskud<\/mark><\/a><\/p>\n\n\n\n<h4 class=\"wp-block-heading\" id=\"egcg\">12. <a href=\"https:\/\/jegharkraeft.dk\/groen-te\/\">EGCG <\/a>(Gr\u00f8n te)<\/h4>\n\n\n\n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-f0b4d431a391af7920531b79b1a85802\"><strong>Link 1:<\/strong> <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/40359763\/\" target=\"_blank\" rel=\"noopener\">Network pharmacology and in vitro analyses reveal EGCG inhibits breast cancer progression via suppression of the EGFR\/Src pathway<\/a> (PubMed, 2025)\n<ul class=\"wp-block-list\">\n<li><strong>Relevans: <\/strong>EGCG kan h\u00e6mme brystkr\u00e6ft ved at blokere EGFR\/Src-vejens signaler, hvilket reducerer kr\u00e6ftcellers v\u00e6kst, invasion og migration, og dermed har potentiale som en terapeutisk agent.<\/li>\n<\/ul>\n<\/li>\n\n\n\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-095854480a62a569634fba2c4bca0ef9\"><strong>Link 2:<\/strong> <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/40446932\/\" target=\"_blank\" rel=\"noopener\">Exploring the cytotoxicity of phytochemicals: Comparative analysis of single and combination therapies in multiple cell lines<\/a> (PubMed, 2025)\n<ul class=\"wp-block-list\">\n<li><strong>Relevans:<\/strong> Curcumin er den mest potente enkeltstof, men ogs\u00e5 kombinationer med EGCG (som resveratrol og andre phytochemicals) kan give st\u00e6rkere kr\u00e6fth\u00e6mmende effekt. EGCG har vist sig at bidrage til den samlede cytotoksicitet, is\u00e6r i kombination, hvilket understreger potentialet i flerstoffer-behandlinger for at forbedre kr\u00e6ftbehandlinger og reducere n\u00f8dvendige doser.<\/li>\n<\/ul>\n<\/li>\n\n\n\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-a09c224857b228c8601aa69f31cdc1c8\"><strong>Link 3:<\/strong><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/40391648\/\" target=\"_blank\" rel=\"noopener\"> Prostate Cancer and Tea: CYP17A1 Inhibition by Phytochemicals from Tea Plant&nbsp;<em>Camellia sinensis L.<\/em>&nbsp;and Implications for Anti-androgenic Effect<\/a> (PubMed, 2025)\n<ul class=\"wp-block-list\">\n<li><strong>Relevans: <\/strong>EGCG, et af de vigtigste stoffer i gr\u00f8n te, kan blokere enzymet CYP17A1, hvilket kan reducere mandligt k\u00f8nshormonproduktion og dermed potentielt forebygge eller behandle prostatakr\u00e6ft.<\/li>\n<\/ul>\n<\/li>\n\n\n\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-5a224772ce7cf9726f818cf18f5fd8e1\"><strong>Link 4:<\/strong> <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/39870235\/\" target=\"_blank\" rel=\"noopener\">GRP78: A new promising candidate in colorectal cancer pathogenesis and therapy<\/a> (PubMed, 2025)\n<ul class=\"wp-block-list\">\n<li><strong>Relevans:<\/strong> GRP78 er et vigtigt protein, der hj\u00e6lper kr\u00e6ftceller i tyktarmen med at h\u00e5ndtere stress, hvilket fremmer tumorv\u00e6kst, invasion og kemoresistens. Det er derfor et lovende m\u00e5l for nye behandlinger, og flere naturlige stoffer, herunder EGCG, kan modvirke dets aktivitet for at forbedre kr\u00e6ftbehandlingerne.<\/li>\n<\/ul>\n<\/li>\n\n\n\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-e02762ba0d006d9faeb935e8bd912824\"><strong>Link 5:<\/strong> <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/40268770\/\" target=\"_blank\" rel=\"noopener\">Modulating the JAK\/STAT pathway with natural products: potential and challenges in cancer therapy<\/a> (PubMed, 2025)\n<ul class=\"wp-block-list\">\n<li><strong>Relevans:<\/strong> Naturlige stoffer som curcumin, resveratrol, apigenin og EGCG kan h\u00e6mme JAK\/STAT-signalvejen og dermed have potential som supplerende kr\u00e6ftbehandlinger, men udfordringer som d\u00e5rlig optagelse skal overvindes gennem avanceret levering og kliniske studier.<\/li>\n<\/ul>\n<\/li>\n\n\n\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-2a53d31d23fc837dfdd6720a6b2a9de6\"><strong>Link 6: <\/strong><a href=\"https:\/\/www.nature.com\/articles\/s41419-020-03144-y\" target=\"_blank\" rel=\"noopener\">Targeting BCL-2 in B-cell malignancies and overcoming resistance <\/a>(Nature, 2020) \n<ul class=\"wp-block-list\">\n<li><strong>Indhold:<\/strong> En autoritativ oversigtsartikel, der bekr\u00e6fter, at h\u00e6mning af BCL-2-familien er en rationel terapeutisk strategi for lymfomer og andre B-celle maligniteter. Artiklen diskuterer, hvordan BCL-2-afh\u00e6ngige tilstande (som f.eks. Follikul\u00e6rt Lymfom) behandles ved at genoprette cellens evne til at d\u00f8 (apoptose).<\/li>\n<\/ul>\n<\/li>\n\n\n\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-91a62d60dd4d30bdbfbcbdecf429c4dd\"><strong>Link 7:<\/strong><a href=\"https:\/\/mednexus.org\/doi\/10.1016\/j.cpt.2025.02.006\" target=\"_blank\" rel=\"noopener\"> Phytoconstituents as emerging therapeutics for breast cancer <\/a>(ScienceDirect.com, Med Nexus, 2025)\n<ul class=\"wp-block-list\">\n<li><strong>Indhold:<\/strong> En meget ny oversigtsartikel, der beskriver plantestoffer som Curcumin og Resveratrol som fremspirende terapeutiske midler mod brystkr\u00e6ft. Artiklen underst\u00f8tter synergien ved at vise, hvordan disse stoffer reducerer tumorst\u00f8rrelse, h\u00e6mmer cellemigration og undertrykker metastase.<\/li>\n<\/ul>\n<\/li>\n\n\n\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-5ae4b82a54b3823511c78a612df52b83\"><strong>Link 8:<\/strong> <a href=\"https:\/\/link.springer.com\/article\/10.1007\/s12672-025-03190-y\" target=\"_blank\" rel=\"noopener\">Therapeutic potential of natural compounds in targeting WNT, Notch, and Hedgehog signaling pathways<\/a> (Springer, 2025) \n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-f73bc3f3dc884ce8e0070d4bb445df4d\"><strong>Indhold:<\/strong> Oversigtsartikel, der beskriver, hvordan naturlige stoffer kan forstyrre de kritiske WNT, Notch og Hedgehog-signalveje. Dette underst\u00f8tter den h\u00f8je relevans for midler som Ivermectin, Resveratrol og EGCG i metaplastisk kr\u00e6ft, der er afh\u00e6ngig af stamcelle-signalering.<\/li>\n<\/ul>\n<\/li>\n\n\n\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-3c30e63a7e55bda649ed727d717d028c\"><strong>Link 9:<\/strong> <a href=\"https:\/\/www.sciencedirect.com\/science\/article\/pii\/S209517792100071X\" target=\"_blank\" rel=\"noopener\">Phytochemicals targeting NF-\u03baB signaling: Potential anti-inflammatory and anti-cancer agents<\/a> (ScienceDirect.com, 2022) \n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-c2be5fe82b306694d403be2f85ce2e52\"><strong>Indhold:<\/strong> Oversigtsartikel, der beskriver, at Curcumin udviser anticancer-aktivitet ved at h\u00e6mme NF-\u03baB p65-proteinets transkriptionelle aktivitet. Dette validerer Curcumins relevans mod b\u00e5de den prim\u00e6re MAPK\/ERK-vej og den inflammatoriske NF-kB-vej i melanom.<\/li>\n<\/ul>\n<\/li>\n\n\n\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-645c189bda03b8ff699a96ffe475c871\"><strong>Link 10:<\/strong><a href=\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC6429180\/\" target=\"_blank\" rel=\"noopener\"> Inhibitory Effects of (\u2212)-Epigallocatechin-3-gallate on Esophageal Cancer<\/a> (National Institutes of Health, 2019)<strong> <\/strong>\n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-aac5017c6bbdee1816fcd65b871a9a1d\"><strong>Indhold:<\/strong> En oversigtsartikel, der fokuserer p\u00e5 EGCG&#8217;s evne til at h\u00e6mme cellev\u00e6kst, for\u00e5rsage celled\u00f8d og undertrykke dannelsen af nye blodkar i spiser\u00f8rskr\u00e6ft. Artiklen beskriver EGCG&#8217;s virkning p\u00e5 flere signalveje og epigenetiske mekanismer.<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">Binyrebarkkr\u00e6ft:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-766c31f8180bd1079e1070c89bed0c11\"><strong>Link 11: <\/strong><a href=\"https:\/\/onlinelibrary.wiley.com\/doi\/10.1155\/2021\/5516285\" target=\"_blank\" rel=\"noopener\">Plant Natural Compounds in the Treatment of ACT and adrenocortical cancer<\/a> (Wiley Online Library, 2021) \n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-38f8af2399f31050a94ca3023cf63e99\"><strong>Indhold:<\/strong> En videnskabelig oversigtsartikel, der gennemg\u00e5r effekten af naturlige plantestoffer mod binyrebarkkr\u00e6ft. Artiklen diskuterer potentialet ved stoffer som EGCG til at h\u00e6mme b\u00e5de tumorv\u00e6kst og den overproduktion af hormoner (steroidogenese), som er karakteristisk for funktionelle tumorer.<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">Hals- og Mundhulekr\u00e6ft:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-cb13f4a655d0fb9b3b88d9f090c142fe\"><strong>Link 12:<\/strong> <a href=\"https:\/\/link.springer.com\/article\/10.1007\/s12672-025-03866-5\" target=\"_blank\" rel=\"noopener\">Therapeutic potential of green tea&#8217;s epigallocatechin-3-gallate in oral squamous cell carcinoma: A review<\/a> (Springer, 2025)\n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-159e046e61af1e6c4b8f3d67520cc6ec\"><strong>Indhold:<\/strong> En videnskabelig gennemgang, der unders\u00f8ger EGCG&#8217;s effekt p\u00e5 pladecellekr\u00e6ft i mundhulen. Artiklen beskriver, hvordan stoffet udviser kr\u00e6fth\u00e6mmende egenskaber ved at regulere oxidativt stress og modulere centrale signalveje som NF-\u03baB og MAPK, hvilket er relevant for denne kr\u00e6ftform.<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">Hjernekr\u00e6ft: <\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-f4b5e92e1f6741e6664a24227bfaf264\"><strong>Link 13:<\/strong> <a href=\"https:\/\/www.frontiersin.org\/journals\/pharmacology\/articles\/10.3389\/fphar.2024.1345522\/full\" target=\"_blank\" rel=\"noopener\">Exploiting the Achilles&#8217; heel of cancer: disrupting glutamine metabolism<\/a> (Frontiers, 2024)\n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-290f22183a8b2f5082221efb0062d89c\"><strong>Indhold:<\/strong> En nyere artikel, der unders\u00f8ger strategien om at ramme glutamin-metabolismen som kr\u00e6ftens &#8220;akillesh\u00e6l&#8221;. Teksten fremh\u00e6ver EGCG som et middel, der effektivt kan forstyrre denne metaboliske afh\u00e6ngighed og fremme celled\u00f8d.<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">Livmoderhalskr\u00e6ft:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-2127afde348eeabf2ea06faa708066d0\"><strong>Link 14:<\/strong> <a href=\"https:\/\/www.researchgate.net\/publication\/350814435_The_Major_Constituent_of_Green_Tea_Epigallocatechin-3-Gallate_EGCG_Inhibits_the_Growth_of_HPV18-Infected_Keratinocytes_by_Stimulating_Proteasomal_Turnover_of_the_E6_and_E7_Oncoproteins\" target=\"_blank\" rel=\"noopener\">The Major Constituent of Green Tea, Epigallocatechin-3-gallate, Inhibits the Growth of Human Papilloma Virus (HPV)-Positive Cervical Cancer Cells <\/a>(ResearchGate, 2025)\n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-54cdf298d0e54deb5372d0946d618704\"><strong>Indhold:<\/strong> En videnskabelig artikel, der dokumenterer, hvordan det aktive stof i gr\u00f8n te (EGCG) h\u00e6mmer v\u00e6ksten af HPV-positive livmoderhalskr\u00e6ftceller. Studiet viser, at stoffet virker ved at gribe ind i virussets mekanismer og bremse cellernes ukontrollerede deling, hvilket underst\u00f8tter dets rolle som en m\u00e5lrettet indsats mod virus-drevet kr\u00e6ft.<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">Nyrekr\u00e6ft:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-0968fa0d903e2168e471a9d67c49bc85\"><strong>Link 15:<\/strong> <a href=\"https:\/\/www.sciencedirect.com\/science\/article\/pii\/S000927972400396X\" target=\"_blank\" rel=\"noopener\">EGCG inhibits migration, invasion and epithelial-mesenchymal transition of renal cell carcinoma by activating TFEB-mediated autophagy<\/a> (ScienceDirect, 2024) \n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-ec2c1a22c948c5f1953838f2bd4d9351\"><strong>Indhold:<\/strong> Et videnskabeligt studie, der kortl\u00e6gger, hvordan EGCG bremser spredningen af nyrekr\u00e6ft. Artiklen viser, at stoffet aktiverer en specifik signalvej (TFEB-medieret autofagi), som forhindrer kr\u00e6ftcellerne i at \u00e6ndre form og invadere nyt v\u00e6v (h\u00e6mning af epithelial-mesenchymal transition).<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">Vulva- og Skedekr\u00e6ft:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-8602597c2f1b4c3c7c74244e03f274e3\"><strong>Link 16:<\/strong> <a href=\"https:\/\/www.mdpi.com\/2076-2607\/12\/9\/1897\" target=\"_blank\" rel=\"noopener\">Treatment with Epigallocatechin Gallate, Folic Acid and Vitamin B12 for HPV Management <\/a>(MDPI, 2024)\n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-78f72580d36b7f753f888ecc05b57b0e\"><strong>Indhold:<\/strong> Et studie der dokumenterer, hvordan EGCG griber ind i HPV-virussets livscyklus. Forskningen viser, at stoffet undertrykker de kr\u00e6ftfremkaldende proteiner (E6 og E7), som virusset bruger til at \u00e6ndre cellerne, hvilket underst\u00f8tter strategien om at bruge gr\u00f8n te-ekstrakt mod virus-drevne kr\u00e6ftformer i underlivet.<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Tilbage til:<\/strong> <a href=\"#skema-02\"><mark style=\"background-color:rgba(0, 0, 0, 0)\" class=\"has-inline-color has-custom-menu-links-color\">Oversigtsskema for Kosttilskud<\/mark><\/a><\/p>\n\n\n\n<h4 class=\"wp-block-heading\" id=\"c\">13. <a href=\"https:\/\/jegharkraeft.dk\/c-vitamin-iv\/\">H\u00f8j-dosis Vitamin C<\/a> (IV)<\/h4>\n\n\n\n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-612fdb7ed4a9329f9bb9e462e64f0773\"><strong>Link 1:<\/strong> <a href=\"https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC3480897\/\" target=\"_blank\" rel=\"noopener\">Effect of high-dose intravenous vitamin C on inflammation in cancer patients<\/a> (PubMed, 2012)\n<ul class=\"wp-block-list\">\n<li><strong>Relevans: <\/strong>Denne artikel forklarer den fundamentale mekanisme: Hvordan C-vitamin i farmakologiske (h\u00f8je) doser skifter fra at v\u00e6re en antioxidant til at v\u00e6re en pro-oxidant, der danner hydrogenperoxid og selektivt dr\u00e6ber kr\u00e6ftceller.<\/li>\n<\/ul>\n<\/li>\n\n\n\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-be71c11d9978093887f4a61ba9e1624e\"><strong>Link 2<\/strong>: <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/22963460\/\" target=\"_blank\" rel=\"noopener\">Effect of high-dose intravenous vitamin C on inflammation in cancer patients<\/a> (PubMed, 2012)\n<ul class=\"wp-block-list\">\n<li><strong>Relevans:<\/strong> H\u00f8jdosis intraven\u00f8s C-vitamin kan reducere inflammation og tumormark\u00f8rer hos kr\u00e6ftpatienter, hvilket tyder p\u00e5, at det kan have en modulerende effekt p\u00e5 inflammation i kr\u00e6ftbehandling. Mere forskning er n\u00f8dvendig for at bekr\u00e6fte disse resultater.<\/li>\n<\/ul>\n<\/li>\n\n\n\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-0401a6add333234380d686642f643466\"><strong>Link 3:<\/strong> <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/40440794\/\" target=\"_blank\" rel=\"noopener\">Pharmacologic ascorbate resistant pancreatic cancer demonstrates enhanced metastatic potential<\/a> (PubMed, 2025)\n<ul class=\"wp-block-list\">\n<li><strong>Relevans: Modstandsdygtige pankreascancer celler kan bedre h\u00e5ndtere oxidative stress, blive mere invasive og \u00f8ge spredningen, hvilket kan forklare, hvorfor nogle patienter ikke reagerer p\u00e5 h\u00f8jdosis intraven\u00f8s C-vitaminbehandling.<\/strong><\/li>\n<\/ul>\n<\/li>\n\n\n\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-4256938a9c8ea87fe99389be82d6c091\"><strong>Link 4:<\/strong><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/39369582\/\" target=\"_blank\" rel=\"noopener\"> A randomized trial of pharmacological ascorbate, gemcitabine, and nab-paclitaxel for metastatic pancreatic cancer<\/a> (PubMed, 2024)\n<ul class=\"wp-block-list\">\n<li><strong>Relevans:<\/strong> Infusioner med h\u00f8jdosis C-vitamin (75 g tre gange om ugen) kan forl\u00e6nge overlevelsen og forsinke sygdomsprogression hos patienter med metastatisk pankreascancer uden at forv\u00e6rre livskvalitet eller \u00f8ge bivirkninger.<\/li>\n<\/ul>\n<\/li>\n\n\n\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-baa309c8d5ade337ed6638608471c441\"><strong>Link 5:<\/strong> <a href=\"https:\/\/www.leicester-ozone.co.uk\/post\/the-power-of-artemisinin-and-high-dose-iv-vitamin-c-in-integrative-cancer-care?fbclid=IwY2xjawO7t8ticmlkETFEbDBJa0gyVzV5YXNiSXhYc3J0YwZhcHBfaWQQMjIyMDM5MTc4ODIwMDg5MgABHhNNAsS0BbNZ8CRMG3FnJvbnGEkBsMkK_xnXOdLl81g6bLGGbnAp8H8UXBnH&amp;brid=-cht4BRO1hheZWpUn8pPUQ\" target=\"_blank\" rel=\"noopener\">The Power of Artemisinin and High-Dose IV Vitamin C in Integrative Cancer Care<\/a> (Leicester Ozone Clinic, 2025)\n<ul class=\"wp-block-list\">\n<li><strong>Indhold:<\/strong> (Fra privat klinik &#8211; ikke uvildig, men god forklaring) Artiklen gennemg\u00e5r det synergistiske potentiale i at kombinere artemisinin med h\u00f8jdosis IV C-vitamin. Ved at udnytte kr\u00e6ftcellers h\u00f8je jernindhold skabes en kraftig oxidativ stressreaktion, der m\u00e5lrettet kan sv\u00e6kke kr\u00e6ftceller og g\u00f8re dem mere modtagelige for konventionel behandling.<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">Lungekr\u00e6ft:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-601e4f69cfa0b1542a4dc5decb265c50\"><strong>Link 6:<\/strong><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/38419398\/\" target=\"_blank\" rel=\"noopener\">Vitamin C Inhibited Pulmonary Metastasis through Activating Nrf2\/HO-1 Pathway<\/a> (NIH, Molecular Nutrition &amp; Food Research, 2024)\n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-db95443a74a51120740287abc7d96896\"><strong>Indhold:<\/strong> Et videnskabeligt studie, der unders\u00f8ger C-vitamins evne til at stoppe spredning af kr\u00e6ft til lungerne (lungemetastaser). Resultaterne viser, at behandling (b\u00e5de som indspr\u00f8jtning og oral indtagelse) aktiverer specifikke signalveje (Nrf2\/HO-1 og p53), som f\u00e5r kr\u00e6ftcellerne til at beg\u00e5 selvmord og forhindrer dem i at vandre, samtidig med at raske celler sk\u00e5nes.<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">Livmoderkr\u00e6ft:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-4543cead74c3d9672c8879d5a5a43cd5\"><strong>Link 7: <\/strong><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/39990670\/\" target=\"_blank\" rel=\"noopener\">High-dose Ascorbate Exhibits Anti-proliferative and Anti-invasive Effects Dependent on PTEN\/AKT\/mTOR Pathway in Endometrial Cancer&nbsp;<em>in vitro<\/em>&nbsp;and&nbsp;<em>in vivo<\/em><\/a> (PubMed, 2925)\n<ul class=\"wp-block-list\">\n<li><strong>Relevans: <\/strong>H\u00f8jdosis C-vitamin (ascorbate), givet enten oralt eller via injektion, viste sig at h\u00e6mme v\u00e6kst og spredning af livmodercancer hos mus ved at forstyrre cellecyklus, \u00f8ge cellestress og DNA-skader samt fremme celled\u00f8d. Kombineret med kemoterapi (paclitaxel) virkede det endnu bedre. Resultaterne tyder p\u00e5, at h\u00f8jdosis C-vitamin kan v\u00e6re en lovende behandling, is\u00e6r sammen med paclitaxel, og b\u00f8r unders\u00f8ges n\u00e6rmere i kliniske fors\u00f8g.<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">Binyrebarkkr\u00e6ft:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-b1fed07f5865fe01ecb5c7afaccbdf5a\"><strong>Link 8:<\/strong><a href=\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC6526932\/\" target=\"_blank\" rel=\"noopener\">Targeting cancer vulnerabilities with high-dose vitamin C<\/a> (National Institutes of Health, 2019)\n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-2c19569aa2f3f4c41e808b6ef9ca7727\"><strong>Indhold:<\/strong> En videnskabelig oversigtsartikel, der beskriver, hvordan h\u00f8je doser C-vitamin udnytter specifikke svagheder hos kr\u00e6ftceller. Artiklen forklarer, at behandlingen rammer cellernes ilt-sensorer (HIF) og forstyrrer deres sukkerstofskifte, hvilket stresser aggressive kr\u00e6ftceller, der er st\u00e6rkt afh\u00e6ngige af disse mekanismer for at overleve.<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">Blodkr\u00e6ft:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-834d5bea38b25b3d5a66195717c365cc\"><strong>Link 9:<\/strong><a href=\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC10685150\/\" target=\"_blank\" rel=\"noopener\">Vitamin C and D supplementation in acute myeloid leukemia<\/a> (National Institutes of Health, 2023)\n<ul class=\"wp-block-list\">\n<li><strong>Indhold:<\/strong> Et klinisk studie fra 2023, der unders\u00f8ger effekten af tilskud med C- og D-vitamin hos patienter med akut myeloid leuk\u00e6mi (AML) under intensiv kemoterapi. Resultaterne indikerer, at tilskuddene er sikre og kan have en positiv indflydelse p\u00e5 behandlingsudfaldet.<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">Tarmkr\u00e6ft:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-5fa6c0e92c86a88effa8fc8af0290cb0\"><strong>Link 10:<\/strong> <a href=\"https:\/\/www.sciencedirect.com\/science\/article\/pii\/S2213231725002393\" target=\"_blank\" rel=\"noopener\">High-dose vitamin C as a targeted treatment for KRAS and BRAF mutant colorectal cancer cells<\/a> (ScienceDirect, 2025)\n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-21e8ff29b9a2ed405e5ae14fe1f3b59d\"><strong>Indhold:<\/strong> Et studie fra 2025, der bekr\u00e6fter og bygger videre p\u00e5 strategien om at bruge h\u00f8jdosis C-vitamin mod KRAS- og BRAF-muteret tarmkr\u00e6ft. Forskningen underbygger, hvordan behandlingen specifikt udnytter de metaboliske s\u00e5rbarheder, som disse mutationer skaber i kr\u00e6ftcellerne.<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">Mave- Tarmkr\u00e6ft:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-fffc23bf4085bdfc0c78ae720931e1cd\"><strong>Link 11:<\/strong> <a href=\"https:\/\/ascopubs.org\/doi\/10.1200\/JCO.2025.43.16_suppl.e15567\" target=\"_blank\" rel=\"noopener\">Role of high-dose vitamin C as adjunct treatment in gastric and colorectal cancers: A systematic review<\/a> (ASCO Publications, 2025)\n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-ff30047519abfb1ac4ca4919bba05d91\"><strong>Indhold:<\/strong> Systematisk review, der diskuterer H\u00f8j-dosis Vitamin C&#8217;s potentiale til at h\u00e6mme kr\u00e6ftcellev\u00e6kst i tarmkr\u00e6ft. Dette underst\u00f8tter strategien med at bruge oxidativt stress som Hovedstrategi (1) mod den s\u00e5rbare MSI-H-subtype.<\/li>\n<\/ul>\n<\/li>\n\n\n\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-1f8a1b585d46b522214d7f457995bcc9\"><strong>Link 12:<\/strong> <a href=\"https:\/\/www.sciencedirect.com\/science\/article\/pii\/S2352304225002314\" target=\"_blank\" rel=\"noopener\">High-dose vitamin C: A promising anti-tumor agent, insight into mechanisms and clinical applications<\/a> (ScienceDirect.com, 2025)\n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-5d7784fb3295b05eac35eb3952104559\"><strong>Indhold:<\/strong> Oversigtsartikel, der beskriver, at h\u00f8j-dosis C-vitamin h\u00e6mmer tumorv\u00e6kst i modeller for KRAS og BRAF mutant tarmkr\u00e6ft uden at p\u00e5virke normale celler. Dette validerer Hovedstrategi (1) for tarmkr\u00e6ft<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">Nyrekr\u00e6ft:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-eff40c191b0c81271d06caf131032665\"><strong>Link 13:<\/strong> <a href=\"https:\/\/onlinelibrary.wiley.com\/doi\/10.1155\/2019\/7286737\" target=\"_blank\" rel=\"noopener\">Pro- and Antioxidant Effects of Vitamin C in Cancer in correspondence to Its Dietary and Pharmacological Concentrations<\/a> (Wiley Online Library, 2019)\n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-9c010674fc279150a170772689c4a4c5\"><strong>Indhold:<\/strong> En videnskabelig gennemgang, der dokumenterer C-vitamins virkningsmekanismer i kr\u00e6ftbehandling. Artiklen bekr\u00e6fter specifikt, at C-vitamin inducerer nedbrydning af faktoren HIF-1\\alpha, hvilket er afg\u00f8rende for at fjerne det overlevelsesgrundlag, som kr\u00e6ftceller (is\u00e6r ved nyrekr\u00e6ft) er afh\u00e6ngige af under iltfattige forhold.<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Tilbage til:<\/strong> <a href=\"#skema-02\"><mark style=\"background-color:rgba(0, 0, 0, 0)\" class=\"has-inline-color has-custom-menu-links-color\">Oversigtsskema for Kosttilskud<\/mark><\/a><\/p>\n\n\n\n<h4 class=\"wp-block-heading\" id=\"ingefaer\">14. <a href=\"https:\/\/jegharkraeft.dk\/ingefaer\/\">Ingef\u00e6r<\/a> (Ginger)<\/h4>\n\n\n\n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-a751778dbfb4c2259d3d783c5b6595e5\"><strong>Link 1: <\/strong><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/40397499\/\" target=\"_blank\" rel=\"noopener\">6-Shogaol inhibits the cell motility of prostate cancer cells by suppressing the PI3K\/AKT\/mTOR and Ras\/Raf\/MAPK pathways with comparable effects to paclitaxel treatment <\/a>(PubMed, 2025)\n<ul class=\"wp-block-list\">\n<li><strong>Relevans:<\/strong> 6-Shogaol, en forbindelse fra ingef\u00e6r, kan h\u00e6mme migration og invasion af prostatakr\u00e6ftceller ved at blokere v\u00e6kstsignaler uden at skade normale celler, hvilket g\u00f8r det til en lovende kandidat til supplerende behandling af metastatic prostatakr\u00e6ft.<\/li>\n<\/ul>\n<\/li>\n\n\n\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-ed4785063e83419f665e051ac2f40949\"><strong>Link 2: <\/strong><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/40446574\/\" target=\"_blank\" rel=\"noopener\">Predicting the molecular mechanism of ginger targeting PRMT1\/BTG2 axis to inhibit gastric cancer based on WGCNA and machine algorithms<\/a> (PubMed, 2025)\n<ul class=\"wp-block-list\">\n<li><strong>Relevans:<\/strong> Forskningsresultaterne tyder p\u00e5, at ginger kan have kr\u00e6fth\u00e6mmende effekt via biomark\u00f8ren PRMT1 og BTG2, hvilket giver nye perspektiver p\u00e5, hvordan ginger kan bek\u00e6mpe mavekr\u00e6ft.<\/li>\n<\/ul>\n<\/li>\n\n\n\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-9779f513daa52b6a434174688dd1f604\"><strong>Link 3:<\/strong> <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/40346944\/\" target=\"_blank\" rel=\"noopener\">Potential of Ginger Oil to Prevent 4-(Methylnitrosamino)-1-(3-Pyridyl)-1-Butanone-Induced Lung Cancer Through Gut Microbiota Modulation and Inflammatory Response Inhibition<\/a> (PubMed, 2025)\n<ul class=\"wp-block-list\">\n<li><strong>Relevans:<\/strong> Ingef\u00e6rolie (GIO) kan reducere risikoen for tobaksskabt lungekr\u00e6ft ved at modvirke inflammatoriske signalveje og \u00e6ndre tarmfloraen, hvilket understreger dets potentiale som et kostbaseret forebyggende middel.<\/li>\n<\/ul>\n<\/li>\n\n\n\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-9dfd8ee366b77e72c25d68e9350e1534\"><strong>Link 4:<\/strong> <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/39636404\/\" target=\"_blank\" rel=\"noopener\">Mechanisms of ferroptotic and non-ferroptotic organ toxicity of chemotherapy: protective and therapeutic effects of ginger, 6-gingerol and zingerone in preclinical studies<\/a> (PubMed, 2025)\n<ul class=\"wp-block-list\">\n<li><strong>Relevans: <\/strong>Chemoterapi kan for\u00e5rsage organbeskadigelse gennem b\u00e5de oxidative stress og ferroptose, men naturlige stoffer som ginger, 6-gingerol og zingeron kan beskytte mod disse skader ved at modvirke b\u00e5de ferroptotiske og ikke-ferroptotiske mekanismer.<\/li>\n<\/ul>\n<\/li>\n\n\n\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-f31714c6024aacf938e2aa9b7a25e41e\"><strong>Link 5:<\/strong> <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/40266430\/\" target=\"_blank\" rel=\"noopener\">Antioral cancer effects of ginger derivative 3-HDM exert oxidative stress-associated apoptosis and DNA damage<\/a> (PubMed, 2025)\n<ul class=\"wp-block-list\">\n<li><strong>Relevans:<\/strong> 3-HDM, en ny ginger-baseret forbindelse, kan m\u00e5lrette og dr\u00e6be orale kr\u00e6ftceller gennem oxidative stress uden at skade normale celler, hvilket g\u00f8r det til en lovende kandidat til behandling af mundhulekr\u00e6ft.<\/li>\n<\/ul>\n<\/li>\n\n\n\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-cf5c91d2f4fabf96f81f1934f3d58d35\"><strong>Link 6:<\/strong> <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/40022126\/\" target=\"_blank\" rel=\"noopener\">Anticancer and cancer preventive activities of shogaol and curcumin from Zingiberaceae family plants in KG-1a leukemic stem cells <\/a>(PubMed, 2025)\n<ul class=\"wp-block-list\">\n<li><strong>Relevans:<\/strong> Shogaol og curcumin fra ingef\u00e6rfamilien har potentiale til at forhindre leuk\u00e6mi ved at h\u00e6mme cellev\u00e6kst, for\u00e5rsage cellecyklusarrest og inducere apoptosis, samtidig med at de har lavere effekt p\u00e5 raske celler.<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\" id=\"ip6\"><strong>Tilbage til:<\/strong> <a href=\"#skema-02\"><mark style=\"background-color:rgba(0, 0, 0, 0)\" class=\"has-inline-color has-custom-menu-links-color\">Oversigtsskema for Kosttilskud<\/mark><\/a><\/p>\n\n\n\n<h4 class=\"wp-block-heading\" id=\"inositol\">15. <a href=\"https:\/\/jegharkraeft.dk\/inositol\/\">IP6 &amp; Inositol<\/a><\/h4>\n\n\n\n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-2e380422b520fb15bc27dcbf801dc11b\"><strong>Link 1:<\/strong> <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/38097134\/\" target=\"_blank\" rel=\"noopener\">Inositol hexaphosphate enhances chemotherapy by reversing senescence induced by persistently activated PERK and diphthamide modification of eEF2<\/a> (PubMed, 2024)\n<ul class=\"wp-block-list\">\n<li><strong>Relevans: <\/strong>Oxaliplatinresistens i kolorektal cancer skyldes cellers stressreaktioner og senescens, men IP6 kan reversere (vende) denne resistens ved at h\u00e6mme PERK-aktivering og eEF2-modifikation, hvilket kan forbedre kemoterapiens effektivitet.<\/li>\n<\/ul>\n<\/li>\n\n\n\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-5752385910f6ee72f29bfdea09fd4f4b\"><strong>Link 2: <\/strong><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/37286513\/\" target=\"_blank\" rel=\"noopener\">The Combination of Inositol Hexaphosphate and Inositol Inhibits Metastasis of Colorectal Cancer Cells by Upregulating Claudin 7<\/a> (PubMed, 2023)\n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-59631a27df415e426efe7c6df7659571\"><strong>Relevans:<\/strong> Kombinationen af IP6 og INS h\u00e6mmer kolorektal kr\u00e6ftmetastase ved at forhindre celle-omdannelse (EMT) gennem opregulering af claudin 7, hvilket kan forbedre behandlingseffekten.<\/li>\n<\/ul>\n<\/li>\n\n\n\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-d3905fbe6f607858e0c0b6e0f4914907\"><strong>Link 3:<\/strong> <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/37371552\/\" target=\"_blank\" rel=\"noopener\">Cellular and Molecular Activities of IP6 in Disease Prevention and Therapy<\/a> (PubMed, 2023)\n<ul class=\"wp-block-list\">\n<li><strong>Relevans: <\/strong>IP6 er en naturlig forbindelse i fr\u00f8 og korn, som har antioxidante, antiinflammatoriske og kr\u00e6fth\u00e6mmende egenskaber, hvilket g\u00f8r det til et lovende kosttilskud til forebyggelse af kroniske sygdomme som kr\u00e6ft, diabetes og osteoporose. Yderligere forskning er n\u00f8dvendig for at fastl\u00e6gge de bedste doser og anvendelsesmetoder.<\/li>\n<\/ul>\n<\/li>\n\n\n\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-f0f0194aff0a96924f7192f4418bb792\"><strong>Link 4:<\/strong> <a href=\"https:\/\/www.nature.com\/articles\/s41419-024-07077-8\" target=\"_blank\" rel=\"noopener\">Targeted therapy of cancer stem cells: inhibition of mTOR signaling pathway<\/a> (Nature, 2024) \n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-4a4d42bbda827b7a34af0b8a82cbe1c2\"><strong>Indhold: <\/strong>Oversigtsartikel, der beskriver, at Metformin h\u00e6mmer mTOR-vejen ved at aktivere AMPK. Dette validerer Metformins Hovedstrategi (1) mod resistens, da h\u00e6mning af mTOR er den mest almindelige m\u00e5de at omg\u00e5 resistens p\u00e5 i BRAF-muterede celler.<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Tilbage til:<\/strong> <a href=\"#skema-02\"><mark style=\"background-color:rgba(0, 0, 0, 0)\" class=\"has-inline-color has-custom-menu-links-color\">Oversigtsskema for Kosttilskud<\/mark><\/a><\/p>\n\n\n\n<h4 class=\"wp-block-heading\" id=\"loevetand\">16. <a href=\"https:\/\/jegharkraeft.dk\/loevetand-maelkeboetterod\/\">L\u00f8vetandrod<\/a> (Dandelion Root)<\/h4>\n\n\n\n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-bc3a74a59fa28c5485306efdd342ac80\"><strong>Link 1:<\/strong> <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/40430483\/\" target=\"_blank\" rel=\"noopener\">Investigation of the Anti-Lung Cancer Mechanisms of&nbsp;<em>Taraxacum officinale<\/em>&nbsp;Based on Network Pharmacology and Multidimensional Experimental Validation<\/a> (PubMed, 2025)\n<ul class=\"wp-block-list\">\n<li><strong>Relevans: <\/strong>Dandelion indeholder flere aktive stoffer, herunder taraxasterol, som kan h\u00e6mme lungekr\u00e6ft ved at p\u00e5virke flere celle- og tumor-milj\u00f8er gennem komplekse molekyl\u00e6re mekanismer, hvilket g\u00f8r det til en lovende naturlig behandling.<\/li>\n<\/ul>\n<\/li>\n\n\n\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-0e88181d744f197c7a44d2873e702fb9\"><strong>Link 2:<\/strong> <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/40109332\/\" target=\"_blank\" rel=\"noopener\">Therapeutic potential of isochlorogenic acid A from&nbsp;<em>Taraxacum officinale<\/em>&nbsp;in improving immune response and enhancing the efficacy of PD-1\/PD-L1 blockade in triple-negative breast cancer<\/a> (PubMed, 2025)\n<ul class=\"wp-block-list\">\n<li><strong>Relevans:<\/strong> Bioaktive stoffer fra m\u00e6lkeb\u00f8tte, ICGA-A og CRA, kan forbedre immunterapi ved at h\u00e6mme kr\u00e6ftv\u00e6kst og styrke kroppens immunrespons i triple-negativ brystkr\u00e6ft, hvilket kan hj\u00e6lpe med at overvinde behandlingsresistens.<\/li>\n<\/ul>\n<\/li>\n\n\n\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-c3000345e3803bd612579bf5d2f584b3\"><strong>Link 3: <\/strong><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/39864604\/\" target=\"_blank\" rel=\"noopener\">Dandelion extract suppresses the stem-like properties of triple-negative breast cancer cells by regulating CUEDC2\/\u03b2-catenin\/OCT4 signaling axis<\/a> (PubMed, 2025)\n<ul class=\"wp-block-list\">\n<li><strong>Relevans:<\/strong> Dandelion-ekstrakt kan h\u00e6mme den kr\u00e6ftstamcelle-lignende egenskab i triple-negativ brystkr\u00e6ft ved at p\u00e5virke CUEDC2\/\u03b2-catenin\/OCT4-signalvejen, hvilket g\u00f8r det til en lovende potentiel behandling.<\/li>\n<\/ul>\n<\/li>\n\n\n\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-b10fbbf241fc5d3ec9b678cdebfe1358\"><strong>Link 4:<\/strong> <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/39840098\/\" target=\"_blank\" rel=\"noopener\">Artificial intelligence-driven identification and mechanistic exploration of synergistic anti-breast cancer compound combinations from&nbsp;<em>Prunella vulgaris<\/em>&nbsp;L.-&nbsp;<em>Taraxacum mongolicum<\/em>&nbsp;Hand.-Mazz. herb pair<\/a> (PubMed, 2025)\n<ul class=\"wp-block-list\">\n<li><strong>Relevans:<\/strong> Denne forskning identificerede og bekr\u00e6ftede, at kombinationer af specifikke kemiske stoffer fra traditionel kinesisk medicin (herunder Dandelion), som PVL og TH, kan have synergistiske kr\u00e6fth\u00e6mmende effekter ved at m\u00e5lrette tumorrelaterede pathway.<\/li>\n<\/ul>\n<\/li>\n\n\n\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-7c2c9ba3f16f08f59ba60bb50e380820\"><strong>Link 5: <\/strong><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/39498069\/\" target=\"_blank\" rel=\"noopener\">Sophora alopecuroide &#8211; Taraxacum decoction (STD) inhibits non-small cell lung cancer via inducing ferroptosis and modulating tumor immune microenvironment <\/a>(PubMed, 2024)\n<ul class=\"wp-block-list\">\n<li><strong>Relevans: <\/strong>Sophora alopecuroide &#8211; Taraxacum Decoction (STD) kan h\u00e6mme tumorv\u00e6kst ved at fremkalde ferroptose og \u00e6ndre immunmilj\u00f8et i tumorer, hvilket g\u00f8r det til en lovende alternativ behandling for ikke-sm\u00e5cellet lungekr\u00e6ft.<\/li>\n<\/ul>\n<\/li>\n\n\n\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-c42bceb53ffaf6ce32657d92f59e7f8d\"><strong>Link 6:<\/strong> <a href=\"https:\/\/www.spandidos-publications.com\/10.3892\/etm.2024.12544\" target=\"_blank\" rel=\"noreferrer noopener\">Dandelion root extracts and taraxasterol inhibit LPS\u2011induced colorectal cancer cell viability by blocking TLR4\u2011NF\u03baB\u2011driven ACE2 and TMPRSS2 pathways<\/a> (Experimental and Therapeutic Medicine, 2024)\n<ul class=\"wp-block-list\">\n<li><strong>Relevans:<\/strong> Dette studie viser, hvordan l\u00f8vetandrodsekstrakt og dets aktive stof, taraxasterol, kan modvirke den v\u00e6kstfremmende effekt, som visse bakterielle signaler (LPS) har p\u00e5 tyktarmskr\u00e6ftceller. Mekanismen involverer en blokering af den pro-inflammatoriske TLR4\/NF\u03baB-signalvej.<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Tilbage til:<\/strong> <a href=\"#skema-02\"><mark style=\"background-color:rgba(0, 0, 0, 0)\" class=\"has-inline-color has-custom-menu-links-color\">Oversigtsskema for Kosttilskud<\/mark><\/a><\/p>\n\n\n\n<h4 class=\"wp-block-heading\" id=\"maitake\">17. <a href=\"https:\/\/jegharkraeft.dk\/maitake\/\">Maitake<\/a> (Grifola frondosa)<\/h4>\n\n\n\n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-231dce7c9872f9416eccdebb6333227c\"><strong>Link 1:<\/strong> <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/39561834\/\" target=\"_blank\" rel=\"noopener\">Polysaccharide with anticancer activity from Grifola frondosa cultured in industrial wastewater of Agaricus bisporus<\/a> (PubMed, 2024)\n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-b36719a5acc972d812c505ecd179e2b4\"><strong>Relevans:<\/strong> Ved at optimere v\u00e6kstbetingelser med spildevand fra champignonproduktion kunne man udvinde polysaccharider fra Grifola frondosa, hvor is\u00e6r NIPGF01 viste st\u00e6rk kr\u00e6fth\u00e6mmende evne ved at inducere celleapoptose i mavesyre- og leverkr\u00e6ftceller.<\/li>\n<\/ul>\n<\/li>\n\n\n\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-cf220467cb288dc17b48643a55d96ec0\"><strong>Link 2:<\/strong> <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/38924315\/\" target=\"_blank\" rel=\"noopener\">A Water Polysaccharide-Protein Complex from Grifola frondosa Inhibit the Growth of Subcutaneous but Not Peritoneal Colon Tumor under Fasting Condition <\/a>(PubMed, 202)\n<ul class=\"wp-block-list\">\n<li><strong>Relevans:<\/strong> G. frondosa polysaccharide-protein complex (G. frondosa PPC) kan h\u00e6mme tumorv\u00e6kst i underhudssvulstmodeller ved at \u00e6ndre fedtsyresammens\u00e6tningen i tumormilj\u00f8et, is\u00e6r under fasteforhold, hvilket g\u00f8r det til en potentiel adjuvans i kr\u00e6ftbehandling.<\/li>\n<\/ul>\n<\/li>\n\n\n\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-384c51cc07f1479bdbe22ef1e8d494cf\"><strong>Link 3:<\/strong> <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/39057091\/\" target=\"_blank\" rel=\"noopener\">Medicinal Mushrooms in Metastatic Breast Cancer: What Is Their Therapeutic Potential as Adjuvant in Clinical Settings? <\/a>(PubMed, 2024)\n<ul class=\"wp-block-list\">\n<li><strong>Relevans:<\/strong> Medicinske svampe som shiitake, maitake og reishi har immunstyrkende og kr\u00e6fth\u00e6mmende egenskaber, og forskningen unders\u00f8ger deres potentiale som st\u00f8ttebehandling i behandling af aggressiv brystkr\u00e6ft, is\u00e6r ved metastaser.<\/li>\n<\/ul>\n<\/li>\n\n\n\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-b91c0955daa91577c081bde4df7fdf78\"><strong>Link 4: <\/strong><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/38670197\/\" target=\"_blank\" rel=\"noopener\">Selenochemical modification of low molecular weight polysaccharides from Grifola frondosa and the mechanism of their inhibitory effects on gastric cancer cells<\/a> (PubMed, 2024)\n<ul class=\"wp-block-list\">\n<li><strong>Relevans:<\/strong> Selenium-bundet LMW-GFP fra Grifola frondosa viser forbedret kr\u00e6fth\u00e6mmende aktivitet ved at aktivere cellernes d\u00f8dsreceptorer og mitochondrier, hvilket g\u00f8r det til et lovende naturligt supplement og potentielt nyt kr\u00e6ftmiddel.<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Tilbage til:<\/strong> <a href=\"#skema-02\"><mark style=\"background-color:rgba(0, 0, 0, 0)\" class=\"has-inline-color has-custom-menu-links-color\">Oversigtsskema for Kosttilskud<\/mark><\/a><\/p>\n\n\n\n<h4 class=\"wp-block-heading\" id=\"marietidsel\">18. <a href=\"https:\/\/jegharkraeft.dk\/marietidsel\/\">Marietidsel<\/a> (Silymarin\/Silybin)<\/h4>\n\n\n\n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-9cabb272dba45f01ee31faf76602202c\"><strong>Link 1: <\/strong><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/31615114\/\" target=\"_blank\" rel=\"noopener\">Metabolism, Transport and Drug-Drug Interactions of Silymarin<\/a> (PubMed, 2019)\n<ul class=\"wp-block-list\">\n<li><strong>Relevans: <\/strong>Silymarin og silybin har potentiale til at beskytte leveren og andre v\u00e6v, men lav biotilg\u00e6ngelighed begr\u00e6nser deres effektivitet. Effluxtransportere som MRP2 og BCRP regulerer absorptionen, og inhibitorer af disse kan forbedre silymarins virkning, men i klinikken er risikoen for interaktioner lav, og det betragtes som sikkert og vel tolereret.<\/li>\n<\/ul>\n<\/li>\n\n\n\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-a91605f09b2be6fff32bf56412bd4854\"><strong>Link 2:<\/strong> <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/39747779\/\" target=\"_blank\" rel=\"noopener\">Mechanistic Insights into Silymarin-Induced Apoptosis and Growth Inhibition in SPC212 Human Mesothelioma Cells <\/a>(PubMed, 2025)\n<ul class=\"wp-block-list\">\n<li><strong>Relevans:<\/strong> Silymarin viser dosisafh\u00e6ngig cytotoxicitet og inducerer apoptose i mesotheliomaceller, hvilket tyder p\u00e5, at det kan have potential som kr\u00e6ftbehandling.<\/li>\n<\/ul>\n<\/li>\n\n\n\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-9677a6be01b0c91edc7ae29de340d731\"><strong>Link 3:<\/strong> <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/40329723\/\" target=\"_blank\" rel=\"noopener\">Milk Thistle (Silybum marianum): Potential Role in Cancer Prevention<\/a> (PubMed, 2025)\n<ul class=\"wp-block-list\">\n<li><strong>Relevans:<\/strong> M\u00e6lkeb\u00f8tteekstrakter indeholder flavonoider, der kan beskytte mod kr\u00e6ft gennem antioxidante, antiinflammatoriske og apoptose-inducerende virkninger samt ved at modulere cellev\u00e6kstsignaler, men yderligere kliniske unders\u00f8gelser er n\u00f8dvendige for at bekr\u00e6fte deres potentiale i kr\u00e6ftforebyggelse og behandling.<\/li>\n<\/ul>\n<\/li>\n\n\n\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-866978678df447fe8e89afe5f6d1d145\"><strong>Link 4:<\/strong> <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/39836338\/\" target=\"_blank\" rel=\"noopener\">Silymarin: a promising modulator of apoptosis and survival signaling in cancer<\/a> (PubMed, 2025)\n<ul class=\"wp-block-list\">\n<li><strong>Relevans:<\/strong> Silymarin, et planteekstrakt med kr\u00e6fth\u00e6mmende egenskaber, kan h\u00e6mme tumorv\u00e6kst ved at p\u00e5virke n\u00f8glestyringsveje som JAK\/STAT og PI3K\/Akt\/mTOR, og nano-leveringssystemer kan forbedre dets effektivitet. Yderligere forskning er n\u00f8dvendig for at udvikle det som en klinisk kr\u00e6ftbehandling.<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Tilbage til:<\/strong> <a href=\"#skema-02\"><mark style=\"background-color:rgba(0, 0, 0, 0)\" class=\"has-inline-color has-custom-menu-links-color\">Oversigtsskema for Kosttilskud<\/mark><\/a><\/p>\n\n\n\n<h4 class=\"wp-block-heading\" id=\"melatonin\">19. <a href=\"https:\/\/jegharkraeft.dk\/melatonin-ved-kraeft\/\">Melatonin<\/a><\/h4>\n\n\n\n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-5aaa5240a1c1a8932631a3a4d50899d2\"><strong>Link 1: <\/strong><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/40444491\/\" target=\"_blank\" rel=\"noopener\">Tryptophan metabolism: From physiological functions to key roles and therapeutic targets in cancer (Review)<\/a> (PubMed, 2025)\n<ul class=\"wp-block-list\">\n<li><strong>Relevans: <\/strong>Tryptofanmetabolisme spiller en vigtig rolle i kroppen ved at p\u00e5virke neurotransmitterproduktion, immunregulering og antioxidantforsvar, men i kr\u00e6ftsygdomme kan det hj\u00e6lpe tumorer med at danne blodkar, undg\u00e5 immunangreb og overleve. Derfor er det et lovende m\u00e5l for nye behandlinger.<\/li>\n<\/ul>\n<\/li>\n\n\n\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-267a622f6ea7a86927a754fd0729f86c\"><strong>Link 2:<\/strong> <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/40122433\/\" target=\"_blank\" rel=\"noopener\">Function of intramitochondrial melatonin and its association with Warburg metabolism<\/a> (PubMed, 2025)\n<ul class=\"wp-block-list\">\n<li><strong>Relevans:<\/strong> Melatonin kan reducere den unormale energimetabolisme i kr\u00e6ftceller ved at genoprette pyruvatindgangen til mitokondrierne, hvilket s\u00e6nker ROS-niveauerne og h\u00e6mmer tumorv\u00e6kst, hvilket g\u00f8r det til en potentiel behandling mod kr\u00e6ft.<\/li>\n<\/ul>\n<\/li>\n\n\n\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-f557881a84ced35431733684eab406a7\"><strong>Link 3:<\/strong> <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/40401443\/\" target=\"_blank\" rel=\"noopener\">Therapeutic Efficacy of Melatonin and Flutamide Combination in Safety for Prostate Cancer: An&nbsp;<em>In Vitro<\/em>&nbsp;Study<\/a> (PubMed, 2025)\n<ul class=\"wp-block-list\">\n<li><strong>Relevans:<\/strong> Melatonin kan forbedre effekten af flutamide i behandling af prostatakr\u00e6ft ved at \u00f8ge cellernes f\u00f8lsomhed og reducere den n\u00f8dvendige dosis, hvilket kan mindske bivirkningerne.<\/li>\n<\/ul>\n<\/li>\n\n\n\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-012f6cf6024a9db1ada2d877a0e026ce\"><strong>Link 4:<\/strong> <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/40285589\/\" target=\"_blank\" rel=\"noopener\">Targeting Melatonin to Mitochondria Mitigates Castration-Resistant Prostate Cancer by Inducing Pyroptosis<\/a> (PubMed, 2025)\n<ul class=\"wp-block-list\">\n<li><strong>Relevans:<\/strong> Mito-Mel, en mitochondriem\u00e5lrettet form af melatonin, kan effektivt h\u00e6mme castration-resistent prostatakr\u00e6ft ved at forstyrre cellernes energiproduktion, skabe immunaktivering og fremkalde pyroptose, hvilket \u00e5bner nye muligheder for behandling af denne aggressive kr\u00e6ftform.<\/li>\n<\/ul>\n<\/li>\n\n\n\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-a06a4b5b9863693acee10b12d8c92ae8\"><strong>Link 5:<\/strong> <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/40127816\/\" target=\"_blank\" rel=\"noopener\">Targeting mitochondrial ribosomal protein expression by andrographolide and melatonin for colon cancer treatment <\/a>(PubMed, 2025)\n<ul class=\"wp-block-list\">\n<li><strong>Relevans: <\/strong>Kombinationen af andrographolide og melatonin kan h\u00e6mme kr\u00e6ft-stamceller i tyktarmen ved at reducere mitokondriernes funktion og specifikt downregulere MRPS6, hvilket f\u00f8rer til mindre cellev\u00e6kst og \u00f8get celled\u00f8d, og dermed har potentiale som en ny terapeutisk strategi mod colorectal cancer.<\/li>\n<\/ul>\n<\/li>\n\n\n\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-d3158d828933108d2496b78c143cd8d5\"><strong>Link 6: <\/strong><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/40107036\/\" target=\"_blank\" rel=\"noopener\">Targeting anti-apoptotic mechanisms in tumour cells: Strategies for enhancing Cancer therapy<\/a> (PubMed, 2025)\n<ul class=\"wp-block-list\">\n<li>R<strong>elevans:<\/strong> Cancer-celler kan undg\u00e5 at d\u00f8 ved at producere anti-apoptotiske proteiner, hvilket bidrager til behandlingresistens. Ved at m\u00e5lrette disse proteiner og bruge naturlige stoffer som curcumin og melatonin, kan man forbedre kr\u00e6ftbehandlinger, reducere doseringerne og minimere bivirkninger ved at fremme cellernes d\u00f8dsprocesser.<\/li>\n<\/ul>\n<\/li>\n\n\n\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-dfb0c9d4e27661b4c246e3b111e37d3c\"><strong>Link 7:<\/strong> <a href=\"https:\/\/www.mdpi.com\/1420-3049\/26\/9\/2506\" target=\"_blank\" rel=\"noopener\">Melatonin in Cancer Treatment: Current Knowledge and Future Challenges<\/a> (MDPI, 2021)\n<ul class=\"wp-block-list\">\n<li><strong>Indhold:<\/strong> En oversigtsartikel, der gennemg\u00e5r, hvordan melatonin p\u00e5virker immunsystemet i kampen mod kr\u00e6ft og kan fungere som et supplement til konventionel behandling. Artiklen belyser dets potentiale til b\u00e5de at h\u00e6mme kr\u00e6ftceller direkte og til at styrke immunforsvarets respons.<\/li>\n<\/ul>\n<\/li>\n\n\n\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-d6df046baa4be4760b071169ee03751a\"><strong>Link 8: <\/strong><a href=\"https:\/\/www.mdpi.com\/2072-6694\/16\/4\/802\" target=\"_blank\" rel=\"noopener\">The Effect of Melatonin Supplementation on Cancer-Related Fatigue during Chemotherapy Treatment of Breast Cancer Patients: A Double-Blind, Randomized Controlled Study<\/a> (MDPI, 2024)\n<ul class=\"wp-block-list\">\n<li><strong>Indhold:<\/strong> Denne oversigtsartikel fra 2024 samler den seneste viden om melatonin som supplement i kr\u00e6ftbehandling. Artiklen fremh\u00e6ver en nylig meta-analyse, der bekr\u00e6fter, at tilskud med melatonin er forbundet med forbedret tumor-respons og en signifikant \u00f8get et-\u00e5rs overlevelse for patienter med solide tumorer.<\/li>\n<\/ul>\n<\/li>\n\n\n\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-1935fa14cf64738be2141eaa74665bab\"><strong>Link 9:<\/strong> <a href=\"https:\/\/www.researchgate.net\/figure\/Protection-of-melatonin-against-chemotherapy-drug-induced-damage-in-various-organs_fig2_341554889\" target=\"_blank\" rel=\"noopener\">Melatonin<\/a> (Research Gate, 2020)\n<ul class=\"wp-block-list\">\n<li><strong>Indhold:<\/strong> En samling af artikler, der specifikt belyser melatonins potentiale til at reducere et bredt spektrum af bivirkninger fra kemoterapi, herunder skader p\u00e5 lunger, lever, nyrer og nerveceller. Kilden d\u00e6kker ogs\u00e5 melatonins rolle i at forbedre livskvalitet, styrke effekten af andre stoffer og dets direkte virkning p\u00e5 kr\u00e6ftstamceller.<\/li>\n<\/ul>\n<\/li>\n\n\n\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-cb82204d8c26f3d033688a52a399f9bb\"><strong>Link 10:<\/strong> <a href=\"https:\/\/mjmr.journals.ekb.eg\/article_306373_792deef89dbdd5aa49e5c23eed49b0d8.pdf\" target=\"_blank\" rel=\"noopener\">Protective effect of melatonin on cisplatin induced liver<\/a> <a href=\"https:\/\/mjmr.journals.ekb.eg\/article_306373_792deef89dbdd5aa49e5c23eed49b0d8.pdf\" target=\"_blank\" rel=\"noopener\">toxicity inalbino Rats; biochemical and histological Study<\/a> (Minia Journal of Medical Researc, 2024)\n<ul class=\"wp-block-list\">\n<li><strong>Indhold:<\/strong> Et dyrestudie, der viser, at melatonin beskytter leveren mod skader fra platin-baseret kemo.<\/li>\n<\/ul>\n<\/li>\n\n\n\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-f550c522d1ebd5d8d32d4ee861735a02\"><strong>Link 11:<\/strong> <a href=\"https:\/\/ar.iiarjournals.org\/content\/34\/12\/7327\" target=\"_blank\" rel=\"noopener\">Melatonin in Patients with Cancer Receiving Chemotherapy: A Randomized, Double-blind, Placebo-controlled Trial <\/a>(Anticancer Research, 2014)\n<ul class=\"wp-block-list\">\n<li><strong>Indhold:<\/strong> Et klinisk studie af h\u00f8j kvalitet (randomiseret, dobbelt-blindet), der unders\u00f8ger effekten af melatonin hos patienter i kemoterapi.<\/li>\n<\/ul>\n<\/li>\n\n\n\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-e3529a44b5f288aa39a42d2a3dba8028\"><strong>Link 12:<\/strong> <a href=\"https:\/\/www.frontiersin.org\/journals\/endocrinology\/articles\/10.3389\/fendo.2023.1184745\/full\" target=\"_blank\" rel=\"noopener\">Protective effects of exogenous melatonin therapy against oxidative stress to male reproductive tissue caused by anti-cancer chemical and radiation therapy: a systematic review and meta-analysis of animal studies<\/a> (Frontiers, 2023)\n<ul class=\"wp-block-list\">\n<li><strong>Indhold:<\/strong> En oversigtsartikel af dyrestudier, der bekr\u00e6fter melatonins beskyttende effekt mod skader fra kemo og str\u00e5ler.<\/li>\n<\/ul>\n<\/li>\n\n\n\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-be0bc2259901195e0b1eaf31dde94ed4\"><strong>Link 13:<\/strong> <a href=\"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/jpi.12782\" target=\"_blank\" rel=\"noopener\">Safety of higher doses of melatonin in adults: A systematic review and meta-analysis<\/a> (Willey, 2021)\n<ul class=\"wp-block-list\">\n<li><strong>Indhold:<\/strong> En oversigtsartikel, der specifikt bekr\u00e6fter, at det er sikkert at anvende h\u00f8je doser melatonin.<\/li>\n<\/ul>\n<\/li>\n\n\n\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-9f408d2a631eb3833755d44445221acb\"><strong>Link 14:<\/strong> <a href=\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC11557022\/\" target=\"_blank\" rel=\"noopener\">A review of the potential use of melatonin in cancer treatment: Data analysis from Clinicaltrials.gov<\/a> (PubMed, 2024)\n<ul class=\"wp-block-list\">\n<li><strong>Indhold:<\/strong> En gennemgang af registrerede kliniske fors\u00f8g, der viser den aktuelle forskningsstatus.<\/li>\n<\/ul>\n<\/li>\n\n\n\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-0a029263e4dee0de7e4f502a1ef48370\"><strong>Link 15:<\/strong> <a href=\"https:\/\/www.mdpi.com\/1999-4923\/15\/6\/1616\" target=\"_blank\" rel=\"noopener\">Therapeutic Potential of Melatonin Counteracting Chemotherapy-Induced Toxicity in Breast Cancer Patients: A Systematic Review <\/a>(MDPI, 2023)\n<ul class=\"wp-block-list\">\n<li><strong>Indhold:<\/strong> En oversigtsartikel, der specifikt fokuserer p\u00e5, hvordan melatonin kan modvirke bivirkninger fra kemoterapi.<\/li>\n<\/ul>\n<\/li>\n\n\n\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-dd2ef3d8a5e9fc6542813733b2e7dcc7\"><strong>Link 16:<\/strong> <a href=\"https:\/\/www.sciencedirect.com\/science\/article\/pii\/S2589537021000432\" target=\"_blank\" rel=\"noopener\">Adjuvant melatonin for the prevention of recurrence and mortality following lung cancer resection (AMPLCaRe): A randomized placebo controlled clinical trial <\/a>(Science Direct, 2021)\n<ul class=\"wp-block-list\">\n<li><strong>Indhold:<\/strong> Et klinisk fors\u00f8g, der viser, at melatonin kan forbedre overlevelse og forhindre tilbagefald hos lungekr\u00e6ftpatienter.<\/li>\n<\/ul>\n<\/li>\n\n\n\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-b8f688c2ab635e84d2904809702f5bd5\"><strong>Link 17:<\/strong> <a href=\"https:\/\/www.mdpi.com\/1422-0067\/22\/1\/438\" target=\"_blank\" rel=\"noopener\">Melatonin as an Oncostatic Molecule Based on Its Anti-Estrogenic and Anti-Proliferative Actions<\/a> (MDPI, 2021) \n<ul class=\"wp-block-list\">\n<li><strong>Indhold:<\/strong> Oversigtsartikel, der validerer Melatonins Hovedstrategi (1)-status i hormonf\u00f8lsom brystkr\u00e6ft. Artiklen beskriver Melatonins v\u00e6ksth\u00e6mmende handling, herunder dets evne til at h\u00e6mme aromatase-aktivitet i brystkr\u00e6ftceller og dermed reducere \u00f8strogenbiosyntesen.<\/li>\n<\/ul>\n<\/li>\n\n\n\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-429b158393764ccc2c39d7655f26ca39\"><strong>Link 18:<\/strong> <a href=\"https:\/\/www.frontiersin.org\/journals\/chemistry\/articles\/10.3389\/fchem.2022.837987\/full\" target=\"_blank\" rel=\"noopener\">Combining EGFR-TKI With SAHA Overcomes EGFR-TKI-Acquired Resistance by Reducing the Protective Autophagy in Non-Small Cell Lung Cancer<\/a> (Frontiers, 2022) \n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-becaac0c5b2c55d3a67dd9d831af6c56\"><strong>Indhold:<\/strong> Studie, der konkluderer, at den tumorh\u00e6mmende effekt af EGFR-TKI&#8217;er forst\u00e6rkes markant, n\u00e5r man h\u00e6mmer autofagi med en autofagi-h\u00e6mmer. Resultatet bekr\u00e6fter, at autofagi er en central resistensmekanisme, der skal blokeres (hvilket Hydroxychloroquin og andre autofagi-h\u00e6mmere g\u00f8r).<\/li>\n<\/ul>\n<\/li>\n\n\n\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-ee1cfa7b89778eba0baf3d0e899f8509\"><strong>Link 19: <\/strong><a href=\"https:\/\/onlinelibrary.wiley.com\/doi\/full\/10.1002\/mba2.58\" target=\"_blank\" rel=\"noopener\">Melatonin: Avenues in cancer therapy and its relationship with immune system<\/a> (Wiley Online Library, 2023) \n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-38189b7e24d1f45a04a9ec4168098eed\"><strong>Indhold:<\/strong> Oversigtsartikel, der beskriver Melatonin som et nontoksisk middel med et bredt spektrum af anticancer-egenskaber, herunder dets evne til at inducere apoptose og h\u00e6mme proliferation. Dette validerer den Hovedstrategi (1), hvor Melatonin skal fungere som stand-alone onkostatisator.<\/li>\n<\/ul>\n<\/li>\n\n\n\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-92c2d756c42fb03aaf84e8cd6c8c9a8e\"><strong>Link 20:<\/strong> <a href=\"https:\/\/www.spandidos-publications.com\/10.3892\/etm.2022.11197\" target=\"_blank\" rel=\"noopener\">Role of melatonin in respiratory diseases (Review)<\/a> (Spandidos Publications, 2022) \n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-1b8c3dcca101ea9a096b4cdd50b6d670\"><strong>Indhold:<\/strong> Oversigtsartikel, der bekr\u00e6fter, at Melatonin reducerer kr\u00e6ftcelleproliferation og fremmer apoptose. Dette validerer den Hovedstrategi (1), hvor Melatonin skal fungere som stand-alone onkostatisator i SCLC (og generel NSCLC).<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">Glioblastom:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-899e4a9c49b19f9477511835e2d2b0da\"><strong>Link 21:<\/strong> <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/32138190\/\" target=\"_blank\" rel=\"noopener\">Melatonin&#8217;s Antineoplastic Potential Against Glioblastoma<\/a> (PubMed, 2020) \n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-2aad5954c36e555718b56ce6625cc2ce\"><strong>Indhold:<\/strong> Oversigtsartikel, der beskriver Melatonins (1) Hovedstrategi. Artiklen validerer stoffets v\u00e6ksth\u00e6mmende (oncostatic) og immunmodulerende potentiale, herunder dets evne til at p\u00e5virke Akt\/STAT3-vejen i stamcellelignende gliomceller.<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">Hudkr\u00e6ft: <\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-2666f0558cccca0012d25b4bec3ac3ce\"><strong>Link 22:<\/strong> <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/40756978\/\" target=\"_blank\" rel=\"noopener\">Melatonin: a natural guardian in cancer treatment<\/a> (PubMed Central, 2025) \n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-6f52247863f8b472ddde9bc2933631f7\"><strong>Indhold:<\/strong> En videnskabelig gennemgang, der beskriver melatonins betydelige anti-kr\u00e6ft effekter. Artiklen fremh\u00e6ver, hvordan hormonet virker ved at h\u00e6mme cellev\u00e6kst, blokere dannelsen af nye blodkar (angiogenese) og fremme celled\u00f8d i tumorer, samtidig med at det kan forst\u00e6rke effekten af andre kr\u00e6ftbehandlinger.<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">Knoglekr\u00e6ft:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-d96f738e1a3a3cc5bf5c9c9b5b1e9d45\"><strong>Link 23:<\/strong> <a href=\"https:\/\/www.mdpi.com\/2218-273X\/14\/2\/145\" target=\"_blank\" rel=\"noopener\">Unveiling the Protective Role of Melatonin in Osteosarcoma<\/a> (MDPI, 2024) \n<ul class=\"wp-block-list\">\n<li><strong>Indhold:<\/strong> En videnskabelig artikel fra 2024, der unders\u00f8ger melatonins rolle ved knoglekr\u00e6ft. Studiet fremh\u00e6ver hormonets potentiale som et kr\u00e6fth\u00e6mmende middel, da det b\u00e5de kan bremse dannelsen af tumorer og fremme programmeret celled\u00f8d (apoptose) i kr\u00e6ftcellerne.<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">Mavekr\u00e6ft<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-7d4714e099ee3896bfd3f580927e8d00\"><strong>Link 24:<\/strong> <a href=\"https:\/\/www.frontiersin.org\/journals\/pharmacology\/articles\/10.3389\/fphar.2025.1617508\/full?gad_source=1&amp;gad_campaignid=23187344532&amp;gbraid=0AAAAAC_sJ7l-FpZC6WdBuI7ORbuaO-bIe&amp;gclid=CjwKCAiAuIDJBhBoEiwAxhgyFm0buZNxbPIgX1qC4ygl2Trp8iI6WP5wbtJTeTWPQdfVutMvcc1L8xoCvBkQAvD_BwE\" target=\"_blank\" rel=\"noopener\">Melatonin: a natural guardian in cancer treatment <\/a>(Frontiers, 2025) \n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-e1458cf230e079a913d68c361cce1d94\"><strong>Indhold:<\/strong> En omfattende artikel, der beskriver melatonins potentiale som en &#8220;naturlig beskytter&#8221; i kr\u00e6ftbehandling. Den gennemg\u00e5r, hvordan melatonin kan h\u00e6mme v\u00e6kst, blokere dannelsen af blodkar og fremme celled\u00f8d i tumorer, herunder i mave-tarm-systemet.<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">Livmoderkr\u00e6ft: <\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-16b5c3d3f23b99da1a8dc7529624edfc\"><strong>Link 25: <\/strong><a href=\"https:\/\/www.researchgate.net\/publication\/339232590_Melatonin_alleviates_progression_of_uterine_endometrial_cancer_by_suppressing_estrogenubiquitin_CSDHB-mediated_succinate_accumulation\" target=\"_blank\" rel=\"noopener\">Melatonin alleviates progression of uterine endometrial cancer<\/a> (ResearchGate, 2020) \n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-688930c9599abf19a3d6d57638dbfaaf\"><strong>Indhold:<\/strong> Et videnskabeligt studie, der dokumenterer, hvordan melatonin specifikt h\u00e6mmer udviklingen af livmoderkr\u00e6ft. Resultaterne viser, at hormonet virker ved at blokere de \u00f8strogen-drevne signalveje, der f\u00e5r tumoren til at vokse, hvilket bekr\u00e6fter dets potentiale som en m\u00e5lrettet, metabolisk behandling.<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">\u00c6ggestokkr\u00e6ft:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-85b19eeaea21d7d957f6941713eaf8dc\"><strong>Link 26:<\/strong> <a href=\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC12314884\/\" target=\"_blank\" rel=\"noopener\">Melatonin: a natural guardian in cancer treatment<\/a> (PubMed Central, 2025) \n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-0b382a30c6154a274e87e5eecad9170a\"><strong>Indhold:<\/strong> En ny videnskabelig artikel fra 2025, der beskriver melatonins potentiale i kr\u00e6ftbehandling. Den fremh\u00e6ver, hvordan melatonin specifikt kan reducere tumorbyrden ved \u00e6ggestokkr\u00e6ft ved at h\u00e6mme centrale signalveje (som AKT og \u03b2-catenin) og bremse cellernes v\u00e6kstcyklus.<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">\u00d8jenkr\u00e6ft:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-45ffaf709c606fd9ad350d4cadeba456\"><strong>Link 27:<\/strong> <a href=\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC9006630\/\" target=\"_blank\" rel=\"noopener\">The rationale for treating uveal melanoma with adjuvant melatonin<\/a> (National Institutes of Health, 2022) \n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-d1da387f8503c6bf20825dd799a34192\"><strong>Indhold:<\/strong> En videnskabelig gennemgang, der argumenterer for brugen af melatonin som en supplerende behandling ved moderm\u00e6rkekr\u00e6ft i \u00f8jet. Artiklen beskriver, hvordan hormonet kan h\u00e6mme metastasering, styrke immunforsvaret og fungere anti-inflammatorisk, hvilket underst\u00f8tter dets potentiale til at forbedre prognosen.<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Tilbage til:<\/strong> <a href=\"#skema-02\"><mark style=\"background-color:rgba(0, 0, 0, 0)\" class=\"has-inline-color has-custom-menu-links-color\">Oversigtsskema for Kosttilskud<\/mark><\/a><\/p>\n\n\n\n<h4 class=\"wp-block-heading\" id=\"modificeret\">20. <a href=\"https:\/\/jegharkraeft.dk\/citrus-pectin\/\">Modificeret Citrus Pectin<\/a> (MCP)<\/h4>\n\n\n\n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-3a23e4abf090bba44e79ab2469c68a22\"><strong>Link 1:<\/strong> <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/38597504\/\" target=\"_blank\" rel=\"noopener\">Breaking barriers: How modified citrus pectin inhibits galectin-8<\/a> (PubMed, 2024)\n<ul class=\"wp-block-list\">\n<li><strong>Relevans:<\/strong> Modified citrus pectin (MCP), is\u00e6r den aktive komponent MCP-30-3, kan binde specifikt til galectin-8 og dermed potentielt h\u00e6mme processer i kr\u00e6ftspredning, hvilket \u00e5bner muligheder for udvikling af funktionelle f\u00f8devarer med anticancer-egenskaber.<\/li>\n<\/ul>\n<\/li>\n\n\n\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-1d93f8ad2a052206c5c790c7ed988258\"><strong>Link 2:<\/strong> <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/38398646\/\" target=\"_blank\" rel=\"noopener\">Therapeutic Potential of Pectin and Its Derivatives in Chronic Diseases<\/a> (PubMed, 2024)\n<ul class=\"wp-block-list\">\n<li><strong>Relevans:<\/strong> Pektin, en naturlig forbindelse fra planter, har vist sig at have gavnlige virkninger mod kroniske sygdomme som hjerte-kar-sygdomme, cancer og andre, og kan v\u00e6re en mindre skadelig alternativ behandling.<\/li>\n<\/ul>\n<\/li>\n\n\n\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-47c850a9075554ed516d586187225b51\"><strong>Link 3:<\/strong> <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/38264044\/\" target=\"_blank\" rel=\"noopener\">Potential therapeutic target for polysaccharide inhibition of colon cancer progression <\/a>(PubMed, 2024)\n<ul class=\"wp-block-list\">\n<li><strong>Relevans:<\/strong> Naturlige polysaccharider, is\u00e6r citruspektin, kan reducere tumorst\u00f8rrelsen i coloncancer og har potentiale som en sikker og effektiv behandling, men udfordringer med bio-tilg\u00e6ngelighed skal overvindes, f\u00f8r de kan anvendes bredt i klinikken.<\/li>\n<\/ul>\n<\/li>\n\n\n\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-7d1fa84eeab480f01564cd5e19113799\"><strong>Link 4:<\/strong> <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/39886510\/\" target=\"_blank\" rel=\"noopener\">How do tumours outside the gastrointestinal tract respond to dietary fibre supplementation?<\/a> (PubMed 2023)\n<ul class=\"wp-block-list\">\n<li><strong>Relevans:<\/strong> Kostfibre, herunder citruspektin, kan forbedre kr\u00e6ftbehandling ved at modulere tarmfloraen, styrke immunresponset og mindske bivirkninger, men mange voksne f\u00e5r ikke nok fibre, hvilket understreger vigtigheden af \u00f8get fiberindtag i kr\u00e6ftpatienter.<\/li>\n<\/ul>\n<\/li>\n\n\n\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-ff0d6803151c142cdf7d7a64a8936e9a\">L<strong>ink 5:<\/strong> <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/37630724\/\" target=\"_blank\" rel=\"noopener\">Modified Citrus Pectin Treatment in Non-Metastatic Biochemically Relapsed Prostate Cancer: Long-Term Results of a Prospective Phase II Study<\/a> (PubMed, 2023)\n<ul class=\"wp-block-list\">\n<li><strong>Relevans:<\/strong> I et langvarigt studie viste kosttilskuddet Modificeret Citrus Pectin (P-MCP) en sikker og holdbar, stabiliserende effekt hos 85% af m\u00e6nd med prostatakr\u00e6ft, hvor kun PSA-tallet stiger (uden tegn p\u00e5 spredning).<\/li>\n<\/ul>\n<\/li>\n\n\n\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-5199cdffb0e3286ae85f9bb6b83af0e1\"><strong>Link 6:<\/strong> <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/34462562\/\" target=\"_blank\" rel=\"noopener\">Modified citrus pectin inhibits breast cancer development in mice by targeting tumor-associated macrophage survival and polarization in hypoxic microenvironment<\/a> (PubMed, 2021)\n<ul class=\"wp-block-list\">\n<li><strong>Relevans:<\/strong> Nye studier viser, at kosttilskuddet Modificeret Citrus Pektin (MCP) bek\u00e6mper brystkr\u00e6ft indirekte ved at sulte og h\u00e6mme de &#8220;hj\u00e6lper-celler&#8221; (TAMs), som er afg\u00f8rende for tumorens v\u00e6kst og overlevelse, is\u00e6r i iltfattige omr\u00e5der.<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Tilbage til:<\/strong> <a href=\"#skema-02\"><mark style=\"background-color:rgba(0, 0, 0, 0)\" class=\"has-inline-color has-custom-menu-links-color\">Oversigtsskema for Kosttilskud<\/mark><\/a><\/p>\n\n\n\n<h4 class=\"wp-block-heading\" id=\"nac\">21. <a href=\"https:\/\/jegharkraeft.dk\/n-acetyl-cystein\/\">N-acetyl-cystein<\/a> (NAC)<\/h4>\n\n\n\n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-9086172b8e9f8f98133f3d1b145ce3e0\"><strong>Link 1:<\/strong> <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/40403956\/\" target=\"_blank\" rel=\"noopener\">N-acetyl-L-cysteine promoted hematopoietic recovery in patients with acute myeloid leukemia after complete remission&#8211;A pilot study<\/a> (PubMed, 2025)\n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-020565a15108feaa2dd1ea5c83c2bf55\"><strong>Relevans: <\/strong>Et pilotstudie p\u00e5 leuk\u00e6mipatienter (AML) viser, at kosttilskuddet N-acetyl-L-cystein (NAC) sikkert og markant fremskynder genopbygningen af blodplader efter kemoterapi. Effekten skyldes, at NAC forbedrer funktionen af de essentielle &#8220;hj\u00e6lper-celler&#8221; i knoglemarven, som er n\u00f8dvendige for at danne nye blodceller.<\/li>\n<\/ul>\n<\/li>\n\n\n\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-249b83c0a5189ba8fc85c7765cd17c3c\"><strong>Link 2:<\/strong> <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/40452041\/\" target=\"_blank\" rel=\"noopener\">Effects of functional antioxidants on the expansion of gamma delta T-cells and their cellular cytotoxicity against bladder cancer cells<\/a> (PubMed, 2025)\n<ul class=\"wp-block-list\">\n<li><strong>Relevans:<\/strong> Et nyt studie viser, at selvom antioxidanter som NAC og E-vitamin svagt h\u00e6mmer v\u00e6ksten af immunceller (T-celler) i laboratoriet, resulterer processen i T-celler, der efterf\u00f8lgende er markant mere effektive til at dr\u00e6be bl\u00e6rekr\u00e6ftceller.<\/li>\n<\/ul>\n<\/li>\n\n\n\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-97caf3d5aace6eeb5a797a36bcc64db2\"><strong>Link 3:<\/strong> <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/40288174\/\" target=\"_blank\" rel=\"noopener\">Ru(II)-thymine complex suppresses acute myeloid leukemia stem cells by inhibiting NF-\u03baB signaling<\/a> (PubMed, 2025)\n<ul class=\"wp-block-list\">\n<li><strong>Relevans:<\/strong> Et nyt Ruthenium-baseret stof (RTC) dr\u00e6ber effektivt stamceller i Akut Myeloid Leuk\u00e6mi (AML) ved at h\u00e6mme en central overlevelses-signalvej (NF-\u03baB). Studiet viste, at denne mekanisme er uafh\u00e6ngig af oxidativt stress, da antioxidanten NAC ikke kunne stoppe den celledr\u00e6bende effekt.<\/li>\n<\/ul>\n<\/li>\n\n\n\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-8ee04d197d20834c812cdbeae24ea8b8\"><strong>Link 4:<\/strong> <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/40389420\/\" target=\"_blank\" rel=\"noopener\">NAT10 promotes hepatocellular carcinoma progression by modulating the ac4C-DDIAS-PI3K-Akt axis<\/a> (PubMed, 2025)\n<ul class=\"wp-block-list\">\n<li><strong>Relevans:<\/strong> Et nyt studie viser, at et h\u00f8jt niveau af proteinet NAT10 er forbundet med d\u00e5rligere overlevelse ved leverkr\u00e6ft. Studiet afd\u00e6kker, at NAT10 driver kr\u00e6ftens v\u00e6kst og spredning ved at aktivere den centrale PI3K\/AKT-signalvej via en nyopdaget mekanisme (ac4C-DDIAS).<\/li>\n<\/ul>\n<\/li>\n\n\n\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-ca49d4714cc2be34604c4e9766fb6421\"><strong>Link 5:<\/strong> <a href=\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC3951553\/\" target=\"_blank\" rel=\"noopener\">Curcumin: A Double Hit on Malignant Mesothelioma &#8211; PMC<\/a> (National Institutes of Health, 2014) \n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-464e401a587b66ef933cde065f0cdc9b\"><strong>Indhold:<\/strong> Studie, der viser, at Curcumin h\u00e6mmer NF-\u03baB og inducerer celled\u00f8d (pyroptose). Artiklen dokumenterer ogs\u00e5, at N-acetyl-L-cysteine blokerer denne celled\u00f8d ved at fjerne det n\u00f8dvendige oxidative stress.<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Tilbage til:<\/strong> <a href=\"#skema-02\"><mark style=\"background-color:rgba(0, 0, 0, 0)\" class=\"has-inline-color has-custom-menu-links-color\">Oversigtsskema for Kosttilskud<\/mark><\/a><\/p>\n\n\n\n<h4 class=\"wp-block-heading\" id=\"omega-3\">22. <a href=\"https:\/\/jegharkraeft.dk\/omega-3\/\">Omega-3<\/a> (Fiskeolie)<\/h4>\n\n\n\n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-fc6d9db20f3602794268afccca654e82\"><strong>Link 1:<\/strong> <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/39895102\/\" target=\"_blank\" rel=\"noopener\">Alpha-linolenic acid-mediated epigenetic reprogramming of cervical cancer cell lines<\/a> (PubMed, 2025)\n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-0b7a92336319e890eca4076fe3697fad\"><strong>Relevans:<\/strong> Et nyt studie viser, at omega-3-fedtsyren ALA (alfa-linolensyre) kan h\u00e6mme v\u00e6ksten af livmoderhalskr\u00e6ftceller. ALA virker ved at justere cellernes &#8220;epigenetiske kontakter&#8221;, hvilket b\u00e5de slukker for kr\u00e6ftfremmende gener og genaktiverer kroppens egne, indbyggede kr\u00e6ft-bremsende gener.<\/li>\n<\/ul>\n<\/li>\n\n\n\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-f4d2416055b06d4ec05828d0891ade34\"><strong>Link 2:<\/strong> <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/40349644\/\" target=\"_blank\" rel=\"noopener\">Effect of omega-3 and omega-6 fatty acids on tumor suppressor pathways in mice tongue oral epithelial dysplasia<\/a> (PubMed, 2025)\n<ul class=\"wp-block-list\">\n<li><strong>Relevans:<\/strong> I et dyrestudie udviklede mus p\u00e5 en di\u00e6t rig p\u00e5 omega-6-fedtsyrer (fra majsolie) signifikant flere forstadier til tungekr\u00e6ft end de mus, der fik en di\u00e6t rig p\u00e5 omega-3 (fra fiskeolie). Studiet konkluderer, at et h\u00f8jere indtag af omega-3 og et lavere indtag af omega-6 kan v\u00e6re en vigtig forebyggende strategi.<\/li>\n<\/ul>\n<\/li>\n\n\n\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-7747de014c670feaf122ab9a8c156da3\"><strong>Link 3:<\/strong> <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/40122242\/\" target=\"_blank\" rel=\"noopener\">Unsaturated fatty acid-doped liposomes deliver piperine to deactivate defensive mechanism for ferroptosis in cancer therapy<\/a> (PubMed, 2025)\n<ul class=\"wp-block-list\">\n<li><strong>Relevans:<\/strong> Et nyt system dr\u00e6ber kr\u00e6ftceller via en proces kaldet ferroptose (en form for celled\u00f8d) ved at bruge en kombination af fedtsyren DHA og piperin (fra sort peber). Kombinationen virker ved samtidigt at deaktivere kr\u00e6ftcellens to vigtigste forsvarssystemer (GPX4 og DHODH) mod denne type angreb.<\/li>\n<\/ul>\n<\/li>\n\n\n\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-e575fed6978b3e0f386a365055a6879f\"><strong>Link 4:<\/strong> <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/40481119\/\" target=\"_blank\" rel=\"noopener\">Effects of polyunsaturated fatty acids on gastric cancer immunity and immunotherapy <\/a>(PubMed, 2025)\n<ul class=\"wp-block-list\">\n<li><strong>Relevans:<\/strong> Et nyt studie af patienter med fremskreden mavekr\u00e6ft i immunterapi viser, at balancen mellem omega-6 og omega-3 fedtsyrer er afg\u00f8rende for behandlingsresultatet. En lavere omega-6\/omega-3-ratio i blodet var forbundet med et bedre immunrespons i tumoren og markant l\u00e6ngere overlevelse.<\/li>\n<\/ul>\n<\/li>\n\n\n\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-81a83962135a1e0e471d3568fbbe7845\"><strong>Link 5:<\/strong> <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/40430008\/\" target=\"_blank\" rel=\"noopener\">Nutrigenetics and Omega-3 and Gamma-Linolenic Acid Intake and Status in Patients with Cancer: A PRISMA Scoping Review of Research Trends and Challenges<\/a> (PubMed, 2025)\n<ul class=\"wp-block-list\">\n<li><strong>Relevans:<\/strong> Genetiske variationer i de fedt-oms\u00e6ttende gener FADS1 og FADS2 er en sandsynlig forklaring p\u00e5, hvorfor kostens fedtsyrer p\u00e5virker kr\u00e6ftrisiko forskelligt fra person til person. Forskningsomr\u00e5det er dog meget nyt, og der mangler endnu solid viden om samspillet mellem kost, gener og kr\u00e6ft.<\/li>\n<\/ul>\n<\/li>\n\n\n\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-f62edaf81f492a0d63d69cf9a94fe36a\"><strong>Link 6: <\/strong><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/40320870\/\" target=\"_blank\" rel=\"noopener\">Synergic Effects and Possible Mechanism of Omega-6 Fatty Acids (\u03c9-6) on Immune System, Inflammation, and Cancer<\/a> (PubMed, 2025)\n<ul class=\"wp-block-list\">\n<li><strong>Relevans:<\/strong> Omega-6-fedtsyrer har en kritisk dobbeltrolle i forhold til kr\u00e6ft: Afh\u00e6ngigt af hvordan de oms\u00e6ttes i kroppen, kan de enten skabe stoffer, der fremmer inflammation og kr\u00e6ftv\u00e6kst, eller stoffer, der aktivt d\u00e6mper inflammation. Da moderne kost ofte er for rig p\u00e5 omega-6, er balancen i forhold til omega-3 i kosten afg\u00f8rende.<\/li>\n<\/ul>\n<\/li>\n\n\n\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-b1311f83b7d20979bbf8bf9028b03c77\"><strong>Link 7:<\/strong><a href=\"https:\/\/www.nature.com\/articles\/s41419-024-06641-6\" target=\"_blank\" rel=\"noopener\"> Dietary factors and their influence on immunotherapy strategies in oncology: a comprehensive review<\/a> (Nature, 2024)\n<ul class=\"wp-block-list\">\n<li><strong>Indhold:<\/strong> En oversigtsartikel der beskriver, hvordan specifikke kostkomponenter (f.eks. fedtsyrer og n\u00e6ringsstoffer) kan forbedre immunterapi ved at modulere immunresponset. Artiklen er relevant, fordi den validerer, at kosttilskud (herunder omega-3) har en immunmodulerende effekt og p\u00e5virker den inflammatoriske del af kr\u00e6ftmilj\u00f8et.<\/li>\n<\/ul>\n<\/li>\n\n\n\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-d20b6e676a6b01cca14f4294014c96e2\"><strong>Link 8:<\/strong> <a href=\"https:\/\/www.mdpi.com\/2076-3417\/14\/11\/4548\" target=\"_blank\" rel=\"noopener\">Cellular Basis of Adjuvant Role of n-3 Polyunsaturated Fatty Acids in Cancer Therapy: Molecular Insights and Therapeutic Potential against Human Melanoma<\/a> (MDPI, 2024)\n<ul class=\"wp-block-list\">\n<li><strong>Indhold:<\/strong> En oversigtsartikel, der beskriver det cellul\u00e6re grundlag for Omega-3 (n-3 PUFA) som adjuverende middel. Artiklen underst\u00f8tter den anti-inflammatoriske og supplerende rolle ved at beskrive, hvordan Omega-3 fungerer sammen med traditionel kr\u00e6ftbehandling.<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">Binyrebarkkr\u00e6ft:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-ad7dbc6f16963affac9efdc8f85b574f\"><strong>Link 9:<\/strong> <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/37264945\/\" target=\"_blank\" rel=\"noopener\">Association Between Omega-3 Fatty Acid Intake and changes in lipid levels<\/a> (National Institutes of Health, 2023) \n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-b23e7ae3d0462b1ca78335c9114e3376\"><strong>Indhold:<\/strong> En omfattende meta-analyse, der dokumenterer Omega-3 fedtsyrers evne til effektivt at s\u00e6nke niveauet af triglycerider og &#8220;d\u00e5rligt&#8221; kolesterol. Da behandling med Mitotane er kendt for at medf\u00f8re voldsomme stigninger i netop disse fedtstoffer, underst\u00f8tter studiet anvendelsen af fiskeolie som en strategi til at modvirke denne bivirkning.<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">Hjernekr\u00e6ft:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-67b4b0b810a6b80e5107ad89b914c53a\"><strong>Link 10:<\/strong> <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/41009329\/\" target=\"_blank\" rel=\"noopener\">The Omega-3 Fatty Acids Eicosapentaenoic Acid and Docosahexaenoic Acid Interfere with Drug Resistance in Glioma<\/a> (PubMed, 2025)\n<ul class=\"wp-block-list\">\n<li><strong>Indhold:<\/strong> Et studie der unders\u00f8ger, hvordan omega-3 fedtsyrer kan modvirke medicinresistens i gliom-celler. Resultaterne peger p\u00e5, at disse fedtsyrer forstyrrer kr\u00e6ftcellernes forsvarsmekanismer.<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">Myelomatose\/ Knoglemarvskr\u00e6ft:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-4ff34f0f92976409a3f132c0225b6e38\"><strong>Link 11:<\/strong> <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/25277647\/\" target=\"_blank\" rel=\"noopener\">Omega-3 fatty acids, EPA and DHA induce apoptosis and enhance drug sensitivity in multiple myeloma cells but not in normal peripheral mononuclear cells<\/a> (PubMed, 2018) \n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-4226fb2a245cef0a6465e7c00d2651ee\"><strong>Indhold:<\/strong> Forskning, der viser, at omega-3 fedtsyrer kan tr\u00e6nge ind i myelomatose-cellernes membraner og udl\u00f8se signaler, der f\u00f8rer til celled\u00f8d, samtidig med at de d\u00e6mper den inflammation (IL-6), der driver sygdommen.<\/li>\n<\/ul>\n<\/li>\n\n\n\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-bdcc5a234f8eeb878edca0cc9dd337ac\"><strong>Link 12:<\/strong> <a href=\"https:\/\/www.nature.com\/articles\/s41598-025-12804-y\" target=\"_blank\" rel=\"noopener\">Genetic evidence reveals phosphatidylcholine as a causal factor for multiple myeloma<\/a> (Nature, 2025) \n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-50e99b4f37a58762baf0ac8edc65284a\"><strong>Indhold:<\/strong> Et videnskabeligt studie, der blandt andet fremh\u00e6ver betydningen af fedtsyrer i myelomatose. Artiklen refererer til forskning, der viser, at omega-3 fedtsyrer kan modvirke kr\u00e6ftcellernes evne til at undertrykke immunsystemet. Konkret hj\u00e6lper omega-3 med at genaktivere kroppens naturlige dr\u00e6berceller (NK-celler) ved at blokere de signaler (exosomer), kr\u00e6ften udsender for at beskytte sig.<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">Nyrekr\u00e6ft:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-6ed243d2546a0e0f409aa91de2f13ac6\"><strong>Link 13:<\/strong> <a href=\"https:\/\/www.spandidos-publications.com\/10.3892\/ol.2013.1336\" target=\"_blank\" rel=\"noopener\">\u03b1-linolenic acid inhibits human renal cell carcinoma cell proliferation and induces apoptosis<\/a> (National Institutes of Health, 2013)\n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-d1d1ff17ab5290c79d2c08a6d8ab8c5b\"><strong>Indhold:<\/strong> Et videnskabeligt studie, der viser, at en bestemt type omega-3 fedtsyre effektivt kan bremse v\u00e6ksten af nyrekr\u00e6ftceller. Resultaterne dokumenterer, at fedtsyrerne aktiverer mekanismer, der tvinger kr\u00e6ftcellerne til at d\u00f8 (apoptose) og samtidig forhindrer dem i at dele sig.<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Tilbage til:<\/strong> <a href=\"#skema-02\"><mark style=\"background-color:rgba(0, 0, 0, 0)\" class=\"has-inline-color has-custom-menu-links-color\">Oversigtsskema for Kosttilskud<\/mark><\/a><\/p>\n\n\n\n<h4 class=\"wp-block-heading\" id=\"pau\">23. <a href=\"https:\/\/jegharkraeft.dk\/pau-darco\/\">Pau D&#8217;Arco<\/a><\/h4>\n\n\n\n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-8794e08983a12500455713360bad5d15\"><strong>Link 1:<\/strong> <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/34118341\/\" target=\"_blank\" rel=\"noopener\">Unfolding the apoptotic mechanism of antioxidant enriched-leaves of Tabebuia pallida (lindl.) miers in EAC cells and mouse model<\/a> (PubMed, 2021)\n<ul class=\"wp-block-list\">\n<li><strong>Relevans:<\/strong> Et ekstrakt fra bladene af medicinplanten <em>Tabebuia pallida<\/em> viser i nye dyre- og laboratoriestudier st\u00e6rk anti-kr\u00e6ft effekt. Ekstraktet tvinger kr\u00e6ftceller i programmeret celled\u00f8d (apoptose) ved at \u00e6ndre balancen i cellens overlevelses- og d\u00f8ds-gener.<\/li>\n<\/ul>\n<\/li>\n\n\n\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-6fea0ce1edd6fc3fc85890a239d2140d\"><strong>Link 2:<\/strong> <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/30769041\/\" target=\"_blank\" rel=\"noopener\">Stem extract of Tabebuia chrysantha induces apoptosis by targeting sEGFR in Ehrlich Ascites Carcinoma<\/a> (PubMed, 2019)\n<ul class=\"wp-block-list\">\n<li><strong>Relevans:<\/strong> Et ekstrakt fra stammebarken p\u00e5 tr\u00e6et <em>Tabebuia chrysantha<\/em>, som indeholder stoffer som \u03b2-lapachone, har i dyrefors\u00f8g vist en st\u00e6rk, celledr\u00e6bende effekt p\u00e5 kr\u00e6ftceller. Studiet konkluderer, at ekstraktet virker ved at h\u00e6mme en vigtig v\u00e6kstfaktor-receptor (sEGFR), hvilket f\u00f8rer til programmeret celled\u00f8d (apoptose).<\/li>\n<\/ul>\n<\/li>\n\n\n\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-ab1bd36863da5975e10c5dca1cd5a81c\"><strong>Link 3:<\/strong> <a href=\"https:\/\/www.verywellhealth.com\/what-is-pau-darco-89494\" target=\"_blank\" rel=\"noopener\">All About Pau D\u2019Arco, an Herbal Ingredient Found in Supplements<\/a> (Very Well Health, 2024)\n<ul class=\"wp-block-list\">\n<li><strong>Relevans:<\/strong> Pau d&#8217;arco er en sydamerikansk medicinplante, der indeholder de aktive stoffer lapachol og beta-lapachone. Forel\u00f8bige laboratoriestudier unders\u00f8ger dens potentiale til at reducere inflammation og bek\u00e6mpe infektioner samt kr\u00e6ft, men planten er truet af skovrydning.<\/li>\n<\/ul>\n<\/li>\n\n\n\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-fb61098b069dfaf4b1a0a8a14da40859\"><strong>Link 4:<\/strong> <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/40233483\/\" target=\"_blank\" rel=\"noopener\">A density functional theory study on the adsorption of the \u03b2-lapachone anti-cancer drug onto the MB<sub>11<\/sub>N<sub>12<\/sub>&nbsp;(M = au, Rh and Ru) nanoclusters as a drug delivery<\/a> (PubMed, 2025)\n<ul class=\"wp-block-list\">\n<li><strong>Relevans: <\/strong>Via computermodeller har forskere vist, at en mikroskopisk &#8220;transport-klynge&#8221; (af typen B12N12), n\u00e5r den opgraderes med et metal-atom som Ruthenium, bliver en meget effektiv transport\u00f8r for anti-kr\u00e6ft stoffet \u03b2-lapachone. Dette \u00e5bner for nye muligheder inden for udviklingen af m\u00e5lrettede systemer til at levere medicin.<\/li>\n<\/ul>\n<\/li>\n\n\n\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-56c8cf99f8940ad4912cf7d502d51a71\"><strong>Link 5:<\/strong> <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/40014262\/\" target=\"_blank\" rel=\"noopener\">Chlorogenic Acid Enhances Beta-Lapachone-Induced Cell Death by Suppressing Autophagy in NQO1-Positive Cancer Cells<\/a> (PubMed, 2025)\n<ul class=\"wp-block-list\">\n<li><strong>Relevans:<\/strong> Et nyt studie viser, at antioxidanten klorogensyre (CGA) markant forst\u00e6rker den celledr\u00e6bende effekt af anti-kr\u00e6ft-stoffet beta-lapachone. Kombinationen virker ved at blokere kr\u00e6ftcellernes overlevelsesmekanisme, kendt som autofagi (cellul\u00e6r selv-spisning), hvilket kan overvinde medicinresistens.<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Tilbage til:<\/strong> <a href=\"#skema-02\"><mark style=\"background-color:rgba(0, 0, 0, 0)\" class=\"has-inline-color has-custom-menu-links-color\">Oversigtsskema for Kosttilskud<\/mark><\/a><\/p>\n\n\n\n<h4 class=\"wp-block-heading\" id=\"probiotika\">24. <a href=\"https:\/\/jegharkraeft.dk\/maelkesyrebakterier\/\">Probiotika<\/a><\/h4>\n\n\n\n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-34de96296c0e385a93666fa4ee066633\"><strong>Link 1:<\/strong> <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/40484980\/\" target=\"_blank\" rel=\"noopener\">Interaction between the breast tumor microenvironment and gut microbiome<\/a> (PubMed, 2025)\n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-3e540caf753033305625e06c26ed5953\"><strong>Relevans:<\/strong> Ny forskning viser, at brystkr\u00e6ft er t\u00e6t forbundet med kroppens bakterier, b\u00e5de i selve brystv\u00e6vet og is\u00e6r i tarmen. En ubalance i tarmfloraen kan p\u00e5virke kroppens \u00f8strogen-niveauer og immunforsvar, mens visse probiotiske bakterier som <em>Akkermansia<\/em> og <em>Bifidobacterium<\/em> ser ud til at have en beskyttende effekt.<\/li>\n<\/ul>\n<\/li>\n\n\n\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-9600ca4f36a7a3f4ddbe8e1f76395840\"><strong>Link 2:<\/strong> <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/40464639\/\" target=\"_blank\" rel=\"noopener\">Implications of gut microbiota-mediated epigenetic modifications in intestinal diseases<\/a> (PubMed, 2025)\n<ul class=\"wp-block-list\">\n<li><strong>Relevans: <\/strong>Ubalance i tarmens bakterier kan drive tarmsygdomme som inflammatorisk tarmsygdom (IBD) og tarmkr\u00e6ft ved at forstyrre kroppens epigenetiske &#8220;t\u00e6nd\/sluk-kontakter&#8221; for gener. Fremtidig behandling kan derfor sigte mod at rette op p\u00e5 disse epigenetiske fejl via m\u00e5lrettede indgreb som probiotika, kost\u00e6ndringer eller transplantation af tarmbakterier.<\/li>\n<\/ul>\n<\/li>\n\n\n\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-0c4143f6ef3ff00e3a073dd965bc53cc\"><strong>Link 3:<\/strong> <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/40166981\/\" target=\"_blank\" rel=\"noopener\">Gut microbiota in hepatocellular carcinoma immunotherapy: immune microenvironment remodeling and gut microbiota modification<\/a> (PubMed, 2025)\n<ul class=\"wp-block-list\">\n<li><strong>Relevans: <\/strong>Tarmbakteriers balance er afg\u00f8rende for leverkr\u00e6ft (HCC) og effekten af immunterapi via den s\u00e5kaldte &#8220;tarm-lever-akse&#8221;. En lovende fremtidig strategi er derfor at manipulere tarmfloraen med f.eks. kost eller probiotika for at forbedre behandlingsresultaterne.<\/li>\n<\/ul>\n<\/li>\n\n\n\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-23e36c87f2c68073a59348edcb0ee5df\"><strong>Link 4:<\/strong> <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/39988618\/\" target=\"_blank\" rel=\"noopener\">Upregulation of&nbsp;<em>Lactobacillus spp<\/em>. in gut microbiota as a novel mechanism for environmental eustress-induced anti-pancreatic cancer effects<\/a> (PubMed, 2025)\n<ul class=\"wp-block-list\">\n<li><strong>Relevans:<\/strong> Et nyt studie viser, at den kr\u00e6fth\u00e6mmende effekt af et positivt, stimulerende milj\u00f8 ved bugspytkirtelkr\u00e6ft er medieret af tarmfloraen. Specifikt \u00f8ger milj\u00f8et m\u00e6ngden af probiotikummet <em>Lactobacillus reuteri<\/em>, som bremser tumorv\u00e6kst ved at aktivere immunforsvarets dr\u00e6berceller (NK-celler) i tumoren.<\/li>\n<\/ul>\n<\/li>\n\n\n\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-cc685cbab36a3f314043fdf207ebd121\"><strong>Link 5:<\/strong> <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/40081224\/\" target=\"_blank\" rel=\"noopener\">Overcoming immunotherapy resistance in colorectal cancer through nano-selenium probiotic complexes and IL-32 modulation<\/a> (PubMed, 2025)\n<ul class=\"wp-block-list\">\n<li><strong>Relevans:<\/strong> Et nyt &#8220;nano-biomateriale&#8221;, der kombinerer nanoteknologi med probiotisk terapi, er blevet udviklet til at overvinde resistens mod immunterapi ved tarmkr\u00e6ft. Systemet virker ved at forst\u00e6rke kroppens egne dr\u00e6bercellers (CD8+ T-celler) evne til at angribe tumoren.<\/li>\n<\/ul>\n<\/li>\n\n\n\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-3a22e09f528f773cdd8eb9d9c3f3d8a4\"><strong>Link 6:<\/strong> <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/40487754\/\" target=\"_blank\" rel=\"noopener\">Gut microbiome versus thyroid cancer: Association and clinical implications (Review)<\/a> (PubMed, 2025)\n<ul class=\"wp-block-list\">\n<li><strong>Relevans:<\/strong> Ny forskning viser en tovejs-forbindelse mellem tarmens bakterier og kr\u00e6ft i skjoldbruskkirtlen, hvor en ubalance i tarmfloraen kan drive kr\u00e6ften via inflammation og \u00e6ndret stofskifte. At genoprette balancen med f.eks. probiotika er derfor en lovende fremtidig strategi til at forbedre eksisterende behandlinger.<\/li>\n<\/ul>\n<\/li>\n\n\n\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-5895cd0077ec13ccfea4ac32c70ffb63\"><strong>Link 7:<\/strong><a href=\"https:\/\/www.nature.com\/articles\/s41419-024-06641-6\" target=\"_blank\" rel=\"noopener\"> Dietary factors and their influence on immunotherapy strategies in oncology: a comprehensive review<\/a> (Nature, 2024)\n<ul class=\"wp-block-list\">\n<li><strong>Indhold:<\/strong> En oversigtsartikel der beskriver, hvordan specifikke kostkomponenter (f.eks. fedtsyrer og n\u00e6ringsstoffer) kan forbedre immunterapi ved at modulere immunresponset. Artiklen er relevant, fordi den validerer, at kosttilskud (herunder probiotika) har en immunmodulerende effekt og p\u00e5virker den inflammatoriske del af kr\u00e6ftmilj\u00f8et.<\/li>\n<\/ul>\n<\/li>\n\n\n\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-44e5e4f612fbbbbe6cbce184880feaf3\"><strong>Link 6:<\/strong><a href=\"https:\/\/cancerci.biomedcentral.com\/articles\/10.1186\/s12935-023-03031-4\" target=\"_blank\" rel=\"noopener\"> 3,3\u2032-Diindolylmethane and indole-3-carbinol: potential chemopreventive agents<\/a> (Cancer Cell International, 2023)\n<ul class=\"wp-block-list\">\n<li><strong>Indhold:<\/strong> En oversigtsartikel, der beskriver, hvordan DIM og I3C (som stammer fra korsblomstrede gr\u00f8ntsager) kan tilbyde beskyttelse mod hormonafh\u00e6ngige kr\u00e6ftformer. Artiklen validerer DIM \/ I3C&#8217;s Hovedstrategi (1)-status i hormonf\u00f8lsom brystkr\u00e6ft ved at fokusere p\u00e5 deres rolle i \u00f8strogen-metabolisme.<\/li>\n<\/ul>\n<\/li>\n\n\n\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-6581d3bfec50edc119a0eef00f4e6220\"><strong>Link 7:<\/strong> <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/40780216\/\" target=\"_blank\" rel=\"noopener\">Tumor-resident probiotic Clostridium butyricum improves aPD-1 efficacy in colorectal cancer models by inhibiting IL-6-mediated immunosuppression <\/a>(PubMed, 2025) \n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-347c5aa2a40a05fe11ade98d42979458\"><strong>Indhold:<\/strong> Studie, der identificerer et Probiotikum (Clostridium butyricum), der forst\u00e6rker anti-tumor effekt i MSI-H-modeller. Dette underst\u00f8tter strategiens fokus p\u00e5 immunmodulering og brug af Probiotika som Hovedstrategi (1).<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Tilbage til:<\/strong> <a href=\"#skema-02\"><mark style=\"background-color:rgba(0, 0, 0, 0)\" class=\"has-inline-color has-custom-menu-links-color\">Oversigtsskema for Kosttilskud<\/mark><\/a><\/p>\n\n\n\n<h4 class=\"wp-block-heading\" id=\"quercetin\">25. <a href=\"https:\/\/jegharkraeft.dk\/quercetin\/\">Quercetin<\/a><\/h4>\n\n\n\n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-bf0b95ce460c3ec3e225528f7d8d9aa9\"><strong>Link 1:<\/strong> <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/40412371\/\" target=\"_blank\" rel=\"noopener\">The role of quercetin in modulating lipid metabolism and enhancing chemotherapy via the STAT3-CPT1B pathway in pancreatic cancer <\/a>(PubMed, 2025)\n<ul class=\"wp-block-list\">\n<li><strong>Relevans:<\/strong> Quercetin har en anti-kr\u00e6ft effekt ved at forstyrre kr\u00e6ftcellers fedtstofskifte via STAT3-signalvejen, og viser desuden en forst\u00e6rket terapeutisk virkning, n\u00e5r det kombineres med kemoterapien gemcitabin.<\/li>\n<\/ul>\n<\/li>\n\n\n\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-1dc1b9334ba75ca46b8e819571eb3916\"><strong>Link 2: <\/strong><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/40209461\/\" target=\"_blank\" rel=\"noopener\">Structural related oxidovanadium(IV)-flavonoid complexes. Influence on their anticancer effects<\/a> (PubMed, 2025)\n<ul class=\"wp-block-list\">\n<li><strong>Relevans:<\/strong> Ved at binde metallet Vanadium til flavonoider som Quercetin har forskere forst\u00e6rket deres anti-kr\u00e6ft effekt. Kombinationen omdanner de normalt beskyttende flavonoider til &#8220;pro-oxidanter&#8221;, der selektivt dr\u00e6ber lungekr\u00e6ftceller ved at skabe m\u00e5lrettet oxidativt stress, mens de i h\u00f8j grad sk\u00e5ner normale celler.<\/li>\n<\/ul>\n<\/li>\n\n\n\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-d3c66cd5005616c20db119282b0a59d0\"><strong>Link 3:<\/strong> <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/40127723\/\" target=\"_blank\" rel=\"noopener\">Quercetin liposomes conjugated with hyaluronidase: An efficient drug delivery system to block pancreatic cancer <\/a>(PubMed, 2025)\n<ul class=\"wp-block-list\">\n<li><strong>Relevans:<\/strong> Forskere har udviklet en ny &#8216;2-i-1&#8217; strategi mod bugspytkirtelkr\u00e6ft, hvor et enzym f\u00f8rst nedbryder tumorens beskyttende skjold. Dette tillader efterf\u00f8lgende det aktive stof, Quercetin, at tr\u00e6nge dybt ind og dr\u00e6be de nu s\u00e5rbare kr\u00e6ftceller.<\/li>\n<\/ul>\n<\/li>\n\n\n\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-e58cb90bcbad73685aaed139ac484f53\"><strong>Link 4:<\/strong> <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/40478357\/\" target=\"_blank\" rel=\"noopener\">Unveiling the mechanisms of Tianjihuang in hepatocellular carcinoma: a network pharmacology and molecular docking study<\/a> (PubMed, 2025)\n<ul class=\"wp-block-list\">\n<li><strong>Relevans:<\/strong> Et bladekstrakt fra medicinplanten <em>Tabebuia pallida<\/em>, der indeholder aktive stoffer som quercetin og lapachol, viser i nye studier st\u00e6rk anti-kr\u00e6ft effekt ved at tvinge kr\u00e6ftceller i programmeret celled\u00f8d (apoptose).<\/li>\n<\/ul>\n<\/li>\n\n\n\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-b021e5e7f2ad738b9ca7b615f19cf771\"><strong>Link 5:<\/strong> <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/40394846\/\" target=\"_blank\" rel=\"noopener\">Assessment of Cytotoxic Effects of Quercetin Nanoemulgel on Different Skin Cancer cell lines<\/a> (PubMed, 2025)\n<ul class=\"wp-block-list\">\n<li><strong>Relevans: <\/strong>Disse resultater indikerer, at et &#8220;nanoemulgel&#8221; er en effektiv leveringsmetode, der forbedrer b\u00e5de opl\u00f8seligheden og den terapeutiske effekt af stoffet quercetin.<\/li>\n<\/ul>\n<\/li>\n\n\n\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-11060493979afe7af2f96b14b4a9f3fc\"><strong>Link 6:<\/strong> <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/39760839\/\" target=\"_blank\" rel=\"noopener\">Synergistic Inhibition of Breast Carcinoma Cell Proliferation by Quercetin and Sulforaphane via Activation of the ERK\/MAPK Pathway<\/a> (PubMed, 2025)\n<ul class=\"wp-block-list\">\n<li><strong>Relevans:<\/strong> En kombination af kosttilskuddene Quercetin og Sulforaphane har i et nyt laboratoriestudie vist en st\u00e6rk synergistisk og celledr\u00e6bende effekt mod brystkr\u00e6ftceller. Effekten opn\u00e5s ved at skabe \u00f8del\u00e6ggende oxidativt stress og blokere den centrale ERK\/MAPK-v\u00e6kstsignalvej.<\/li>\n<\/ul>\n<\/li>\n\n\n\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-c822784fb911328f878409bf04290405\"><strong>Link 7: <\/strong><a href=\"https:\/\/www.nature.com\/articles\/s41419-020-03144-y\" target=\"_blank\" rel=\"noopener\">Targeting BCL-2 in B-cell malignancies and overcoming resistance <\/a>(Nature, 2020)\n<ul class=\"wp-block-list\">\n<li><strong>Indhold:<\/strong> En autoritativ oversigtsartikel, der bekr\u00e6fter, at h\u00e6mning af BCL-2-familien er en rationel terapeutisk strategi for lymfomer og andre B-celle maligniteter. Artiklen diskuterer, hvordan BCL-2-afh\u00e6ngige tilstande (som f.eks. Follikul\u00e6rt Lymfom) behandles ved at genoprette cellens evne til at d\u00f8 (apoptose).<\/li>\n<\/ul>\n<\/li>\n\n\n\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-2b9dcf12f4554430fe6ed372bc6de9ad\"><strong>Link 8:<\/strong><a href=\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC10927384\/\" target=\"_blank\" rel=\"noopener\"> Curcumin in treatment of hematological cancers<\/a> (National Institutes of Health, 2024)\n<ul class=\"wp-block-list\">\n<li><strong>Indhold:<\/strong> En ny oversigtsartikel (2024), der specifikt underbygger relevansen af Curcumin og Quercetin i Hodgkin&#8217;s Lymfom (HL). Artiklen beskriver, hvordan begge stoffer inducerer celled\u00f8d ved at h\u00e6mme den centrale v\u00e6kstvej NF-\u03baB (som HL er afh\u00e6ngig af) og STAT3.<\/li>\n<\/ul>\n<\/li>\n\n\n\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-15518969ce24b26d6a53b982ef627211\"><strong>Link 9: <\/strong><a href=\"https:\/\/www.nature.com\/articles\/s41392-020-0110-5\" target=\"_blank\" rel=\"noopener\">Targeting cancer stem cell pathways for cancer therapy<\/a> (Nature, 2020)\n<ul class=\"wp-block-list\">\n<li><strong>Indhold:<\/strong> Oversigtsartikel, der opsummerer de prim\u00e6re faktorer og signalveje, der regulerer udviklingen af kr\u00e6ftstamceller (CSCs). Artiklen underst\u00f8tter, at CSCs er n\u00f8gledrivere for resistens og validerer de mange strategier i skemaet, der sigter mod at blokere CSC-veje.<\/li>\n<\/ul>\n<\/li>\n\n\n\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-a634580b58f1dc9bd63f0318c1e8545c\"><strong>Link 10:<\/strong> <a href=\"https:\/\/www.nature.com\/articles\/s41419-024-07077-8\" target=\"_blank\" rel=\"noopener\">Targeted therapy of cancer stem cells: inhibition of mTOR signaling pathway<\/a> (Nature, 2024) \n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-4a4d42bbda827b7a34af0b8a82cbe1c2\"><strong>Indhold: <\/strong>Oversigtsartikel, der beskriver, at Metformin h\u00e6mmer mTOR-vejen ved at aktivere AMPK. Dette validerer Metformins Hovedstrategi (1) mod resistens, da h\u00e6mning af mTOR er den mest almindelige m\u00e5de at omg\u00e5 resistens p\u00e5 i BRAF-muterede celler.<\/li>\n<\/ul>\n<\/li>\n\n\n\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-4a8c5d1f8485df24e1db03732272c79f\"><strong>Link 11:<\/strong> <a href=\"https:\/\/www.sciencedirect.com\/science\/article\/pii\/S209517792100071X\" target=\"_blank\" rel=\"noopener\">Phytochemicals targeting NF-\u03baB signaling: Potential anti-inflammatory and anti-cancer agents<\/a> (ScienceDirect.com, 2022) \n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-c2be5fe82b306694d403be2f85ce2e52\"><strong>Indhold:<\/strong> Oversigtsartikel, der beskriver, at Curcumin udviser anticancer-aktivitet ved at h\u00e6mme NF-\u03baB p65-proteinets transkriptionelle aktivitet. Dette validerer Curcumins relevans mod b\u00e5de den prim\u00e6re MAPK\/ERK-vej og den inflammatoriske NF-kB-vej i melanom.<\/li>\n<\/ul>\n<\/li>\n\n\n\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-18edef027a1fc80f5f62ab69c55d151a\"><strong>Link 12:<\/strong> <a href=\"https:\/\/www.nature.com\/articles\/s41598-025-87537-z\" target=\"_blank\" rel=\"noopener\">Metformin inhibits the growth of SCLC cells by inducing autophagy and apoptosis via the suppression of EGFR and AKT signalling<\/a> (Nature, 2025) \n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-6cac701017cee1ae1f6afc6071693eb9\"><strong>Indhold:<\/strong> Studie, der beskriver, hvordan Metformin kan genoprette f\u00f8lsomheden i NSCLC-celler over for EGFR-h\u00e6mmere ved at h\u00e6mme EGFR\/PI3K-signalvejen. Dette validerer Metformins Hovedstrategi (1) mod resistens.<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">Mavekr\u00e6ft:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-39c63e3f06d58c77fddcd3a578d5ca3a\"><strong>Link 13:<\/strong> <a href=\"https:\/\/www.mdpi.com\/1420-3049\/30\/1\/3\" target=\"_blank\" rel=\"noopener\">Resveratrol, Piceatannol, Curcumin, and Quercetin as Therapeutic Targets in Gastric Cancer<\/a> (MDPI, 2025) \n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-0bce2f2bd5d69f3d31e7e949d270aa5f\"><strong>Indhold:<\/strong> En helt ny gennemgang fra 2025, der samler evidensen for Curcumin og andre polyfenoler mod mavekr\u00e6ft. Artiklen fremh\u00e6ver Curcumins evne til at h\u00e6mme spredning, inducere celled\u00f8d og blokere centrale signalveje som NF-kB og Wnt.<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Tilbage til:<\/strong> <a href=\"#skema-02\"><mark style=\"background-color:rgba(0, 0, 0, 0)\" class=\"has-inline-color has-custom-menu-links-color\">Oversigtsskema for Kosttilskud<\/mark><\/a><\/p>\n\n\n\n<h4 class=\"wp-block-heading\" id=\"resveratrol\">26. <a href=\"https:\/\/jegharkraeft.dk\/resveratrol\/\">Resveratrol<\/a><\/h4>\n\n\n\n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-f8a296fe3dbc71ebf8e06eaefbb1dcac\"><strong>Link 1:<\/strong> <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/40316059\/\" target=\"_blank\" rel=\"noopener\">Resveratrol induces ferroptosis in triple-negative breast cancer through NEDD4L-mediated GPX4 ubiquitination and degradation <\/a>(PubMed, 2025)\n<ul class=\"wp-block-list\">\n<li><strong>Relevans:<\/strong> Et nyt studie viser, at stoffet resveratrol kan dr\u00e6be de aggressive trippel-negative brystkr\u00e6ftceller (TNBC) ved at udl\u00f8se en specifik type celled\u00f8d kaldet ferroptose. Mekanismen er, at resveratrol fjerner et af kr\u00e6ftcellernes centrale forsvars-proteiner (GPX4), hvilket g\u00f8r dem s\u00e5rbare over for denne type angreb.<\/li>\n<\/ul>\n<\/li>\n\n\n\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-7668e9a8c2ad61bdd5c8c6b23de7b699\"><strong>Link 2: <\/strong><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/40458080\/\" target=\"_blank\" rel=\"noopener\">Resveratrol Downregulated PRDX4 Expression to Inhibit the Progression of Renal Cell Carcinoma via Wnt\/\u03b2-Catenin Pathway <\/a>(PubMed, 2025)\n<ul class=\"wp-block-list\">\n<li><strong>Relevans:<\/strong> Et nyt studie viser, at stoffet resveratrol h\u00e6mmer v\u00e6kst og spredning af nyrekr\u00e6ft (RCC). Mekanismen er, at resveratrol neds\u00e6tter m\u00e6ngden af proteinet PRDX4, hvilket efterf\u00f8lgende blokerer den centrale Wnt\/\u03b2-catenin-v\u00e6kstsignalvej i kr\u00e6ftcellerne.<\/li>\n<\/ul>\n<\/li>\n\n\n\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-ff424ccfc9c17301d78284d815624bed\"><strong>Link 3:<\/strong> <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/40188654\/\" target=\"_blank\" rel=\"noopener\">Resveratrol interrupts Wnt\/\u03b2-catenin signalling in cervical cancer by activating ten-eleven translocation 5-methylcytosine dioxygenase 1<\/a> (PubMed, 2025)\n<ul class=\"wp-block-list\">\n<li><strong>Relevans:<\/strong> Et nyt studie viser, at resveratrol bek\u00e6mper livmoderhalskr\u00e6ft ved at genaktivere det beskyttende, epigenetiske enzym TET1. Dette f\u00f8rer efterf\u00f8lgende til en h\u00e6mning af den overaktive Wnt\/\u03b2-catenin-v\u00e6kstsignalvej i kr\u00e6ftcellerne.<\/li>\n<\/ul>\n<\/li>\n\n\n\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-94d627e2edc15453f67f39e58e2c0ebf\"><strong>Link 4:<\/strong> <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/40022909\/\" target=\"_blank\" rel=\"noopener\">Enhancing prostate cancer cells&#8217; sensitivity to flutamide by resveratrol: An in-vitro study<\/a> (PubMed, 2025)\n<ul class=\"wp-block-list\">\n<li><strong>Relevans:<\/strong> I laboratoriefors\u00f8g med prostatakr\u00e6ftceller \u00f8gede resveratrol f\u00f8lsomheden over for hormonbehandlingen flutamid. Dette gjorde det muligt at neds\u00e6tte dosis af l\u00e6gemidlet og samtidig mindske dets bivirkninger.<\/li>\n<\/ul>\n<\/li>\n\n\n\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-56fa678d5b4bdad224c3858ef4e145ab\"><strong>Link 5:<\/strong> <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/40305947\/\" target=\"_blank\" rel=\"noopener\">Resveratrol protects against letrozole-induced renal damage in a rat model of polycystic ovary syndrome: A biochemical, histological, and immunohistochemical study<\/a> (PubMed, 2025)\n<ul class=\"wp-block-list\">\n<li><strong>Relevans:<\/strong> I en PCOS-rotte model beskytter RSV effektivt mod nyreskade for\u00e5rsaget af letrozol. Det er mere effektivt end metformin til at forbedre nyrefunktion, reducere apoptose og mindske v\u00e6vsscorpe. RSV kan derfor have potentiale som supplerende behandling mod PCOS-relaterede nyreskader, men mere forskning er n\u00f8dvendig.<\/li>\n<\/ul>\n<\/li>\n\n\n\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-d137d6ea9ce9575a5ae7a5170f192f15\"><strong>Link 6:<\/strong><a href=\"https:\/\/www.mdpi.com\/1422-0067\/22\/1\/438\" target=\"_blank\" rel=\"noopener\"> Melatonin as an Oncostatic Molecule Based on Its Anti-Estrogenic and Anti-Proliferative Actions<\/a> (MDPI, 2021)\n<ul class=\"wp-block-list\">\n<li><strong>Indhold:<\/strong> Oversigtsartikel, der validerer Melatonins Hovedstrategi (1)-status i hormonf\u00f8lsom brystkr\u00e6ft. Artiklen beskriver Melatonins v\u00e6ksth\u00e6mmende handling, herunder dets evne til at h\u00e6mme aromatase-aktivitet i brystkr\u00e6ftceller og dermed reducere \u00f8strogenbiosyntesen.<\/li>\n<\/ul>\n<\/li>\n\n\n\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-91a62d60dd4d30bdbfbcbdecf429c4dd\"><strong>Link 7:<\/strong><a href=\"https:\/\/mednexus.org\/doi\/10.1016\/j.cpt.2025.02.006\" target=\"_blank\" rel=\"noopener\"> Phytoconstituents as emerging therapeutics for breast cancer <\/a>(ScienceDirect.com, Med Nexus, 2025)\n<ul class=\"wp-block-list\">\n<li><strong>Indhold:<\/strong> En meget ny oversigtsartikel, der beskriver plantestoffer som Curcumin og Resveratrol som fremspirende terapeutiske midler mod brystkr\u00e6ft. Artiklen underst\u00f8tter synergien ved at vise, hvordan disse stoffer reducerer tumorst\u00f8rrelse, h\u00e6mmer cellemigration og undertrykker metastase.<\/li>\n<\/ul>\n<\/li>\n\n\n\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-5ae4b82a54b3823511c78a612df52b83\"><strong>Link 8:<\/strong> <a href=\"https:\/\/link.springer.com\/article\/10.1007\/s12672-025-03190-y\" target=\"_blank\" rel=\"noopener\">Therapeutic potential of natural compounds in targeting WNT, Notch, and Hedgehog signaling pathways<\/a> (Springer, 2025) \n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-f73bc3f3dc884ce8e0070d4bb445df4d\"><strong>Indhold:<\/strong> Oversigtsartikel, der beskriver, hvordan naturlige stoffer kan forstyrre de kritiske WNT, Notch og Hedgehog-signalveje. Dette underst\u00f8tter den h\u00f8je relevans for midler som Ivermectin, Resveratrol og EGCG i metaplastisk kr\u00e6ft, der er afh\u00e6ngig af stamcelle-signalering.<\/li>\n<\/ul>\n<\/li>\n\n\n\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-cdad895cc5b3818f901c0b354d31d0a2\"><strong>Link 9:<\/strong> <a href=\"https:\/\/onlinelibrary.wiley.com\/doi\/full\/10.1002\/fsn3.70829\" target=\"_blank\" rel=\"noopener\">Curcumin and Resveratrol as Dual Modulators of the STAT3 Pathway in Lung Cancer: A Comprehensive Review<\/a> (Wiley Online Library, 2025)\n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-760e54f82176ccf9c291adf0b6359a54\"><strong>Indhold:<\/strong> Oversigtsartikel, der viser, at Curcumin h\u00e6mmer STAT3-signalvejen i lungekr\u00e6ftceller, hvilket leder til en 40-60% reduktion i tumorst\u00f8rrelse og en afbrydelse af kommunikationen med tumormikromilj\u00f8et. Dette validerer Curcumins Hovedstrategi (1) mod den inflammationsdrevne KRAS-subtype.<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">Mavekr\u00e6ft: <\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-f8b1c2fb0f53353514425dc5b97ea7a1\"><strong>Link 10:<\/strong> <a href=\"https:\/\/www.mdpi.com\/1420-3049\/30\/1\/3\" target=\"_blank\" rel=\"noopener\">Resveratrol, Piceatannol, Curcumin, and Quercetin as Therapeutic Targets in Gastric Cancer<\/a> (MDPI, 2025)\n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-0bce2f2bd5d69f3d31e7e949d270aa5f\"><strong>Indhold:<\/strong> En helt ny gennemgang fra 2025, der samler evidensen for Curcumin og andre polyfenoler mod mavekr\u00e6ft. Artiklen fremh\u00e6ver Curcumins evne til at h\u00e6mme spredning, inducere celled\u00f8d og blokere centrale signalveje som NF-kB og Wnt.<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Tilbage til:<\/strong> <a href=\"#skema-02\"><mark style=\"background-color:rgba(0, 0, 0, 0)\" class=\"has-inline-color has-custom-menu-links-color\">Oversigtsskema for Kosttilskud<\/mark><\/a><\/p>\n\n\n\n<h4 class=\"wp-block-heading\" id=\"selen\">27. <a href=\"https:\/\/jegharkraeft.dk\/selen\/\">Selen<\/a><\/h4>\n\n\n\n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-805e8e93d49b79418c20b87a52d289e7\"><strong>Link 1:<\/strong> <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/40347624\/\" target=\"_blank\" rel=\"noopener\">Anticancer signal transduction pathways of selenium nanoparticles in mouse colorectal cancer model<\/a> (PubMed, 2025)\n<ul class=\"wp-block-list\">\n<li><strong>Relevans:<\/strong> Et nyt dyrestudie viser, at nanopartikler af selen (SeNPs) naturligt ophobes i tarmkr\u00e6fttumorer. Her \u00e6ndrer de kr\u00e6ftcellernes gen-udtryk, hvilket f\u00f8rer til \u00f8get anti-inflammatorisk aktivitet og markant h\u00e6mning af b\u00e5de tumorv\u00e6kst og spredning (metastase).<\/li>\n<\/ul>\n<\/li>\n\n\n\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-9188c05dfc6adbbbcefb14f712e4bb87\"><strong>Link 2:<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/40024314\/\" target=\"_blank\" rel=\"noopener\"> <\/a><\/strong><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/40024314\/\" target=\"_blank\" rel=\"noopener\">Targeting mineral metabolism in cancer: Insights into signaling pathways and therapeutic strategies<\/a> (PubMed, 2025)\n<ul class=\"wp-block-list\">\n<li><strong>Relevans:<\/strong> En ubalance i essentielle mineraler som kobber, jern, zink og selen spiller en afg\u00f8rende rolle for kr\u00e6ftudvikling, da kr\u00e6ftceller har et forstyrret stofskifte for disse stoffer. Denne ubalance skaber en s\u00e5rbarhed, der potentielt kan udnyttes til at udvikle nye, m\u00e5lrettede behandlinger og biomark\u00f8rer for diagnose.<\/li>\n<\/ul>\n<\/li>\n\n\n\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-1df896d1bc3f885be8affa22ca9738f0\"><strong>Link 3:<\/strong> <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/40199010\/\" target=\"_blank\" rel=\"noopener\">Synthesis of N-heterocyclic carbene\u2011selenium complexes modulating apoptosis and autophagy in cancer cells: Probing the interactions with biomolecules and enzymes<\/a> (PubMed, 2025)\n<ul class=\"wp-block-list\">\n<li><strong>Relevans:<\/strong> Nye, laboratorie-fremstillede stoffer, der indeholder selen (Selen-NHC), viser st\u00e6rk celledr\u00e6bende effekt mod livmoderhalskr\u00e6ftceller. De virker ved at angribe kr\u00e6ftcellen fra flere vinkler samtidigt, bl.a. ved at udl\u00f8se programmeret celled\u00f8d (apoptose), forstyrre autofagi og stoppe celledeling.<\/li>\n<\/ul>\n<\/li>\n\n\n\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-add5283916985eef66360eea7022ddc6\"><strong>Link 4: <\/strong><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/40273628\/\" target=\"_blank\" rel=\"noopener\">Anti-cancer potential of chitosan-starch selenium Nanocomposite: Targeting osteoblastoma and insights of molecular docking<\/a> (PubMed, 2025)\n<ul class=\"wp-block-list\">\n<li><strong>Relevans:<\/strong> En nyudviklet nanopartikel baseret p\u00e5 selen og chitosan viser i laboratoriefors\u00f8g en st\u00e6rk og m\u00e5lrettet effekt mod knogletumorceller (osteoblastom). Partiklen dr\u00e6ber kr\u00e6ftcellerne ved at skabe \u00f8del\u00e6ggende oxidativt stress og kan binde sig til kr\u00e6ft-specifikke proteiner i knoglev\u00e6vet.<\/li>\n<\/ul>\n<\/li>\n\n\n\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-3a05835a731dee79c4d526a5956383f7\"><strong>Link 5:<\/strong> <a href=\"https:\/\/www.spandidos-publications.com\/10.3892\/ol.2022.13407\" target=\"_blank\" rel=\"noopener\">Tumor metabolic reprogramming in lung cancer progression<\/a> (Spandidos Publications, 2022) \n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-2cc7f36316dfa232fcdbc50c930bed6c\"><strong>Indhold:<\/strong> Oversigtsartikel, der opsummerer de abnormale \u00e6ndringer i metabolismen af glukose, fedt og aminosyrer i lungekr\u00e6ft, samt de underliggende molekyl\u00e6re mekanismer.<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Tilbage til:<\/strong> <a href=\"#skema-02\"><mark style=\"background-color:rgba(0, 0, 0, 0)\" class=\"has-inline-color has-custom-menu-links-color\">Oversigtsskema for Kosttilskud<\/mark><\/a><\/p>\n\n\n\n<h4 class=\"wp-block-heading\" id=\"sort-valnoed\">28. <a href=\"https:\/\/jegharkraeft.dk\/valnoed-sort\/\">Sort Valn\u00f8d<\/a> (Juglone)<\/h4>\n\n\n\n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-0ec77552b54a13e7e32ace1216738295\"><strong>Link 1:<\/strong> <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/40178102\/\" target=\"_blank\" rel=\"noopener\">Phytomediated Chitosan-Modified TiO<sub>2<\/sub>&nbsp;NPs for Enhanced Photocatalytic and Potential Application for Breast Cancer Therapy<\/a> (PubMed, 2025)\n<ul class=\"wp-block-list\">\n<li><strong>Relevans:<\/strong> Forskere har udviklet nye nanopartikler ved hj\u00e6lp af ekstrakt fra valn\u00f8ddeblade og chitosan, som effektivt h\u00e6mmer v\u00e6ksten af hormonf\u00f8lsomme brystkr\u00e6ftceller. Partiklerne virker ved b\u00e5de at reducere de lokale \u00f8strogen-niveauer og ved at aktivere programmeret celled\u00f8d (apoptose) i kr\u00e6ftcellerne.<\/li>\n<\/ul>\n<\/li>\n\n\n\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-3bc9619e4aec3dd04f1596d3104e77b7\"><strong>Link 2:<\/strong> <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/39869626\/\" target=\"_blank\" rel=\"noopener\">Antioxidant and anti-inflammatory function of walnut green husk aqueous extract (WNGH-AE) on human hepatocellular carcinoma cells (HepG2) treated with t-BHP<\/a> (PubMed, 2025)\n<ul class=\"wp-block-list\">\n<li><strong>Relevans:<\/strong> Et vandigt ekstrakt fra gr\u00f8nne valn\u00f8ddeskaller har i et nyt laboratoriestudie vist en st\u00e6rk antioxidant og anti-inflammatorisk effekt. Ekstraktet virker ved at fjerne skadelige frie radikaler og ved at h\u00e6mme den centrale inflammations-signalvej NF-\u03baB. (Der er alts\u00e5 her tale om almindelig valn\u00f8d).<\/li>\n<\/ul>\n<\/li>\n\n\n\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-a1589a59fccbbcff2b77df77258aa45c\"><strong>Link 3:<\/strong> <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/39223184\/\" target=\"_blank\" rel=\"noopener\">Green synthesis of copper oxide nanoparticles using walnut shell and their size dependent anticancer effects on breast and colorectal cancer cell lines<\/a> (PubMed, 2024)\n<ul class=\"wp-block-list\">\n<li><strong>Relevans:<\/strong> Nye kobberoxid-nanopartikler, fremstillet ved hj\u00e6lp af valn\u00f8ddeskal-pulver, viser i laboratoriefors\u00f8g en selektiv, celledr\u00e6bende effekt p\u00e5 bryst- og tarmkr\u00e6ftceller. Partiklerne virker ved at aktivere de gener (p53 og Bax), der udl\u00f8ser programmeret celled\u00f8d (apoptose).<\/li>\n<\/ul>\n<\/li>\n\n\n\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-ef420276c95112ccab830662f1da3f2d\"><strong>Link 4:<\/strong> <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/39000038\/\" target=\"_blank\" rel=\"noopener\">Comprehensive Characterization of Phytochemical Composition, Membrane Permeability, and Antiproliferative Activity of&nbsp;<em>Juglans nigra<\/em>&nbsp;Polyphenols<\/a> (PubMed, 2024)\n<ul class=\"wp-block-list\">\n<li><strong>Relevans<\/strong>: En ny analyse af sort valn\u00f8d (<em>Juglans nigra<\/em>) bekr\u00e6fter, at dets prim\u00e6re aktive stof, Juglone, har en st\u00e6rk celledr\u00e6bende effekt p\u00e5 kr\u00e6ftceller, som er p\u00e5 niveau med standard-l\u00e6gemidler. Vigtigt er det, at laboratoriemodeller ogs\u00e5 forudsiger, at Juglone er i stand til at krydse blod-hjerne-barrieren.<\/li>\n<\/ul>\n<\/li>\n\n\n\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-b4fb62bf5cf2edb7de0e3817f34f2058\"><strong>Link 5:<\/strong> <a href=\"https:\/\/inc.nutfruit.org\/research-shows-walnuts-may-help-reduce-inflammation-and-colon-cancer-risk\/\" target=\"_blank\" rel=\"noreferrer noopener\">Research Shows Walnuts May Help Reduce Inflammation and Colon Cancer Risk<\/a> (Cancer Prevention Research, 2025)\n<ul class=\"wp-block-list\">\n<li><strong>Relevans:<\/strong> Selvom dette studie omhandler almindelige valn\u00f8dder (ikke specifikt sort valn\u00f8d), er det yderst relevant. Forskningen viser, at stoffet urolithin A, som dannes i tarmen efter indtag af valn\u00f8dder, er forbundet med sundere tarmv\u00e6v og lavere niveauer af inflammation. Dette peger p\u00e5 en mulig mekanisme for, hvordan valn\u00f8dder kan have en beskyttende effekt mod tyktarmskr\u00e6ft.<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Tilbage til:<\/strong> <a href=\"#skema-02\"><mark style=\"background-color:rgba(0, 0, 0, 0)\" class=\"has-inline-color has-custom-menu-links-color\">Oversigtsskema for Kosttilskud<\/mark><\/a><\/p>\n\n\n\n<h4 class=\"wp-block-heading\" id=\"sulforaphane\">29. <a href=\"https:\/\/jegharkraeft.dk\/sulforaphane\/\">Sulforaphane<\/a><\/h4>\n\n\n\n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-964b1ee46e432453fd563c0f73127b23\"><strong>Link 1: <\/strong><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/40157290\/\" target=\"_blank\" rel=\"noopener\">Sulforaphane downregulates mitochondrial TIGAR via inhibiting mitochondrial transmembrane assembly and LONP1\/CASP3 axis causing apoptosis<\/a> (PubMed, 2025)\n<ul class=\"wp-block-list\">\n<li><strong>Relevans:<\/strong> Et nyt studie afd\u00e6kker, hvordan sulforaphane (SFN) bek\u00e6mper ikke-sm\u00e5cellet lungekr\u00e6ft ved at fjerne det skadelige protein TIGAR fra kr\u00e6ftcellernes &#8220;energifabrikker&#8221; (mitokondrierne). SFN bruger en dobbelt-mekanisme, der b\u00e5de blokerer for, at nyt TIGAR kan komme ind, og samtidig fremmer \u00f8del\u00e6ggelsen af det, der er der i forvejen, hvilket f\u00f8rer til celled\u00f8d.<\/li>\n<\/ul>\n<\/li>\n\n\n\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-08ff3645e9203e9910ad1b34c698c807\"><strong>Link 2:<\/strong> <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/40058183\/\" target=\"_blank\" rel=\"noopener\">Exploring the broad-spectrum activity of carbohydrate-based Iberin analogues: From anticancer effect to antioxidant properties<\/a> (PubMed, 2025)\n<ul class=\"wp-block-list\">\n<li><strong>Relevans:<\/strong> Forskere har skabt nye, potente stoffer mod is\u00e6r bl\u00e6rekr\u00e6ft ved at koble sukkermolekyler p\u00e5 naturstoffet iberin (som er besl\u00e6gtet med sulforaphane). De nye forbindelser har en dobbelt effekt, da de b\u00e5de aktiverer kroppens eget antioxidant-forsvar (via Nrf2-signalvejen) og direkte h\u00e6mmer en central kr\u00e6ft-signalvej (STAT3).<\/li>\n<\/ul>\n<\/li>\n\n\n\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-e2675e3b99cec014052eae0a18fbbf6f\"><strong>Link 3:<\/strong> <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/40426874\/\" target=\"_blank\" rel=\"noopener\">Sulforaphane&#8217;s Role in Osteosarcoma Treatment: A Systematic Review and Meta-Analysis of Preclinical Studies<\/a> (PubMed, 2025)\n<ul class=\"wp-block-list\">\n<li><strong>Relevans:<\/strong> En ny oversigtsartikel fremh\u00e6ver lovende laboratoriefors\u00f8g, hvor sulforaphane (SFN) h\u00e6mmer v\u00e6kst og fremmer celled\u00f8d i knoglekr\u00e6ft (osteosarkom). P\u00e5 baggrund af dette efterlyser forskerne nu kliniske studier p\u00e5 mennesker for at bekr\u00e6fte potentialet.<\/li>\n<\/ul>\n<\/li>\n\n\n\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-b12e1d7bdef3d867c2f616683b780ec9\"><strong>Link 4:<\/strong> <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/39657365\/\" target=\"_blank\" rel=\"noopener\">Targeting p62 by sulforaphane promotes autolysosomal degradation of SLC7A11, inducing ferroptosis for osteosarcoma treatment<\/a> (PubMed, 2025)\n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-cfd329d92c3695e415b4b91079dc3b25\"><strong>Relevans:<\/strong> Et nyt studie viser, at sulforaphane (SFN) fra korsblomstrede gr\u00f8ntsager dr\u00e6ber knoglekr\u00e6ftceller (osteosarkom) ved at udl\u00f8se en specifik type celled\u00f8d kaldet ferroptose. Mekanismen er, at SFN f\u00e5r kr\u00e6ftcellen til at nedbryde et af sine egne centrale forsvars-proteiner (SLC7A1L1), hvilket g\u00f8r den s\u00e5rbar.<\/li>\n<\/ul>\n<\/li>\n\n\n\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-713bb3321df806ba3d28ad55134b30bd\"><strong>Link 5: <\/strong><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/40013196\/\" target=\"_blank\" rel=\"noopener\">Impact of Sulforaphane on Breast Cancer Progression and Radiation Therapy Outcomes: A Systematic Review<\/a> (PubMed, 2025)\n<ul class=\"wp-block-list\">\n<li><strong>Relevans:<\/strong> En ny systematisk oversigtsartikel, der samler 20 studier, bekr\u00e6fter, at sulforaphane (SFN) er yderst effektivt mod brystkr\u00e6ft. Stoffet virker ved at h\u00e6mme kr\u00e6ftcellers v\u00e6kst og spredning, fremme programmeret celled\u00f8d og samtidig beskytte raske celler under behandling.<\/li>\n<\/ul>\n<\/li>\n\n\n\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-eacb5e2338c24dbd4f8771e2479146e0\"><strong>Link 6:<\/strong><a href=\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC10052731\/\" target=\"_blank\" rel=\"noopener\"> Metabolic Reprogramming and Potential Therapeutic Targets in Lymphoma<\/a> (National Institutes of Health, 2023)\n<ul class=\"wp-block-list\">\n<li><strong>Indhold:<\/strong> En systematisk gennemgang af, hvordan lymfomceller oml\u00e6gger deres stofskifte (fokus p\u00e5 h\u00f8j glukoseoptagelse og deregulerede glykolyse-enzymer). Artiklen underbygger relevansen af at blokere glykolyse som en terapeutisk strategi, hvilket er centralt for is\u00e6r Burkitt&#8217;s Lymfom og DLBCL.<\/li>\n<\/ul>\n<\/li>\n\n\n\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-87bea419b9a0b53e7e5cc94fe7ed5d21\"><strong>Link 7:<\/strong> <a href=\"https:\/\/www.sciencedirect.com\/science\/article\/abs\/pii\/S0024320524006234\" target=\"_blank\" rel=\"noopener\">ALDH and cancer stem cells: Pathways, challenges, and therapeutic opportunities <\/a>(ScienceDirect.com, 2024) \n<ul class=\"wp-block-list\">\n<li><strong>Indhold:<\/strong> Oversigtsartikel, der beskriver ALDH-enzymerne som en central mark\u00f8r og driver for kr\u00e6ftstamceller (CSCs). Artiklen validerer, at ALDH-enheder spiller en rolle i CSC-progression og kan for\u00e5rsage resistens over for behandling.<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">Binyrebarkkr\u00e6ft:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-fc907ccd8dbf84e2491a63e0597cdf42\"><strong>Link 8:<\/strong> <a href=\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC6011061\/\" target=\"_blank\" rel=\"noopener\">Anticancer Activity of Sulforaphane: The Epigenetic Mechanisms and the Nrf2 Signaling Pathway<\/a> (National Institutes of Health, 2018) \n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-825cef1ac788d0d17076844aa5431e80\"><strong>Indhold:<\/strong> En videnskabelig oversigtsartikel, der beskriver Sulforaphanes evne til at fungere som en epigenetisk modulator. Artiklen forklarer, hvordan stoffet kan &#8220;t\u00e6nde&#8221; for slukkede gener (via DNA-metylering og histon-modificering) \u2013 en mekanisme, der er essentiel for at genoprette kontrollen i kr\u00e6ftceller, der er l\u00f8bet l\u00f8bsk.<\/li>\n<\/ul>\n<\/li>\n\n\n\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-20c1b11c8c5a599c2942881873538786\"><strong>Link 9:<\/strong> <a href=\"https:\/\/www.mdpi.com\/1422-0067\/16\/12\/26195\" target=\"_blank\" rel=\"noopener\">The Role of Sulforaphane in Epigenetic Mechanisms <\/a>(MDPI, 2015) \n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-9a71e1616436ca7ea424c0e0fee1384c\"><strong>Indhold: <\/strong>En videnskabelig gennemgang, der dokumenterer Sulforaphanes evne til at fungere som en HDAC-h\u00e6mmer. Artiklen forklarer, hvordan stoffet gennem denne mekanisme kan &#8220;t\u00e6nde&#8221; for gener, der normalt skal bremse kr\u00e6ftv\u00e6kst, men som ofte er slukket ved aggressive kr\u00e6ftformer.<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">Bl\u00e6rekr\u00e6ft og Urinvejskr\u00e6ft:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-6dbaa2d3a4f8d1e3efe17c6bd5461173\"><strong>Link 10: <\/strong><a href=\"https:\/\/www.frontiersin.org\/journals\/pharmacology\/articles\/10.3389\/fphar.2023.1254236\/full\" target=\"_blank\" rel=\"noopener\">Sulforaphane and bladder cancer: a potential novel therapeutic strategy<\/a> (Frontiers, 2023) \n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-7ced68c76d5f8d569d39c44aac3f4a56\"><strong>Indhold:<\/strong> En videnskabelig oversigtsartikel, der unders\u00f8ger Sulforaphanes potentiale i behandling af bl\u00e6rekr\u00e6ft. Artiklen beskriver, hvordan stoffet fungerer som en HDAC-h\u00e6mmer (specifikt HDAC 1, 2, 4 og 6) og derved p\u00e5virker de epigenetiske processer, der bremser kr\u00e6ftcellernes v\u00e6kst.<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">Prostatakr\u00e6ft: <\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-a24811a732ce177c20ce0ef0f70e5a3a\"><strong>Link 11:<\/strong> <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/26990292\/\" target=\"_blank\" rel=\"noopener\">Sulforaphane Inhibits c-Myc-Mediated Prostate Cancer Stem-Like Traits<\/a> (PMC &#8211; NIH, 2016)\n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-418c38a9b46eaa2b84de29553d34386e\"><strong>Indhold:<\/strong> Studie, der validerer Sulforaphanes rolle mod stamceller. Artiklen viser, at Sulforaphane h\u00e6mmer prostatakr\u00e6ftcellers stamcelle-egenskaber og virker via HDAC-h\u00e6mning og andre epigenetiske mekanismer.<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">Glioblastom:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-a804bbaf6ad4e785a4d023136f72b0b9\"><strong>Link 12:<\/strong> <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/28059653\/\" target=\"_blank\" rel=\"noopener\">Sulforaphane suppresses the growth of glioblastoma cells, glioblastoma stem cell\u2013like spheroids, and tumor xenografts through multiple cell signaling pathways<\/a> (PubMed Central, 2017)\n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-770d061bbc697597bf079609358f5cba\"><strong>Indhold:<\/strong> Studie, der validerer Sulforaphanes (1) Hovedstrategi. Det viser, at SFN er effektivt til at eliminere glioblastom-stamceller (GSCs), som er ansvarlige for tilbagefald.<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">Hjernekr\u00e6ft:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-d79cd4da3384b00a0b5ded526be7f543\"><strong>Link 13:<\/strong> <a href=\"https:\/\/www.mdpi.com\/2072-6643\/10\/11\/1755\" target=\"_blank\" rel=\"noopener\">Sulforaphane from Cruciferous Vegetables: Recent Advances to Improve Glioblastoma Treatment <\/a>(MDPI, 2018)\n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-1cbc2cce58f8f2496904a77f67622f8e\"><strong>Indhold:<\/strong> En videnskabelig gennemgang, der fremh\u00e6ver sulforaphans evne til at h\u00e6mme enzymet HDAC (histon-deacetylase). Denne mekanisme er t\u00e6t forbundet med kontrol af cellev\u00e6kst og er en n\u00f8glestrategi ved epigenetisk drevne tumorer.<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">Myelomatose\/ Knoglemarvskr\u00e6ft:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-5b9d1a41e62077243d7f0814dc20e5f9\"><strong>Link 14:<\/strong> <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/21712538\/\" target=\"_blank\" rel=\"noopener\">Anti-tumor activity and signaling events triggered by the isothiocyanates, sulforaphane and phenethyl isothiocyanate, in multiple myeloma <\/a>(National Institutes of Health, 2011) \n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-394c3ed14cf394ed42950ffcb877ea59\"><strong>Indhold:<\/strong> Et videnskabeligt studie, der demonstrerer, at Sulforaphane effektivt dr\u00e6ber myelomatoseceller \u2013 ogs\u00e5 dem, der er resistente over for standardbehandling. Artiklen viser, at stoffet virker ved at standse cellernes deling (cyklus-arrest) og fremprovokere celled\u00f8d, samt at det forst\u00e6rker effekten af andre behandlinger som bortezomib.<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">Nyrekr\u00e6ft:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-9571d4eed767a6d897734b3253b572ef\"><strong>Link 15:<\/strong> <a href=\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC9265746\/\" target=\"_blank\" rel=\"noopener\">Phytochemicals for the Prevention and Treatment of Renal Cell Carcinoma<\/a> (National Institutes of Health, 2022)\n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-2cdb9e3216bfce5c6ed1421ca1703dca\"><strong>Indhold:<\/strong> En videnskabelig oversigtsartikel, der gennemg\u00e5r planters virkning mod nyrekr\u00e6ft. Artiklen bekr\u00e6fter, at sulforaphane effektivt undertrykker kr\u00e6ftcellernes v\u00e6kst samt deres evne til at migrere og invadere omkringliggende v\u00e6v, hvilket er centralt for at modvirke metastaser.<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">Prostatakr\u00e6ft:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-623ee98c0217a5139e71eca3d3e4ae24\"><strong>Link 16: <\/strong><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/16280330\/\" target=\"_blank\" rel=\"noopener\">Sulforaphane inhibits histone deacetylase activity in BPH-1, LnCaP and PC-3 prostate epithelial cells<\/a> (Molecular Cancer Therapeutics, 2006) \n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-03412865504bd0a276bd100a97fa5719\"><strong>Indhold:<\/strong> Et studie, der viser, at sulforaphane fungerer som en HDAC-h\u00e6mmer i myelomatose. Dette hj\u00e6lper med at &#8220;rette op&#8221; p\u00e5 de epigenetiske fejl i kr\u00e6ftcellerne og g\u00f8re dem mere modtagelige for behandling.<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Tilbage til:<\/strong> <a href=\"#skema-02\"><mark style=\"background-color:rgba(0, 0, 0, 0)\" class=\"has-inline-color has-custom-menu-links-color\">Oversigtsskema for Kosttilskud<\/mark><\/a><\/p>\n\n\n\n<h4 class=\"wp-block-heading\" id=\"turkey-tail\">30. <a href=\"https:\/\/jegharkraeft.dk\/turkey-tail\/\">Turkey Tail<\/a> (Coriolus versicolor)<\/h4>\n\n\n\n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-08a970c0f8331b1d539011596af0b28f\"><strong>Link 1:<\/strong> <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/40004020\/\" target=\"_blank\" rel=\"noopener\">Enhanced Anti-Cancer Potential: Investigating the Combined Effects with&nbsp;<em>Coriolus versicolor<\/em>&nbsp;Extract and Phosphatidylinositol 3-Kinase Inhibitor (LY294002) In Vitro <\/a>(PubMed, 2025)\n<ul class=\"wp-block-list\">\n<li><strong>Relevans:<\/strong> Et nyt studie viser, at den celledr\u00e6bende effekt af svampeekstraktet Coriolus versicolor (Turkey Tail) forst\u00e6rkes markant, n\u00e5r det kombineres med en specifik PI3K-h\u00e6mmer. Kombinationen virker ved at levere en mere effektiv blokade af den centrale PI3K-v\u00e6kstsignalvej, hvilket stopper celledeling og fremmer programmeret celled\u00f8d.<\/li>\n<\/ul>\n<\/li>\n\n\n\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-a920a7b72806565575f49bdcd4657e3b\"><strong>Link 2:<\/strong> <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/39680299\/\" target=\"_blank\" rel=\"noopener\">In vitro treatment of triple-negative breast cancer cells with an extract from the Coriolus versicolor mushroom changes macrophage properties related to tumourigenesis<\/a> (PubMed, 2024)\n<ul class=\"wp-block-list\">\n<li><strong>Relevans:<\/strong> Et nyt studie viser, at svampeekstraktet Coriolus versicolor (CV) f\u00e5r brystkr\u00e6ftceller til at udsende nye signaler. Disse signaler omprogrammerer de omkringliggende immunceller (makrofager) fra at v\u00e6re &#8220;hj\u00e6lpere&#8221; for tumoren til i stedet at blive &#8220;angribere&#8221;, der aktivt bek\u00e6mper kr\u00e6ften.<\/li>\n<\/ul>\n<\/li>\n\n\n\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-0e00ace78efc104193564fa4fffe3d67\"><strong>Link 3:<\/strong> <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/39647730\/\" target=\"_blank\" rel=\"noopener\">Characterization of the three-phase partitioned laccase from Trametes versicolor strain with antiproliferative activity against breast cancer cells<\/a> (PubMed, 2025)\n<ul class=\"wp-block-list\">\n<li><strong>Relevans:<\/strong> Forskere har isoleret et specifikt enzym (laccase) fra svampen Turkey Tail (<em>Trametes versicolor<\/em>). I laboratoriefors\u00f8g viste dette rene enzym sig at have en selektiv, celledr\u00e6bende effekt p\u00e5 brystkr\u00e6ftceller, hvilket peger p\u00e5 dets potentiale som et anti-kr\u00e6ft middel.<\/li>\n<\/ul>\n<\/li>\n\n\n\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-3ba292ab155e1c403f72eb95f6c731e9\"><strong>Link 4:<\/strong> <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/38218293\/\" target=\"_blank\" rel=\"noopener\">A novel polysaccharide isolated from Coriolus versicolor polarizes M2 macrophages into an M1 phenotype and reversesits immunosuppressive effect on tumor microenvironment <\/a>(PubMed, 2024)\n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-470ba6cc7ec000f3a8b9c85308483972\"><strong>Relevans:<\/strong> Et nyt, aktivt stof (et polysakkarid kaldet CVPW-1), som er isoleret fra svampen Coriolus versicolor (Turkey Tail), har i dyrefors\u00f8g vist sig at h\u00e6mme tumorv\u00e6kst. Stoffet virker ved at omprogrammere de &#8220;d\u00e5rlige&#8221; immunceller (M2-makrofager) i en tumor til at blive &#8220;gode&#8221; M1-typer, der aktivt bek\u00e6mper kr\u00e6ften.<\/li>\n<\/ul>\n<\/li>\n\n\n\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-165c7359b79a3215aa2f647c87a1e3c4\"><strong>Link 5: <\/strong><a href=\"https:\/\/www.nature.com\/articles\/s41419-024-06641-6\" target=\"_blank\" rel=\"noopener\">Dietary factors and their influence on immunotherapy strategies in oncology: a comprehensive review<\/a> (Nature, 2024)\n<ul class=\"wp-block-list\">\n<li><strong>Indhold:<\/strong> En oversigtsartikel der beskriver, hvordan specifikke kostkomponenter (f.eks. fedtsyrer og n\u00e6ringsstoffer) kan forbedre immunterapi ved at modulere immunresponset. Artiklen er relevant, fordi den validerer, at kosttilskud (herunder turkey tail) har en immunmodulerende effekt og p\u00e5virker den inflammatoriske del af kr\u00e6ftmilj\u00f8et.<\/li>\n<\/ul>\n<\/li>\n\n\n\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-868b67bfe47104c1c281966b4458d0ed\"><strong>Link 6:<\/strong> <a href=\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC10452867\/\" target=\"_blank\" rel=\"noopener\">BRAF Mutations in Melanoma: Biological Aspects and Therapeutic Approaches<\/a> (National Institutes of Health, 2023) \n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-e064667540e39d2a1e21a14daad09eb7\"><strong>Indhold:<\/strong> Oversigtsartikel, der beskriver, at kombinationsbehandlinger sigter mod at h\u00e6mme forskellige transduktionsveje, der er kritiske for kr\u00e6ftcellers overlevelse. Dette validerer den overordnede strategi i skemaet om at angribe b\u00e5de MAPK og alternative veje for at forhindre resistens.<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Tilbage til:<\/strong> <a href=\"#skema-02\"><mark style=\"background-color:rgba(0, 0, 0, 0)\" class=\"has-inline-color has-custom-menu-links-color\">Oversigtsskema for Kosttilskud<\/mark><\/a><\/p>\n\n\n\n<h4 class=\"wp-block-heading\" id=\"vitamin-c\">31. <a href=\"https:\/\/jegharkraeft.dk\/c-vitamin-iv\/\">Vitamin C i.v. <\/a>\/ <a href=\"https:\/\/jegharkraeft.dk\/vitamin-c\/\">Vitamin C oral<\/a><\/h4>\n\n\n\n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-714a6037b9d0b331b44a5b4c588b7b3b\"><strong>Link 1:<\/strong><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/38419398\/\" target=\"_blank\" rel=\"noopener\">Vitamin C Inhibited Pulmonary Metastasis through Activating Nrf2\/HO-1 Pathway<\/a> (PubMed, 2024)\n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-38ef30bb8303530fa67ebb5d4430db5a\"><strong>Relevans:<\/strong> Studiet viste, at vitamin C kan hj\u00e6lpe med at forhindre spredning af lungekr\u00e6ft i mus. Intraven\u00f8s vitamin C \u00f8ger cellestress og d\u00f8delighed via DNA-skader, mens oral vitamin C aktiverer p53 og beskytter mod metastase. Begge metoder h\u00e6mmer kr\u00e6ftcellev\u00e6kst og spredning uden at skade normale celler. Resultaterne \u00e5bner muligheder for at bruge vitamin C i behandling af lungekr\u00e6ft.<\/li>\n<\/ul>\n<\/li>\n\n\n\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-934ade5c059b05a192cde29d39252f79\"><strong>Link 2:<\/strong> <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/31623675\/\" target=\"_blank\" rel=\"noopener\">Oral vitamin C supplementation to patients with myeloid cancer on azacitidine treatment: Normalization of plasma vitamin C induces epigenetic changes <\/a>(PubMed, 2019)\n<ul class=\"wp-block-list\">\n<li><strong>Relevans:<\/strong> I en lille unders\u00f8gelse fik patienter med blodkr\u00e6ft oral vitamin C (500 mg dagligt), hvilket genoprettede lave vitamin C-niveauer og \u00f8gede aktiv DNA-\u00e6ndring (5hmC\/5mC-ratio). Dette kan potentielt forbedre kr\u00e6ftbehandlingen, men st\u00f8rre studier er n\u00f8dvendige for at bekr\u00e6fte effekten.<\/li>\n<\/ul>\n<\/li>\n\n\n\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-d81166d7f03f7d865db374cc6cbcdef0\"><strong>Link 3:<\/strong> <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/40118136\/\" target=\"_blank\" rel=\"noopener\">Vitamin C and D do not increase the chemopreventive effect of aspirin on colon carcinogenesis in a mouse model<\/a> (PubMed, 2025)\n<ul class=\"wp-block-list\">\n<li><strong>Relevans:<\/strong> <strong>Studiet viste, at aspirin effektivt reducerede forstadier til colonkr\u00e6ft hos mus, is\u00e6r ved at mindske oxidative stress og DNA-skader. Vitaminer C og D blev givet oralt, men de forbedrede ikke effekten af aspirin. Vitamin D alene mindskede ogs\u00e5 kr\u00e6ftforstadier, mens vitamin C havde begr\u00e6nset effekt. Samlet set gav vitaminerne ikke ekstra beskyttelse ud over aspirin.<\/strong><\/li>\n<\/ul>\n<\/li>\n\n\n\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-2769636855c6026b1e29122b7b2268c9\"><strong>Link 4: <\/strong><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/39990670\/\" target=\"_blank\" rel=\"noopener\">High-dose Ascorbate Exhibits Anti-proliferative and Anti-invasive Effects Dependent on PTEN\/AKT\/mTOR Pathway in Endometrial Cancer&nbsp;<em>in vitro<\/em>&nbsp;and&nbsp;<em>in vivo<\/em><\/a> (PubMed, 2925)\n<ul class=\"wp-block-list\">\n<li><strong>Relevans: <\/strong>H\u00f8jdosis C-vitamin (ascorbate), givet enten oralt eller via injektion, viste sig at h\u00e6mme v\u00e6kst og spredning af livmodercancer hos mus ved at forstyrre cellecyklus, \u00f8ge cellestress og DNA-skader samt fremme celled\u00f8d. Kombineret med kemoterapi (paclitaxel) virkede det endnu bedre. Resultaterne tyder p\u00e5, at h\u00f8jdosis C-vitamin kan v\u00e6re en lovende behandling, is\u00e6r sammen med paclitaxel, og b\u00f8r unders\u00f8ges n\u00e6rmere i kliniske fors\u00f8g.<\/li>\n<\/ul>\n<\/li>\n\n\n\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-c3801b64b056990a4ccc530d99f91386\"><strong>Link 5:<\/strong> <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/39411937\/\" target=\"_blank\" rel=\"noopener\">Potentiation of Tumor Hallmarks by the Loss of GULO, a Vitamin C Biosynthesis Gene in Humans<\/a> (PubMed, 2024)\n<ul class=\"wp-block-list\">\n<li><strong>Relevans:<\/strong> Mennesker kan ikke selv lave vitamin C p\u00e5 grund af manglen p\u00e5 genet GULO, hvilket kan \u00f8ge kr\u00e6ftrisiko. Mangel p\u00e5 vitamin C kan fremme tumorv\u00e6kst, spredning og behandlingsresistens. Derfor er det vigtigt at unders\u00f8ge, hvordan tilstr\u00e6kkeligt vitamin C kan forbedre kr\u00e6ftbehandling, og behovet for mere forskning i vitamin C som adjuvans.<\/li>\n<\/ul>\n<\/li>\n\n\n\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-1bade76f1bffdc0086596d1edaf4335d\"><strong>Link 6:<\/strong> <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/39039956\/\" target=\"_blank\" rel=\"noopener\">Association between dietary vitamin C intake\/blood level and risk of digestive system cancer: a systematic review and meta-analysis of prospective studies<\/a> (PubMed, 2024)\n<ul class=\"wp-block-list\">\n<li><strong>Relevans:<\/strong> En stor gennemgang viste, at h\u00f8jere indtag af vitamin C kan reducere risikoen for visse mave-tarmkr\u00e6ftformer, is\u00e6r i hals, sv\u00e6lg, mave og colon. Vitamin C kan is\u00e6r beskytte mod hals-, sv\u00e6lg-, og mavekr\u00e6ft, mens blodniveauer af vitamin C kun var knyttet til lavere risiko for mavekr\u00e6ft. Mere forskning er n\u00f8dvendig for at bekr\u00e6fte disse resultater.<\/li>\n<\/ul>\n<\/li>\n\n\n\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-b0e0c1ed27d2622f20fd6199bfd92176\"><strong>Link 7: <\/strong><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/37888131\/\" target=\"_blank\" rel=\"noopener\">The Role of Vitamins in Oral Potentially Malignant Disorders and Oral Cancer: A Systematic Review<\/a> (PubMed, 2023)\n<ul class=\"wp-block-list\">\n<li><strong>Relevans:<\/strong> Unders\u00f8gelsen viste, at visse vitaminer, is\u00e6r vitamin C, D, A og K, kan have gavnlige virkninger p\u00e5 orale forstadier og kr\u00e6ft. Resultaterne er blandede, men nogle studier tyder p\u00e5, at vitamintilskud kan hj\u00e6lpe med behandling. Mere ensartet forskning er n\u00f8dvendig for at fastsl\u00e5 effektiviteten.<\/li>\n<\/ul>\n<\/li>\n\n\n\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-94873b0c7e34da574b1831b6bd25e11d\"><strong>Link 8:<\/strong> <a href=\"https:\/\/www.sciencedirect.com\/science\/article\/pii\/S2352304225002314\" target=\"_blank\" rel=\"noopener\">High-dose vitamin C: A promising anti-tumor agent, insight into mechanisms and clinical applications<\/a> (ScienceDirect.com, 2025) \n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-adb6179c9cb865ce1947e1707c139434\"><strong>Indhold:<\/strong> Oversigtsartikel, der beskriver, at h\u00f8j-dosis C-vitamin h\u00e6mmer tumorv\u00e6kst i modeller for KRAS og BRAF mutant tarmkr\u00e6ft uden at p\u00e5virke normale celler. Dette validerer Hovedstrategi (1) for tarmkr\u00e6ft.<\/li>\n<\/ul>\n<\/li>\n\n\n\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-c6d19d31cbf56d0541e0898b64ac0e01\"><strong>Link 9:<\/strong> <a href=\"https:\/\/ascopubs.org\/doi\/10.1200\/JCO.2025.43.16_suppl.e15567\" target=\"_blank\" rel=\"noopener\">Role of high-dose vitamin C as adjunct treatment in gastric and colorectal cancers: A systematic review<\/a> (ASCO Publications, 2025) \n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-ff30047519abfb1ac4ca4919bba05d91\"><strong>Indhold:<\/strong> Systematisk review, der diskuterer H\u00f8j-dosis Vitamin C&#8217;s potentiale til at h\u00e6mme kr\u00e6ftcellev\u00e6kst i tarmkr\u00e6ft. Dette underst\u00f8tter strategien med at bruge oxidativt stress som Hovedstrategi (1) mod den s\u00e5rbare MSI-H-subtype.<\/li>\n<\/ul>\n<\/li>\n\n\n\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-87a18b5d90256769aac37095fdf6d932\"><strong>Link 10:<\/strong> <a href=\"https:\/\/www.cell.com\/cell\/fulltext\/S0092-8674(17)30868-1\" target=\"_blank\" rel=\"noopener\">Restoration of TET2 Function Blocks Aberrant Self-Renewal and Leukemia Progression<\/a> (Cell Press, 2017)\n<ul class=\"wp-block-list\">\n<li><strong>Indhold:<\/strong> Et markant studie der viser, hvordan C-vitamin fungerer som en n\u00f8dvendig &#8220;kontakt&#8221; for TET2-enzymet. Studiet p\u00e5viser, at h\u00f8je doser C-vitamin kan genoprette funktionen i kr\u00e6ftceller med TET2-mutationer, hvilket f\u00e5r dem til at stoppe deres ukontrollerede v\u00e6kst og d\u00f8 naturligt (apoptose).<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">Binyrebarkkr\u00e6ft:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-ee0b22c0db6c23511c1d85c0fdb0dac1\"><strong>Link 11:<\/strong><a href=\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC6526932\/\" target=\"_blank\" rel=\"noopener\">Targeting cancer vulnerabilities with high-dose vitamin C<\/a> (National Institutes of Health, 2019)\n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-2c19569aa2f3f4c41e808b6ef9ca7727\"><strong>Indhold:<\/strong> En videnskabelig oversigtsartikel, der beskriver, hvordan h\u00f8je doser C-vitamin udnytter specifikke svagheder hos kr\u00e6ftceller. Artiklen forklarer, at behandlingen rammer cellernes ilt-sensorer (HIF) og forstyrrer deres sukkerstofskifte, hvilket stresser aggressive kr\u00e6ftceller, der er st\u00e6rkt afh\u00e6ngige af disse mekanismer for at overleve.<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">Blodkr\u00e6ft:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-91a5ebf10171012f09aff7d226291713\"><strong>Link 12:<\/strong><a href=\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC10685150\/\" target=\"_blank\" rel=\"noopener\">Vitamin C and D supplementation in acute myeloid leukemia<\/a> (National Institutes of Health, 2023)\n<ul class=\"wp-block-list\">\n<li><strong>Indhold:<\/strong> Et klinisk studie fra 2023, der unders\u00f8ger effekten af tilskud med C- og D-vitamin hos patienter med akut myeloid leuk\u00e6mi (AML) under intensiv kemoterapi. Resultaterne indikerer, at tilskuddene er sikre og kan have en positiv indflydelse p\u00e5 behandlingsudfaldet.<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">Tarmkr\u00e6ft:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-f8336fd5ead9bcf04ee2a7b2f919dbd3\"><strong>Link 13:<\/strong> <a href=\"https:\/\/www.sciencedirect.com\/science\/article\/pii\/S2213231725002393\" target=\"_blank\" rel=\"noopener\">High-dose vitamin C as a targeted treatment for KRAS and BRAF mutant colorectal cancer cells<\/a> (ScienceDirect, 2025)\n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-21e8ff29b9a2ed405e5ae14fe1f3b59d\"><strong>Indhold:<\/strong> Et studie fra 2025, der bekr\u00e6fter og bygger videre p\u00e5 strategien om at bruge h\u00f8jdosis C-vitamin mod KRAS- og BRAF-muteret tarmkr\u00e6ft. Forskningen underbygger, hvordan behandlingen specifikt udnytter de metaboliske s\u00e5rbarheder, som disse mutationer skaber i kr\u00e6ftcellerne.<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">Nyrekr\u00e6ft:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-fe1dd04177b3ec3c9ca5790db85cabfe\"><strong>Link 14:<\/strong> <a href=\"https:\/\/onlinelibrary.wiley.com\/doi\/10.1155\/2019\/7286737\" target=\"_blank\" rel=\"noopener\">Pro- and Antioxidant Effects of Vitamin C in Cancer in correspondence to Its Dietary and Pharmacological Concentrations<\/a> (Wiley Online Library, 2019)\n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-9c010674fc279150a170772689c4a4c5\"><strong>Indhold:<\/strong> En videnskabelig gennemgang, der dokumenterer C-vitamins virkningsmekanismer i kr\u00e6ftbehandling. Artiklen bekr\u00e6fter specifikt, at C-vitamin inducerer nedbrydning af faktoren HIF-1\\alpha, hvilket er afg\u00f8rende for at fjerne det overlevelsesgrundlag, som kr\u00e6ftceller (is\u00e6r ved nyrekr\u00e6ft) er afh\u00e6ngige af under iltfattige forhold.<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n\n\n\n<h4 class=\"wp-block-heading\" id=\"vitamin-d\">32. <a href=\"https:\/\/jegharkraeft.dk\/vitamin-d\/\">Vitamin D<\/a><\/h4>\n\n\n\n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-b1e2b9bfef59b2d7e0416928a9d78ccc\"><strong>Link 1: <\/strong><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/40194750\/\" target=\"_blank\" rel=\"noopener\">Vitamin D: What role in obesity-related cancer?<\/a> (PubMed, 2025)\n<ul class=\"wp-block-list\">\n<li><strong>Relevans:<\/strong> Selvom D-vitamin kan modvirke mange af de kr\u00e6ftfremmende effekter, der er forbundet med fedme (s\u00e5som inflammation og insulinresistens), begr\u00e6nses dets beskyttende virkning. Dette skyldes, at overskydende fedtv\u00e6v binder og &#8220;fanger&#8221; D-vitaminet, hvilket neds\u00e6tter dets tilg\u00e6ngelighed i kroppen.<\/li>\n<\/ul>\n<\/li>\n\n\n\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-2f142938352ce473e0b4fd56fed90c28\"><strong>Link 2:<\/strong> <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/40465178\/\" target=\"_blank\" rel=\"noopener\">The genetic landscape of CYP24A1 polymorphisms in cancer risk: evidence from a systematic review<\/a> (PubMed, 2025)\n<ul class=\"wp-block-list\">\n<li><strong>Relevans:<\/strong> If\u00f8lge en ny, stor oversigtsartikel er genetiske variationer i det D-vitamin-oms\u00e6ttende gen CYP24A1 direkte forbundet med en persons risiko for at udvikle kr\u00e6ft. Afh\u00e6ngigt af den specifikke gen-variant kan en person have enten en forh\u00f8jet eller nedsat risiko for at udvikle bl.a. bryst-, prostata- og skjoldbruskkirtelkr\u00e6ft.<\/li>\n<\/ul>\n<\/li>\n\n\n\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-864dde448a87006208ffcf1b0fb7e67c\"><strong>Link 3:<\/strong> <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/40465176\/\" target=\"_blank\" rel=\"noopener\">Beneficial health effects of ultraviolet radiation: expert review and conference report<\/a> (PubMed, 2025)\n<ul class=\"wp-block-list\">\n<li><strong>Relevans:<\/strong> En ny ekspertgennemgang udfordrer de restriktive sol-anbefalinger og fremh\u00e6ver, at sollys&#8217; mange sundhedsfordele ud over D-vitamin-dannelse (f.eks. lavere blodtryk) er forbundet med en l\u00e6ngere samlet levetid. Forskerne efterlyser en bedre balance mellem advarslerne mod hudkr\u00e6ft og solens dokumenterede, positive effekter i de officielle sundhedsr\u00e5d.<\/li>\n<\/ul>\n<\/li>\n\n\n\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-e2b4ab43f1dbb138b51f884366576fa9\"><strong>Link 4:<\/strong> <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/40096917\/\" target=\"_blank\" rel=\"noopener\">The effect of vitamin D supplementation on cancer incidence in the randomised controlled D-Health Trial: Implications for policy and practice<\/a> (PubMed, 2025)\n<ul class=\"wp-block-list\">\n<li><strong>Relevans:<\/strong> Et stort, nyt studie med over 21.000 deltagere bekr\u00e6fter, at tilskud med D-vitamin ikke forhindrer, at man udvikler kr\u00e6ft. Da D-vitamin vides at neds\u00e6tte <em>d\u00f8deligheden<\/em> af kr\u00e6ft, konkluderer forskerne, at den gavnlige effekt i stedet m\u00e5 skyldes en forbedret overlevelse, <em>efter<\/em> diagnosen er stillet.<\/li>\n<\/ul>\n<\/li>\n\n\n\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-adb44a13fe51e0bb6b54416f00876e11\"><strong>Link 5:<\/strong> <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/40446866\/\" target=\"_blank\" rel=\"noopener\">Ferroptosis induction, androgen biosynthesis disruption and prostate cancer suppression by androgen and vitamin D combination<\/a> (PubMed, 2015)\n<ul class=\"wp-block-list\">\n<li><strong>Relevans:<\/strong> En lav, sikker dosis aktivt D-vitamin (calcitriol), der er virkningsl\u00f8s alene, bliver en potent kr\u00e6fth\u00e6mmer mod resistent prostatakr\u00e6ft (CRPC), n\u00e5r den kombineres med et normalt niveau af mandligt k\u00f8nshormon. Kombinationen virker ved b\u00e5de at tvinge kr\u00e6ftcellen til at nedbryde sit eget br\u00e6ndstof (androgener) og ved at udl\u00f8se en specifik type celled\u00f8d kaldet ferroptose.<\/li>\n<\/ul>\n<\/li>\n\n\n\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-d69c190b3a0a35d15839b7e1b326e7a3\"><strong>Link 6:<\/strong> <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/40429656\/\" target=\"_blank\" rel=\"noopener\">Vitamin D and Immune Checkpoint Inhibitors in Lung Cancer: A Synergistic Approach to Enhancing Treatment Efficacy<\/a> (PubMed, 2025)\n<ul class=\"wp-block-list\">\n<li><strong>Relevans:<\/strong> D-vitamin viser et betydeligt potentiale til at forbedre effekten af immunterapi (ICI&#8217;er) mod lungekr\u00e6ft. Det virker ved at regulere immunforsvaret og d\u00e6mpe inflammation direkte i tumorens mikromilj\u00f8, hvilket kan overvinde resistens og forst\u00e6rke behandlingen.<\/li>\n<\/ul>\n<\/li>\n\n\n\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-2e66f3911ebe73611fb97c0898743fcf\"><strong>Link 7:<\/strong><a href=\"https:\/\/onkologisktidsskrift.dk\/behandlinger\/3344-forskere-fastslar-sammenhaeng-mellem-d-vitamin-og-kraeft.html\" target=\"_blank\" rel=\"noopener\"> Forskere fastsl\u00e5r sammenh\u00e6ng mellem D-vitamin og kr\u00e6ft<\/a> (Onkologisk Tidsskrift, 2024)\n<ul class=\"wp-block-list\">\n<li><strong>Relevans:<\/strong> Et stort, dansk-ledet studie, baseret p\u00e5 data fra 1,5 millioner danskere, bekr\u00e6fter en klar sammenh\u00e6ng mellem lavt D-vitamin og \u00f8get kr\u00e6ftrisiko. Studiet viser som noget nyt, at D-vitamins positive effekt sandsynligvis skyldes dets evne til at p\u00e5virke tarmfloraen og dermed styrke kroppens immunrespons mod kr\u00e6ft.<\/li>\n<\/ul>\n<\/li>\n\n\n\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-025a7d5e64702de1ebe22c49bbfd1dad\"><strong>Link 8:<\/strong> <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/41006934\/\" target=\"_blank\" rel=\"noopener\">Therapeutic implications of vitamin D in leukemia<\/a> (National Institutes of Health, 2025) \n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-a8c0aaf3152aa3f7796df1b9f3463992\"><strong>Indhold:<\/strong> En ny oversigtsartikel, der beskriver den terapeutiske relevans af D-vitamin i abnorme blodceller (h\u00e6matologiske maligniteter). Artiklen underst\u00f8tter skemaets h\u00f8je relevans ved at vise, at D-vitamin fremmer celled\u00f8d, stimulerer differentiering og h\u00e6mmer proliferation.<\/li>\n<\/ul>\n<\/li>\n\n\n\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-9beaa517bf7f9eea329fbd8766b81ed9\"><strong>Link 9:<\/strong> <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/36308576\/\" target=\"_blank\" rel=\"noopener\">Role of vitamin D in targeting cancer and cancer stem cell progression<\/a> (National Institutes of Health, 2022) \n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-8f8d136292a1bb6744747fce833aa4e5\"><strong>Indhold:<\/strong> Oversigtsartikel, der unders\u00f8ger D-vitamins terapeutiske effekt og dets molekyl\u00e6re processer i m\u00e5lretning af kr\u00e6ftstamceller. Artiklen underst\u00f8tter den h\u00f8je relevans ved at vise, hvordan D-vitamin bidrager til at tvinge stamceller til differentiering og neds\u00e6tter proliferation.<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">Hudkr\u00e6ft:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-131891fc5586aef9caadd79c5c674ee0\"><strong>Link 10:<\/strong> <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/39740829\/\" target=\"_blank\" rel=\"noopener\">Malignant Melanoma: Vitamin D Status as a Risk and Prognostic Factor<\/a> (PubMed, 2025) \n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-22a153e8a0f52707407fb129eb7913ce\"><strong>Indhold:<\/strong> En omfattende meta-analyse fra december 2024, der bekr\u00e6fter en klar sammenh\u00e6ng: Lave niveauer af D-vitamin er forbundet med b\u00e5de en \u00f8get risiko for at udvikle moderm\u00e6rkekr\u00e6ft og en d\u00e5rligere prognose for patienter, der allerede har sygdommen. Studiet understreger vitaminets tumor-beskyttende rolle.<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">Blodkr\u00e6ft:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-86c38a307153cc097b2ebd7475458121\"><strong>Link 11:<\/strong> <a href=\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC10685150\/\" target=\"_blank\" rel=\"noopener\">Vitamin C and D supplementation in acute myeloid leukemia<\/a> (National Institutes of Health, 2023) \n<ul class=\"wp-block-list\">\n<li class=\"has-custom-sort-tekst-color has-text-color has-link-color wp-elements-9bebf87fc2a57cf0e121eec60b453e43\"><strong>Indhold:<\/strong> Et klinisk studie fra 2023, der unders\u00f8ger effekten af tilskud med C- og D-vitamin hos patienter med akut myeloid leuk\u00e6mi (AML) under intensiv kemoterapi. Resultaterne indikerer, at tilskuddene er sikre og kan have en positiv indflydelse p\u00e5 behandlingsudfaldet.<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\"><\/p>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<p class=\"has-custom-menu-links-color has-text-color has-link-color wp-elements-78958270cc4840b7bdca48105c79180e wp-block-paragraph\"><strong><a href=\"#menu\" data-type=\"internal\" data-id=\"#diagnose\">(Til menu)<\/a><\/strong><\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Siden er oprettet: <\/strong><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">d. 10.06.25, senest revideret d. 01.12.25<\/p>\n\n\n\n<p class=\"has-text-align-center wp-block-paragraph\"><mark style=\"background-color:rgba(0, 0, 0, 0)\" class=\"has-inline-color has-custom-menu-links-color\">\u2764<\/mark><\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Hvad du l\u00e6ser p\u00e5 <\/strong><em><strong>Jeg har Kr\u00e6ft<\/strong><\/em><strong> er ikke en anbefaling. S\u00f8g kompetent vejledning.<\/strong><\/p>\n<\/div>\n<\/div>\n<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_83 counter-hierarchy ez-toc-counter ez-toc-grey ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<p class=\"ez-toc-title\" style=\"cursor:inherit\">Indhold<\/p>\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"Toggle Table of Content\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Toggle<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewBox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewBox=\"0 0 24 24\" version=\"1.2\" baseProfile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1 ' ><ul class='ez-toc-list-level-2' ><li class='ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/jegharkraeft.dk\/en\/tarmkraeft-metabolisk-blokering\/#Behandlinger\" >Behandlinger<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-1'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/jegharkraeft.dk\/en\/tarmkraeft-metabolisk-blokering\/#Tarmkraeft_%E2%80%93_skemaoversigt_Metabolisk_strategi_mod_kraeft_%E2%80%93_Pathways_blokering\" >Tarmkr\u00e6ft &#8211; skemaoversigt Metabolisk strategi mod kr\u00e6ft &#8211; Pathways blokering<\/a><ul class='ez-toc-list-level-2' ><li class='ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/jegharkraeft.dk\/en\/tarmkraeft-metabolisk-blokering\/#Tarmkraeft_%E2%80%93_Oversigt\" >Tarmkr\u00e6ft &#8211; Oversigt<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/jegharkraeft.dk\/en\/tarmkraeft-metabolisk-blokering\/#Metaboliske_strategier_ved_Tarmkraeft\" >Metaboliske strategier ved Tarmkr\u00e6ft<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/jegharkraeft.dk\/en\/tarmkraeft-metabolisk-blokering\/#Tarmkraeft_%E2%80%93_Bloker_Pathways\" >Tarmkr\u00e6ft &#8211; Bloker Pathways<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/jegharkraeft.dk\/en\/tarmkraeft-metabolisk-blokering\/#Om_kraeft_i_tarmsystemet_%E2%80%93_typer\" >Om kr\u00e6ft i tarmsystemet &#8211; typer<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-7\" href=\"https:\/\/jegharkraeft.dk\/en\/tarmkraeft-metabolisk-blokering\/#Metabolisk_strategi_Oversigt_1_%E2%80%93_Laegemidler\" >Metabolisk strategi Oversigt 1 &#8211; L\u00e6gemidler<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-8\" href=\"https:\/\/jegharkraeft.dk\/en\/tarmkraeft-metabolisk-blokering\/#Oversigt_over_metabolisk_strategi_%E2%80%93_Laegemidler\" >Oversigt over metabolisk strategi &#8211; L\u00e6gemidler<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-9\" href=\"https:\/\/jegharkraeft.dk\/en\/tarmkraeft-metabolisk-blokering\/#Oversigt_1_Repurposed_Drugs\" >Oversigt 1: Repurposed Drugs<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-10\" href=\"https:\/\/jegharkraeft.dk\/en\/tarmkraeft-metabolisk-blokering\/#Metabolisk_strategi_Kosttilskud_Oversigt_2\" >Metabolisk strategi Kosttilskud Oversigt 2<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-11\" href=\"https:\/\/jegharkraeft.dk\/en\/tarmkraeft-metabolisk-blokering\/#Oversigt_over_metabolisk_strategi_%E2%80%93_Kosttilskud\" >Oversigt over metabolisk strategi &#8211; Kosttilskud<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-12\" href=\"https:\/\/jegharkraeft.dk\/en\/tarmkraeft-metabolisk-blokering\/#Oversigt_2_Kosttilskud\" >Oversigt 2: Kosttilskud<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-13\" href=\"https:\/\/jegharkraeft.dk\/en\/tarmkraeft-metabolisk-blokering\/#Metaboliske_strategier_Links\" >Metaboliske strategier Links<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-14\" href=\"https:\/\/jegharkraeft.dk\/en\/tarmkraeft-metabolisk-blokering\/#Links\" >Links<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-15\" href=\"https:\/\/jegharkraeft.dk\/en\/tarmkraeft-metabolisk-blokering\/#Repurposed_drugs\" >Repurposed drugs<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-16\" href=\"https:\/\/jegharkraeft.dk\/en\/tarmkraeft-metabolisk-blokering\/#Kosttilskud\" >Kosttilskud<\/a><\/li><\/ul><\/li><\/ul><\/li><\/ul><\/nav><\/div>\n","protected":false},"excerpt":{"rendered":"<p>Behandlinger Bloker kr\u00e6ftens v\u00e6kstveje Tarmkr\u00e6ft &#8211; skemaoversigtMetabolisk strategi mod kr\u00e6ft &#8211; Pathways blokering OBS.: For at se alt indhold i skemaet, skal der swipes\/scrolles til h\u00f8jre. (Der er desuden mange r\u00e6kker). Indhold: Kort resum\u00e9 om Metabolisk tilgang Dette er en side, der giver overblik over hvilke strategier der kan v\u00e6re hensigtsm\u00e6ssige, hvis man vil udfordre [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":24821,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"inline_featured_image":false,"_lmt_disableupdate":"no","_lmt_disable":"","footnotes":""},"categories":[109,18,174],"tags":[],"class_list":["post-24818","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-beslutning-om-behandling","category-behandlinger","category-metabolisk-strategi"],"modified_by":"Hanne","wpml_current_locale":"da_DK","wpml_translations":[],"_links":{"self":[{"href":"https:\/\/jegharkraeft.dk\/en\/wp-json\/wp\/v2\/posts\/24818","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/jegharkraeft.dk\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/jegharkraeft.dk\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/jegharkraeft.dk\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/jegharkraeft.dk\/en\/wp-json\/wp\/v2\/comments?post=24818"}],"version-history":[{"count":0,"href":"https:\/\/jegharkraeft.dk\/en\/wp-json\/wp\/v2\/posts\/24818\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/jegharkraeft.dk\/en\/wp-json\/wp\/v2\/media\/24821"}],"wp:attachment":[{"href":"https:\/\/jegharkraeft.dk\/en\/wp-json\/wp\/v2\/media?parent=24818"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/jegharkraeft.dk\/en\/wp-json\/wp\/v2\/categories?post=24818"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/jegharkraeft.dk\/en\/wp-json\/wp\/v2\/tags?post=24818"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}